# Chapter 145: Personality Change Due to Another Medical Condition

## **Chapter 7: The Biological and Neurological Basis of Personality Change Due to Another Medical Condition**

### Introduction

Personality, the intricate tapestry of enduring patterns of thinking, feeling, and behaving that characterizes an individual, has long been considered a stable psychological construct. However, clinical practice has consistently demonstrated that profound and persistent changes in personality can emerge as a direct pathophysiological consequence of a medical condition. This phenomenon, recognized as Personality Change Due to Another Medical Condition, represents a critical intersection of neurology, psychiatry, and biology. It challenges the traditional separation of mind and body, positing that the very essence of self can be altered by physiological disturbances affecting the central nervous system. Understanding the biological and neurological underpinnings of this condition is paramount for accurate diagnosis, effective management, and the development of targeted therapeutic interventions.

From a biological perspective, personality is not an ephemeral concept but rather a complex phenotype, representing the set of observable characteristics of an individual that result from the interaction of their genotype with the environment (Marks, 2024). These traits are considered aspects of an organism's developmental pattern (Dobzhansky, 1956), with stable individual characteristics deriving substantially from an individual's unique genetic endowment (Bisova & Bysova, 2019; Unknown, 2020). A medical condition can be viewed as a significant environmental or internal disruption that alters the physiological landscape, thereby modifying this genotype-phenotype interaction. The resulting changes can manifest behaviorally, leading to what is clinically observed as a personality change. Indeed, some conditions are known to cause "painful changes in the personality structure," which lead to a violation of its holistic integrity (Alexeeva & Mindubaeva, 2024).

The core thesis of this chapter is that the mechanisms driving personality change are not unique to this condition but are rooted in fundamental biological processes that govern cellular function, tissue homeostasis, and organismal adaptation. Pathological processes seen in a wide array of medical conditions—from oncogenesis and metabolic disorders to neurodegeneration and inflammatory diseases—provide a powerful framework for understanding how the brain's structure and function can be pathologically remodeled. These processes include genetic mutations, epigenetic modifications, altered gene expression profiles, disruptions in signaling pathways, and changes in cellular composition and connectivity. By examining these mechanisms in other medical contexts, we can construct a robust, evidence-based model for the biological basis of personality change.

This chapter will systematically explore the biological and neurological foundations of Personality Change Due to Another Medical Condition. We will begin by examining the large-scale neurobiological systems implicated, including neurotransmitter pathways and neural circuits. Subsequently, we will delve into the genetic and molecular basis, exploring how heritable factors, de novo mutations, and epigenetic modifications can confer vulnerability or directly cause alterations in brain function. We will then review findings related to brain structure and function, drawing parallels from various disease models to illustrate how pathological changes can impact neural substrates of behavior. The chapter will also consider the developmental aspects, the biological basis of potential treatments, and future directions for research. Throughout this exploration, we will draw upon a diverse body of evidence demonstrating that personality, far from being immutable, is a dynamic biological state susceptible to the profound influence of systemic medical illness.

### Neurobiological Systems

The brain functions through the coordinated activity of intricate neurobiological systems, including neurotransmitter networks, neurotrophic signaling pathways, and complex neural circuits. Disruption of these systems by a medical condition is a primary mechanism through which personality change can manifest. The motivation for changing from one behavior to another has clear physiological underpinnings (Broom & Fraser, 2015), and when these physiological factors are pathologically altered, the resulting behavioral shifts can be profound.

**Neurotransmitter and Neuromodulatory Systems**

Neurotransmitter systems are fundamental to mood, cognition, and behavior. Polymorphisms in genes that regulate these systems, such as the serotonin transporter gene, are recognized as predisposing factors for various behavioral disorders (Ali, 2008). Similarly, neuromodulators that act on these systems, such as antibodies to dopamine, can significantly alter behavioral responses (Евсеев, 2003; Vetrilé et al., 2002). Therefore, any medical condition that alters the synthesis, release, reuptake, or receptor binding of key neurotransmitters like serotonin, dopamine, or norepinephrine can logically be expected to impact personality-related domains such as affect regulation, impulse control, and social behavior.

The opioid system is another critical modulator of emotion and behavior. Opiate receptors are central to the pharmacological functions of many analgesic drugs (Law & Loh, 2001), and naturally occurring opioids have a unique primary structure that determines their biological specificity (Usenko et al., 2002). Some synthetic peptides possess potent morphine-like properties (Baxter et al., 1977). Medical conditions that cause chronic pain or inflammation can lead to endogenous changes in the opioid system, potentially contributing to the apathy, irritability, or anhedonia seen in some personality change syndromes. Furthermore, chronic exposure to opioid drugs, often used to treat medical conditions, is known to alter neurons in specific brain areas, partly through modulation of neurotrophic factors (Stern, 2009).

**Neurotrophic Factors and Neuronal Plasticity**

Neurotrophic factors are essential for neuronal survival, development, and plasticity. Brain-derived neurotrophic factor (BDNF) is a key molecule in this regard, with a gene structure that includes multiple promoters driving the expression of diverse transcripts, allowing for complex regulation of its function (You et al., 2023; Hobbs et al., 2017). BDNF is deeply involved in neuronal plasticity and has been implicated as a peripheral marker for the action of antidepressants (Kim & Lee, 2007). Its role in modulating neuronal properties following chronic drug exposure highlights how systemic factors can induce lasting changes in brain function (Stern, 2009). Medical conditions that induce chronic stress, inflammation, or hypoxia can alter the expression of BDNF and other neurotrophic factors (Recombinant Methionyl Human Brain-Derived Factor, 2020), thereby impairing the brain's capacity for adaptive plasticity and potentially leading to maladaptive behavioral patterns characteristic of personality change (Ikemoto, 2002; Zu et al., 2014). For instance, stem cells modified by BDNF can be promoted to differentiate into neurons and enhance function after brain injury (Zhang et al., 2009), illustrating the powerful role of this factor in neural remodeling.

**Neural Circuits and Functional Connectivity**

Personality traits are emergent properties of activity within and between large-scale neural circuits. Medical conditions can disrupt these circuits, leading to altered behavioral outputs. For example, studies of fear conditioning demonstrate that specific stimuli can lead to changes in prefrontal oscillations and output that drive conditioned fear behavior (Sohal, 2014; Monti & Smith, 1976). Specific neuronal populations within the amygdala control different components of the fear response (Stern, 2011). A medical condition that causes chronic inflammation or metabolic stress could conceivably alter the excitability or connectivity of these circuits, leading to a persistent state of anxiety, fearfulness, or aggression.

The brain's ability to detect changes in the validity of an action as a predictor of reward is dependent on a hippocampo-cortical pathway (Piquet et al., 2023), and this process is fundamental to goal-directed behavior and motivation. Long-term potentiation (LTP), a cellular mechanism of synaptic plasticity, has been shown to facilitate behavioral responding to stimulation of specific pathways (Skelton et al., 1985). Other forms of short-term plasticity are also modulated by behavioral state (Castro‐Alamancos, 1996). A medical condition could disrupt these fundamental plastic processes, impairing an individual's ability to adapt to new contingencies and leading to rigid, perseverative, or apathetic behaviors. The overall behavioral repertoire is shaped by the brain's connectivity pattern (Unknown, 2012), and any pathological process that alters this pattern has the potential to induce a change in personality.

**Central Signaling Pathways**

At a molecular level, the function of these neurobiological systems is governed by key intracellular signaling pathways. The mechanistic target of rapamycin (mTOR) pathway is a central regulator of a vast array of processes in both health and disease (Gargalionis et al., 2024; Manning, 2017). mTOR signaling is crucial for the cellular response to various stresses (Aramburu et al., 2014; Unknown, 2020) and is implicated in modulating mutagenesis in response to stress (Unknown, 2020). Given its role in integrating signals related to nutrients, energy status, and stress, it is plausible that systemic metabolic disturbances from a medical condition could lead to dysregulated mTOR signaling in the brain, affecting neuronal metabolism, plasticity, and ultimately, behavior. Other pathways, such as those involving MAPK, are also subject to complex regulation by factors like phosphatases, which control the dynamic response to external signals (Dyjack et al., 2017). Medical conditions that alter the expression or activity of these signaling components can have far-reaching effects on cellular function throughout the body, including the brain.

### Genetic and Molecular Basis

The manifestation of personality, as a complex biological phenotype, is fundamentally rooted in an individual's genetic makeup and the intricate molecular machinery that translates this genetic code into function (Bisova & Bysova, 2019; Unknown, 2020). Medical conditions that cause personality change often do so by directly altering this genetic and molecular landscape through mutations, epigenetic modifications, or dysregulation of gene expression programs. The study of how such mechanisms drive phenotypic changes in other diseases, particularly cancer, provides a powerful paradigm for understanding the molecular basis of personality alterations (Ryan & Bernstein, 2012).

**Heritability and Genetic Predisposition**

There is a significant heritable component to personality, and genetic variation is a key source of phenotypic diversity (Taylor et al., 2024). Polymorphic variations in genes can predispose individuals to certain behavioral traits or increase their susceptibility to psychiatric disorders (Ali, 2008; Annas et al., 1997). For example, specific polymorphisms in genes regulating follicular helper T cell differentiation can predict the formation of donor-specific antibodies after liver transplantation (Ono et al., 2024; Ono et al., 2024), illustrating how genetic variants can determine complex biological responses. Similarly, polymorphisms in neuropeptide genes can act as drivers of differential gene expression (Quinn et al., 2013). It is therefore highly probable that certain genetic backgrounds may confer a vulnerability to developing personality changes in the context of a specific medical stressor. Modifier genes can also play a significant role in the phenotypic expression of a primary genetic disorder (Fain et al., 2005; Jacolot et al., 2003; Lai et al., 2005; Mehta et al., 2007), suggesting that the impact of a medical condition on personality may be modulated by an individual’s broader genetic context.

**Genetic Lesions and Candidate Genes**

Direct genetic alterations, such as point mutations, deletions, or translocations, are potent drivers of pathological phenotypes. In cancer, mutations in key tumor suppressor genes like *TP53* are frequent genetic lesions that serve as independent predictors of survival and disease evolution (Rossi et al., 2009; Győrffy et al., 2014; Unknown, 2022). Such mutations can produce a common conformational effect in the protein (Gannon et al., 1990; Blagosklonny et al., 1995), alter its transcriptional activity (Willis et al., 2004; Monti et al., 2002), and facilitate cellular transformation (Sarig et al., 2010). Just as these mutations drive oncogenesis, mutations in genes critical for neurodevelopment and function can lead to neuropsychiatric phenotypes.

Several genes implicated in brain development represent strong candidates for involvement in personality change. The *CRMP1* gene encodes a key protein involved in brain development (Liu et al., 2024), and *DISC1* is a susceptibility gene for neuropsychiatric disorders that influences multiple aspects of neurodevelopment through its various interaction partners (Adler, 2011). Mutations in genes encoding components of the chromatin-remodeling machinery, such as *ADNP*, have been linked to autism spectrum disorder (Mefford, 2014). Furthermore, mutations in genes with broader physiological roles can have profound neurological consequences; for instance, the gene mutated in Wilson disease is a putative copper-transporting ATPase (Bull et al., 1993; Unknown, 1994), and its dysfunction leads to copper accumulation and severe neuropsychiatric symptoms, including personality changes. A single nucleotide polymorphism in a *Plasmodium* transcription factor can alter the development of the host's immune response (Akkaya et al., 2020), demonstrating how a single genetic change can have far-reaching systemic and potentially behavioral consequences.

**Epigenetic Mechanisms and Phenotypic Plasticity**

Epigenetics provides a crucial mechanism for mediating the interaction between genes and the environment, underpinning the concept of phenotypic plasticity (Budd et al., 2022; Lucon‐Xiccato et al., 2023). These mechanisms, which include DNA methylation and histone modification, can direct heritable alterations in gene regulation without changing the DNA sequence itself (Hollick, 2005). DNA methylation is a fundamental process (Lage et al., 2023) that can restrict cellular differentiation (Hupkes et al., 2011) and is involved in generating neuronal diversity during development (Toyoda et al., 2014).

Medical conditions are often associated with profound epigenetic reprogramming. Chronic inflammation, a common feature of many diseases, can enhance the fitness of cells with certain mutations and promote their evolution, partly through epigenetic mechanisms (Unknown, 2023). Similarly, metabolic by-products like fumarate can act as epigenetic modifiers that elicit major cellular transitions (Sciacovelli et al., 2016; Unknown, 2016). In cancer, genetic mutations in chromatin-related genes are common and support a role for epigenetic mechanisms in driving the disease (Ryan & Bernstein, 2012; Unknown, 2014). Given that epigenetic changes can be induced by systemic factors and environmental stress (Denver, 1997), it is highly plausible that a medical condition could induce lasting epigenetic modifications in brain cells, altering the expression of genes that regulate mood and behavior, thereby causing a stable personality change.

**Regulation of Gene Expression**

The ultimate output of genetic and epigenetic information is the pattern of gene expression, which is tightly controlled by a complex interplay of transcription factors, promoters, enhancers, and post-transcriptional modifications.
*   **Transcription Factors (TFs):** TFs are master regulators of cell identity and function (Gray et al., 2009). Brain-specific TFs, such as those containing a POU domain, are critical for establishing neural phenotypes (Mathis et al., 1992; Ingraham et al., 1988). The dysregulation of a single TF, such as PU.1, can cause characteristic transcriptional changes and dramatic phenotypic outcomes (Steidl et al., 2004; TONDRAVI, 1996). Medical conditions can alter the activity of TFs through various mechanisms, including mutation (Chan et al., 2005) or changes in upstream signaling, leading to widespread changes in gene expression (Li et al., 2005).
*   **Promoters and Enhancers:** These cis-regulatory elements are essential for directing the precise temporal and spatial expression of genes (Gray et al., 2009). The activity of an enhancer can be cell-type dependent (Forsberg & Westin, 1991), and their dysregulation is a key feature of many diseases (Unknown, 2017; Unknown, 2018). For example, a polymorphism in a super-enhancer region can mediate risk for neuroblastoma (Unknown, 2016), highlighting how non-coding genetic variation can have significant phenotypic consequences.
*   **Alternative Splicing and Post-Translational Modifications (PTMs):** Alternative splicing generates a diversity of protein isoforms from a single gene (Duterque‐Coquillaud et al., 1993), which can have altered functional properties (Dairaghi et al., 1995). Stress can induce coordinated changes in splicing (Chandler et al., 2023), and aberrant splicing is increasingly recognized as a causal factor in disease (Rayner, 2016). Similarly, PTMs such as phosphorylation, acetylation, and ubiquitination are crucial for regulating protein function, stability, and localization (Yang & Li, 2020; Pincus et al., 2013; Faktor et al., 2019). Medical conditions can disrupt the enzymes that mediate these modifications (Pickersgill, 2010), leading to widespread protein dysfunction that could easily extend to the neural substrates of personality.

### Brain Structure and Function

Personality change arising from a medical condition is fundamentally a manifestation of altered brain function, which in turn reflects changes in the brain's underlying structure at multiple levels, from cellular composition to synaptic connectivity. While direct neuroimaging evidence from the specific cohort of available research is limited, principles derived from various models of disease and neural function allow for a comprehensive understanding of how medical conditions can structurally and functionally remodel the brain.

**Cellular and Neuroanatomical Alterations**

The cellular composition of brain regions is critical for their function. Medical conditions can lead to significant shifts in this composition. For instance, common gene expression signatures in neurodegenerative disorders like Parkinson’s disease are driven by changes in the underlying cell composition of affected brain regions (Nido et al., 2020). Pathological processes can induce the emergence of new cell types with distinct characteristics, such as mesenchymal cells with progenitor-like properties that appear during hypoxia-induced vascular remodeling (Frid et al., 2009). A medical condition could similarly induce gliosis, neuronal loss, or changes in the relative populations of different interneuron subtypes in brain regions critical for emotional regulation, such as the prefrontal cortex or amygdala. The properties of interneurons can be altered by activity-dependent transcriptional regulation (Gough, 2015), providing a mechanism by which systemic physiological changes could reshape local circuit function. Neuroanatomical studies of animals with differing behavioral traits have shown that variations exist in brain structures, suggesting a physical basis for behavioral predispositions (Dmitrieva et al., 1983).

**Disruption of Neural Circuits and Connectivity**

Behavioral repertoires are shaped by the brain's patterns of connectivity (Unknown, 2012), and alterations in these patterns can lead to profound behavioral changes. The prefrontal cortex is a key hub for executive function and emotional regulation. Pathological processes that disrupt its function can manifest as personality changes. For example, in models of conditioned fear, conditioned stimuli lead to the inhibition of specific interneurons in the prefrontal cortex, resulting in changes in network oscillations and behavioral output (Sohal, 2014). A medical condition that chronically activates stress or inflammatory pathways could persistently alter this circuitry, leading to a state of heightened anxiety or irritability.

The amygdala is another critical node, with specific neuronal populations controlling distinct behavioral and physiological components of the fear response (Stern, 2011). The hippocampus is crucial for contextualizing experience and modulating behavior based on predictions of reward, a function mediated by a hippocampo-cortical pathway (Piquet et al., 2023). Medical conditions affecting these limbic structures through ischemia, inflammation, or metabolic dysfunction could impair emotional processing, memory, and motivation, leading to symptoms like apathy, emotional lability, or paranoia.

**Synaptic and Cellular Mechanisms of Functional Change**

At the microscopic level, the functional integrity of the brain relies on the strength and plasticity of its trillions of synapses. Long-term potentiation (LTP) is a well-established cellular model of learning and memory that facilitates behavioral responding (Skelton et al., 1985). Other forms of synaptic plasticity, both short-term and long-term, are modulated by the overall behavioral state of the organism (Castro‐Alamancos, 1996). Systemic medical conditions can release humoral factors (Itonaga et al., 1999) or inflammatory cytokines that cross the blood-brain barrier and interfere with these delicate synaptic processes. This could impair the ability to learn from experience, adapt to new situations, or regulate emotional responses, all of which are core components of personality.

The intrinsic properties of neurons themselves are also subject to change. For example, mitochondrial function is a primary variable affecting cellular phenotypes (Mahlum, 2001) and is critical for neuronal health. Medical conditions that induce oxidative stress (Ohta, 2011) or alter cellular redox biochemistry (Hensley & Denton, 2014) can impair mitochondrial dynamics and function (Feng et al., 2019; Stucki et al., 2018), leading to neuronal dysfunction or death. The protein Drp1 is critical for mitochondrial fission and has been implicated in neuronal death in Parkinson's disease (Feng et al., 2019). Such mitochondrial compromise in key brain circuits could underlie the fatigue, apathy, and cognitive slowing that can accompany personality changes.

While structural and functional neuroimaging techniques such as MRI and fMRI are indispensable tools for investigating these changes in human patients, the current body of literature under review does not include such studies. This represents a significant gap and a crucial direction for future research. A comprehensive understanding will require integrating molecular and cellular findings with systems-level neuroimaging to map how specific medical conditions alter the brain networks that give rise to an individual's unique personality.

### Developmental Neurobiology

The development of the brain is a protracted and exquisitely orchestrated process, vulnerable to disruption at multiple stages. The timing and sequence of neurodevelopmental events establish the neural architecture that will support cognitive and emotional function throughout life. Personality itself is not static but undergoes development, shaped by the continuous interplay between genetic predispositions and environmental influences (Lawrence, 1985). A medical condition can act as a potent environmental disruptor, and its impact on personality may be profoundly influenced by the developmental stage at which it occurs.

**Critical Periods and Neurodevelopmental Trajectories**

The brain exhibits periods of heightened plasticity, known as critical periods, during which it is particularly sensitive to environmental stimuli. Experiences during these times can induce permanent changes in neural circuits and behavior. Environmental stress can act as a powerful developmental cue, with hormones like corticotropin-releasing factor serving as proximate mediators of adaptive phenotypic plasticity (Denver, 1997). A severe or chronic medical condition during infancy, childhood, or adolescence—key periods for the maturation of circuits involved in social cognition and emotional regulation—could alter the trajectory of brain development, leading to lasting changes in personality. Factors that differentiate biomechanics in growing versus adult individuals (Melsen, 1988) are analogous to how the developing brain responds differently to physiological insults compared to the mature brain.

The emergence of personality traits is linked to the maturation of specific brain regions and networks. Genes involved in neurodevelopment, such as *DISC1* and *CRMP1*, are critical for this process (Adler, 2011; Liu et al., 2024). Mutations or altered expression of these genes can lead to neurodevelopmental disorders that are often characterized by distinct personality and behavioral profiles. A systemic medical condition could potentially influence the expression of these crucial developmental genes, thereby altering the course of brain maturation. For example, transcription factors serve as molecular switches in the sequential production of different brain cell types (Webb, 2008), and any factor that interferes with their precise timing and expression could have cascading effects on brain structure and function.

**Molecular Mechanisms of Developmental Programming**

Epigenetic modifications are a primary mechanism through which early life experiences are biologically embedded, leading to long-term changes in gene expression and phenotype. Developmental epigenetic modification is known to regulate the stochastic expression of genes, thereby generating single-neuron diversity and contributing to the complexity of neural circuits (Toyoda et al., 2014). Genomic imprinting, another epigenetic phenomenon, is also implicated in development (Kobayashi et al., 2022). A medical condition that alters the epigenetic machinery—for example, by affecting the availability of methyl donors like methionine (Mubarak & Zahir, 2022) or by inducing inflammatory pathways that influence DNA methyltransferases or histone-modifying enzymes—could leave a permanent mark on the developing brain's epigenome. Such changes could establish a new, stable pattern of gene expression that manifests as an altered personality phenotype.

Furthermore, the process of cellular differentiation is fundamental to development. Stem and progenitor cells must respond to a precise sequence of cues to generate the diverse cell types of the mature brain. Factors such as hypoxia-inducible factors (HIFs) have distinct and stage-specific roles during cellular reprogramming and differentiation (Mathieu et al., 2014). Medical conditions associated with hypoxia, inflammation, or metabolic disruption could interfere with these signaling pathways. For instance, secreted factors from one cell type can be essential for inducing the differentiation of another (Hanamura et al., 1987; Higuchi et al., 2008), and a medical illness could alter the production or reception of these critical developmental signals. This could lead to subtle but significant abnormalities in the number, type, or connectivity of neurons in key brain regions, establishing a neurobiological substrate for a lifelong personality alteration. The renin cell, for example, has been identified as a progenitor for multiple cell types (Sequeira‐Lopez & Gómez, 2005), illustrating the principle that developmental origins can be complex and that disrupting a single progenitor pool can have widespread consequences.

### Treatment Mechanisms

Understanding the biological basis of Personality Change Due to Another Medical Condition is not merely an academic exercise; it is the essential foundation for developing rational and effective treatments. If personality changes are driven by specific, identifiable pathophysiological mechanisms, then interventions that target these mechanisms should, in principle, be capable of ameliorating or reversing the behavioral phenotype. The principles of modern therapeutics, particularly in fields like oncology and immunology, are increasingly focused on targeting the precise molecular drivers of disease. This approach provides a powerful conceptual framework for considering how to treat personality changes secondary to medical illness.

**Targeting Dysregulated Signaling Pathways**

Many medical conditions are characterized by the aberrant activity of key intracellular signaling pathways. The mTOR pathway, a central regulator of cell growth and metabolism, is frequently dysregulated in disease (Gargalionis et al., 2024; Manning, 2017). The development of mTOR inhibitors has provided a therapeutic strategy for conditions driven by this pathway (Unknown, 2014; Tan et al., 2023). Similarly, inhibitors targeting the PI3K pathway (Wallin et al., 2023; Zhang et al., 2020) and specific kinases like p38 MAPK (Campbell et al., 2023) have shown robust activity in various disease models. If a specific medical condition is found to cause personality changes through the chronic activation of one of these pathways in the central nervous system, then brain-penetrant inhibitors of that pathway could represent a viable therapeutic strategy. For example, the atypical antipsychotic olanzapine has been identified as a potent agonist for a specific chemogenetic receptor (Weston et al., 2019), demonstrating the feasibility of using small molecules to precisely modulate neural circuit activity.

**Modulating Protein Function and Homeostasis**

Altered protein function, due to mutation or abnormal post-translational modification, is another common disease mechanism. In some cancers, mutant p53 protein acquires a new conformation that can be selectively destabilized by certain compounds (Blagosklonny et al., 1995), suggesting that targeting the specific properties of a pathological protein is possible. Proteasome inhibitors are another class of drugs that function by altering protein homeostasis, inducing cell death in cancer cells that are particularly reliant on the proteasome for survival (Giletto et al., 2019; Tao et al., 2014). If a personality change is driven by the accumulation of a misfolded or dysfunctional protein in neurons, strategies aimed at enhancing its degradation or restoring its proper conformation could be beneficial. The molecular chaperone Hsp90, for instance, is a major stress protein involved in protein folding (Kimura & Yahara, 1996), and modulating its activity could be a therapeutic avenue.

**Reversing Epigenetic and Transcriptional Abnormalities**

Since epigenetic modifications are a key mechanism through which medical conditions can induce lasting phenotypic changes, reversing these modifications is an attractive therapeutic goal (Tsay, 2018). Demethylating drugs can alter cellular development and regeneration (Kiełkowska & Brąszewska-Zalewska, 2025), and histone deacetylase (HDAC) inhibitors are another class of agents that can reprogram gene expression. If a personality change is found to be associated with a specific epigenetic signature, such as the hypermethylation of a promoter for a key neuroregulatory gene (Abe et al., 2023), then epigenetic therapies could potentially restore a more normal pattern of gene expression and function. Similarly, since transcription factors are often the ultimate effectors of pathological signaling, developing inhibitors that block the activity of a specific transcription factor represents another targeted approach (Goldman et al., 1996).

**Cell-Based and Restorative Therapies**

In cases where a medical condition has caused irreversible neuronal loss, restorative strategies may be necessary. Research into induced pluripotent stem cells (iPSCs) has shown that adult cells can be genetically reprogrammed to an embryonic-like state (Yahata & Inoue, 2020; Baker, 2007) and then differentiated into functional cell types, including hepatocytes that can contribute to liver regeneration (Liu et al., 2011). This raises the long-term possibility of using patient-derived stem cells to replace damaged neurons in the brain. Furthermore, enhancing the brain's own regenerative capacity is a promising strategy. Neurotrophic factors, such as BDNF (Recombinant Methionyl Human Brain-Derived Factor, 2020) and nerve growth factor (NGF) (Harrison, 2019; Bader & Machens, 2010), are potent stimulators of neuronal survival and differentiation, and their therapeutic administration could help repair damaged neural circuits. The success of these approaches will depend critically on a precise understanding of the specific cells and circuits that have been compromised by the underlying medical condition.

### Future Directions

The exploration of the biological basis for Personality Change Due to Another Medical Condition is still in its nascent stages. While the principles of molecular pathology, genetics, and neurobiology provide a strong theoretical foundation, the direct evidence linking specific medical conditions to distinct personality alterations via defined neurological mechanisms is sparse within the reviewed literature. The path forward requires a multi-pronged, integrative research approach to bridge the gap between systemic illness and its neuropsychiatric manifestations.

A primary and critical need is for prospective, longitudinal studies that combine detailed clinical phenotyping with advanced biological measures. Characterizing personality changes requires more than anecdotal observation; it necessitates the use of standardized, validated instruments to capture the specific domains being affected (e.g., affect regulation, impulse control, social cognition) (Loper et al., 1973; Shaheen et al., 1970). These clinical data must be integrated with comprehensive biological profiling.

One of the most significant gaps is the lack of neuroimaging data. Structural and functional magnetic resonance imaging (fMRI), positron emission tomography (PET), and diffusion tensor imaging (DTI) are essential for identifying which brain regions and neural networks are affected by a given medical condition. These techniques can reveal changes in brain volume, cortical thickness, functional connectivity, and the integrity of white matter tracts, providing a systems-level picture of the pathology. This macroscopic view must be linked to microscopic and molecular investigations.

Future genomic and epigenomic studies are essential. Genome-wide association studies (GWAS) can identify genetic variants that confer susceptibility to personality changes in the face of a medical stressor (Albertsen & Ward, 2016). Furthermore, analyzing the epigenome (e.g., DNA methylation and histone modification patterns) of brain tissue or relevant peripheral cells can provide a "memory" of the physiological stress induced by the illness and reveal how gene expression programs have been durably altered (Unknown, 2014; Yousefi et al., 2021). Single-cell transcriptomics will be particularly powerful, allowing researchers to identify how specific cell types within the brain (e.g., excitatory neurons, specific interneuron classes, microglia, astrocytes) are affected (Gerakopoulos et al., 2025).

The role of the tumor microenvironment in cancer provides a compelling analogy for how the brain's local environment might be altered by systemic disease. Factors within the microenvironment, such as the extracellular matrix and secreted proteins, can profoundly influence cell behavior and disease progression (Eckhardt et al., 2023; Unknown, 2021; Hara et al., 2000). Future research should investigate how medical conditions alter the brain's "microenvironment," including the function of glial cells, the integrity of the blood-brain barrier, and the composition of the cerebrospinal fluid.

The influence of the gut microbiome on brain function and behavior—the "microbiome-gut-brain axis"—is a rapidly emerging field of high relevance. The gut microbiota is shaped by host metabolism (Real et al., 2024; Real et al., 2023) and can be significantly altered by diet, stress, and disease (Panzetta & Valdivia, 2024). These microbes and their metabolites can influence host immunity, metabolism, and even neurochemistry (Xu et al., 2019). Investigating how chronic medical conditions alter the microbiome and how these changes, in turn, impact brain function and behavior is a critical avenue for future research.

Finally, the role of inflammation and the immune system as mediators between systemic illness and brain function cannot be overstated. Many medical conditions are associated with chronic inflammation, leading to elevated levels of circulating cytokines and other immune modulators (Mahmud et al., 2020). These factors can cross the blood-brain barrier and activate microglia, the brain's resident immune cells, which in turn can remodel synapses and alter neuronal function. Understanding this neuroinflammatory link is key to explaining how a peripheral disease can have profound central consequences (Patel et al., 2023).

### Conclusion

Personality Change Due to Another Medical Condition stands as a testament to the profound integration of mind and body. The enduring patterns of behavior that constitute an individual's personality are not insulated from physiological distress but are, in fact, a direct reflection of the brain's biological integrity. This chapter has synthesized a framework for understanding this condition by drawing upon fundamental principles of genetics, molecular biology, and neuroscience, illustrating how mechanisms that drive phenotypic changes in diverse medical contexts can be applied to explain alterations in the complex phenotype of personality.

We have established that personality can be conceptualized as a biological trait with a significant genetic and heritable basis (Bisova & Bysova, 2019; Unknown, 2020). The onset of a medical condition introduces a powerful disruptive force, capable of inducing pathological changes at every level of biological organization. At the molecular level, this includes direct genetic mutations, widespread epigenetic reprogramming (Budd et al., 2022; Ryan & Bernstein, 2012), and the dysregulation of transcription factors and signaling pathways that are the ultimate arbiters of cellular function (Goebl, 1990; Gargalionis et al., 2024). These molecular events cascade upwards, leading to alterations in cellular function, such as impaired neuronal plasticity (Stern, 2009), and changes in the structure and connectivity of the neural circuits that subserve emotion, cognition, and behavior (Sohal, 2014; Unknown, 2012).

While direct evidence from the specific literature reviewed is often analogical, the convergence of mechanisms across different diseases is striking. The same fundamental processes—such as altered gene expression driven by mutations in *p53* in cancer (Rossi et al., 2009), or phenotypic plasticity driven by DNA methylation in response to environmental change (Budd et al., 2022)—provide a robust and plausible blueprint for how a medical condition can remodel brain function. The disruption of key neurobiological systems, including neurotransmitter pathways and neurotrophic factor signaling (Ali, 2008; You et al., 2023), offers a direct link between physiological disturbance and behavioral change.

Ultimately, this biological perspective is not one of reductionism but of integration. It provides a causal pathway from a systemic medical condition to a deeply personal and often distressing change in an individual's sense of self. This understanding demystifies the condition, moving it from the realm of the purely psychological to the domain of neuropsychiatry and biology. By elucidating the specific genetic vulnerabilities, dysregulated pathways, and affected neural circuits, future research holds the promise of developing targeted, mechanism-based therapies that can restore not just physiological function, but the very personality that was altered by disease.

## References

1. Aa, A., Nb, D., Mk, K., Aa, K., Fm, S., Og, E., & Bi, M. (1993). [3'-Fluoro-deoxythymidine-5-fluorophosphate--an effective inhibitor of reproduction of human immunodeficiency virus in cell cultures].. PubMed.
2. Abe, M., Ohira, M., Kaneda, A., Yagi, Y., Yamamoto, S., Kitano, Y., Takato, T., Nakagawara, A., & Ushijima, T. (2023). Supplementary Figure Legends from CpG Island Methylator Phenotype Is a Strong Determinant of Poor Prognosis in Neuroblastomas. https://doi.org/10.1158/0008-5472.22365506
3. Abe, M., Ohira, M., Kaneda, A., Yagi, Y., Yamamoto, S., Kitano, Y., Takato, T., Nakagawara, A., & Ushijima, T. (2023). Supplementary Figure Legends from CpG Island Methylator Phenotype Is a Strong Determinant of Poor Prognosis in Neuroblastomas. https://doi.org/10.1158/0008-5472.22365506.v1
4. Abe, M., Ohira, M., Kaneda, A., Yagi, Y., Yamamoto, S., Kitano, Y., Takato, T., Nakagawara, A., & Ushijima, T. (2023). Supplementary Tables 1-3 from CpG Island Methylator Phenotype Is a Strong Determinant of Poor Prognosis in Neuroblastomas. https://doi.org/10.1158/0008-5472.22365503
5. Abe, M., Ohira, M., Kaneda, A., Yagi, Y., Yamamoto, S., Kitano, Y., Takato, T., Nakagawara, A., & Ushijima, T. (2023). Supplementary Tables 1-3 from CpG Island Methylator Phenotype Is a Strong Determinant of Poor Prognosis in Neuroblastomas. https://doi.org/10.1158/0008-5472.22365503.v1
6. Acar, M., Jafar‐Nejad, H., Takeuchi, H., Rajan, A., Ibrani, D., Rana, N. A., Pan, H., Haltiwanger, R. S., & Bellen, H. J. (2008). Rumi Is a CAP10 Domain Glycosyltransferase that Modifies Notch and Is Required for Notch Signaling. Cell. https://doi.org/10.1016/j.cell.2007.12.016
7. Adams, S. E., Robinson, E., Miller, D. J., Rizkallah, P., Hallett, M. B., & Allemann, R. K. (2015). Conformationally restricted calpain inhibitors. Chemical Science. https://doi.org/10.1039/c5sc01158b
8. Adler, E. M. (2011). A Scaffold for Neurodevelopment. Science Signaling. https://doi.org/10.1126/scisignal.4200ec324
9. Agarwal, P., & Agarwal, P. K. (2013). Pathogenesis related-10 proteins are small, structurally similar but with diverse role in stress signaling. Molecular Biology Reports. https://doi.org/10.1007/s11033-013-2897-4
10. Ahmad, R., Raina, D., Joshi, M. D., Kawano, T., Ren, J., Kharbanda, S., & Küfe, D. (2023). Supplementary Figure 1A-C from MUC1-C Oncoprotein Functions as a Direct Activator of the Nuclear Factor-κB p65 Transcription Factor. https://doi.org/10.1158/0008-5472.22379288
11. Ahmad, R., Raina, D., Joshi, M. D., Kawano, T., Ren, J., Kharbanda, S., & Küfe, D. (2023). Supplementary Figure 1A-C from MUC1-C Oncoprotein Functions as a Direct Activator of the Nuclear Factor-κB p65 Transcription Factor. https://doi.org/10.1158/0008-5472.22379288.v1
12. Ahmad, S. (2010). New Hope for Premature Newborns. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.3001292
13. Ahmadiyeh, N., Churchill, G. A., Solberg, L. C., Baum, A. E., Shimonura, K., Takahashi, J. S., & Redei, E. E. (2005). Lineage is an Epigenetic Modifier of QTL Influencing Behavioral Coping with Stress. Behavior Genetics. https://doi.org/10.1007/s10519-004-1018-5
14. Akkaya, M., Bansal, A., Sheehan, P. W., Peña, M., Molina-Cruz, A., Orchard, L., Cimperman, C. K., Qi, C., Ross, P., Yazew, T., Sturdevant, D. E., Anzick, S. L., Thiruvengadam, G., Otto, T. D., Billker, O., Llinás, M., Miller, L. H., & Pierce, S. K. (2020). A single-nucleotide polymorphism in a <i>Plasmodium berghei</i> ApiAP2 transcription factor alters the development of host immunity. Science Advances. https://doi.org/10.1126/sciadv.aaw6957
15. Akopyan, K. Z., & Gazaryan, K. G. (1990). Structure of PstI repeats adjoining the growth hormone gene, and their transcription in different organs of bulls..
16. Alamäe, T., Viigand, K., Rätsep, B., Tammus, K., Kosa, C. P., Valach, M., Lubomir, T., Wolfe, K. H., Nosek, J., Fairhead, C., & Dujon, B. (2005). 01. Evolutionary and comparative genomics. Yeast. https://doi.org/10.1002/yea.1256
17. Albertsen, H., & Ward, K. (2016). Genes Linked to Endometriosis by GWAS Are Integral to Cytoskeleton Regulation and Suggests That Mesothelial Barrier Homeostasis Is a Factor in the Pathogenesis of Endometriosis. Reproductive Sciences. https://doi.org/10.1177/1933719116660847
18. Alexeeva, O., & Mindubaeva, L. (2024). A pathogenetic role of personality traits in patients with vertebrogenic pain syndromes. Manual Therapy. https://doi.org/10.54504/1684-6753-2023-3-4-65-68
19. Ali, F. (2008). Polymorphic DNA repeats in the human serotonin transporter gene locus, predisposing to behavioural disorders, emerge as functional regulators of gene expression. https://doi.org/10.17638/03072490
20. Ali, T., Venkata, M., Kumar, S., Basu, S., & Swaminathan, R. (2014). MD Simulation Trajectories of Multiple Intrinsically Disordered Proteins Reveal Order to Disorder Transitions that Bear Functional Significance. Biophysical Journal. https://doi.org/10.1016/j.bpj.2013.11.2733
21. Alisi, A., Spaziani, A., Anticoli, S., Ghidinelli, M., & Balsano, C. (2007). PKR is a novel functional direct player that coordinates skeletal muscle differentiation via p38MAPK/AKT pathways. Cellular Signalling. https://doi.org/10.1016/j.cellsig.2007.11.006
22. Alonso, M. B. D., Hernández, I. L., Fuente, M. Á. D. L., Sancho, J. G., Giráldez, F., & Schimmang, T. (2024). Correction: Transcription factor induced conversion of human fibroblasts towards the hair cell lineage. PLoS ONE. https://doi.org/10.1371/journal.pone.0297736
23. Al‐Taie, O., Seufert, J., Mörk, H., Treis, H., Mentrup, B., Thalheimer, A., Starostik, P., Abel, J., Scheurlen, M., Köhrle, J., & Jakob, F. (2002). A complex DNA-repeat structure within the Selenoprotein P promoter contains a functionally relevant polymorphism and is genetically unstable under conditions of mismatch repair deficiency. European Journal of Human Genetics. https://doi.org/10.1038/sj.ejhg.5200811
24. Amin, A. S., & Wilde, A. A. (2018). The phenotype is equally important in promoting variants from benign to pathogenic as well as in demoting variants from pathogenic to benign. Heart Rhythm. https://doi.org/10.1016/j.hrthm.2018.01.007
25. Amin, M. R., Mercer, W. E., Sauve, G. J., Appella, E., Ullrich, S. J., & Romano, J. (1990). Wild type human p53 is antiproliferative in SV40-transformed hamster cells.. PubMed.
26. Annas, P., Garpenstrand, H., Ekblom, J., Oreland, L., & Fredrikson, M. (1997). The D4DR gene and platelet MAO are markers for human fear conditioning..
27. Ao, J., Zhu, X., Chai, Z., Cai, H., Zhang, Y., Zhang, K., Kong, L., Zhang, N., Ye, B., Ma, D.-N., & Sun, H. (2023). Supplementary figure legends from Colony-Stimulating Factor 1 Receptor Blockade Inhibits Tumor Growth by Altering the Polarization of Tumor-Associated Macrophages in Hepatocellular Carcinoma. https://doi.org/10.1158/1535-7163.22508724
28. Ao, J., Zhu, X., Chai, Z., Cai, H., Zhang, Y., Zhang, K., Kong, L., Zhang, N., Ye, B., Ma, D.-N., & Sun, H. (2023). Supplementary figure legends from Colony-Stimulating Factor 1 Receptor Blockade Inhibits Tumor Growth by Altering the Polarization of Tumor-Associated Macrophages in Hepatocellular Carcinoma. https://doi.org/10.1158/1535-7163.22508724.v1
29. Arboit, M., Zorzan, I., Pellegrini, M., Martini, P., Carbognin, E., & Martello, G. (2023). Author Reply to Peer Reviews of KLF7 is a general inducer of human pluripotency. https://doi.org/10.15252/rc.2024484666
30. Arlt, J., Vlaic, S., Feuer, R., Thomas, M., Settmacher, U., Dahmen, U., & Dirsch, O. (2022). Additional file 1 of Selective gene expression profiling contributes to a better understanding of the molecular pathways underlying the histological changes observed after RHMVL. Figshare. https://doi.org/10.6084/m9.figshare.21298960
31. Arlt, M. F., Mullé, J. G., Schaibley, V. M., Ragland, R. L., Durkin, S. G., Warren, S. T., & Glover, T. W. (2009). Replication Stress Induces Genome-wide Copy Number Changes in Human Cells that Resemble Polymorphic and Pathogenic Variants. The American Journal of Human Genetics. https://doi.org/10.1016/j.ajhg.2009.01.024
32. Armon, L., Ben‐Ami, I., Ron-El, R., & Eisenbach, M. (2014). Human oocyte-derived sperm chemoattractant is a hydrophobic molecule associated with a carrier protein. Fertility and Sterility. https://doi.org/10.1016/j.fertnstert.2014.06.011
33. Armstrong, S. A., Staunton, J., Silverman, L. B., Pieters, R., Boer, M. L. D., Minden, M. D., Sallan, S. E., Lander, E. S., Golub, T. R., & Korsmeyer, S. J. (2001). MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nature Genetics. https://doi.org/10.1038/ng765
34. Asada, S., Suzuki, T., Azuma, Y., Tokuda, T., Yoshida, H., & Yamaguchi, M. (2017). Identification of epigenetic factors which genetically interacts with Cabeza , a human ALS-causing gene FUS homologue.. The Japanese Biochemical Society/The Molecular Biology Society of Japan.
35. Atochina-Vasserman, E., Winkler, C., Abramova, H., Beers, M., Schaumann, F., Krug, N., Gow, A. J., & Hohlfeld, J. M. (2009). Segmental Antigen Challenge Produces Alterations in Surfactant Protein D Expression and Multimeric Structure in Humans.. https://doi.org/10.1164/ajrccm-conference.2009.179.1_meetingabstracts.a6272
36. Attia, M., Huet, E., Delbé, J., Ledoux, D., Ménashi, S., & Isabelle, M. (2010). Erratum: Extracellular matrix metalloproteinase inducer (EMMPRIN/CD147) as a novel regulator of myogenic cell differentiation [J Cell Physiol 226:141–149. doi: 10.1002/jcp.22315]. Journal of Cellular Physiology. https://doi.org/10.1002/jcp.22547
37. Audouin, M., Barkatz, J., Cox, D. G., Rouprêt, M., Cormier, L., Valeri, A., Azzouzi, A.-R., Ondet, V., Gaffory, C., Cancel‐Tassin, G., & Cussenot, O. (2016). 100 A prostate cancer risk polymorphism (rs12500426) of the PDLIM5 gene is a strong determinant of age related benign prostate hypertrophy. European Urology Supplements. https://doi.org/10.1016/s1569-9056(16)60102-1
38. Bader, A., & Machens, H. (2010). Recombinant Human Erythropoietin Plays a Pivotal Role As a Topical Stem Cell Activator to Reverse Effects of Damage to the Skin in Aging and Trauma. Rejuvenation Research. https://doi.org/10.1089/rej.2010.1064
39. Bafna, S., Singh, A., Moniaux, N., Eudy, J. D., Meza, J. L., & Batra, S. K. (2023). Supplementary Figure Legend from MUC4, a Multifunctional Transmembrane Glycoprotein, Induces Oncogenic Transformation of NIH3T3 Mouse Fibroblast Cells. https://doi.org/10.1158/0008-5472.22376193
40. Bafna, S., Singh, A., Moniaux, N., Eudy, J. D., Meza, J. L., & Batra, S. K. (2023). Supplementary Figure Legend from MUC4, a Multifunctional Transmembrane Glycoprotein, Induces Oncogenic Transformation of NIH3T3 Mouse Fibroblast Cells. https://doi.org/10.1158/0008-5472.22376193.v1
41. Bagchi, A. (2014). Structural characterization of Fis — A transcriptional regulator from pathogenic Pasteurella multocida essential for expression of virulence factors. Gene. https://doi.org/10.1016/j.gene.2014.10.044
42. Bain, N., Trezise, A. E. O., Knight, M. M., O’Donnell, L. J., & Murdock, B. K. (2001). A unique profile of muscle regulatory factors directs the functional specialisation of the intrinsic laryngeal muscles.
43. Baker, C. A., Guan, X.-J., Choi, M., & Murthy, M. (2024). The role of <i>fruitless</i> in specifying courtship behaviors across divergent <i>Drosophila</i> species. Science Advances. https://doi.org/10.1126/sciadv.adk1273
44. Baker, M. (2007). From skin cell to stem cell. Nature reports. Stem cells. https://doi.org/10.1038/stemcells.2007.6
45. Bakkaiova, J., Marini, V., Willcox, S., Nosek, J., Griffith, J. D., Krejčí, L., & Tomáška, Ľ. (2016). Yeast mitochondrial HMG proteins: DNA-binding properties of the most evolutionarily divergent component of mitochondrial nucleoids. Carolina Digital Repository (University of North Carolina at Chapel Hill). https://doi.org/10.17615/rnck-rz81
46. Balcells, M. (2014). Regenerative Medicine Gets Vocal. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.3008471
47. Bamberger, C., Martínez‐Bartolomé, S., Montgomery, M., Lavallée‐Adam, M., & Yates, J. R. (2018). Increased proteomic complexity in <i>Drosophila</i> hybrids during development. Science Advances. https://doi.org/10.1126/sciadv.aao3424
48. Banerjee, S., Lin, C.-F. L., Skinner, K. A., Schiffhauer, L., Peacock, J., Hicks, D. G., Redmond, E. M., Morrow, D. A., Huston, A., Shayne, M., Langstein, H. N., Miller‐Graziano, C., Strickland, J., O'Donoghue, L., & De, A. K. (2023). Supplementary Figure 1 from Heat Shock Protein 27 Differentiates Tolerogenic Macrophages That May Support Human Breast Cancer Progression. https://doi.org/10.1158/0008-5472.22386804.v1
49. Banerjee, S., Lin, C.-F. L., Skinner, K. A., Schiffhauer, L., Peacock, J., Hicks, D. G., Redmond, E. M., Morrow, D. A., Huston, A., Shayne, M., Langstein, H. N., Miller‐Graziano, C., Strickland, J., O'Donoghue, L., & De, A. K. (2023). Supplementary Figure 2 from Heat Shock Protein 27 Differentiates Tolerogenic Macrophages That May Support Human Breast Cancer Progression. https://doi.org/10.1158/0008-5472.22386801.v1
50. Banerjee, S., Lin, C.-F. L., Skinner, K. A., Schiffhauer, L., Peacock, J., Hicks, D. G., Redmond, E. M., Morrow, D. A., Huston, A., Shayne, M., Langstein, H. N., Miller‐Graziano, C., Strickland, J., O'Donoghue, L., & De, A. K. (2023). Supplementary Figure Legends 1-2 from Heat Shock Protein 27 Differentiates Tolerogenic Macrophages That May Support Human Breast Cancer Progression. https://doi.org/10.1158/0008-5472.22386795
51. Banerjee, S., Lin, C.-F. L., Skinner, K. A., Schiffhauer, L., Peacock, J., Hicks, D. G., Redmond, E. M., Morrow, D. A., Huston, A., Shayne, M., Langstein, H. N., Miller‐Graziano, C., Strickland, J., O'Donoghue, L., & De, A. K. (2023). Supplementary Figure Legends 1-2 from Heat Shock Protein 27 Differentiates Tolerogenic Macrophages That May Support Human Breast Cancer Progression. https://doi.org/10.1158/0008-5472.22386795.v1
52. Barak, Y., Juven, T., Zauberman, A., George, D. L., & Oren, M. (1993). Wild type p53 can mediate sequence-specific transactivation of an internal promoter within the mdm2 gene.. PubMed.
53. Barre, A., Damme, E. J. M. V., Peumans, W. J., & Rougé, P. (1997). Curculin, a sweet-tasting and taste-modifying protein, is a non-functional mannose-binding lectin.. Plant Molecular Biology. https://doi.org/10.1023/a:1005704616565
54. Barrie, J. A., King, H. E., McCulloch, M. C., Kyriakides, E., Beechey, C., Cattanach, B., & Griffiths, I. R. (1997). Hindshaker, a novel myelin mutant showing hypomyelination preferentially affecting the spinal cord.. Journal of Neurocytology. https://doi.org/10.1023/a:1015486508111
55. Barthel, S. R., Hays, D. L., Yazawa, E. M., Opperman, M., Walley, K. C., Nimrichter, L., Burdick, M. M., Gillard, B. M., Moser, M. T., Pantel, K., Foster, B. A., Pienta, K. J., & Dimitroff, C. J. (2023). Supplementary Figure 3 from Definition of Molecular Determinants of Prostate Cancer Cell Bone Extravasation. https://doi.org/10.1158/0008-5472.22398834
56. Barthel, S. R., Hays, D. L., Yazawa, E. M., Opperman, M., Walley, K. C., Nimrichter, L., Burdick, M. M., Gillard, B. M., Moser, M. T., Pantel, K., Foster, B. A., Pienta, K. J., & Dimitroff, C. J. (2023). Supplementary Figure 3 from Definition of Molecular Determinants of Prostate Cancer Cell Bone Extravasation. https://doi.org/10.1158/0008-5472.22398834.v1
57. Bartling, B., Niemann, K., Pliquett, R. U., Treede, H., & Simm, A. (2018). Altered gene expression pattern indicates the differential regulation of the immune response system as an important factor in cardiac aging. Experimental Gerontology. https://doi.org/10.1016/j.exger.2018.05.001
58. Battista, S., Martelli, M., Fedele, M., Chiappetta, G., Trapasso, F., Vita, G. D., Battaglia, C., Santoro, M., Viglietto, G., Fagin, J. A., & Fusco, A. (1995). A mutated p53 gene alters thyroid cell differentiation.. PubMed.
59. Baxter, M. G., Follenfant, R., Miller, A. A., & Sethna, D. M. (1977). Some morphine-like properties of a potent antinociceptive synthetic pentapeptide in relation to physical dependence in rodents [proceedings].. PubMed.
60. Bazinet, A., Bataller, À., Montalban‐Bravo, G., Chien, K. S., Sasaki, K., Jen, W., Swaminathan, M., Kadia, T. M., DiNardo, C. D., Ravandi, F., Garcia‐Manero, G., & Kantarjian, H. (2025). PTPN11 mutations define a rare but highly adverse subset of myelodysplastic syndromes. Haematologica. https://doi.org/10.3324/haematol.2025.287874
61. Begolli, R., Chatziangelou, M., Samiotaki, M., Goutas, A., Barda, S., Goutzourelas, N., Kevrekidis, D. P., Malea, P., Trachana, V., Liu, M., Lin, X., Kollatos, N., Stagos, D., & Giakountis, A. (2023). Additional file 1 of Transcriptome and proteome analysis reveals the anti-cancer properties of Hypnea musciformis marine macroalga extract in liver and intestinal cancer cells. Figshare. https://doi.org/10.6084/m9.figshare.23812481
62. Beheshti, A., Benzekry, S., McDonald, J. T., Ma, L., Peluso, M. J., Hahnfeldt, P., & Hlatky, L. (2023). Supplemental Table 1 from Host Age Is a Systemic Regulator of Gene Expression Impacting Cancer Progression. https://doi.org/10.1158/0008-5472.22407710
63. Beheshti, A., Benzekry, S., McDonald, J. T., Ma, L., Peluso, M. J., Hahnfeldt, P., & Hlatky, L. (2023). Supplemental Table 1 from Host Age Is a Systemic Regulator of Gene Expression Impacting Cancer Progression. https://doi.org/10.1158/0008-5472.22407710.v1
64. Benasciutti, E., Mariani, E., Perilli, E., Barras, E., Faccio, R., Reith, W., & Cenci, S. (2009). Mouse genetic models reveal MHC Class II Transactivator as a novel regulator of osteoclastogenesis and bone homeostasis co-opted from adaptive immunity. Bone. https://doi.org/10.1016/j.bone.2009.03.080
65. Benedetti, F., Poletti, S., Hoogenboezem, T. A., Locatelli, C., Ambrée, O., Wit, H. D., Wijkhuijs, A., Mazza, E., Bulgarelli, C., Vai, B., Colombo, C., Smeraldi, E., Arolt, V., & Drexhage, H. A. (2016). Stem Cell Factor (SCF) is a putative biomarker of antidepressant response. Journal of Neuroimmune Pharmacology. https://doi.org/10.1007/s11481-016-9672-y
66. Benichou, M., Li, Z., Tournier, B., Chaves, A. L. S., Zegzouti, H., Jauneau, A., Delalande, C., Lachaux, A., Bouzayen, M., Spremulli, L., & Pech, J. (2003). Tomato EF-Ts<sub>mt</sub>, a functional mitochondrial translation elongation factor from higher plants. Plant Molecular Biology. https://doi.org/10.1023/b:plan.0000006943.23747.7d
67. Benítez‐King, G., Huerto‐Delgadillo, L., Villarreal, M. L., & Antón‐Tay, F. (2014). La melatonina es un modulador de la arquitectura celular.
68. Bergen, D. J. M., Qiao, T., Shukla, A., Newham, E., Zethof, J., Lundberg, M., Ryan, R., Youlten, S. E., Frysz, M., Croucher, P. I., Flik, G., Richardson, R. J., Kemp, J. P., Hammond, C. L., & Metz, J. R. (2022). Additional file 3 of Regenerating zebrafish scales express a subset of evolutionary conserved genes involved in human skeletal disease. Figshare. https://doi.org/10.6084/m9.figshare.18849029
69. Berna, A., Bernier, F. P., Chabrière, E., Perera, T., & Scott, K. (2008). Ding Proteins, novel members of a prokaryotic phosphate-binding protein superfamily which extends into the eukaryotic kingdom.. HAL (Le Centre pour la Communication Scientifique Directe).
70. Bessarabova, M., Pustovalova, O., Shi, W., Serebriyskaya, T., Ishkin, A., Polyák, K., Velculescu, V. E., Nikolskaya, T., & Nikolsky, Y. (2023). Supplementary Excel File 1 from Functional Synergies yet Distinct Modulators Affected by Genetic Alterations in Common Human Cancers. https://doi.org/10.1158/0008-5472.22388027
71. Bessarabova, M., Pustovalova, O., Shi, W., Serebriyskaya, T., Ishkin, A., Polyák, K., Velculescu, V. E., Nikolskaya, T., & Nikolsky, Y. (2023). Supplementary Figure 1 from Functional Synergies yet Distinct Modulators Affected by Genetic Alterations in Common Human Cancers. https://doi.org/10.1158/0008-5472.22387967
72. Bessarabova, M., Pustovalova, O., Shi, W., Serebriyskaya, T., Ishkin, A., Polyák, K., Velculescu, V. E., Nikolskaya, T., & Nikolsky, Y. (2023). Supplementary Figure 1 from Functional Synergies yet Distinct Modulators Affected by Genetic Alterations in Common Human Cancers. https://doi.org/10.1158/0008-5472.22387967.v1
73. Bhagwat, S. V., Mur, C., Vandekopple, M., Zhao, B., Shen, W., Marugán, C., Capen, A., Kindler, L., Stephens, J. R., Huber, L., Castanares, M., Garcia-Tapia, D., Cohen, J. D., Bastian, J., Mattioni, B., Yuen, E., Baker, T. K., Cruz, V. R., Fei, D., ... Dios, A. D. (2025). Supplemental Figure 1 from Imlunestrant Is an Oral, Brain-Penetrant Selective Estrogen Receptor Degrader with Potent Antitumor Activity in ESR1 Wild-Type and Mutant Breast Cancer. https://doi.org/10.1158/0008-5472.28428310
74. Bhagwat, S. V., Mur, C., Vandekopple, M., Zhao, B., Shen, W., Marugán, C., Capen, A., Kindler, L., Stephens, J. R., Huber, L., Castanares, M., Garcia-Tapia, D., Cohen, J. D., Bastian, J., Mattioni, B., Yuen, E., Baker, T. K., Cruz, V. R., Fei, D., ... Dios, A. D. (2025). Supplemental Figure 1 from Imlunestrant Is an Oral, Brain-Penetrant Selective Estrogen Receptor Degrader with Potent Antitumor Activity in ESR1 Wild-Type and Mutant Breast Cancer. https://doi.org/10.1158/0008-5472.28431404
75. Bhattacharyya, T., Ghosh, A., Verma, S., Raghu, P., & Sowdhamini, R. (2023). Structural rationale to understand the effect of disease-associated mutations on Myotubularin. Current Research in Structural Biology. https://doi.org/10.1016/j.crstbi.2023.100100
76. Biasio, A. D., Opakua, A. I. D., Cordeiro, T. N., Villate, M., Merino, N., Sibille, N., Lelli, M., Diercks, T., Bernadó, P., & Blanco, F. J. (2014). p15PAF Is an Intrinsically Disordered Protein with Nonrandom Structural Preferences at Sites of Interaction with Other Proteins. Biophysical Journal. https://doi.org/10.1016/j.bpj.2013.12.046
77. Bidwell, J. P. (2010). Faculty Opinions recommendation of Per-1 is a specific clock gene regulated by parathyroid hormone (PTH) signaling in osteoblasts and is functional for the transcriptional events induced by PTH.. Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature. https://doi.org/10.3410/f.7270957.7520055
78. Bignell, C., Malau‐Aduli, A., Nichols, P. D., McCulloch, R., & Kijas, J. (2010). East Friesian sheep carry a <i>Myostatin</i> allele known to cause muscle hypertrophy in other breeds. Animal Genetics. https://doi.org/10.1111/j.1365-2052.2010.02021.x
79. Bisova, V., & Bysova, V. M. (2019). Metacognitive awareness in the structure of personal potential of students. https://doi.org/10.26226/morressier.5cf632c2af72dec2b055498e
80. Bissell, M. (2007). Meta-analysis of the p53 Mutation Database for Mutant p53 Biological Activity Reveals a Methodologic Bias in Mutation Detection. Yearbook of Pathology and Laboratory Medicine. https://doi.org/10.1016/s1077-9108(08)70512-7
81. Blagosklonny, M. V., Toretsky, J. A., & Neckers, L. (1995). Geldanamycin selectively destabilizes and conformationally alters mutated p53.. PubMed.
82. Blankvoort, S., Witter, M. P., Noonan, J. P., Cotney, J., & Kentros, C. G. (2018). Marked Diversity of Unique Cortical Enhancers Enables Neuron-Specific Tools by Enhancer-Driven Gene Expression. Current Biology. https://doi.org/10.1016/j.cub.2018.05.015
83. Blog, U. (2017). EFECTOS DE LA SELENOPROTEÍNA EN EL EJERCICIO.
84. Boivin, S., Saucède, T., Laffont, R., Steimetz, É., & Neige, P. (2018). Correction: Diversification rates indicate an early role of adaptive radiations at the origin of modern echinoid fauna. PLoS ONE. https://doi.org/10.1371/journal.pone.0196375
85. Bordt, E. A., Clerc, P., Roelofs, B. A., Saladino, A. J., Tretter, L., Ádám‐Vizi, V., Cherok, E., Khalil, A., Yadava, N., Ge, S., Francis, T. C., Kennedy, N. W., Picton, L. K., Kumar, T. R., Uppuluri, S., Miller, A. M., Itoh, K., Karbowski, M., Sesaki, H., ... Polster, B. M. (2017). The Putative Drp1 Inhibitor mdivi-1 Is a Reversible Mitochondrial Complex I Inhibitor that Modulates Reactive Oxygen Species. Developmental Cell. https://doi.org/10.1016/j.devcel.2017.02.020
86. Bosi, A., Zanellato, S., Gallazzi, M., Imperatori, A., Dominioni, L., Albini, A., Noonan, D. M., Bruno, A., & Mortara, L. (2018). Natural killer cells from malignant pleural effusion show a decidual-like phenotype and an alternative activatory state..
87. Bossolani, J. W., Sá, M. E. D., Merloti, L. F., Bettiol, J. V. T., Oliveira, G. R. F. D., & Pereira, D. D. S. T. (2017). Plant biostimulant associated with a resistance inducer in the production components of the common bean.. Revista Agro mbiente On-line.
88. Bourcy, M., Suarez‐Carmona, M., Lambert, J., Francart, M., Schroeder, H., Delierneux, C., Skrypek, N., Thompson, E. W., Jérusalem, G., Berx, G., Thiry, M., Blacher, S., Hollier, B. G., Noël, A., Oury, C., Polette, M., & Gilles, C. (2023). Supplementary Figure Legends from Tissue Factor Induced by Epithelial–Mesenchymal Transition Triggers a Procoagulant State That Drives Metastasis of Circulating Tumor Cells. https://doi.org/10.1158/0008-5472.22409394
89. Brakenhoff, R. H. (2011). Another NOTCH for Cancer. Science. https://doi.org/10.1126/science.1210986
90. Brandt, M., Gokden, A., Ziosi, M., & Lappalainen, T. (2020). Additional file 1 of A polyclonal allelic expression assay for detecting regulatory effects of transcript variants. Figshare. https://doi.org/10.6084/m9.figshare.12940507
91. Bravo, T. P., & Vargas, B. B. (2015). PACAP: Lessons From A Potent Migraine Inducer?.
92. Briscoe, A. D. (2024). A genetic cause of male mate preference. Science. https://doi.org/10.1126/science.ado4079
93. Bristow, R. G., Benchimol, S., & Hill, R. P. (1996). The p53 gene as a modifier of intrinsic radiosensitivity: implications for radiotherapy. Radiotherapy and Oncology. https://doi.org/10.1016/0167-8140(96)01806-3
94. Broom, D. M., & Fraser, A. F. (2015). Motivation.. CABI eBooks. https://doi.org/10.1079/9781780645391.0046
95. Brown, F., Bosch, J. A., Aldred, S., Drayson, M. T., & Turner, J. (2016). Abstract # 1810 Exercise induces a differential mobilisation of haematopoietic stem cell subsets into peripheral blood which is partly influenced by donor age.. Brain Behavior and Immunity. https://doi.org/10.1016/j.bbi.2016.07.098
96. Brumbaugh, J., Kim, I. S., Ji, F., Huebner, A. J., Stefano, B. D., Schwarz, B. A., Charlton, J., Coffey, A., Choi, J., Walsh, R., Schindler, J. W., Anselmo, A., Meissner, A., Sadreyev, R. I., Bernstein, B., Hock, H., & Hochedlinger, K. (2019). Inducible histone K-to-M mutations are dynamic tools to probe the physiological role of site-specific histone methylation in vitro and in vivo. Nature Cell Biology. https://doi.org/10.1038/s41556-019-0403-5
97. Brázda, V., Čechová, J., Battistin, M., Coufal, J., Jagelská, E. B., Raimondi, I., & Inga, A. (2016). The structure formed by inverted repeats in p53 response elements determines the transactivation activity of p53 protein. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2016.12.113
98. Budd, A. M., Robins, J. B., Whybird, O., & Jerry, D. R. (2022). Epigenetics underpins phenotypic plasticity of protandrous sex change in fish. Ecology and Evolution. https://doi.org/10.1002/ece3.8730
99. Bull, P. C., Thomas, G. R., Rommens, J. M., Forbes, J., & Cox, D. W. (1993). The Wilson disease gene is a putative copper transporting P–type ATPase similar to the Menkes gene. Nature Genetics. https://doi.org/10.1038/ng1293-327
100. Buranelli, G., Barbosa, M. B., Garcia, C. F. D., Duarte, S. G., Marangoni, A. C., Coelho, L. M. D. F. R., Reis, A. C. M. B., & Isaac, M. D. L. (2009). Mismatch Negativity (MMN) response studies in elderly subjects. Brazilian Journal of Otorhinolaryngology. https://doi.org/10.1016/s1808-8694(15)30545-0
101. Bureau, J. P., Henry, L., Baz, A., Scherrer, K., & Château, M. (1997). Prosomes (proteasomes) changes during differentiation are related to the type of inducer.. Molecular Biology Reports. https://doi.org/10.1023/a:1006856707793
102. Burrus, V., Pavlovic, G., Decaris, B., & Guédon, G. (2002). The ICESt1 element of Streptococcus thermophilus belongs to a large family of integrative and conjugative elements that exchange modules and change their specificity of integration. Plasmid. https://doi.org/10.1016/s0147-619x(02)00102-6
103. Bv, K., Na, M., Rs, B., Vm, R., & Mv, P. (1976). [Study of the immunological specificity of the growth-inhibiting factor, a product of the mutant brachypodism-H gene in the mouse].. PubMed.
104. Bártová, J., Svobodová, K., Podzimek, Š., & Hollá, L. I. (2011). Immune Mechanisms in the Pathogenesis of Periodontitis.
105. Cabrita, M. A., Bose, R., Vanzyl, E. J., Pastic, A., Marcellus, K. A., Pan, E., Hamill, J. D., & McKay, B. C. (2017). The p53 protein induces stable miRNAs that have the potential to modify subsequent p53 responses. Gene. https://doi.org/10.1016/j.gene.2017.01.018
106. Campbell, R. M., Anderson, B. D., Brooks, N. A., Brooks, H. B., Chan, E. M., Dios, A. D., Gilmour, R., Graff, J. R., Jambrina, E., Mader, M. M., McCann, D., Na, S., Parsons, S. H., Pratt, S. E., Shih, C., Stancato, L. F., Starling, J. J., Tate, C. M., Velasco, J. A., ... Ye, X. S. (2023). Supplementary Methods, Table 1 from Characterization of LY2228820 Dimesylate, a Potent and Selective Inhibitor of p38 MAPK with Antitumor Activity. https://doi.org/10.1158/1535-7163.22500811
107. Campbell, R. M., Anderson, B. D., Brooks, N. A., Brooks, H. B., Chan, E. M., Dios, A. D., Gilmour, R., Graff, J. R., Jambrina, E., Mader, M. M., McCann, D., Na, S., Parsons, S. H., Pratt, S. E., Shih, C., Stancato, L. F., Starling, J. J., Tate, C. M., Velasco, J. A., ... Ye, X. S. (2023). Supplementary Methods, Table 1 from Characterization of LY2228820 Dimesylate, a Potent and Selective Inhibitor of p38 MAPK with Antitumor Activity. https://doi.org/10.1158/1535-7163.22500811.v1
108. Campos, M., Macedo, S. B. M., Fernandes, M., Pestana, A., Pardal, J., Baptista, R., Vinagre, J., Sanches, A. C., Baptista, A., Lopes, J. M., & Soares, P. (2018). Les mutations du promoteur de la télomérase sont un biomarqueur pronostique dans le carcinome épidermoïde cutané. Annales de Dermatologie et de Vénéréologie. https://doi.org/10.1016/j.annder.2018.09.045
109. Cao, X., Zhang, Y., Payer, L. M., Lords, H., Steranka, J. P., Burns, K. H., & Xing, J. (2020). Additional file 7 of Polymorphic mobile element insertions contribute to gene expression and alternative splicing in human tissues. Figshare. https://doi.org/10.6084/m9.figshare.12726587
110. Cao, X., Zhang, Y., Payer, L. M., Lords, H., Steranka, J. P., Burns, K. H., & Xing, J. (2020). Additional file 8 of Polymorphic mobile element insertions contribute to gene expression and alternative splicing in human tissues. Figshare. https://doi.org/10.6084/m9.figshare.12726590
111. Cassano, M., Biressi, S., Finan, A., Benedetti, L., Omes, C., Boratto, R., Martin, F., Allegretti, M., Broccoli, V., Angelis, M. G. C. D., Comoglio, P. M., Basilico, C., Torrente, Y., Michieli, P., Cossu, G., & Sampaolesi, M. (2019). Correction: Magic-Factor 1, a Partial Agonist of Met, Induces Muscle Hypertrophy by Protecting Myogenic Progenitors from Apoptosis. PLoS ONE. https://doi.org/10.1371/journal.pone.0220357
112. Castro‐Alamancos, M. A. (1996). The augmenting response, a form of short-term plasticity in the neocortex that is modulated by behavioral state.. PubMed.
113. Chachad, D., Patel, L. R., Recio, C. V., Pourebrahim, R., Whitley, E. M., Wang, W., Su, X., Xu, A., Lee, D., & Lozano, G. (2023). Supplementary Figures from Unique Transcriptional Profiles Underlie Osteosarcomagenesis Driven by Different p53 Mutants. https://doi.org/10.1158/0008-5472.23684083
114. Chachad, D., Patel, L. R., Recio, C. V., Pourebrahim, R., Whitley, E. M., Wang, W., Su, X., Xu, A., Lee, D., & Lozano, G. (2023). Supplementary Figures from Unique Transcriptional Profiles Underlie Osteosarcomagenesis Driven by Different p53 Mutants. https://doi.org/10.1158/0008-5472.23684083.v1
115. Chachad, D., Patel, L. R., Recio, C. V., Pourebrahim, R., Whitley, E. M., Wang, W., Su, X., Xu, A., Lee, D., & Lozano, G. (2023). Supplementary Table 1 from Unique Transcriptional Profiles Underlie Osteosarcomagenesis Driven by Different p53 Mutants. https://doi.org/10.1158/0008-5472.23684080
116. Chachad, D., Patel, L. R., Recio, C. V., Pourebrahim, R., Whitley, E. M., Wang, W., Su, X., Xu, A., Lee, D., & Lozano, G. (2023). Supplementary Table 1 from Unique Transcriptional Profiles Underlie Osteosarcomagenesis Driven by Different p53 Mutants. https://doi.org/10.1158/0008-5472.23684080.v1
117. Chachad, D., Patel, L. R., Recio, C. V., Pourebrahim, R., Whitley, E. M., Wang, W., Su, X., Xu, A., Lee, D., & Lozano, G. (2023). Supplementary Table 2 from Unique Transcriptional Profiles Underlie Osteosarcomagenesis Driven by Different p53 Mutants. https://doi.org/10.1158/0008-5472.23684077
118. Chachad, D., Patel, L. R., Recio, C. V., Pourebrahim, R., Whitley, E. M., Wang, W., Su, X., Xu, A., Lee, D., & Lozano, G. (2023). Supplementary Table 2 from Unique Transcriptional Profiles Underlie Osteosarcomagenesis Driven by Different p53 Mutants. https://doi.org/10.1158/0008-5472.23684077.v1
119. Chachad, D., Patel, L. R., Recio, C. V., Pourebrahim, R., Whitley, E. M., Wang, W., Su, X., Xu, A., Lee, D., & Lozano, G. (2023). Supplementary Table 3 from Unique Transcriptional Profiles Underlie Osteosarcomagenesis Driven by Different p53 Mutants. https://doi.org/10.1158/0008-5472.23684074
120. Chachad, D., Patel, L. R., Recio, C. V., Pourebrahim, R., Whitley, E. M., Wang, W., Su, X., Xu, A., Lee, D., & Lozano, G. (2023). Supplementary Table 3 from Unique Transcriptional Profiles Underlie Osteosarcomagenesis Driven by Different p53 Mutants. https://doi.org/10.1158/0008-5472.23684074.v1
121. Chachad, D., Patel, L. R., Recio, C. V., Pourebrahim, R., Whitley, E. M., Wang, W., Su, X., Xu, A., Lee, D., & Lozano, G. (2023). Supplementary Table 4 from Unique Transcriptional Profiles Underlie Osteosarcomagenesis Driven by Different p53 Mutants. https://doi.org/10.1158/0008-5472.23684071
122. Chachad, D., Patel, L. R., Recio, C. V., Pourebrahim, R., Whitley, E. M., Wang, W., Su, X., Xu, A., Lee, D., & Lozano, G. (2023). Supplementary Table 4 from Unique Transcriptional Profiles Underlie Osteosarcomagenesis Driven by Different p53 Mutants. https://doi.org/10.1158/0008-5472.23684071.v1
123. Chachad, D., Patel, L. R., Recio, C. V., Pourebrahim, R., Whitley, E. M., Wang, W., Su, X., Xu, A., Lee, D., & Lozano, G. (2023). Supplementary Table 5 from Unique Transcriptional Profiles Underlie Osteosarcomagenesis Driven by Different p53 Mutants. https://doi.org/10.1158/0008-5472.23684068
124. Chachad, D., Patel, L. R., Recio, C. V., Pourebrahim, R., Whitley, E. M., Wang, W., Su, X., Xu, A., Lee, D., & Lozano, G. (2023). Supplementary Table 5 from Unique Transcriptional Profiles Underlie Osteosarcomagenesis Driven by Different p53 Mutants. https://doi.org/10.1158/0008-5472.23684068.v1
125. Chachad, D., Patel, L. R., Recio, C. V., Pourebrahim, R., Whitley, E. M., Wang, W., Su, X., Xu, A., Lee, D., & Lozano, G. (2024). Supplementary Figures from Unique transcriptional profiles underlie osteosarcomagenesis driven by different p53 mutants. https://doi.org/10.1158/0008-5472.27027887
126. Chachad, D., Patel, L. R., Recio, C. V., Pourebrahim, R., Whitley, E. M., Wang, W., Su, X., Xu, A., Lee, D., & Lozano, G. (2024). Supplementary Figures from Unique transcriptional profiles underlie osteosarcomagenesis driven by different p53 mutants. https://doi.org/10.1158/0008-5472.27027887.v1
127. Chachad, D., Patel, L. R., Recio, C. V., Pourebrahim, R., Whitley, E. M., Wang, W., Su, X., Xu, A., Lee, D., & Lozano, G. (2024). Supplementary Table 1 from Unique transcriptional profiles underlie osteosarcomagenesis driven by different p53 mutants. https://doi.org/10.1158/0008-5472.27027884
128. Chachad, D., Patel, L. R., Recio, C. V., Pourebrahim, R., Whitley, E. M., Wang, W., Su, X., Xu, A., Lee, D., & Lozano, G. (2024). Supplementary Table 1 from Unique transcriptional profiles underlie osteosarcomagenesis driven by different p53 mutants. https://doi.org/10.1158/0008-5472.27027884.v1
129. Chachad, D., Patel, L. R., Recio, C. V., Pourebrahim, R., Whitley, E. M., Wang, W., Su, X., Xu, A., Lee, D., & Lozano, G. (2024). Supplementary Table 2 from Unique transcriptional profiles underlie osteosarcomagenesis driven by different p53 mutants. https://doi.org/10.1158/0008-5472.27027881
130. Chachad, D., Patel, L. R., Recio, C. V., Pourebrahim, R., Whitley, E. M., Wang, W., Su, X., Xu, A., Lee, D., & Lozano, G. (2024). Supplementary Table 2 from Unique transcriptional profiles underlie osteosarcomagenesis driven by different p53 mutants. https://doi.org/10.1158/0008-5472.27027881.v1
131. Chachad, D., Patel, L. R., Recio, C. V., Pourebrahim, R., Whitley, E. M., Wang, W., Su, X., Xu, A., Lee, D., & Lozano, G. (2024). Supplementary Table 3 from Unique transcriptional profiles underlie osteosarcomagenesis driven by different p53 mutants. https://doi.org/10.1158/0008-5472.27027878
132. Chachad, D., Patel, L. R., Recio, C. V., Pourebrahim, R., Whitley, E. M., Wang, W., Su, X., Xu, A., Lee, D., & Lozano, G. (2024). Supplementary Table 3 from Unique transcriptional profiles underlie osteosarcomagenesis driven by different p53 mutants. https://doi.org/10.1158/0008-5472.27027878.v1
133. Chachad, D., Patel, L. R., Recio, C. V., Pourebrahim, R., Whitley, E. M., Wang, W., Su, X., Xu, A., Lee, D., & Lozano, G. (2024). Supplementary Table 4 from Unique transcriptional profiles underlie osteosarcomagenesis driven by different p53 mutants. https://doi.org/10.1158/0008-5472.27027875
134. Chachad, D., Patel, L. R., Recio, C. V., Pourebrahim, R., Whitley, E. M., Wang, W., Su, X., Xu, A., Lee, D., & Lozano, G. (2024). Supplementary Table 4 from Unique transcriptional profiles underlie osteosarcomagenesis driven by different p53 mutants. https://doi.org/10.1158/0008-5472.27027875.v1
135. Chachad, D., Patel, L. R., Recio, C. V., Pourebrahim, R., Whitley, E. M., Wang, W., Su, X., Xu, A., Lee, D., & Lozano, G. (2024). Supplementary Table 5 from Unique transcriptional profiles underlie osteosarcomagenesis driven by different p53 mutants. https://doi.org/10.1158/0008-5472.27027872
136. Chachad, D., Patel, L. R., Recio, C. V., Pourebrahim, R., Whitley, E. M., Wang, W., Su, X., Xu, A., Lee, D., & Lozano, G. (2024). Supplementary Table 5 from Unique transcriptional profiles underlie osteosarcomagenesis driven by different p53 mutants. https://doi.org/10.1158/0008-5472.27027872.v1
137. Chamseddine, A. N., Wei, Y., Cabrero, M., Gañán‐Gómez, I., Colla, S., Takahashi, K., Yang, H., Estecio, M. R., Bohannan, Z. S., Pierce, S., Bueso‐Ramos, C. E., Kantarjian, H. M., Jabbour, E., & Garcia‐Manero, G. (2015). PDE4 Differential Expression Is a Potential Prognostic Factor and a Therapeutic Target in Myelodysplastic Syndromes. Blood. https://doi.org/10.1182/blood.v126.23.5227.5227
138. Chan, R. J., Voorhorst, C. S., Kondo, T., & Hashino, E. (2005). Activating PTPN11 Mutants Promote Myelomonocytic Differentiation Due to Altered Hematopoietic Lineage-Specific Transcription Factor Expression.. Blood. https://doi.org/10.1182/blood.v106.11.3519.3519
139. Chandler, D. S., Singh, R., Caldwell, L., Bitler, J. L., & Lozano, G. (2023). Supplementary Figure 1 from Genotoxic Stress Induces Coordinately Regulated Alternative Splicing of the p53 Modulators MDM2 and MDM4. https://doi.org/10.1158/0008-5472.22364841
140. Chandler, D. S., Singh, R., Caldwell, L., Bitler, J. L., & Lozano, G. (2023). Supplementary Figure 1 from Genotoxic Stress Induces Coordinately Regulated Alternative Splicing of the p53 Modulators MDM2 and MDM4. https://doi.org/10.1158/0008-5472.22364841.v1
141. Chandradas, S., Deikus, G., Tardos, J. G., Bechhofer, D. H., & Bogdanov, V. Y. (2009). Four SR Proteins Play Opposing Roles in the Regulated Biosynthesis of Tissue Factor in Human Monocytic Cells.. Blood. https://doi.org/10.1182/blood.v114.22.2128.2128
142. Chandran, A. S., Suri, S., & Choudhary, P. (2023). Sustainable plant protein: an up-to-date overview of sources, extraction techniques and utilization. Sustainable Food Technology. https://doi.org/10.1039/d3fb00003f
143. Chang, W., Tu, C., Chen, T., Bikle, D. D., & Shoback, D. (2008). The Extracellular Calcium-Sensing Receptor (CaSR) Is a Critical Modulator of Skeletal Development. Science Signaling. https://doi.org/10.1126/scisignal.1159945
144. Chatterjee, E., Betti, M. J., Sheng, Q., Gamazon, E. R., Emont, M. P., Li, G., Amancherla, K., Garcia‐Contreras, M., Gokulnath, P., Limpitikul, W. B., Whittaker, O. R., Luong, K., Azzam, C., Gee, D. W., Hutter, M., Flanders, K., Sahu, P., Flynn, C. R., Brown, J. D., ... Das, S. (2025). The extracellular vesicle transcriptome provides tissue-specific functional genomic annotation relevant to disease susceptibility in obesity. Cell Genomics. https://doi.org/10.1016/j.xgen.2025.100925
145. Chaudhuri, R., Sadrieh, A., Hoffman, N. J., Parker, B. L., Humphrey, S. J., StĂśckli, J., Hill, A. P., James, D. E., & Yang, J. (2015). Additional file 1: of PhosphOrtholog: a web-based tool for cross-species mapping of orthologous protein post-translational modifications. Figshare. https://doi.org/10.6084/m9.figshare.c.3624176_d2
146. Chen, G. (2015). Phospholamban as a crucial determinant of the inotropic response of human pluripotent stem cell-derived ventricular cardiomyocytes and tissue constructs. https://doi.org/10.5353/th_b5570786
147. Chen, L., Chen, J., Huang, Y.-J., Gu, Y., Qiu, J., Qian, H., Shao, C., Zhang, X., Hu, J., Li, H., He, S., Zhou, Y., Abdel‐Wahab, O., Zhang, D., & Fu, X. (2018). The Augmented R-Loop Is a Unifying Mechanism for Myelodysplastic Syndromes Induced by High-Risk Splicing Factor Mutations. Molecular Cell. https://doi.org/10.1016/j.molcel.2017.12.029
148. Chen, P., Li, Y., Long, Q., Zuo, T., Zhang, Z., Guo, J., Xu, D., Li, K., Liu, S., Li, S., Yin, J., Chang, L., Kukić, P., Liddell, M., Tulum, L., Carmichael, P. L., Peng, S., Li, J., Zhang, Q., & Xu, P. (2023). The phosphoproteome is a first responder in tiered cellular adaptation to chemical stress followed by proteomics and transcriptomics alteration. Chemosphere. https://doi.org/10.1016/j.chemosphere.2023.140329
149. Chen, P., Liu, X., Gu, C., Zhong, P., Song, N., Li, M., Dai, Z., Fang, X., Liu, Z., Zhang, J., Tang, R., Fan, S., & Lin, X. (2022). A plant-derived natural photosynthetic system for improving cell anabolism. Nature. https://doi.org/10.1038/s41586-022-05499-y
150. Chen, T., Greene, G. H., Motley, J., Mwimba, M., Luo, G., Xu, G., Karapetyan, S., Xiang, Y., Liu, C., He, C., & Dong, X. (2024). m <sup>6</sup> A modification plays an integral role in mRNA stability and translation during pattern-triggered immunity. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2411100121
151. Cheng, A. J., Walden, F. V., & Lanner, J. T. (2023). Orai1 as a potential “fits-all approach” therapeutic target for the treatment of DMD. The Journal of General Physiology. https://doi.org/10.1085/jgp.202213224
152. Chhajer, M., & Crippen, G. M. (2002). A protein folding potential that places the native states of a large number of proteins near a local minimum.. BMC Structural Biology. https://doi.org/10.1186/1472-6807-2-4
153. Chiang, C. (2005). Faculty Opinions recommendation of A novel human p53 isoform is an essential element of the ATR-intra-S phase checkpoint.. Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature. https://doi.org/10.3410/f.1027009.326543
154. Chinkers, M., Brugge, J. S., Elbein, A. D., Mitchell, M., Sanford, B. A., Fellows, L. E., & Evans, S. V. (1985). Additions and Corrections. Journal of Biological Chemistry. https://doi.org/10.1016/s0021-9258(18)89687-9
155. Chng, W. J., Keats, J. J., Braggio, E., Baker, A., Bergsagel, P. L., Carpten, J. D., & Fonseca, R. (2007). Multiple Myeloma (MM) Is Characterized by Genomic Instability Regardless of Ploidy Categories and Degree of Karyotypic Complexity Is an Important Prognostic Factor.. Blood. https://doi.org/10.1182/blood.v110.11.1476.1476
156. Chow, K.-H., Shin, D., Jenkins, M. H., Miller, E. E., Shih, D. J., Choi, S., Low, B. E., Philip, V. M., Rybinski, B., Bronson, R. T., Taylor, M. D., & Yun, K. (2023). Supplementary Table 1 from Epigenetic States of Cells of Origin and Tumor Evolution Drive Tumor-Initiating Cell Phenotype and Tumor Heterogeneity. https://doi.org/10.1158/0008-5472.22400670
157. Chow, K.-H., Shin, D., Jenkins, M. H., Miller, E. E., Shih, D. J., Choi, S., Low, B. E., Philip, V. M., Rybinski, B., Bronson, R. T., Taylor, M. D., & Yun, K. (2023). Supplementary Table 1 from Epigenetic States of Cells of Origin and Tumor Evolution Drive Tumor-Initiating Cell Phenotype and Tumor Heterogeneity. https://doi.org/10.1158/0008-5472.22400670.v1
158. Chowdhury, M., Tromp, G., Kuivaniemi, H., Edwin, S., & Romero, R. (2004). Novel functional sequence variants in the promoter of a gene downregulated in preterm prom: A possible genetic basis for the predisposition to membrane rupture?. American Journal of Obstetrics and Gynecology. https://doi.org/10.1016/j.ajog.2004.09.089
159. Chu, S. N., Wang, J., Gillis-Buck, E. M., Qiu, L., Rickert, C. G., & Gardner, J. M. (2024). 442.7: Aire-expressing cells are novel mediators of allograft tolerance in a murine heterotopic heart transplant model.. Transplantation. https://doi.org/10.1097/01.tp.0001066512.78637.9f
160. Cibula, D., Kvasnička, J., Salaj, P., Vorlová, Z., Unzeitig, & Zivný, J. (2003). [Consensus statement regarding indications for Leiden (FVL-factor V Leiden) mutation determination when recommending combined hormonal contraception or hormone replacement therapy].. PubMed.
161. Cifuentes, G., Bermúdez, A., Rodríguez, R., & Patarroyo, M. A. (2015). Shifting the Polarity of some Critical Residues in Malarial Peptides Binding to Host Cells is a Key Factor in Breaking Conserved Antigens. https://doi.org/10.2210/pdb2mua/pdb
162. Cigognetti, M., Lonardi, S., Fisogni, S., Balzarini, P., Pellegrini, V., Tironi, A., Bercich, L., Bugatti, M., Rossi, G., Murer, B., Barbareschi, M., Giuliani, S., Cavazza, A., Marchetti, G., Vermi, W., & Facchetti, F. (2015). BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations. Modern Pathology. https://doi.org/10.1038/modpathol.2015.65
163. Cintas, C., Douché, T., Dantes, Z., Mouton‐Barbosa, E., Bousquet, M., Cayron, C., Therville, N., Pont, F., Ramos‐Delgado, F., Guyon, C., Garmy‐Susini, B., Cappello, P., Burlet‐Schiltz, O., Hirsch, E., Gomez‐Brouchet, A., Thibault, B., Reichert, M., & Guillermet‐Guibert, J. (2023). Supplementary Table 1 from Phosphoproteomics Identifies PI3K Inhibitor–selective Adaptive Responses in Pancreatic Cancer Cell Therapy and Resistance. https://doi.org/10.1158/1535-7163.22522695.v1
164. Clark, N., Galindo, C. G., Patel, V., Parry, M., Stoll, R., Yavorski, J. M., Pinkason, E., Johnson, E., Walker, C., Johnson, J., Sexton, W. J., Coppola, D., & Blanck, G. (2017). MOESM4 of The human, F-actin-based cytoskeleton as a mutagen sensor. Figshare. https://doi.org/10.6084/m9.figshare.5696926
165. Clouse, R. M., Sharma, P. P., Giribet, G., & Wheeler, W. C. (2013). Elongation factor-1α, a putative single-copy nuclear gene, has divergent sets of paralogs in an arachnid. Molecular Phylogenetics and Evolution. https://doi.org/10.1016/j.ympev.2013.04.025
166. Coll-Bonfill, N., Mahajan, U., Shashkova, E. V., Lin, C., Mecham, R. P., & Gonzalo, S. (2022). Progerin induces a phenotypic switch in vascular smooth muscle cells and triggers replication stress and an aging-associated secretory signature. GeroScience. https://doi.org/10.1007/s11357-022-00694-1
167. Collins, J., Fritz, H., & Jochum, M. (1992). Proteinase Inhibitor Candidates for Therapy of Enzyme-Inhibitor Imbalances. Current topics in rehabilitation. https://doi.org/10.1007/978-1-4471-3771-9_8
168. Colosi, H. A., Dulf, E. H., Roman, M. N., & Achimaș, A. (2008). Modeling and Simulation of Controlled Orthodontic Tipping and Translation of Single-rooted Teeth. IEEE International Conference on Automation, Quality and Testing, Robotics. https://doi.org/10.1109/aqtr.2008.4588901
169. Company, M., & Errede, B. (1988). A Ty1 cell-type-specific regulatory sequence is a recognition element for a constitutive binding factor.. Carolina Digital Repository (University of North Carolina at Chapel Hill). https://doi.org/10.17615/7ggz-d266
170. Conejero, V., Bellés, J. M., Domingo, C., Fayos, J., García-Breijo, F., Garro, R., Yago, J. H., Rodrigo, I., Ruiz‐Saurí, A., Tornero, P., & Vera, P. (1991). Tomato pathogenesis-related (PR) proteins as components of the plant response to pathogens ano other stressing agents..
171. Connor, K. M., Hempel, N., Nelson, K. K., Dabiri, G., Gamarra, A., Belarmino, J., Water, L. V. D., Mian, B. M., & Melendez, J. A. (2023). Supplementary Movie 1 from Manganese Superoxide Dismutase Enhances the Invasive and Migratory Activity of Tumor Cells. https://doi.org/10.1158/0008-5472.22370886
172. Connor, K. M., Hempel, N., Nelson, K. K., Dabiri, G., Gamarra, A., Belarmino, J., Water, L. V. D., Mian, B. M., & Melendez, J. A. (2023). Supplementary Movie 1 from Manganese Superoxide Dismutase Enhances the Invasive and Migratory Activity of Tumor Cells. https://doi.org/10.1158/0008-5472.22370886.v1
173. Cook, D. P., & Vanderhyden, B. C. (2022). Transcriptional census of epithelial-mesenchymal plasticity in cancer. Science Advances. https://doi.org/10.1126/sciadv.abi7640
174. Cooper, C., Liggins, A. P., Ait‐Tahar, K., Banham, A. H., & Pulford, K. (2005). Protein Expression Profiles Confirm PASD1 as a Cancer Testis Antigen and a Potential Candidate for Lymphoma Immunotherapy.. Blood. https://doi.org/10.1182/blood.v106.11.2825.2825
175. Cordy, R. J., Nilsson, S., Montgomery, J., Dankwa, S., Egan, E. S., Morahan, B. J., Seydel, K. B., Bertuccini, L., Alano, P., Williamson, K. C., Duraisingh, M. T., Taylor, T. E., Milner, D. A., & Marti, M. (2014). <i>Plasmodium falciparum</i> transmission stages accumulate in the human bone marrow. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.3008882
176. Cruz, C. S. D. (2014). Matrix in the Driver’s Seat. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.3009249
177. Cruz‐Ortega, R., & Ownby, J. D. (1993). A protein similar to PR (pathogenesis-related) proteins is elicited by metal toxicity in wheat roots. Physiologia Plantarum. https://doi.org/10.1034/j.1399-3054.1993.890131.x
178. Cui, G., Perloff, J. K., Plunkett, M., Laks, H., & Sen, L. (2007). Abstract 2135: Alteration Of Metalloproteinase Expression Profile In Proximal Pulmonary Arterial Wall From Patients With Fallot’S Tetralogy. Circulation.
179. Daft, P. G., Yuan, K., Warram, J. M., Klein, M. J., Siegal, G. P., & Zayzafoon, M. (2023). Supplementary Table 1 from Alpha-CaMKII Plays a Critical Role in Determining the Aggressive Behavior of Human Osteosarcoma. https://doi.org/10.1158/1541-7786.22510077
180. Daft, P. G., Yuan, K., Warram, J. M., Klein, M. J., Siegal, G. P., & Zayzafoon, M. (2023). Supplementary Table 1 from Alpha-CaMKII Plays a Critical Role in Determining the Aggressive Behavior of Human Osteosarcoma. https://doi.org/10.1158/1541-7786.22510077.v1
181. Dai, C., Whitesell, L., Rogers, A. B., & Lindquist, S. (2007). Heat Shock Factor 1 Is a Powerful Multifaceted Modifier of Carcinogenesis. Cell. https://doi.org/10.1016/j.cell.2007.07.020
182. Dai, J., Hall, C. L., Escara‐Wilke, J., Mizokami, A., Keller, J. M., & Keller, E. T. (2023). Supplementary Figure 1 from Prostate Cancer Induces Bone Metastasis through Wnt-Induced Bone Morphogenetic Protein-Dependent and Independent Mechanisms. https://doi.org/10.1158/0008-5472.22374852
183. Dai, J., Hall, C. L., Escara‐Wilke, J., Mizokami, A., Keller, J. M., & Keller, E. T. (2023). Supplementary Figure 1 from Prostate Cancer Induces Bone Metastasis through Wnt-Induced Bone Morphogenetic Protein-Dependent and Independent Mechanisms. https://doi.org/10.1158/0008-5472.22374852.v1
184. Dai, J., Zhang, J., Koh, A. J., McCauley, L. K., & Keller, E. T. (2003). Bone morphogenetic proteins and parathyroid hormone-related protein are bone microenvironment factors that modulate prostate cancer -induced bone remodeling through regulation of vascular endothelial growth factor. Proceedings of the American Association for Cancer Research Annual Meeting.
185. Dairaghi, D. J., Shadel, G. S., & Clayton, D. A. (1995). The Alternatively Spliced Form of Human Mitochondrial Transcription Factor a Displays Altered DNA Binding Properties. Progress in cell research. https://doi.org/10.1016/b978-0-444-82235-2.50027-8
186. Dale, E., Frank-Kamenetsky, M., Taborn, K., Aklilu, K., Liu, Y., Berkovitch, S. S., Brown, J. M., Pachamuthu, K., Kumarasamy, J., Mathieu, S., Iwamoto, N., Yin, Y., Yang, H., Standley, S. M., Favaloro, F., Longo, K., Byrne, M., & Vargeese, C. (2020). Stereopure Oligonucleotides for the Selective Silencing of Mutant Huntingtin (4703). Neurology. https://doi.org/10.1212/wnl.94.15_supplement.4703
187. Damaskou, A., Wilson, R. E., Shanmugiah, V., Rak, J., Tzelepis, K., Göttgens, B., Gozdecka, M., & Vassiliou, G. S. (2023). <i>NPM1c</i> Mutations Are Associated with Reduced Levels of Multiple Ribosome Biogenesis Factors Leading to Therapeutic Vulnerabilities. Blood. https://doi.org/10.1182/blood-2023-186084
188. Davis, L., Polk, B. I., Mann, A., Wolff, R. K., Kerr, G. S., Reimold, A., Cannon, G. W., Mikuls, T. R., & Caplan, L. (2014). Folic acid pathway single nucleotide polymorphisms associated with methotrexate significant adverse events in United States veterans with rheumatoid arthritis.. Clinical and Experimental Rheumatology.
189. Davis, R. J. (2012). A Scaffold Switch to Insulate. Science. https://doi.org/10.1126/science.1227747
190. Dawson, C. A., Milevskiy, M. J. G., Capaldo, B. D., Yip, R. K. H., Song, X., Vaillant, F., Prokopuk, L., Jackling, F. C., Smyth, G. K., Chen, Y., Lindeman, G. J., & Visvader, J. E. (2024). Hormone-responsive progenitors have a unique identity and exhibit high motility during mammary morphogenesis. Cell Reports. https://doi.org/10.1016/j.celrep.2024.115073
191. De, S., Musil, F., Ingram, T., Baldauf, C., & Ceriotti, M. (2017). MOESM1 of Mapping and classifying molecules from a high-throughput structural database. Figshare. https://doi.org/10.6084/m9.figshare.c.3698497_d1
192. Debrabant, A., Bastien, P., & Dwyer, D. M. (2001). A unique surface membrane anchored purine-salvage enzyme is conserved among a group of primitive eukaryotic human pathogens.. Molecular and Cellular Biochemistry. https://doi.org/10.1023/a:1010809420104
193. DeGroot, M. S., Shi, H., Eastman, A., McKillop, A. N., & Liu, J. (2018). The <i>Caenorhabditis elegans</i> SMOC-1 Protein Acts Cell Nonautonomously To Promote Bone Morphogenetic Protein Signaling. Genetics. https://doi.org/10.1534/genetics.118.301805
194. Denver, R. J. (1997). Environmental Stress as a Developmental Cue: Corticotropin-Releasing Hormone Is a Proximate Mediator of Adaptive Phenotypic Plasticity in Amphibian Metamorphosis. Hormones and Behavior. https://doi.org/10.1006/hbeh.1997.1383
195. Depreeuw, J., Stelloo, E., Osse, E. M., Creutzberg, C. L., Nout, R. A., Moisse, M., Garcia-Dios, D. A., Dewaele, M., Willekens, K., Marine, J., Matías‐Guiu, X., Amant, F., Lambrechts, D., & Bosse, T. (2023). Figure S4 from Amplification of 1q32.1 Refines the Molecular Classification of Endometrial Carcinoma. https://doi.org/10.1158/1078-0432.22466561
196. Depreeuw, J., Stelloo, E., Osse, E. M., Creutzberg, C. L., Nout, R. A., Moisse, M., Garcia-Dios, D. A., Dewaele, M., Willekens, K., Marine, J., Matías‐Guiu, X., Amant, F., Lambrechts, D., & Bosse, T. (2023). Figure S4 from Amplification of 1q32.1 Refines the Molecular Classification of Endometrial Carcinoma. https://doi.org/10.1158/1078-0432.22466561.v1
197. Devaux, F., Marc, P., Bouchoux, C., Delaveau, T., Hikkel, I., Potier, M., & Jacq, C. (2001). An artificial transcription activator mimics the genome‐wide properties of the yeast Pdr1 transcription factor. EMBO Reports. https://doi.org/10.1093/embo-reports/kve114
198. Deverson, E. V., Gow, I. R., Coadwell, W. J., Monaco, J. J., Butcher, G. W., & Howard, J. C. (2008). Pillars Article: MHC Class II Region Encoding Proteins Related to the Multidrug Resistance Family of Transmembrane Transporters. Nature 1990. 348: 738–741.. The Journal of Immunology.
199. Dhar, S. K., Tangpong, J., Chaiswing, L., Oberley, T. D., & Clair, D. K. S. (2023). Supplementary Figure 1 from Manganese Superoxide Dismutase Is a &lt;i&gt;p53&lt;/i&gt;-Regulated Gene That Switches Cancers between Early and Advanced Stages. https://doi.org/10.1158/0008-5472.22389525
200. Dhar, S. K., Tangpong, J., Chaiswing, L., Oberley, T. D., & Clair, D. K. S. (2023). Supplementary Table 1 from Manganese Superoxide Dismutase Is a &lt;i&gt;p53&lt;/i&gt;-Regulated Gene That Switches Cancers between Early and Advanced Stages. https://doi.org/10.1158/0008-5472.22389519
201. Dias, A., Garcia, C. J., Alfaro, R. J., Majewski, M., Jaworski, T., Skoczylas, T., Wallner, G., Popławski, C., & Sarosiek, J. (2011). Significantly Augmented Salivary Transforming Growth Factor α Secretion in Patients With Barrett's Esophagus Could Potentially Be a Predisposing Factor to Its Malignant Transformation.. Gastroenterology. https://doi.org/10.1016/s0016-5085(11)61237-7
202. Diaz, A. V., & Reis, T. (2020). Muscle signals to the rescue. eLife. https://doi.org/10.7554/elife.64587
203. Dijkman, P. M., Marzluf, T., Zhang, Y., Chang, S. S., Helm, D., Lanzer, M., Bujard, H., & Kudryashev, M. (2021). Structure of the merozoite surface protein 1 from <i>Plasmodium falciparum</i>. Science Advances. https://doi.org/10.1126/sciadv.abg0465
204. Dillard, C., Kiyohara, M., Mah, V., McDermott, S., Bazzoun, D., Tsui, J., Chan, A. M., Haddad, G., Pellegrini, M., Chang, Y., Elshimali, Y., Wu, Y., Vadgama, J. V., Kim, S. R., Goodglick, L., Law, S. M., Patel, D. D., Dhawan, P., O’Brien, N. A., ... Wadehra, M. (2023). Table S3 from EMP2 Is a Novel Regulator of Stemness in Breast Cancer Cells. https://doi.org/10.1158/1535-7163.22521490
205. Dillard, C., Kiyohara, M., Mah, V., McDermott, S., Bazzoun, D., Tsui, J., Chan, A. M., Haddad, G., Pellegrini, M., Chang, Y., Elshimali, Y., Wu, Y., Vadgama, J. V., Kim, S. R., Goodglick, L., Law, S. M., Patel, D. D., Dhawan, P., O’Brien, N. A., ... Wadehra, M. (2023). Table S3 from EMP2 Is a Novel Regulator of Stemness in Breast Cancer Cells. https://doi.org/10.1158/1535-7163.22521490.v1
206. Ding, S., Gu, Y., Cai, Y., Cai, M., Yang, T., Bao, S., Shen, W., Ni, X., Chen, G., & Xing, L. (2020). Additional file 1 of Integrative systems and functional analyses reveal a role of dopaminergic signaling in myelin pathogenesis. Figshare. https://doi.org/10.6084/m9.figshare.11924901
207. Diop, A., Torrance, E. L., Stott, C. M., & Bobay, L. (2022). Additional file 5 of Gene flow and introgression are pervasive forces shaping the evolution of bacterial species. Figshare. https://doi.org/10.6084/m9.figshare.21542222
208. Diotti, R., Kalan, S., Matveyenko, A., & Loayza, D. (2023). Supplemental Figures-Legends from DNA-Directed Polymerase Subunits Play a Vital Role in Human Telomeric Overhang Processing. https://doi.org/10.1158/1541-7786.22517145
209. Dobzhansky, T. (1956). What is an Adaptive Trait?. The American Naturalist. https://doi.org/10.1086/281944
210. Dolatshad, N. F., Brockington, M., Torelli, S., Skordis, L., WEVER, U., Wells, D. J., Muntoni, F., & Brown, S. (2005). Mutated fukutin-related protein (FKRP) localises as wild type in differentiated muscle cells. Experimental Cell Research. https://doi.org/10.1016/j.yexcr.2005.06.017
211. Dongre, A., Rashidian, M., Reinhardt, F., Bagnato, A., Keckesova, Z., Ploegh, H. L., & Weinberg, R. A. (2023). Supplementary Figure 5 from Epithelial-to-Mesenchymal Transition Contributes to Immunosuppression in Breast Carcinomas. https://doi.org/10.1158/0008-5472.22414554
212. Dongre, A., Rashidian, M., Reinhardt, F., Bagnato, A., Keckesova, Z., Ploegh, H. L., & Weinberg, R. A. (2023). Supplementary Figure 5 from Epithelial-to-Mesenchymal Transition Contributes to Immunosuppression in Breast Carcinomas. https://doi.org/10.1158/0008-5472.22414554.v1
213. Dreier, R., Grässel, S., Fuchs, S., Schaumburger, J., & Brückner, P. (2004). Pro-MMP-9 is a specific macrophage product and is activated by osteoarthritic chondrocytes via MMP-3 or a MT1-MMP/MMP-13 cascade. Experimental Cell Research. https://doi.org/10.1016/j.yexcr.2004.02.027
214. Du, J., Malaisé, M., Junk, B., Wittke, K., Zimmermann, M., Reinhardt, D., Doehner, K., Debatin, K., & Corbacioglu, S. (2009). Polymorphisms of Exon 10 in Stem Cell Factor Receptor KIT Are Associated with a Significantly Improved Relapse-Free Survival in Childhood AML.. Blood. https://doi.org/10.1182/blood.v114.22.2636.2636
215. Duterque‐Coquillaud, M., Niel, C., Plaza, S., & Stéhelin, D. (1993). New human erg isoforms generated by alternative splicing are transcriptional activators.. PubMed.
216. Dyjack, N., Azeredo-Tseng, C., & Yıldırım, N. (2017). Mathematical modeling reveals differential regulation of MAPK activity by phosphatase proteins in the yeast pheromone response pathway. Molecular BioSystems. https://doi.org/10.1039/c7mb00213k
217. Dynek, J. N., Chan, S. M., Liu, J., Zha, J., Fairbrother, W. J., & Vucic, D. (2023). Supplementary Figure 2 from Microphthalmia-Associated Transcription Factor Is a Critical Transcriptional Regulator of Melanoma Inhibitor of Apoptosis in Melanomas. https://doi.org/10.1158/0008-5472.22375454
218. Díaz-Carballo, D., Saka, S., Klein, J., Rennkamp, T., Acikelli, A. H., Malak, S., Jastrow, H., Wennemuth, G., Tempfer, C., Schmitz, I., Tannapfel, A., & Strumberg, D. (2023). Supplemental Figure 1 from A Distinct Oncogenerative Multinucleated Cancer Cell Serves as a Source of Stemness and Tumor Heterogeneity. https://doi.org/10.1158/0008-5472.22418948
219. Díaz-Carballo, D., Saka, S., Klein, J., Rennkamp, T., Acikelli, A. H., Malak, S., Jastrow, H., Wennemuth, G., Tempfer, C., Schmitz, I., Tannapfel, A., & Strumberg, D. (2023). Supplemental Figure 1 from A Distinct Oncogenerative Multinucleated Cancer Cell Serves as a Source of Stemness and Tumor Heterogeneity. https://doi.org/10.1158/0008-5472.22418948.v1
220. Ebrahimi, A., Korshunov, A., Reifenberger, G., Capper, D., Felsberg, J., Trisolini, E., Pollo, B., Calatozzolo, C., Prinz, M., Staszewski, O., Schweizer, L., Schittenhelm, J., Harter, P. N., Paulus, W., Thomas, C., Kohlhof‐Meinecke, P., Seiz‐Rosenhagen, M., Milde, T., Casalini, B., ... Stichel, D. (2022). Additional file 1 of Pleomorphic xanthoastrocytoma is a heterogeneous entity with pTERT mutations prognosticating shorter survival. Figshare. https://doi.org/10.6084/m9.figshare.18132339
221. Eckhardt, B. L., Parker, B. S., Laar, R. K. V., Restall, C. M., Natoli, A., Tavaria, M. D., Stanley, K. L., Sloan, E. K., Moseley, J. M., & Anderson, R. L. (2023). Supplementary Data 1 from Genomic Analysis of a Spontaneous Model of Breast Cancer Metastasis to Bone Reveals a Role for the Extracellular Matrix&lt;sup&gt;1&lt;/sup&gt;. https://doi.org/10.1158/1541-7786.22520646
222. Eckhardt, B. L., Parker, B. S., Laar, R. K. V., Restall, C. M., Natoli, A., Tavaria, M. D., Stanley, K. L., Sloan, E. K., Moseley, J. M., & Anderson, R. L. (2023). Supplementary Data 1 from Genomic Analysis of a Spontaneous Model of Breast Cancer Metastasis to Bone Reveals a Role for the Extracellular Matrix&lt;sup&gt;1&lt;/sup&gt;. https://doi.org/10.1158/1541-7786.22520646.v1
223. Eibl, M., Ahmad, R., Wolf, H., Linnau, Y., Gotz, E., & Mannhalter, J. W. (1987). A component of factor VIII preparations which can be separated from factor VIII activity down modulates human monocyte functions. Blood. https://doi.org/10.1182/blood.v69.4.1153.bloodjournal6941153
224. Eigenbrood, J., Wong, N., Mallory, P., Pereira, J. S., Williams, D., Morris-II, D. W., Beck, J. A., Cronk, J. C., Sayers, C. M., Mendez, M., Kaiser, L., Galindo, J., Singh, J., Cardamone, A., Pore, M., Kelly, M. C., LeBlanc, A. K., Cotter, J., Kaplan, R. N., & McEachron, T. A. (2025). Supplemental Table 1 from Spatial Profiling Identifies Regionally Distinct Microenvironments and Targetable Immunosuppressive Mechanisms in Pediatric Osteosarcoma Pulmonary Metastases. https://doi.org/10.1158/0008-5472.29326923
225. Ekstrom, T. L., Hussain, S., Bedekovics, T., Ali, A., Paolini, L., Mahmood, H., Rosok, R. M., Köster, J., Johnsen, S. A., & Galardy, P. J. (2024). Supplementary Figure S11 from USP44 Overexpression Drives a MYC-Like Gene Expression Program in Neuroblastoma through Epigenetic Reprogramming. https://doi.org/10.1158/1541-7786.26934784
226. Ekstrom, T. L., Hussain, S., Bedekovics, T., Ali, A., Paolini, L., Mahmood, H., Rosok, R. M., Köster, J., Johnsen, S. A., & Galardy, P. J. (2024). Supplementary Figure S11 from USP44 Overexpression Drives a MYC-Like Gene Expression Program in Neuroblastoma through Epigenetic Reprogramming. https://doi.org/10.1158/1541-7786.26934784.v1
227. Elgin, R. G., Busby, W. H., & Clemmons, D. R. (1987). An insulin-like growth factor (IGF) binding protein enhances the biologic response to IGF-I.. Carolina Digital Repository (University of North Carolina at Chapel Hill). https://doi.org/10.17615/a9v7-gg94
228. Eliáš, D., Vever, H., Lænkholm, A., Gjerstorff, M. F., Yde, C. W., Lykkesfeldt, A. E., & Ditzel, H. J. (2014). Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy. Oncogene. https://doi.org/10.1038/onc.2014.138
229. Eliáš, D., Vever, H., Lænkholm, A., Gjerstorff, M. F., Yde, C. W., Lykkesfeldt, A. E., & Ditzel, H. J. (2019). Correction: Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy. Oncogene. https://doi.org/10.1038/s41388-019-1096-8
230. Everaert, E., Carro‐Muino, I., Lambrecht, B. N., Joos, G., & Pauwels, R. (1999). Lung antigen presenting cells are an important source of substance P in allergic airway inflammation.. American Journal of Respiratory and Critical Care Medicine.
231. Fahmy, N. M., Fayez, S., Mohamed, R. W., Elissawy, A. M., Eldahshan, O. A., Zengin, G., & Singab, A. N. B. (2024). Moringa oleifera flowers: insights into their aroma chemistry, anti-inflammatory, antioxidant, and enzyme inhibitory properties. BMC Complementary Medicine and Therapies. https://doi.org/10.1186/s12906-024-04579-y
232. Fahs, S. A., Hille, M. T., Shi, Q., Weiler, H., & Montgomery, R. R. (2014). A conditional knockout mouse model reveals endothelial cells as the principal and possibly exclusive source of plasma factor VIII. Blood. https://doi.org/10.1182/blood-2014-02-555151
233. Fain, P. R., McFann, K. K., Taylor, M. R., Tison, M., Johnson, M., Reed, B., & Schrier, R. W. (2005). Modifier genes play a significant role in the phenotypic expression of PKD1. Kidney International. https://doi.org/10.1111/j.1523-1755.2005.00203.x
234. Faisal, M. (2017). Functional characterisation of constitutive expresser of pathogenesis-related genes 5 : a thesis presented in partial fulfilment of the requirements for the degree of Doctor of Philosophy in Molecular Biology at Massey University, Palmerston North, New Zealand.
235. Faktor, J., Pjechová, M., Hernychová, L., & Vojtěšek, B. (2019). Protein Ubiquitination Research in Oncology. Klinicka onkologie. https://doi.org/10.14735/amko20193s56
236. Fan, K.-J., Peng, Y., Ren, Z., Li, D., Zhen, S., Hey, S., Yu, C., Fu, J., Gu, R., Wang, J., Wang, G., & Li, L. (2021). Erratum to: Maize <i>Defective Kernel605</i> Encodes a Canonical DYW-Type PPR Protein that Edits a Conserved Site of <i>nad1</i> and Is Essential for Seed Nutritional Quality. Plant and Cell Physiology. https://doi.org/10.1093/pcp/pcab083
237. Fantl, W. J., Escobedo, J. A., Martin, G. A., Turck, C. W., Rosario, M. D., McCormick, F., & Williams, L. T. (1992). Distinct phosphotyrosines on a growth factor receptor bind to specific molecules that mediate different signaling pathways. Cell. https://doi.org/10.1016/0092-8674(92)90444-h
238. Farmer, D., Bautista, T. G., Jones, S., Stanić, D., & Dutschmann, M. (2014). The midbrain periaqueductal grey has no role in the generation of the respiratory motor pattern, but provides command function for the modulation of respiratory activity. Respiratory Physiology & Neurobiology. https://doi.org/10.1016/j.resp.2014.07.011
239. Fattori, A., Reita, D., Brinkert, D., Willaume, T., Gantzer, J., Karanian, M., Lhermitte, B., Wolf, T., Pinieux, G. D., & Weingertner, N. (2024). Coxal giant cell‐rich tumour harbouring an <i>NUTM1</i> gene fusion: a new molecular subtype of giant cell tumour of bone?. Histopathology. https://doi.org/10.1111/his.15139
240. Feau, S., & Schoenberger, S. P. (2009). Ex Uno Plura. Science. https://doi.org/10.1126/science.1169409
241. Federico, G., Chen, T. C., Battini, R., Saggese, G., & Holick, M. F. (1991). PTH RELATED PEPTIDE (PTHrp) IS A POTENT DIFFERENTIATION FACTOR WHICH INDUCES THE MATURATION OF PERIPHERAL BLOOD MONOCYTES TO FORM MULTINUCLEATED GIANT CELLS IN CULTURE. De Gruyter eBooks. https://doi.org/10.1515/9783110850345-120
242. Feng, S., Wang, Z., Yuan, Y., Wang, X., Sun, H., Chen, N., & Zhang, Y. (2019). Dynamin-related protein 1: A protein critical for mitochondrial fission, mitophagy, and neuronal death in Parkinson’s disease. Pharmacological Research. https://doi.org/10.1016/j.phrs.2019.104553
243. Feng, X., Higgs, B. W., Huang, J., Morehouse, C., Zhu, W., Yao, X., Brohawn, P. Z., Xiao, Z., Sebastian, Y., Liu, Z., Xia, Y., Shen, D., Kuziora, M., Dong, Z., Han, H., Gu, Y., Gu, J., Xia, Q., & Yao, Y. (2015). MOESM1 of 
                     HERC5 is a prognostic biomarker for post-liver transplant recurrent human hepatocellular carcinoma. Figshare. https://doi.org/10.6084/m9.figshare.c.3626357_d2
244. Field, M. G., Decatur, C. L., Kurtenbach, S., Gezgin, G., Velden, P. A. V. D., Jager, M. J., Kozak, K. N., & Harbour, J. W. (2023). Supplementary Figure 1 from PRAME as an Independent Biomarker for Metastasis in Uveal Melanoma. https://doi.org/10.1158/1078-0432.22456832
245. Field, M. G., Decatur, C. L., Kurtenbach, S., Gezgin, G., Velden, P. A. V. D., Jager, M. J., Kozak, K. N., & Harbour, J. W. (2023). Supplementary Figure 1 from PRAME as an Independent Biomarker for Metastasis in Uveal Melanoma. https://doi.org/10.1158/1078-0432.22456832.v1
246. Finnigan, T. J. A., Wall, B. T., Wilde, P. J., Stephens, F. B., Taylor, S. L., & Freedman, M. (2019). Mycoprotein: The Future of Nutritious Nonmeat Protein, a Symposium Review. Current Developments in Nutrition. https://doi.org/10.1093/cdn/nzz021
247. Floegel, T. A., Giacobbi, P. R., Dzierzewski, J. M., Aiken‐Morgan, A. T., Roberts, B. L., McCrae, C. S., Marsiske, M., & Buman, M. P. (2015). Intervention Markers of Physical Activity Maintenance in Older Adults. American Journal of Health Behavior. https://doi.org/10.5993/ajhb.39.4.5
248. Florio, M., Namba, T., Pääbo, S., Hiller, M., & Huttner, W. Β. (2016). A single splice site mutation in human-specific <i>ARHGAP11B</i> causes basal progenitor amplification. Science Advances. https://doi.org/10.1126/sciadv.1601941
249. Forman, J., Qamar, S., Paci, E., Sandford, R., & Clarke, J. (2005). The Remarkable Mechanical Strength of Polycystin-1 Supports a Direct Role in Mechanotransduction. Journal of Molecular Biology. https://doi.org/10.1016/j.jmb.2005.04.008
250. Forsberg, M., & Westin, G. (1991). Enhancer activation by a single type of transcription factor shows cell type dependence.. The EMBO Journal. https://doi.org/10.1002/j.1460-2075.1991.tb07794.x
251. Fowler, J., Mundy, G. R., Lwin, S. T., & Edwards, C. M. (2023). Supplementary Figures 1-8 from Bone Marrow Stromal Cells Create a Permissive Microenvironment for Myeloma Development: A New Stromal Role for Wnt Inhibitor Dkk1. https://doi.org/10.1158/0008-5472.22394597
252. Fowler, J., Mundy, G. R., Lwin, S. T., & Edwards, C. M. (2023). Supplementary Figures 1-8 from Bone Marrow Stromal Cells Create a Permissive Microenvironment for Myeloma Development: A New Stromal Role for Wnt Inhibitor Dkk1. https://doi.org/10.1158/0008-5472.22394597.v1
253. Frankowski, K. J., Wang, C., Patnaik, S., Schoenen, F. J., Southall, N., Li, D., Teper, Y., Sun, W., Kandela, I., Hu, D., Dextras, C., Knotts, Z., Bian, Y., Norton, J. T., Titus, S., Lewandowska, M. A., Wen, Y., Farley‐Barnes, K. I., Griner, L. A. M., ... Huang, S. (2018). Metarrestin, a perinucleolar compartment inhibitor, effectively suppresses metastasis. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.aap8307
254. Frey, U. H., Michalsen, A., Merse, S., Gj, D., & Siffert, W. (2008). A functional GNAS promoter polymorphism is associated with altered weight loss during short-term fasting.. PubMed.
255. Frid, M., Burke, D., Anwar, J., Thukaram, R., & Stenmark, K. (2009). Hypoxia-Induced Pulmonary Artery Remodeling Is Associated with Emergence of Mesenchymal Cells with Progenitor-Like Characteristics.. https://doi.org/10.1164/ajrccm-conference.2009.179.1_meetingabstracts.a1840
256. Friedli, A., Fischer, E., Novak‐Hofer, I., Cohrs, S., Ballmer‐Hofer, K., Schubiger, P. A., Schibli, R., & Grünberg, J. (2009). The soluble form of the cancer-associated L1 cell adhesion molecule is a pro-angiogenic factor. The International Journal of Biochemistry & Cell Biology. https://doi.org/10.1016/j.biocel.2009.01.006
257. Fu, R. (2023). Statistic data. Figshare. https://doi.org/10.6084/m9.figshare.24117624
258. Fu, X., Yuan, Y., Jha, A., Giltrap, A. M., Levin, N., Ren, J., Mamalis, D., Mohammed, S., & Davis, B. G. (2023). Stereoretentive Post-Translational Protein Editing. Zenodo (CERN European Organization for Nuclear Research). https://doi.org/10.5281/zenodo.7011026
259. Fujiwara, H., Okuda, H., Omi, T., Iwamoto, S., Tanaka, Y., Takahashi, J., Tani, Y., Minakami, H., Araki, S., Sato, I., & Kajii, E. (1999). The STR polymorphisms in intron 8 may provide information about the molecular evolution of RH haplotypes. Human Genetics. https://doi.org/10.1007/s004390050958
260. Fujiwara, S., Nawa, A., Nakanishi, T., Shimoyama, Y., Kajiyama, H., Shibata, K., Ino, K., Nakamura, S., Kikkawa, F., & Yatabe, Y. (2009). Thyroid transcription factor 1 expression in ovarian carcinomas is an independent prognostic factor. Human Pathology. https://doi.org/10.1016/j.humpath.2009.09.010
261. Fujiwara, T., Kagawa, S., Ogawa, N., Yasuda, T., Tanaka, N., Orita, K., Cai, D., Zhang, W. W., & Roth, J. A. (1996). [Recombinant virus-mediated transfer of the wild-type p53 gene is a potent therapeutic strategy for human cancer].. PubMed.
262. Fukushima, T., Maruyama, K., Mochizuki, S., Kawamura, K., & Miyauchi, M. (1992). Human T-cell leukemia virus type I as agent inducing genetic changes in infected human lymphocytes.. PubMed.
263. Fung, K. L., Pan, J., Ohnuma, S., Lund, P. E., Pixley, J. N., Kimchi‐Sarfaty, C., Ambudkar, S. V., & Gottesman, M. M. (2023). Supplementary Methods from &lt;i&gt;MDR1&lt;/i&gt; Synonymous Polymorphisms Alter Transporter Specificity and Protein Stability in a Stable Epithelial Monolayer. https://doi.org/10.1158/0008-5472.22400628
264. Gallagher, J. E., Ser, S. L., Ayers, M. C., Nassif, C., & Pupo, A. (2020). The Polymorphic PolyQ Tail Protein of the Mediator Complex, Med15, Regulates Variable Response to Diverse Stresses.
265. Gannon, J., Greaves, R., Iggo, R., & Lane, D. P. (1990). Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form.. The EMBO Journal. https://doi.org/10.1002/j.1460-2075.1990.tb08279.x
266. Gao, Y., Sarode, A., Kokoroskos, N., Ukidve, A., Zhao, Z., Guo, S., Flaumenhaft, R., Gupta, A. S., Saillant, N., & Mitragotri, S. (2020). A polymer-based systemic hemostatic agent. Science Advances. https://doi.org/10.1126/sciadv.aba0588
267. García-Moreno, C., Gómara, M. J., Sanmartí, R., & Haro, I. (2022). Peptides Bearing Multiple Post-Translational Modifications as Antigenic Targets for Biomarkers towards Personalized Rheumatology. https://doi.org/10.17952/36eps/36eps.2022.171
268. Gargalionis, A. N., Papavassiliou, K. A., & Papavassiliou, A. G. (2024). mTOR Signaling: Recent Progress. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25052587
269. Gawłowska, M., Święcicki, W., Gorny, A., Ratajczak, D., Niewiadomska, A., & Boros, L. (2019). Identyfikacja rejonów w genomie grochu, warunkujących wybrane parametry sprawności fizjologicznej, jako istotnego elementu odporności na stresy abiotyczne. Biuletyn Instytutu Hodowli i Aklimatyzacji Roślin. https://doi.org/10.37317/biul-2019-0075
270. Gc, A., Ga, T., Saracco, G. M., Rizzetto, M., Bellone, G., Capaldi, S., & Trapani, C. (1985). [Adult human liver cells grown in a culture media containing a transforming factor similar to epidermal growth factor].. PubMed.
271. Ge, X., Low, M., Zou, P., Li, L., Yin, S. O. S., Bloodworth, B. C., & Koh, H. (2008). Structural elucidation of a PDE-5 inhibitor detected as an adulterant in a health supplement. Journal of Pharmaceutical and Biomedical Analysis. https://doi.org/10.1016/j.jpba.2008.08.019
272. Gellert, J., Agardy, D. A., Kumar, S., Kourtesakis, A., Boschert, T., Jähne, K., Breckwoldt, M. O., Bunse, L., Wick, W., Davies, M. A., Platten, M., & Bunse, T. (2024). Supplementary Figure S4 from Tumoral Interferon Beta Induces an Immune-Stimulatory Phenotype in Tumor-Associated Macrophages in Melanoma Brain Metastases. https://doi.org/10.1158/2767-9764.26797529
273. Gellert, J., Agardy, D. A., Kumar, S., Kourtesakis, A., Boschert, T., Jähne, K., Breckwoldt, M. O., Bunse, L., Wick, W., Davies, M. A., Platten, M., & Bunse, T. (2024). Supplementary Figure S4 from Tumoral Interferon Beta Induces an Immune-Stimulatory Phenotype in Tumor-Associated Macrophages in Melanoma Brain Metastases. https://doi.org/10.1158/2767-9764.26797529.v1
274. Gellert, J., Agardy, D. A., Kumar, S., Kourtesakis, A., Boschert, T., Jähne, K., Breckwoldt, M. O., Bunse, L., Wick, W., Davies, M. A., Platten, M., & Bunse, T. (2024). Supplementary Figure S4 from Tumoral Interferon Beta Induces an Immune-Stimulatory Phenotype in Tumor-Associated Macrophages in Melanoma Brain Metastases. https://doi.org/10.1158/2767-9764.27628013
275. Gellert, J., Agardy, D. A., Kumar, S., Kourtesakis, A., Boschert, T., Jähne, K., Breckwoldt, M. O., Bunse, L., Wick, W., Davies, M. A., Platten, M., & Bunse, T. (2024). Supplementary Table S4 from Tumoral Interferon Beta Induces an Immune-Stimulatory Phenotype in Tumor-Associated Macrophages in Melanoma Brain Metastases. https://doi.org/10.1158/2767-9764.26797517
276. Gellert, J., Agardy, D. A., Kumar, S., Kourtesakis, A., Boschert, T., Jähne, K., Breckwoldt, M. O., Bunse, L., Wick, W., Davies, M. A., Platten, M., & Bunse, T. (2024). Supplementary Table S4 from Tumoral Interferon Beta Induces an Immune-Stimulatory Phenotype in Tumor-Associated Macrophages in Melanoma Brain Metastases. https://doi.org/10.1158/2767-9764.26797517.v1
277. Gellert, J., Agardy, D. A., Kumar, S., Kourtesakis, A., Boschert, T., Jähne, K., Breckwoldt, M. O., Bunse, L., Wick, W., Davies, M. A., Platten, M., & Bunse, T. (2024). Supplementary Table S4 from Tumoral Interferon Beta Induces an Immune-Stimulatory Phenotype in Tumor-Associated Macrophages in Melanoma Brain Metastases. https://doi.org/10.1158/2767-9764.27628001
278. Gellert, J., Agardy, D. A., Kumar, S., Kourtesakis, A., Boschert, T., Jähne, K., Breckwoldt, M. O., Bunse, L., Wick, W., Davies, M. A., Platten, M., & Bunse, T. (2025). Supplementary Figure S4 from Tumoral Interferon Beta Induces an Immune-Stimulatory Phenotype in Tumor-Associated Macrophages in Melanoma Brain Metastases. https://doi.org/10.1158/2767-9764.28688605
279. Gellert, J., Agardy, D. A., Kumar, S., Kourtesakis, A., Boschert, T., Jähne, K., Breckwoldt, M. O., Bunse, L., Wick, W., Davies, M. A., Platten, M., & Bunse, T. (2025). Supplementary Table S4 from Tumoral Interferon Beta Induces an Immune-Stimulatory Phenotype in Tumor-Associated Macrophages in Melanoma Brain Metastases. https://doi.org/10.1158/2767-9764.28688593
280. Gentile, A., Lazzari, L., Benvenuti, S., Trusolino, L., & Comoglio, P. M. (2023). Supplementary Figure 1 from Ror1 Is a Pseudokinase That Is Crucial for Met-Driven Tumorigenesis. https://doi.org/10.1158/0008-5472.22390244
281. Gentile, A., Lazzari, L., Benvenuti, S., Trusolino, L., & Comoglio, P. M. (2023). Supplementary Figure 1 from Ror1 Is a Pseudokinase That Is Crucial for Met-Driven Tumorigenesis. https://doi.org/10.1158/0008-5472.22390244.v1
282. Gentile, A., Lazzari, L., Benvenuti, S., Trusolino, L., & Comoglio, P. M. (2023). Supplementary Figure 2 from Ror1 Is a Pseudokinase That Is Crucial for Met-Driven Tumorigenesis. https://doi.org/10.1158/0008-5472.22390241
283. Gentile, A., Lazzari, L., Benvenuti, S., Trusolino, L., & Comoglio, P. M. (2023). Supplementary Figure 2 from Ror1 Is a Pseudokinase That Is Crucial for Met-Driven Tumorigenesis. https://doi.org/10.1158/0008-5472.22390241.v1
284. Gentile, A., Lazzari, L., Benvenuti, S., Trusolino, L., & Comoglio, P. M. (2023). Supplementary Figure 3 from Ror1 Is a Pseudokinase That Is Crucial for Met-Driven Tumorigenesis. https://doi.org/10.1158/0008-5472.22390238
285. Gentile, A., Lazzari, L., Benvenuti, S., Trusolino, L., & Comoglio, P. M. (2023). Supplementary Figure 3 from Ror1 Is a Pseudokinase That Is Crucial for Met-Driven Tumorigenesis. https://doi.org/10.1158/0008-5472.22390238.v1
286. Gentile, A., Lazzari, L., Benvenuti, S., Trusolino, L., & Comoglio, P. M. (2023). Supplementary Figure 4 from Ror1 Is a Pseudokinase That Is Crucial for Met-Driven Tumorigenesis. https://doi.org/10.1158/0008-5472.22390235
287. Gentile, A., Lazzari, L., Benvenuti, S., Trusolino, L., & Comoglio, P. M. (2023). Supplementary Figure 4 from Ror1 Is a Pseudokinase That Is Crucial for Met-Driven Tumorigenesis. https://doi.org/10.1158/0008-5472.22390235.v1
288. Gentile, A., Lazzari, L., Benvenuti, S., Trusolino, L., & Comoglio, P. M. (2023). Supplementary Figure 5 from Ror1 Is a Pseudokinase That Is Crucial for Met-Driven Tumorigenesis. https://doi.org/10.1158/0008-5472.22390229
289. Gentile, A., Lazzari, L., Benvenuti, S., Trusolino, L., & Comoglio, P. M. (2023). Supplementary Figure 5 from Ror1 Is a Pseudokinase That Is Crucial for Met-Driven Tumorigenesis. https://doi.org/10.1158/0008-5472.22390229.v1
290. George, S., Milea, A., & Shaw, P. A. (2023). Supplementary Table 1 from Proliferation in the Normal FTE Is a Hallmark of the Follicular Phase, Not BRCA Mutation Status. https://doi.org/10.1158/1078-0432.22447017
291. George, S., Milea, A., & Shaw, P. A. (2023). Supplementary Table 1 from Proliferation in the Normal FTE Is a Hallmark of the Follicular Phase, Not BRCA Mutation Status. https://doi.org/10.1158/1078-0432.22447017.v1
292. Gerakopoulos, V., Ramos, C., Müller, C., Walterskirchen, N., Vintila, S., Zotter, C., Ilg, M., Pap, A., Riss, S., Bergmann, M., Unger, L., Vogt, A. B., Oehler, R., & Lukowski, S. W. (2025). Single-cell transcriptomic analysis identifies tissue-specific fibroblasts as the main modulators of myeloid cells in peritoneal metastasis of different origin. Cancer Letters. https://doi.org/10.1016/j.canlet.2025.217678
293. Giletto, M. B., Osmulski, P. A., Jones, C. L., Gaczyńska, M., & Tepe, J. J. (2019). Pipecolic esters as minimized templates for proteasome inhibition. Organic & Biomolecular Chemistry. https://doi.org/10.1039/c9ob00122k
294. Ginckel, R. V., Penant, S., Gaussin, J., Darro, F., & Kiss, R. (2004). Syngeneic mouse tumor models remain a useful tool to select compounds for further development..
295. Gioannini, T. L., Weiss, E. R., Johnson, G. L., Hiller, J. M., & Simon, E. J. (1992). Immunoblots with rhodopsin antisera suggest that a purified mu opioid binding protein has structural characteristics of a G-protein-coupled receptor.. Carolina Digital Repository (University of North Carolina at Chapel Hill). https://doi.org/10.17615/0m52-1k16
296. Godfried, M. H., Romijn, J. A., Poll, T. V. D., Weverling, G. J., Corssmit, E. P., Endert, E., Schattenkerk, J. K. M. E., & Sauerwein, H. (1995). Soluble receptors for tumor necrosis factor are markers for clinical course but not for major metabolic changes in human immunodeficiency virus infection. Metabolism. https://doi.org/10.1016/0026-0495(95)90076-4
297. Goebl, M. G. (1990). The PU.1 transcription factor is the product of the putative oncogene Spi-1. Cell. https://doi.org/10.1016/0092-8674(90)90676-6
298. Goldman, M. E., Ransone, L. J., Anderson, D. W., Gaarde, W. A., Suto, M. J., Sullivan, R. W., Shorthouse, R., Morikawa, M., & Morris, R. E. (1996). SP100030 is a novel T-cell-specific transcription factor inhibitor that possesses immunosuppressive activity in vivo.. PubMed.
299. Gonen, N., Futtner, C. R., Wood, S., Garcia-Moreno, S. A., Salamone, I. M., Samson, S. C., Sekido, R., Poulat, F., Maatouk, D. M., & Lovell‐Badge, R. (2018). Sex reversal following deletion of a single distal enhancer of <i>Sox9</i>. Science. https://doi.org/10.1126/science.aas9408
300. Good, M., Chu, T., Shaw, P., McClain, L., Chamberlain, A., Castro, C. A., Rimer, J. M., Mihi, B., Gong, Q., Nolan, L. S., Cooksey, K., Linneman, L., Agrawal, P., Finegold, D. N., & Peters, D. G. (2020). Additional file 1 of Global hypermethylation of intestinal epithelial cells is a hallmark feature of neonatal surgical necrotizing enterocolitis. Figshare. https://doi.org/10.6084/m9.figshare.13468311
301. Gough, N. R. (2012). A Coincidence Detector with a Memory. Science Signaling. https://doi.org/10.1126/scisignal.2002954
302. Gough, N. R. (2015). Changing properties of interneurons. Science Signaling. https://doi.org/10.1126/scisignal.aad4150
303. Graaff, P. D., Berrevoets, C., Laar, A. V., Tomassen, M., Wichers, H. J., Debets, R., & Govers, C. (2019). Food-derived β-glucans polarize M2 macrophages towards an M1-like phenotype characterized by production of T cell chemo-attractants.
304. Grabiner, B. C., Nardi, V., Birsoy, K., Possemato, R., Shen, K., Sinha, S., Jordan, A., Beck, A. H., & Sabatini, D. M. (2023). Supplementary Figure 6 from A Diverse Array of Cancer-Associated &lt;i&gt;MTOR&lt;/i&gt; Mutations Are Hyperactivating and Can Predict Rapamycin Sensitivity. https://doi.org/10.1158/2159-8290.22529642.v1
305. Grandt, D., Schimiczek, M., Feth, F., Ahrens, O., Rascher, W., Goebell, H., Reeve, J., Mc, M., & Ve, E. (1992). Peptide YY 3–36 is an endogenous Y2 selective agonist and a major molecular form of PYY in circulating blood in man. Regulatory Peptides. https://doi.org/10.1016/0167-0115(92)90240-u
306. Gray, J. C., Bevan, M., Brutnell, T. P., Buell, C. R., Cone, K. C., Hake, S., Jackson, D., Kellogg, E. A., Lawrence, C. J., McCouch, S. R., Mockler, T. C., Moose, S. P., Paterson, A., Peterson, T., Rokshar, D., Souza, G. M., Springer, N. M., Stein, N., Timmermans, M. C., ... Grotewold, E. (2009). A Recommendation for Naming Transcription Factor Proteins in the Grasses. PLANT PHYSIOLOGY. https://doi.org/10.1104/pp.108.128504
307. Gray, K. J., DiGruccio, M. R., Roberts, J., Weaver, V., Marcinczyk, R., Lyons, L., Wanninayake, U., Liu, S., Brignol, N., Sheikh, O., Booth, C. J., Ortmeier, S. B., White, K. M., Do, H., & Gotshall, R. (2024). M021 (rhGAA) has a unique glycosylation profile which enables more efficient glycogen reduction and may allow for alternative Pompe ERT dosing strategies. Molecular Genetics and Metabolism. https://doi.org/10.1016/j.ymgme.2023.107861
308. Grillo, G., Keshavarzian, T., Linder, S., Arlidge, C., Mout, L., Nand, A., Teng, M., Qamra, A., Zhou, S., Kron, K. J., Murison, A., Hawley, J. R., Fraser, M., Kwast, T. V. D., Raj, G. V., He, H. H., Zwart, W., & Lupien, M. (2023). Supplementary Table S4 from Transposable Elements Are Co-opted as Oncogenic Regulatory Elements by Lineage-Specific Transcription Factors in Prostate Cancer. https://doi.org/10.1158/2159-8290.24473978
309. Grillo, G., Keshavarzian, T., Linder, S., Arlidge, C., Mout, L., Nand, A., Teng, M., Qamra, A., Zhou, S., Kron, K. J., Murison, A., Hawley, J. R., Fraser, M., Kwast, T. V. D., Raj, G. V., He, H. H., Zwart, W., & Lupien, M. (2023). Supplementary Table S4 from Transposable Elements Are Co-opted as Oncogenic Regulatory Elements by Lineage-Specific Transcription Factors in Prostate Cancer. https://doi.org/10.1158/2159-8290.24473978.v1
310. Gros, A., Martínez‐Quintanilla, J., Puig, C., Guedan, S., Mollevı́, D. G., Alemany, R., & Cascalló, M. (2023). Supplementary Figure 1 from Bioselection of a Gain of Function Mutation that Enhances Adenovirus 5 Release and Improves Its Antitumoral Potency. https://doi.org/10.1158/0008-5472.22376975
311. Gros, A., Martínez‐Quintanilla, J., Puig, C., Guedan, S., Mollevı́, D. G., Alemany, R., & Cascalló, M. (2023). Supplementary Figure 1 from Bioselection of a Gain of Function Mutation that Enhances Adenovirus 5 Release and Improves Its Antitumoral Potency. https://doi.org/10.1158/0008-5472.22376975.v1
312. Grubor, P., Manojlović, S., Manojlovic, N., & Grubor, M. (2013). Endoprosthesis and Obesity. Medical Archives. https://doi.org/10.5455/medarh.2013.67.446-449
313. Gualberto, A., Hixon, M. L., Finco, T. S., Perkins, N. D., Nabel, G. J., & Baldwin, A. S. (1995). A proliferative p53-responsive element mediates tumor necrosis factor alpha induction of the human immunodeficiency virus type 1 long terminal repeat.. Carolina Digital Repository (University of North Carolina at Chapel Hill). https://doi.org/10.17615/wjja-9s04
314. Guan, C., Zhang, X., & Yu, L. (2024). Figure S1 from A Review of Recent Advances in the Molecular Mechanisms Underlying Brain Metastasis in Lung Cancer. https://doi.org/10.1158/1535-7163.25735645
315. Guan, C., Zhang, X., & Yu, L. (2024). Figure S1 from A Review of Recent Advances in the Molecular Mechanisms Underlying Brain Metastasis in Lung Cancer. https://doi.org/10.1158/1535-7163.25735645.v1
316. Guglielmelli, P., Coltro, G., Mannelli, F., Rotunno, G., Loscocco, G. G., Mannarelli, C., Maccari, C., Paoli, C., Romagnoli, S., Bartalucci, N., & Vannucchi, A. M. (2022). <i>ASXL1</i> mutations are prognostically significant in PMF, but not MF following essential thrombocythemia or polycythemia vera. Blood Advances. https://doi.org/10.1182/bloodadvances.2021006350
317. Guillou, E., Bousquet, C., Daloyau, M., Emorine, L. J., & Belenguer, P. (2005). MSP1P is an intermembrane space dynamin-related protein that mediates mitochondrial fusion in a DNM1P-dependent manner in S.pombe.. HAL (Le Centre pour la Communication Scientifique Directe).
318. Guisan, A., Pitteloud, C., Salamin, N., Litsios, G., Reymond, A., & Jean-Nicolas, P. (2023). Orthopteran partial CO1 DNA sequence data. Figshare. https://doi.org/10.6084/m9.figshare.23605404.v1
319. Guo, C., Gao, Y.-Y., Ju, Q., Wang, M., Zhang, C., Gong, M., & Li, Z. (2021). Additional file 8 of MAPK14 over-expression is a transcriptomic feature of polycythemia vera and correlates with adverse clinical outcomes. Figshare. https://doi.org/10.6084/m9.figshare.14707894
320. Guo, T., Xing, Y., Chen, Z., Wang, X., Zhu, H.-Y., Yang, L., & Yan, Y. (2020). Core-binding factor beta is required for osteoblast differentiation during fibula fracture healing. Research Square (Research Square). https://doi.org/10.21203/rs.2.24603/v2
321. Gupta, A., Weinand, K., Nathan, A., Sakaue, S., Zhang, M. J., Donlin, L. T., Wei, K., Price, A. L., Amariuta, T., & Raychaudhuri, S. (2023). Dynamic regulatory elements in single-cell multimodal data implicate key immune cell states enriched for autoimmune disease heritability. Nature Genetics. https://doi.org/10.1038/s41588-023-01577-7
322. Győrffy, B., Bottai, G., Lehmann‐Che, J., Kéri, G., Örfi, L., Iwamoto, T., Desmedt, C., Bianchini, G., Turner, N. C., Thé, H. D., André, F., Sotiriou, C., Hortobagyi, G. N., Leo, A. D., Pusztai, L., & Santarpia, L. (2014). <i>TP53</i> mutation‐correlated genes predict the risk of tumor relapse and identify MPS1 as a potential therapeutic kinase in <i>TP53</i>‐mutated breast cancers. Molecular Oncology. https://doi.org/10.1016/j.molonc.2013.12.018
323. Göhring, G., Michalová, K., Beverloo, B., Betts, D. R., Harbott, J., Haas, O. A., Kerndrup, G., Sainati, L., Bergstraesser, E., Hasle, H., Starý, J., Trebo, M., Heuvel‐Eibrink, M. V. D., Zecca, M., Fischer, A., Noellke, P., Locatelli, F., Schlegelberger, B., & Niemeyer, C. M. (2007). A Complex Karyotype but Not Monosomy 7 Is an Independent Prognostic Factor in Advanced Childhood MDS.. Blood. https://doi.org/10.1182/blood.v110.11.2452.2452
324. Haertle, L., Barrio, S., Munawar, U., Han, S., Zhou, X., Šimíček, M., Vogt, C., Truger, M., Fernández, R. A., Steinhardt, M., Weingart, J., Šnaurová, R., Nerreter, S., Teufel, E., Garitano-Trojaola, A., Vià, M. C. D., Ruiz‐Heredia, Y., Rosenwald, A., Bolli, N., ... Kortüm, K. M. (2023). Supplementary Table 1 from Single-Nucleotide Variants and Epimutations Induce Proteasome Inhibitor Resistance in Multiple Myeloma. https://doi.org/10.1158/1078-0432.22489568
325. Haertle, L., Barrio, S., Munawar, U., Han, S., Zhou, X., Šimíček, M., Vogt, C., Truger, M., Fernández, R. A., Steinhardt, M., Weingart, J., Šnaurová, R., Nerreter, S., Teufel, E., Garitano-Trojaola, A., Vià, M. C. D., Ruiz‐Heredia, Y., Rosenwald, A., Bolli, N., ... Kortüm, K. M. (2023). Supplementary Table 1 from Single-Nucleotide Variants and Epimutations Induce Proteasome Inhibitor Resistance in Multiple Myeloma. https://doi.org/10.1158/1078-0432.22489568.v1
326. Hajjari, M., Khoshnevisan, A., & Behmanesh, M. (2014). Compositional features are potentially involved in the regulation of gene expression of tumor suppressor genes in human tissues. Gene. https://doi.org/10.1016/j.gene.2014.10.011
327. Haldar, S. M. (2014). The Key to <i>Myheart</i>. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.3010126
328. Halder, I., Champlin, J. J., Sheu, L. K., Goodpaster, B. H., Manuck, S. B., Ferrell, R. E., & Muldoon, M. F. (2014). PPARα gene polymorphisms modulate the association between physical activity and cardiometabolic risk. Nutrition Metabolism and Cardiovascular Diseases. https://doi.org/10.1016/j.numecd.2014.02.007
329. Hall, B. G. (1995). Genetics of selection-induced mutations: I. uvrA, uvrB, uvrC, and uvrD are selection-induced specific mutator loci. Journal of Molecular Evolution. https://doi.org/10.1007/bf00166599
330. Han, Y., Liu, X., Ye, H., Tian, Y., & Ji, Z. (2020). Additional file 1 of Lower mutant-allele tumor heterogeneity is a biomarker in FGFR3-mutant bladder cancer for better prognosis. Figshare. https://doi.org/10.6084/m9.figshare.13294982
331. Hansford, L. M., McKee, A. E., Zhang, L., George, R. E., Gerstle, J. T., Thorner, P. S., Smith, K. M., Look, A. T., Yeger, H., Miller, F. D., Irwin, M. S., Thiele, C. J., & Kaplan, D. R. (2023). Supplementary Figure 1 from Neuroblastoma Cells Isolated from Bone Marrow Metastases Contain a Naturally Enriched Tumor-Initiating Cell. https://doi.org/10.1158/0008-5472.22370480
332. Hansford, L. M., McKee, A. E., Zhang, L., George, R. E., Gerstle, J. T., Thorner, P. S., Smith, K. M., Look, A. T., Yeger, H., Miller, F. D., Irwin, M. S., Thiele, C. J., & Kaplan, D. R. (2023). Supplementary Table 1 from Neuroblastoma Cells Isolated from Bone Marrow Metastases Contain a Naturally Enriched Tumor-Initiating Cell. https://doi.org/10.1158/0008-5472.22370474
333. Hansford, L. M., McKee, A. E., Zhang, L., George, R. E., Gerstle, J. T., Thorner, P. S., Smith, K. M., Look, A. T., Yeger, H., Miller, F. D., Irwin, M. S., Thiele, C. J., & Kaplan, D. R. (2023). Supplementary Table 1 from Neuroblastoma Cells Isolated from Bone Marrow Metastases Contain a Naturally Enriched Tumor-Initiating Cell. https://doi.org/10.1158/0008-5472.22370474.v1
334. Hara, Y., Ogata, Y., & Shirouzu, K. (2000). Early tumor growth in metastatic organs influenced by the microenvironment is an important factor which provides organ specificity of colon cancer metastasis.. PubMed.
335. Harrison, L. (2019). Nerve growth factor promising for dry eye.
336. Hart, M., Diener, C., Lunkes, L., Rheinheimer, S., Krammes, L., Keller, A., & Meese, E. (2023). Additional file 5 of miR-34a-5p as molecular hub of pathomechanisms in Huntington’s disease. Figshare. https://doi.org/10.6084/m9.figshare.22621451
337. Hassan, G., Ohara, T., Afify, S. M., Kumon, K., Zahra, M. H., Fu, X., Kadi, M. A., Seno, A., Salomon, D., & Seno, M. (2022). Additional file 1 of Different pancreatic cancer microenvironments convert iPSCs into cancer stem cells exhibiting distinct plasticity with altered gene expression of metabolic pathways. Figshare. https://doi.org/10.6084/m9.figshare.18864647
338. Hatake, K., Hanamura, T., Motoyoshi, K., Miura, Y., & Saito, M. (1987). Human colony-stimulating factor-producing lung cancer tissue releases a differentiation-inducing factor for human leukemic cells.. PubMed.
339. Hattori, Y., Okamoto, S., Du, W., Yamada, T., Shimada, N., Matsumoto, K., Sagawa, M., & Ikeda, Y. (2008). Hepatocyte Growth Factor-Producing Multiple Myeloma (HGF myeloma) Is a Distinct Clinical Entity and Needs for Molecular Targeted Therapy.. Blood. https://doi.org/10.1182/blood.v112.11.1717.1717
340. Haupt, S. E., Agostino, S. D., Mizrahi, I., Alsheich-Bartok, O., Voorhoeve, M., Damalas, A., Blandino, G., & Haupt, Y. (2023). Supplementary Figure 1 from Promyelocytic Leukemia Protein is Required for Gain of Function by Mutant p53. https://doi.org/10.1158/0008-5472.22377942.v1
341. Haupt, S. E., Agostino, S. D., Mizrahi, I., Alsheich-Bartok, O., Voorhoeve, M., Damalas, A., Blandino, G., & Haupt, Y. (2023). Supplementary Figure 3 from Promyelocytic Leukemia Protein is Required for Gain of Function by Mutant p53. https://doi.org/10.1158/0008-5472.22377936
342. Haupt, S. E., Agostino, S. D., Mizrahi, I., Alsheich-Bartok, O., Voorhoeve, M., Damalas, A., Blandino, G., & Haupt, Y. (2023). Supplementary Figure 3 from Promyelocytic Leukemia Protein is Required for Gain of Function by Mutant p53. https://doi.org/10.1158/0008-5472.22377936.v1
343. Haupt, S. E., Agostino, S. D., Mizrahi, I., Alsheich-Bartok, O., Voorhoeve, M., Damalas, A., Blandino, G., & Haupt, Y. (2023). Supplementary Figure 4 from Promyelocytic Leukemia Protein is Required for Gain of Function by Mutant p53. https://doi.org/10.1158/0008-5472.22377933
344. Haupt, S. E., Agostino, S. D., Mizrahi, I., Alsheich-Bartok, O., Voorhoeve, M., Damalas, A., Blandino, G., & Haupt, Y. (2023). Supplementary Figure 4 from Promyelocytic Leukemia Protein is Required for Gain of Function by Mutant p53. https://doi.org/10.1158/0008-5472.22377933.v1
345. He, C., Tang, Y., Chen, X., Long, T., He, Y.-N., Wei, J., Wu, J., Lan, C., Yu, L., Huang, F., Gu, C., Liu, J., Yu, C., Wong, V. K. W., Law, B. Y. K., Qin, D., Wu, A., & Zhou, X. (2022). Folium Hibisci Mutabilis extract, a potent autophagy enhancer, exhibits neuroprotective properties in multiple models of neurodegenerative diseases. Phytomedicine. https://doi.org/10.1016/j.phymed.2022.154548
346. He, L., Sun, G., & Zhang, P. (2009). [Apoptotic protease activating factor 1 inducing apoptosis and related anti-tumor therapy -- review].. Journal of Experimental Hematology.
347. Heimberger, T., Andrulis, M., Fischbach, S., Stühmer, T., Einsele, H., Bargou, R. C., & Chatterjee, M. (2009). Inhibition of the Heat Shock Transcription Factor 1 as a Potential New Therapeutic Strategy to Target Multiple Oncogenic Heat Shock Proteins in Multiple Myeloma.. Blood. https://doi.org/10.1182/blood.v114.22.2829.2829
348. Heinen, S., Wiehl, U., Lauer, N., Dahse, H., Hartmann, A., Schirmer, S., Enghardt, T., Wallich, R., Hälbich, S., Mihlan, M., Schlötzer‐Schrehardt, U., Zipfel, P. F., & Skerka, C. (2008). Disease associated protein complement factor H related protein 1 (CFHR1) is a regulator of the human alternative complement pathway. Molecular Immunology. https://doi.org/10.1016/j.molimm.2008.08.027
349. Hensley, K., & Denton, T. T. (2014). Alternative functions of the brain transsulfuration pathway represent an underappreciated aspect of brain redox biochemistry with significant potential for therapeutic engagement. Free Radical Biology and Medicine. https://doi.org/10.1016/j.freeradbiomed.2014.10.581
350. Herrera, M., Islam, A. B., Herrera, A., Martín, P., Garcı́a, V., Silva, J., Garcia, J. M., Salas, C., Casal, J. I., Herreros, A. G. D., Bonilla, F., & Peña, C. (2023). Supplementary Figure 2 from Functional Heterogeneity of Cancer-Associated Fibroblasts from Human Colon Tumors Shows Specific Prognostic Gene Expression Signature. https://doi.org/10.1158/1078-0432.22449891
351. Herrera, M., Islam, A. B., Herrera, A., Martín, P., Garcı́a, V., Silva, J., Garcia, J. M., Salas, C., Casal, J. I., Herreros, A. G. D., Bonilla, F., & Peña, C. (2023). Supplementary Figure 2 from Functional Heterogeneity of Cancer-Associated Fibroblasts from Human Colon Tumors Shows Specific Prognostic Gene Expression Signature. https://doi.org/10.1158/1078-0432.22449891.v1
352. Herzinger, T., Wolf, D. A., Eick, D., & Kind, P. (1995). The pRb-related protein p130 is a possible effector of transforming growth factor beta 1 induced cell cycle arrest in keratinocytes.. PubMed.
353. Higgins, L. S., Murphy, G., Forno, L. S., Catalano, R., & Cordell, B. (1996). P3 beta-amyloid peptide has a unique and potentially pathogenic immunohistochemical profile in Alzheimer's disease brain.. PubMed.
354. Higuchi, T., Seki, Y., Koike, M., Yasuda, E., Yamada, S., & Kurosawa, H. (2008). 2Cp23 Elucidation of an essential factor that arise the change of differentiation status of embryoid body resulted by seeding ES cells with different cell number.. 日本生物工学会大会講演要旨集.
355. Hikita, H., Satoh, A., Kawashima, T., Toru, M., Tamura, M., Ohhigashi, H., Miyazaki, S., Yoshihide, T., Kobori, A., Nozato, T., Takei, A., Taishi, K., Hiroe, M., Isobe, M., & Atsushi, T. (2008). リポ蛋白質(a)は急性心筋梗塞患者の責任病変でのプラーク形態を決定する重要因子である. Circulation.
356. Hildebrand, M. S., Braden, R., Lauretta, M., Kaspi, A., Leventer, R. J., Anderson, M., Goel, H., Bahlo, M., Scheffer, I. E., Amor, D. J., Janowski, R., Niessing, D., & Morgan, A. (2024). Inherited <i>PURA</i> Pathogenic Variant Associated With a Mild Neurodevelopmental Disorder. Neurology Genetics. https://doi.org/10.1212/nxg.0000000000200181
357. Hiltpold, M., Kadri, N. K., Janett, F., Witschi, U., Schmitz‐Hsu, F., & Pausch, H. (2021). Additional file 5 of Autosomal recessive loci contribute significantly to quantitative variation of male fertility in a dairy cattle population. Figshare. https://doi.org/10.6084/m9.figshare.14344343
358. Hiraga, T., Shimada, M., Okubo, M., Nakanishi, K., Kobayashi, T., & Murase, T. (1996). Lipoprotein(a) is an independent risk factor for multiple cerebral infarctions. Atherosclerosis. https://doi.org/10.1016/0021-9150(95)05743-9
359. Hjertson, M., Sundström, C., Lyman, S. D., Nilsson, K., & Nilsson, G. (1996). Stem cell factor, but not flt3 ligand, induces differentiation and activation of human mast cells.. PubMed.
360. Hobbs, J. W., Maynard, K. R., & Martinowich, K. (2017). 495. Disruption of Brain-Derived Neurotrophic Factor Production from Promoter I Causes Social Behavioral Deficits. Biological Psychiatry. https://doi.org/10.1016/j.biopsych.2017.02.1103
361. Hollick, J. B. (2005). Paramutation in Plants. Encyclopedia of Life Sciences. https://doi.org/10.1038/npg.els.0001199
362. Hontecillas‐Prieto, L., García-Domínguez, D. J., Vaca, D. P., García-Mejías, R., Marcilla, D., Ramírez, G., Sáez, C., & Álava, E. D. (2017). Correction: Multidrug resistance transporter profile reveals MDR3 as a marker for stratification of blastemal Wilms tumour patients. Oncotarget. https://doi.org/10.18632/oncotarget.20708
363. Hoshi, A., Kakizawa, S., Oshima, K., & Nanba, N. (2010). TENGU, a small protein that changes plant morphology.. KAGAKU TO SEIBUTSU.
364. Hoshiko, S., Kawaguchi, M., Fukushima, T., Haruyama, Y., Yorita, K., Tanaka, H., Seiki, M., Inatsu, H., Kitamura, K., & Kataoka, H. (2023). Supplementary Figure 1 from Hepatocyte Growth Factor Activator Inhibitor Type 1 Is a Suppressor of Intestinal Tumorigenesis. https://doi.org/10.1158/0008-5472.22398354
365. Hoshiko, S., Kawaguchi, M., Fukushima, T., Haruyama, Y., Yorita, K., Tanaka, H., Seiki, M., Inatsu, H., Kitamura, K., & Kataoka, H. (2023). Supplementary Figure 1 from Hepatocyte Growth Factor Activator Inhibitor Type 1 Is a Suppressor of Intestinal Tumorigenesis. https://doi.org/10.1158/0008-5472.22398354.v1
366. Hoshiko, S., Kawaguchi, M., Fukushima, T., Haruyama, Y., Yorita, K., Tanaka, H., Seiki, M., Inatsu, H., Kitamura, K., & Kataoka, H. (2023). Supplementary Table 1 from Hepatocyte Growth Factor Activator Inhibitor Type 1 Is a Suppressor of Intestinal Tumorigenesis. https://doi.org/10.1158/0008-5472.22398345
367. Hoshiko, S., Kawaguchi, M., Fukushima, T., Haruyama, Y., Yorita, K., Tanaka, H., Seiki, M., Inatsu, H., Kitamura, K., & Kataoka, H. (2023). Supplementary Table 1 from Hepatocyte Growth Factor Activator Inhibitor Type 1 Is a Suppressor of Intestinal Tumorigenesis. https://doi.org/10.1158/0008-5472.22398345.v1
368. Hosogane, N., Huang, Z., Rawlins, B. A., Liu, X., Boachie-Adjei, O., Boskey, A. L., & Zhu, W. (2010). Stromal derived factor-1 regulates bone morphogenetic protein 2-induced osteogenic differentiation of primary mesenchymal stem cells. The International Journal of Biochemistry & Cell Biology. https://doi.org/10.1016/j.biocel.2010.03.020
369. Hsieh, C.-L., Botta, G., Gao, S., Li, T., Allen, E. M. V., Treacy, D. J., Cai, C., He, H. H., Sweeney, C. J., Brown, M., Balk, S. P., Nelson, P. S., Garraway, L. A., & Kantoff, P. W. (2023). Supplementary Information from PLZF, a Tumor Suppressor Genetically Lost in Metastatic Castration-Resistant Prostate Cancer, Is a Mediator of Resistance to Androgen Deprivation Therapy. https://doi.org/10.1158/0008-5472.22404618
370. Hsieh, C.-L., Botta, G., Gao, S., Li, T., Allen, E. M. V., Treacy, D. J., Cai, C., He, H. H., Sweeney, C. J., Brown, M., Balk, S. P., Nelson, P. S., Garraway, L. A., & Kantoff, P. W. (2023). Supplementary Information from PLZF, a Tumor Suppressor Genetically Lost in Metastatic Castration-Resistant Prostate Cancer, Is a Mediator of Resistance to Androgen Deprivation Therapy. https://doi.org/10.1158/0008-5472.22404618.v1
371. Hsieh, C.-L., Botta, G., Gao, S., Li, T., Allen, E. M. V., Treacy, D. J., Cai, C., He, H. H., Sweeney, C. J., Brown, M., Balk, S. P., Nelson, P. S., Garraway, L. A., & Kantoff, P. W. (2023). Supplementary Table 1 from PLZF, a Tumor Suppressor Genetically Lost in Metastatic Castration-Resistant Prostate Cancer, Is a Mediator of Resistance to Androgen Deprivation Therapy. https://doi.org/10.1158/0008-5472.22404615
372. Hsieh, C.-L., Botta, G., Gao, S., Li, T., Allen, E. M. V., Treacy, D. J., Cai, C., He, H. H., Sweeney, C. J., Brown, M., Balk, S. P., Nelson, P. S., Garraway, L. A., & Kantoff, P. W. (2023). Supplementary Table 1 from PLZF, a Tumor Suppressor Genetically Lost in Metastatic Castration-Resistant Prostate Cancer, Is a Mediator of Resistance to Androgen Deprivation Therapy. https://doi.org/10.1158/0008-5472.22404615.v1
373. Hsu, J. H.-R., Hubbell-Engler, B., Adelmant, G., Huang, J., Joyce, C. E., Vázquez, F., Weir, B. A., Montgomery, P., Tsherniak, A., Giacomelli, A. O., Perry, J. A., Trowbridge, J. J., Fujiwara, Y., Cowley, G. S., Xie, H., Kim, W., Novina, C. D., Hahn, W. C., Marto, J. A., & Orkin, S. H. (2023). Supplementary method from PRMT1-Mediated Translation Regulation Is a Crucial Vulnerability of Cancer. https://doi.org/10.1158/0008-5472.22414182
374. Hsu, J. H.-R., Hubbell-Engler, B., Adelmant, G., Huang, J., Joyce, C. E., Vázquez, F., Weir, B. A., Montgomery, P., Tsherniak, A., Giacomelli, A. O., Perry, J. A., Trowbridge, J. J., Fujiwara, Y., Cowley, G. S., Xie, H., Kim, W., Novina, C. D., Hahn, W. C., Marto, J. A., & Orkin, S. H. (2023). Supplementary method from PRMT1-Mediated Translation Regulation Is a Crucial Vulnerability of Cancer. https://doi.org/10.1158/0008-5472.22414182.v1
375. Hu, M., & Chen, X. (2024). A review of the known MTA-cooperative PRMT5 inhibitors. RSC Advances. https://doi.org/10.1039/d4ra05497k
376. Hu, M., & Santin, J. M. (2022). Raw data from Transformation to ischemia tolerance of frog brain function corresponds with dynamic changes in mRNA co-expression across metabolic pathways. Figshare. https://doi.org/10.6084/m9.figshare.20236844
377. Huang, J., Xue, F., Zhu, R., Guo, D., Wei, Y., Cao, X., Ma, Y., & Shi, D. (2020). Additional file 5 of Comparative transcriptome analysis reveals that PCK1 is a potential gene affecting IMF deposition in buffalo. Figshare. https://doi.org/10.6084/m9.figshare.13083306
378. Huang, J., Xue, F., Zhu, R., Guo, D., Wei, Y., Cao, X., Ma, Y., & Shi, D. (2020). Additional file 6 of Comparative transcriptome analysis reveals that PCK1 is a potential gene affecting IMF deposition in buffalo. Figshare. https://doi.org/10.6084/m9.figshare.13083309
379. Huang, T., Li, J., & Wang, S. M. (2022). Additional file 5 of Core promoter mutation contributes to abnormal gene expression in bladder cancer. Figshare. https://doi.org/10.6084/m9.figshare.18482101
380. Huang, T., Li, J., & Wang, S. M. (2022). Additional file 7 of Core promoter mutation contributes to abnormal gene expression in bladder cancer. Figshare. https://doi.org/10.6084/m9.figshare.18482107
381. Huang, T., Li, J., & Wang, S. M. (2022). Additional file 9 of Core promoter mutation contributes to abnormal gene expression in bladder cancer. Figshare. https://doi.org/10.6084/m9.figshare.18482113
382. Huang, Y., Carrier, G., Cunff, L. L., Vialet, S., Guiraud, J.-L., Torregrosa, L., Bertrand, Y., Cheynier, V., This, P., & Terrier, N. (2013). A MYB factor, identified through expression quantitative locus mapping, negatively regulates the proanthocyanidin pathway in grape berry.. HAL (Le Centre pour la Communication Scientifique Directe).
383. Huang, Y., Chang, H., Huang, S., Cheng, C.-H., Lee, B., Cheng, S.-Y., & Su, K.-H. (2005). Plasma pyridoxal 5′-phosphate is a significant indicator of immune responses in the mechanically ventilated critically ill. Nutrition. https://doi.org/10.1016/j.nut.2004.11.013
384. Huang, Y.-Z., Sang, M., Xi, P.-W., Xu, R.-X., Cai, M., Wang, Z.-W., Zhao, J., Li, Y.-H., Wei, J., & Ding, Q. (2024). Figure S1 from FANCI Inhibition Induces PARP1 Redistribution to Enhance the Efficacy of PARP Inhibitors in Breast Cancer. https://doi.org/10.1158/0008-5472.27231256
385. Huang, Z., Zhang, L., Chen, H., Liu, X., Tan, L., Huang, D., Liu, Y., Wang, Y., Zhang, X., Cheng, A. S., Wang, M. H., Kang, W., To, K., Yu, J., Ko, H., Yu, L., Wong, S. H., Gin, T., Chan, M. T., ... Wu, W. K. K. (2025). Supplementary Table 1 from Tumor Suppressor Genes with Segmental Duplications Are Prone to Somatic Deletions and Structural Variations. https://doi.org/10.1158/0008-5472.29759741
386. Hughes, A. L., Packer, B., Welch, R., Chanock, S. J., & Yeager, M. (2005). High level of functional polymorphism indicates a unique role of natural selection at human immune system loci. Immunogenetics. https://doi.org/10.1007/s00251-005-0052-7
387. Huhnke, F. H., Russo, J. D., Wysmolek, P. M., Diemer, J., Dhanovici, N., Spatz, J. P., & Serwane, F. (2019). The tissue within a retina organoid shows a yield stress, the amount of mechanical stress necessary to induce irreversible deformations, which regulates the retina’s mechanical integrity..
388. Hupkes, M., Someren, E. P. V., Middelkamp, S., Piek, E., Zoelen, E. J. V., & Dechering, K. J. (2011). DNA methylation restricts spontaneous multi-lineage differentiation of mesenchymal progenitor cells, but is stable during growth factor-induced terminal differentiation. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. https://doi.org/10.1016/j.bbamcr.2011.01.022
389. Hurtley, S. M. (2011). Parasite Replication Trigger. Science Signaling. https://doi.org/10.1126/scisignal.4158ec34
390. Hurtley, S. M. (2011). Use It, Then Lose It. Science Signaling. https://doi.org/10.1126/scisignal.4183ec208
391. Hurtley, S. M. (2014). In the PINK1. Science Signaling. https://doi.org/10.1126/scisignal.2005360
392. Hurtley, S. M. (2014). Push Me, Pull You, That’s the Way to Move. Science Signaling. https://doi.org/10.1126/scisignal.2005854
393. Ikeda, M., Hirota, Y., Sakaguchi, M., Yamada, O., Kida, Y. S., Ogura, T., Otsuka, T., Okano, H., & Sawamoto, K. (2009). Role of Diversin as a possible switch of distinct Wnt pathways regulating multiple steps of adult neurogenesis. Neuroscience Research. https://doi.org/10.1016/j.neures.2009.09.129
394. Ikemoto, K. (2002). [Change in gene expression of SPARC, the inducing factor for morphine reverse tolerance].. PubMed.
395. Imai, Y., Busby, W. H., Smith, C. E., Clarke, J. B., Garmong, A. J., Horwitz, G. D., Rees, C., & Clemmons, D. R. (1997). Protease-resistant form of insulin-like growth factor-binding protein 5 is an inhibitor of insulin-like growth factor-I actions on porcine smooth muscle cells in culture.. Carolina Digital Repository (University of North Carolina at Chapel Hill). https://doi.org/10.17615/m32d-h220
396. Indeglia, A., Leung, J. C., Miller, S. A., Leu, J. I.-J., Dougherty, J. F., Clarke, N. L., Kirven, N. A., Shao, C., Ke, L., Lovell, S., Barnoud, T., Lu, D. Y., Lin, C., Kannan, T., Battaile, K., Yang, T. H. L., Oliva, I. B., Claiborne, D. T., Vogel, P., ... Murphy, M. E. (2024). Table S4 from An African-specific variant of TP53 reveals PADI4 as a regulator of p53-mediated tumor suppression. https://doi.org/10.1158/2159-8290.27025556
397. Indeglia, A., Leung, J. C., Miller, S. A., Leu, J. I.-J., Dougherty, J. F., Clarke, N. L., Kirven, N. A., Shao, C., Ke, L., Lovell, S., Barnoud, T., Lu, D. Y., Lin, C., Kannan, T., Battaile, K., Yang, T. H. L., Oliva, I. B., Claiborne, D. T., Vogel, P., ... Murphy, M. E. (2024). Table S4 from An African-specific variant of TP53 reveals PADI4 as a regulator of p53-mediated tumor suppression. https://doi.org/10.1158/2159-8290.27025556.v1
398. Ingraham, H. A., Chen, R., Mangalam, H. J., Elsholtz, H. P., Flynn, S. E., Lin, C. R., Simmons, D. M., Swanson, L. W., & Rosenfeld, M. G. (1988). A tissue-specific transcription factor containing a homeodomain specifies a pituitary phenotype. Cell. https://doi.org/10.1016/0092-8674(88)90038-4
399. Ishikane, S., Ikushima, E., Igawa, K., Tomooka, K., & Takahashi‐Yanaga, F. (2020). Differentiation-inducing factor-1 potentiates adipogenic differentiation and attenuates the osteogenic differentiation of bone marrow-derived mesenchymal stem cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. https://doi.org/10.1016/j.bbamcr.2020.118909
400. Itani, S., Hamie, M., Jammal, R. E., Abdine, W., Doumit, M., Charafeddine, A., El‐Sabban, M., Patinote, C., Deleuze‐Masquéfa, C., Bonnet, P., Obeid, M., & Hajj, H. E. (2024). Imiquimod Reverses Chronic Toxoplasmosis-Associated Behavioral and Neurocognitive Anomalies in a Rat Model. Biomedicines. https://doi.org/10.3390/biomedicines12061295
401. Itonaga, I., Neale, S. D., Smith, R. L., Wass, J., & Athanasou, N. A. (1999). Humoral factors influencing osteoclast differentiation from circulating mononuclear precursors in Paget's disease.. Journal of Bone and Mineral Research.
402. Iwai, R., Inoue, M., Tabata, H., Konno, D., Suzuki, M., Hamakubo, T., Matsuzaki, F., Nagata, K., & Mizutani, K. (2017). Prdm16 is crucial for progression of the multipolar phase during neural differentiation.. The Japanese Biochemical Society/The Molecular Biology Society of Japan.
403. Jacolot, S., Gac, G. L., Scotet, V., Quéré, I., Mura, C., & Férec, C. (2003). HAMP as a modifier gene that increases the phenotypic expression of the HFE pC282Y homozygous genotype. Blood. https://doi.org/10.1182/blood-2003-10-3366
404. Jaeger, A. M., Stopfer, L., Lee, S., Gaglia, G., Sandel, D., Santagata, S., Lin, N. U., Trepel, J. B., White, F. M., Jacks, T., Lindquist, S., & Whitesell, L. (2023). Supplementary Data from Rebalancing Protein Homeostasis Enhances Tumor Antigen Presentation. https://doi.org/10.1158/1078-0432.22475243
405. Jaeger, A. M., Stopfer, L., Lee, S., Gaglia, G., Sandel, D., Santagata, S., Lin, N. U., Trepel, J. B., White, F. M., Jacks, T., Lindquist, S., & Whitesell, L. (2023). Supplementary Data from Rebalancing Protein Homeostasis Enhances Tumor Antigen Presentation. https://doi.org/10.1158/1078-0432.22475243.v1
406. Jankowski, J., Lee, H., Liu, C., Wilflingseder, J., & Hennighausen, L. (2024). Sexually dimorphic renal expression of<i>Klotho</i>is directed by a kidney-specific distal enhancer responsive to HNF1b. bioRxiv (Cold Spring Harbor Laboratory). https://doi.org/10.1101/2024.02.29.582831
407. Jasny, B. R. (2009). From Model to Marker. Science Signaling. https://doi.org/10.1126/scisignal.260ec86
408. Jennings, H. S. (2005). Behavior of paramecium (continued): Special features of the reactions to a number of different classes of stimuli.. Columbia University Press eBooks. https://doi.org/10.1037/10817-004
409. Jeremiasse, B., Matta, C., Fellows, C. R., Boocock, D. J., Smith, J. R., Liddell, S., Lafeber, F., Spil, W. V., & Mobasheri, A. (2020). Additional file 6 of Alterations in the chondrocyte surfaceome in response to pro-inflammatory cytokines. Figshare. https://doi.org/10.6084/m9.figshare.12569651
410. Jia, C., Brown, R. W., Malone, H. M., Burgess, K. C., Gill, W. D., Keasey, M. P., & Hagg, T. (2018). Ciliary neurotrophic factor is a key sex-specific regulator of depressive-like behavior in mice. Psychoneuroendocrinology. https://doi.org/10.1016/j.psyneuen.2018.09.038
411. Jin, W., Yun, C., Kim, H.-S., & Kim, S. (2023). Supplementary Table 1 from TrkC Binds to the Bone Morphogenetic Protein Type II Receptor to Suppress Bone Morphogenetic Protein Signaling. https://doi.org/10.1158/0008-5472.22368014
412. Jin, W., Yun, C., Kim, H.-S., & Kim, S. (2023). Supplementary Table 1 from TrkC Binds to the Bone Morphogenetic Protein Type II Receptor to Suppress Bone Morphogenetic Protein Signaling. https://doi.org/10.1158/0008-5472.22368014.v1
413. Johnson, R. R., Narvaez, J., An, G., Ryan, C. A., Vayda, M. E., & Park, W. D. (1990). Expression of proteinase inhibitor genes from potato and tomato in transgenic plants enhances defense against an insect predator..
414. Johnson, R. W., Nguyen, M. P., Padalecki, S. S., Grubbs, B. G., Merkel, A. R., Oyajobi, B. O., Matrisian, L. M., Mundy, G. R., & Sterling, J. A. (2023). Supplementary Figure 1 from TGF-β Promotion of Gli2-Induced Expression of Parathyroid Hormone-Related Protein, an Important Osteolytic Factor in Bone Metastasis, Is Independent of Canonical Hedgehog Signaling. https://doi.org/10.1158/0008-5472.22391259
415. Johnson, R. W., Nguyen, M. P., Padalecki, S. S., Grubbs, B. G., Merkel, A. R., Oyajobi, B. O., Matrisian, L. M., Mundy, G. R., & Sterling, J. A. (2023). Supplementary Figure 1 from TGF-β Promotion of Gli2-Induced Expression of Parathyroid Hormone-Related Protein, an Important Osteolytic Factor in Bone Metastasis, Is Independent of Canonical Hedgehog Signaling. https://doi.org/10.1158/0008-5472.22391259.v1
416. Jung, Y. H., Wang, H. V., Ali, S., Corces, V. G., & Kremsky, I. (2023). Additional file 3 of Characterization of a strain-specific CD-1 reference genome reveals potential inter- and intra-strain functional variability. Figshare. https://doi.org/10.6084/m9.figshare.23849633
417. Jungmann, J., Reins, H., Lee, J. C.-Y., Romeo, A. M., Hassett, R., Kosman, D. J., & Jentsch, S. (1993). MAC1, a nuclear regulatory protein related to Cu-dependent transcription factors is involved in Cu/Fe utilization and stress resistance in yeast.. The EMBO Journal. https://doi.org/10.1002/j.1460-2075.1993.tb06198.x
418. Jégo, G., Pellat‐Deceunynck, C., David, C., & Regis, B. (2005). Pathogen-Associated Molecular Patterns Are Growth and Survival Factors for Human Myeloma Cells through Toll-Like Receptors.. Blood. https://doi.org/10.1182/blood.v106.11.3403.3403
419. Kalra, R. S., Chaudhary, A., Omar, A., Li, X., Khurana, M., Kaul, S. C., & Wadhwa, R. (2023). Stress-induced changes in CARF expression serve as a quantitative predictive measure of cell proliferation fate. Experimental Cell Research. https://doi.org/10.1016/j.yexcr.2023.113669
420. Kalyanaraman, H., Schwappacher, R., Joshua, J., Zhuang, S., Scott, B. T., Klos, M., Casteel, D. E., Frangos, J. A., Dillmann, W., Boss, G. R., & Pilz, R. B. (2014). Nongenomic Thyroid Hormone Signaling Occurs Through a Plasma Membrane–Localized Receptor. Science Signaling. https://doi.org/10.1126/scisignal.2004911
421. Kaminska, K. H., & Bujnicki, J. M. (2008). Bacteriophage Mu Mom protein responsible for DNA modification is a new member of the acyltransferase superfamily. Cell Cycle. https://doi.org/10.4161/cc.7.1.5158
422. Kan, C. E., Cipriano, R., & Jackson, M. W. (2023). Supplementary Figures 1-8 from c-MYC Functions as a Molecular Switch to Alter the Response of Human Mammary Epithelial Cells to Oncostatin M. https://doi.org/10.1158/0008-5472.22389410
423. Kan, C. E., Cipriano, R., & Jackson, M. W. (2023). Supplementary Figures 1-8 from c-MYC Functions as a Molecular Switch to Alter the Response of Human Mammary Epithelial Cells to Oncostatin M. https://doi.org/10.1158/0008-5472.22389410.v1
424. Kang, J., Toita, R., Tomiyama, T., Oishi, J., Asai, D., Mori, T., Niidome, T., & Katayama, Y. (2009). Cellular signal-specific peptide substrate is essential for the gene delivery system responding to cellular signals. Bioorganic & Medicinal Chemistry Letters. https://doi.org/10.1016/j.bmcl.2009.09.034
425. Kaplan, A. H., Manchester, M., Smith, T., Yang, Y., & Swanstrom, R. (1996). Conditional human immunodeficiency virus type 1 protease mutants show no role for the viral protease early in virus replication.. Carolina Digital Repository (University of North Carolina at Chapel Hill). https://doi.org/10.17615/62gx-y756
426. Karcher, D. (1983). Myelin basic protein, a specific protein of the central nervous system.. PubMed.
427. Karp, C. M., Tan, T. T., Mathew, R., Nelson, D., Mukherjee, C., Degenhardt, K., Karantza‐Wadsworth, V., & White, E. (2023). Supplementary Video 1 from Role of the Polarity Determinant Crumbs in Suppressing Mammalian Epithelial Tumor Progression. https://doi.org/10.1158/0008-5472.22373783
428. Karp, C. M., Tan, T. T., Mathew, R., Nelson, D., Mukherjee, C., Degenhardt, K., Karantza‐Wadsworth, V., & White, E. (2023). Supplementary Video 1 from Role of the Polarity Determinant Crumbs in Suppressing Mammalian Epithelial Tumor Progression. https://doi.org/10.1158/0008-5472.22373783.v1
429. Kaur, J., Adhikari, M., Sabol, H. M., Anloague, A., Khan, S., Kurihara, N., Diaz‐delCastillo, M., Andreasen, C. M., Barnes, C. L., Stambough, J. B., Palmieri, M., Reyes-Castro, O., Zarrer, J., Taipaleenmäki, H., Ambrogini, E., Almeida, M., O’Brien, C. A., Nookaew, I., & Delgado‐Calle, J. (2024). Supplementary figure 1 from Single-Cell Transcriptomic Analysis Identifies Senescent Osteocytes That Trigger Bone Destruction in Breast Cancer Metastasis. https://doi.org/10.1158/0008-5472.27938604
430. Kaur, J., Adhikari, M., Sabol, H. M., Anloague, A., Khan, S., Kurihara, N., Diaz‐delCastillo, M., Andreasen, C. M., Barnes, C. L., Stambough, J. B., Palmieri, M., Reyes-Castro, O., Zarrer, J., Taipaleenmäki, H., Ambrogini, E., Almeida, M., O’Brien, C. A., Nookaew, I., & Delgado‐Calle, J. (2024). Supplementary Table 1 from Single-Cell Transcriptomic Analysis Identifies Senescent Osteocytes That Trigger Bone Destruction in Breast Cancer Metastasis. https://doi.org/10.1158/0008-5472.27938607
431. Kawamura, R., Hayashi, Y., Murakami, H., & Nakashima, M. (2016). Additional file 1: Figure S1. of EDTA soluble chemical components and the conditioned medium from mobilized dental pulp stem cells contain an inductive microenvironment, promoting cell proliferation, migration, and odontoblastic differentiation.
432. Kazamia, R., Keravnou, A., Moushi, A., Sokratous, K., Michailidou, K., Yiangou, K., Soteriou, M., Xenophontos, S., Cariolou, M. A., & Bashiardes, E. (2023). Additional file 1 of Tissue and plasma proteomic profiling indicates AHSG as a potential biomarker for ascending thoracic aortic aneurysms. Figshare. https://doi.org/10.6084/m9.figshare.22621393
433. Kerr, S. E., Schnabel, C. A., Sullivan, P., Zhang, Y., Singh, V., Carey, B., Erlander, M. G., Highsmith, W. E., Dry, S., & Brachtel, E. F. (2023). Supplementary Figure 1 from Multisite Validation Study to Determine Performance Characteristics of a 92-Gene Molecular Cancer Classifier. https://doi.org/10.1158/1078-0432.22447493
434. Kerr, S. E., Schnabel, C. A., Sullivan, P., Zhang, Y., Singh, V., Carey, B., Erlander, M. G., Highsmith, W. E., Dry, S., & Brachtel, E. F. (2023). Supplementary Figure 1 from Multisite Validation Study to Determine Performance Characteristics of a 92-Gene Molecular Cancer Classifier. https://doi.org/10.1158/1078-0432.22447493.v1
435. Khan, A. A., Huat, T. J., Mutery, A. A., El-Serafi, A., Kacem, H. H., Abdallah, S. H., Reza, M. F., Abdullah, J. M., & Jaafar, H. (2020). Additional file 5 of Significant transcriptomic changes are associated with differentiation of bone marrow-derived mesenchymal stem cells into neural progenitor-like cells in the presence of bFGF and EGF. Figshare. https://doi.org/10.6084/m9.figshare.13161660
436. Khan, J. M., Muhammad, T., Qamar, M., Shi, D., Rauf, M., Noreen, R., Ayaz, M., KHAN, M. H., Ahmad, M., Khurshid, U., Saeed, S., Iqbal, M. S., Younas, Q. U. A., Hameed, Y., Shu, Men, & Naz, S. (2022). ERRATUM: Mutations in the Bone Morphogenetic Protein 15 Gene Causing Defective Protein Secretion in Cholistani Infertile sheep. Brazilian Journal of Biology. https://doi.org/10.1590/1519-6984.256923er
437. Kiberstis, P. A. (2010). Fat’s Mixed Messages. Science Signaling. https://doi.org/10.1126/scisignal.3132ec229
438. Kiberstis, P. A. (2014). Drug with a (Re)Purpose. Science Signaling. https://doi.org/10.1126/scisignal.2005081
439. Kiberstis, P. A. (2014). Mutant Protein in Tumors Hits the DEK. Science Signaling. https://doi.org/10.1126/scisignal.2005995
440. Kilgour, M. K., MacPherson, S., Zacharias, L. G., Ellis, A. E., Sheldon, R. D., Liu, E. Y., Keyes, S., Pauly, B., Carleton, G., Allard, B., Smazynski, J., Williams, K. S., Watson, P. H., Stagg, J., Nelson, B. H., DeBerardinis, R. J., Jones, R. G., Hamilton, P. T., & Lum, J. J. (2021). 1-Methylnicotinamide is an immune regulatory metabolite in human ovarian cancer. Science Advances. https://doi.org/10.1126/sciadv.abe1174
441. Kim, C. K., Maharjan, K., Bialkowska, A. B., & Yang, V. W. (2019). Sa1101 – KrüPpel-Like Factor 5 is Critical for Intestinal Stem Cell Functions and Identity During Self-Renewal and Regeneration Post-Injury. Gastroenterology. https://doi.org/10.1016/s0016-5085(19)37484-0
442. Kim, J. S., Cheong, J., Min, Y. H., Suh, C., Kim, H., Jo, D. Y., Ryoo, H. M., Kım, K., Yoon, S. S., & Lee, J. H. (2007). Complete Remission Status at Autologous Transplantation Is an Important Prognostic Factor in Multiple Myeloma Patients Received Upfront Single Autologous Transplantation.. Blood. https://doi.org/10.1182/blood.v110.11.955.955
443. Kim, S.-S., Kim, J.-R., Moon, J.-K., Choi, B., Kim, T., Kim, K., Kim, J.-J., & Lee, C. (2009). Transcriptional Alteration of p53 Related Processes As a Key Factor for Skeletal Muscle Characteristics in Sus scrofa. Molecules and Cells. https://doi.org/10.1007/s10059-009-0159-z
444. Kim, Y., & Lee, H. (2007). P.2.a.002 Plasma BDNF as a peripheral marker for the action mechanism of antidepressants. European Neuropsychopharmacology. https://doi.org/10.1016/s0924-977x(07)70444-3
445. Kim, Y., Lee, B., Hong, J.-B., Ham, B., & Na, K. (2015). P.3.d.011 Vascular endothelial growth factor may have a neuroprotective role in the improvement of schizophrenia or in the treatment effects of antipsychotics. European Neuropsychopharmacology. https://doi.org/10.1016/s0924-977x(15)30663-5
446. Kimura, Y., & Yahara, I. (1996). [Functions of Hsp90, a major stress protein, as a molecular chaperone].. PubMed.
447. Kimura, Y., Morita, T., Hayashi, K., Miki, T., & Sobue, K. (2023). Supplementary Methods, Figure 1, Table 1 from Myocardin Functions as an Effective Inducer of Growth Arrest and Differentiation in Human Uterine Leiomyosarcoma Cells. https://doi.org/10.1158/0008-5472.22383252
448. Kimura, Y., Morita, T., Hayashi, K., Miki, T., & Sobue, K. (2023). Supplementary Methods, Figure 1, Table 1 from Myocardin Functions as an Effective Inducer of Growth Arrest and Differentiation in Human Uterine Leiomyosarcoma Cells. https://doi.org/10.1158/0008-5472.22383252.v1
449. Kispert, A., Koschorz, B., & Herrmann, B. G. (1995). The T protein encoded by Brachyury is a tissue-specific transcription factor.. The EMBO Journal. https://doi.org/10.1002/j.1460-2075.1995.tb00158.x
450. Kobayashi, E., Shibata, S., Oike, A., Kobayashi, N., Hamada, H., Okae, H., & Arima, T. (2022). Genomic imprinting in human placentation. Reproductive Medicine and Biology. https://doi.org/10.1002/rmb2.12490
451. Kogelman, L. J. A., Ernst, M., Falkenberg, K., Mazzoni, G., Courraud, J., Lundgren, L. P., Laursen, S. S., Cohen, A. S., Olesen, J., & Hansen, T. F. (2022). Additional file 1 of Multi-omics to predict changes during cold pressor test. Figshare. https://doi.org/10.6084/m9.figshare.21591135
452. Koken, M., Linares‐Cruz, G., Quignon, F., Viron, A., Chelbi‐Alix, M. K., Sobczak‐Thépot, J., Juhlin, L., Degos, L., Calvo, F., & Thé, H. D. (1995). The PML growth-suppressor has an altered expression in human oncogenesis.. PubMed.
453. Kolianchuk, Y., Jaksch, A., Nedopytanska, N., Bubalo, N., & Rashkivska, I. (2023). P09-39: The estrous cycle is one of the biomarkers of a chemical's endocrine disruptor properties. Toxicology Letters. https://doi.org/10.1016/s0378-4274(23)00600-8
454. Komachi, T., Saigusa, H., Yamaguchi, S., Kadosono, O., Ito, H., & Okubo, K. (2024). Physiological Studies of the Palatopharyngeal Muscle as a Speech Muscle in the Adjustment of Velar Position during Speech Production. Journal of Nippon Medical School. https://doi.org/10.1272/jnms.jnms.2024_91-509
455. Kominsky, S. L., Abdelmagid, S. M., Doucet, M., Brady, K., & Weber, K. (2023). Supplementary Figure 1 from Macrophage Inflammatory Protein–1δ: A Novel Osteoclast Stimulating Factor Secreted by Renal Cell Carcinoma Bone Metastasis. https://doi.org/10.1158/0008-5472.22374224
456. Kominsky, S. L., Abdelmagid, S. M., Doucet, M., Brady, K., & Weber, K. (2023). Supplementary Figure 1 from Macrophage Inflammatory Protein–1δ: A Novel Osteoclast Stimulating Factor Secreted by Renal Cell Carcinoma Bone Metastasis. https://doi.org/10.1158/0008-5472.22374224.v1
457. Kominsky, S. L., Abdelmagid, S. M., Doucet, M., Brady, K., & Weber, K. (2023). Supplementary Figure 1 Legend from Macrophage Inflammatory Protein–1δ: A Novel Osteoclast Stimulating Factor Secreted by Renal Cell Carcinoma Bone Metastasis. https://doi.org/10.1158/0008-5472.22374227
458. Kominsky, S. L., Abdelmagid, S. M., Doucet, M., Brady, K., & Weber, K. (2023). Supplementary Figure 1 Legend from Macrophage Inflammatory Protein–1δ: A Novel Osteoclast Stimulating Factor Secreted by Renal Cell Carcinoma Bone Metastasis. https://doi.org/10.1158/0008-5472.22374227.v1
459. Kondo, N., Bessho, H., Honda, S., & Negi, A. (2010). Additional evidence to support the role of a common variant near the complement factor I gene in susceptibility to age-related macular degeneration. European Journal of Human Genetics. https://doi.org/10.1038/ejhg.2009.243
460. Kondo, Y., & Shimosegawa, T. (2014). The expression level of Myeloid differentiation factor 88 might be a significant biomarker for the prognosis of HCC patients. Translational gastrointestinal cancer.
461. Kondratov, R. V., En, P., Kuznetsov, N. V., Vs, P., Bp, K., & Chumakov, P. M. (1996). [The human adenosine deaminase gene contains a p53-responsive element].. PubMed.
462. Kovacs, C. S. (2014). Parathyroid Hormone-Related Protein: Not Just a Parathyrin Mimic but a Key Regulator of Diverse Tissues and Physiological Systems. Clinical Reviews in Bone and Mineral Metabolism. https://doi.org/10.1007/s12018-014-9171-8
463. Kozlov, N., Humeniuk, L., Ufer, C., Ivanov, I., Golovanov, A., Stehling, S., Heydeck, D., & Kühn, H. (2018). Functional characterization of novel ALOX15 orthologs representing key steps in mammalian evolution supports the Evolutionary Hypothesis of reaction specificity. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. https://doi.org/10.1016/j.bbalip.2018.12.016
464. Krapp, A., Knöfler, M., Frutiger, S., Hughes, G., Hagenbüchle, O., & Wellauer, P. K. (1996). The p48 DNA-binding subunit of transcription factor PTF1 is a new exocrine pancreas-specific basic helix-loop-helix protein.. The EMBO Journal. https://doi.org/10.1002/j.1460-2075.1996.tb00806.x
465. Krasner, J. R., Alyouha, N., Pusztaszeri, M., Forest, V., Hier, M. P., Avior, G., & Payne, R. J. (2019). MOESM1 of Molecular mutations as a possible factor for determining extent of thyroid surgery. Figshare. https://doi.org/10.6084/m9.figshare.10001450
466. Krivich, R. S. (2014). Neurotrophic keratitis treatment gains orphan drug designation. Ophthalmology Times eReport.
467. Krüger, J., Prellberg, M., Gutsmann, B., Schleinitz, D., Breitfeld, J., Kern, M., Klöting, N., Blüher, M., Stümvoll, M., & Kovács, P. (2014). Adipose tissue mRNA expression of WHR-associated genes correlates with fat distribution. Diabetologie und Stoffwechsel. https://doi.org/10.1055/s-0034-1375034
468. Ksepka, D. T., Tennyson, A. J., Fordyce, R. E., & Richards, M. D. (2023). Phylogenetic Matrix and Character List. Figshare. https://doi.org/10.6084/m9.figshare.24175026
469. Kustikova, O., Schmidt, M., Modlich, U., Li, Z., Schmidt, S., Deichmann, A., Rudolph, C., Neuhoff, N. V., Schlegelberger, B., Fehse, B., Kalle, C. V., & Baum, C. (2004). More Than One Mutation Is Required for Leukemia Development Following Retroviral Vector-Mediated Gene Transfer.. Blood. https://doi.org/10.1182/blood.v104.11.294.294
470. Lab, W. (2019). MSB Gene Expression Variability. Figshare. https://doi.org/10.6084/m9.figshare.11410212
471. Lababede, A., Man, B., & Crown, N. (2024). Genetic background effects on meiotic recombination.. PubMed. https://doi.org/10.17912/micropub.biology.001247
472. Labie, D. (1997). Ostéopétrose par défaut en PU.1, un facteur de transcription actif sur le premier précurseur hématopoïétique. médecine/sciences. https://doi.org/10.4267/10608/448
473. Lage, L. D., PENA, L. A. C., & LARA, R. P. (2023). A INFLUÊNCIA EPIGENÉTICA NO PROCESSO E NA QUALIDADE DO ENVELHECIMENTO: UMA REVISÃO DE LITERATURA. https://doi.org/10.51161/conbrasau2023/17041
474. Lai, M. I., Jiang, J., Silver, N., Best, S., Menzel, S., Garner, C., Weiss, M. J., & Thein, S. L. (2005). AHSP Is a Quantitative Trait Gene That Modifies the Phenotype of β Thalassemia.. Blood. https://doi.org/10.1182/blood.v106.11.3638.3638
475. Lau, Y.-K. I., Murray, L. B., Houshmandi, S. S., Xu, Y., Gutmann, D. H., & Yu, Q. (2023). Supplementary Figure 1 from Merlin Is a Potent Inhibitor of Glioma Growth. https://doi.org/10.1158/0008-5472.22374347
476. Lau, Y.-K. I., Murray, L. B., Houshmandi, S. S., Yin, X., Gutmann, D. H., & Yu, Q. (2023). Supplementary Figure 1 from Merlin Is a Potent Inhibitor of Glioma Growth. https://doi.org/10.1158/0008-5472.22374347.v1
477. Lau, Y.-K. I., Murray, L. B., Houshmandi, S. S., Yin, X., Gutmann, D. H., & Yu, Q. (2023). Supplementary Table 1 from Merlin Is a Potent Inhibitor of Glioma Growth. https://doi.org/10.1158/0008-5472.22374344
478. Lau, Y.-K. I., Murray, L. B., Houshmandi, S. S., Yin, X., Gutmann, D. H., & Yu, Q. (2023). Supplementary Table 1 from Merlin Is a Potent Inhibitor of Glioma Growth. https://doi.org/10.1158/0008-5472.22374344.v1
479. Laurin, M., Everett, M. L., & Parker, W. (2011). The cecal appendix: one more immune component with a function disturbed by post-industrial culture..
480. Law, P., & Loh, H. H. (2001). Opiate Receptors. Encyclopedia of Life Sciences. https://doi.org/10.1038/npg.els.0000290
481. Lawrence, J. H. (1985). Developmental needs as intrinsic incentives. New Directions for Higher Education. https://doi.org/10.1002/he.36919855107
482. Lazarski, C. A., Chaves, F. A., Jenks, S. A., Wu, S., Richards, K. A., Weaver, J. M., & Sant, A. J. (2005). The Kinetic Stability of MHC Class II:Peptide Complexes Is a Key Parameter that Dictates Immunodominance. Immunity. https://doi.org/10.1016/j.immuni.2005.05.009
483. Lee, C., Brock, K. D., Hasapis, S., Zhang, D., Sibley, A. B., Qin, X., Gresham, J. S., Caraballo, I., Luo, L., Daniel, A. R., Hilton, M. J., Owzar, K., & Kirsch, D. G. (2023). Supplementary Table 4 from Whole-Exome Sequencing of Radiation-Induced Thymic Lymphoma in Mouse Models Identifies Notch1 Activation as a Driver of p53 Wild-Type Lymphoma. https://doi.org/10.1158/0008-5472.22428720
484. Lee, C., Brock, K. D., Hasapis, S., Zhang, D., Sibley, A. B., Qin, X., Gresham, J. S., Caraballo, I., Luo, L., Daniel, A. R., Hilton, M. J., Owzar, K., & Kirsch, D. G. (2023). Supplementary Table 4 from Whole-Exome Sequencing of Radiation-Induced Thymic Lymphoma in Mouse Models Identifies Notch1 Activation as a Driver of p53 Wild-Type Lymphoma. https://doi.org/10.1158/0008-5472.22428720.v1
485. Lee, K., Gamini, R., Olmer, M., Ikuta, Y., Hasei, J., Baek, J., Alvarez-Garcia, O., Grogan, S. P., D’Lima, D. D., Asahara, H., Su, A. I., & Lotz, M. (2020). Mohawk is a transcription factor that promotes meniscus cell phenotype and tissue repair and reduces osteoarthritis severity. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.aan7967
486. Lee, K., Yeo, S.-Y., Sung, C. O., & Kim, S.-H. (2023). Supplementary Methods from Twist1 Is a Key Regulator of Cancer-Associated Fibroblasts. https://doi.org/10.1158/0008-5472.22406199
487. Lee, K., Yeo, S.-Y., Sung, C. O., & Kim, S.-H. (2023). Supplementary Methods from Twist1 Is a Key Regulator of Cancer-Associated Fibroblasts. https://doi.org/10.1158/0008-5472.22406199.v1
488. Lee, S. H., Lim, C. L., Shen, W., Tan, S. M. X., Woo, A. R. E., Yap, Y. H. Y., Sian, C. A. S., Goh, W. W. B., Yu, W., Li, L., & Lin, V. C. L. (2022). Additional file 4 of Activation function 1 of progesterone receptor is required for progesterone antagonism of oestrogen action in the uterus. Figshare. https://doi.org/10.6084/m9.figshare.21285891
489. Lee, S., Choi, S., Seo, S.-J., & Kim, H. (2014). Shell cross-linked polyethylenimine-modified micelles for temperature-triggered drug release and gene delivery. RSC Advances. https://doi.org/10.1039/c4ra10596f
490. Lee, Y., Lin, S.-C., Yu, G., Cheng, C.-J., Liu, B., Liu, H., Hawke, D. H., Parikh, N. U., Varkaris, A., Corn, P. G., Logothetis, C. J., Satcher, R. L., Yu‐Lee, L., Gallick, G. E., & Lin, S.-H. (2023). Supplemental Table S1 from Identification of Bone-Derived Factors Conferring &lt;i&gt;De Novo&lt;/i&gt; Therapeutic Resistance in Metastatic Prostate Cancer. https://doi.org/10.1158/0008-5472.22410323
491. Leleu, X., Xu, L., Santos, D., Ho, A. W., Hunter, Z. R., O’Connor, K., Manning, R., Tournilhac, O., Chemaly, M., Branagan, A. R., Patterson, C. J., Anderson, K. C., & Treon, S. P. (2005). The Unfolded Protein Response Is a Determinant of Disease Actvity in Waldenstrom’s Macroglobulinemia (WM).. Blood. https://doi.org/10.1182/blood.v106.11.996.996
492. Lemke, E. A., Babu, M. M., Kriwacki, R. W., Mittag, T., Pappu, R. V., Wright, P. E., & Forman‐Kay, J. D. (2024). Intrinsic disorder: A term to define the specific physicochemical characteristic of protein conformational heterogeneity. Molecular Cell. https://doi.org/10.1016/j.molcel.2024.02.024
493. Lemma, R. B., Fleischer, T., Martinsen, E., Ledsaak, M., Kristensen, V. N., Eskeland, R., Gabrielsen, O. S., & Mathelier, A. (2022). Additional file 1 of Pioneer transcription factors are associated with the modulation of DNA methylation patterns across cancers. Figshare. https://doi.org/10.6084/m9.figshare.19619304
494. Leonardi, D. P., Giovanini, A. F., Almeida, S., Schramm, C. A., & Baratto‐Filho, F. (2011). Alterações pulpares e periapicais. RSBO Revista Sul-Brasileira de Odontologia.
495. Lepp, N. T., Caprau, D., Johnson, K. A., Marazita, M. L., Dagle, J. M., & Murray, J. C. (2005). 15 Single Nucleotide Polymorphisms in Smooth Muscle Regulation Genes as Risk Factors for Spontaneous Preterm Delivery.. Pediatric Research. https://doi.org/10.1203/00006450-200510000-00045
496. Lerdau, M. (2007). A Positive Feedback with Negative Consequences. Science. https://doi.org/10.1126/science.1141486
497. Leslie, N. R. (2012). PTEN: An Intercellular Peacekeeper?. Science Signaling. https://doi.org/10.1126/scisignal.2003685
498. Leung, M. H. Y., Tong, X., Bøifot, K. O., Bezdan, D., Butler, D., Danko, D., Gohli, J., Green, D. C., Hernandez, M., Kelly, F. J., Levy, S., Mason-Buck, G., Nieto‐Caballero, M., Syndercombe‐Court, D., Udekwu, K. I., Young, B. G., Mason, C. E., Dybwad, M., & Lee, P. K. H. (2021). Additional file 1 of Characterization of the public transit air microbiome and resistome reveals geographical specificity. Figshare. https://doi.org/10.6084/m9.figshare.14684652
499. Li, C.-C., Chu, H.-Y., Yang, C., Chou, C., & Tsai, T. (2023). Supplementary Data from Aurora-A Overexpression in Mouse Liver Causes p53-Dependent Premitotic Arrest during Liver Regeneration. https://doi.org/10.1158/1541-7786.22518507
500. Li, C.-C., Chu, H.-Y., Yang, C., Chou, C., & Tsai, T. (2023). Supplementary Data from Aurora-A Overexpression in Mouse Liver Causes p53-Dependent Premitotic Arrest during Liver Regeneration. https://doi.org/10.1158/1541-7786.22518507.v1
501. Li, D., & Bie, Z. (2017). Metal–organic framework incorporated monolithic capillary for selective enrichment of phosphopeptides. RSC Advances. https://doi.org/10.1039/c7ra00263g
502. Li, D., Chen, T., & Li, Q. (2023). Additional file 1 of Identification of a m6A-related ferroptosis signature as a potential predictive biomarker for lung adenocarcinoma. Figshare. https://doi.org/10.6084/m9.figshare.22655244
503. Li, G., He, Y., Liew, A., Huang, C., Song, B., Jia, X., Sathuvan, M., Zhong, S., & Cheong, K. (2025). Dietary polysaccharides from dragon fruit pomace, a co-product of the fruit processing industry, exhibit therapeutic potential in high-fat diet-induced metabolic disorders. Food Research International. https://doi.org/10.1016/j.foodres.2025.115818
504. Li, J., Tang, M., Li, Y., Amos, C. I., & Cheng, C. (2022). Additional file 5 of Genetic variants associated mRNA stability in lung. Figshare. https://doi.org/10.6084/m9.figshare.19343182
505. Li, K., Wei, X., Li, K., Zhang, Q., Zhang, J., Ding, W., & Yang, J. (2023). Dietary restriction to optimize T cell immunity is an ancient survival strategy conserved in vertebrate evolution. Cellular and Molecular Life Sciences. https://doi.org/10.1007/s00018-023-04865-x
506. Li, L., Jiang, D., Liu, H., Guo, C., Zhang, Q., Li, X., Chen, X., Chen, Z., Feng, J., Tan, S., Huang, W., Huang, J., Xu, C., Liu, C., Yu, W., Hou, Y., & Ding, C. (2024). Supplementary Figure 1 from Comprehensive Proteogenomic Profiling Reveals the Molecular Characteristics of Colorectal Cancer at Distinct Stages of Progression. https://doi.org/10.1158/0008-5472.26934697
507. Li, L., Jiang, D., Liu, H., Guo, C., Zhang, Q., Li, X., Chen, X., Chen, Z., Feng, J., Tan, S., Huang, W., Huang, J., Xu, C., Liu, C., Yu, W., Hou, Y., & Ding, C. (2024). Supplementary Figure 1 from Comprehensive Proteogenomic Profiling Reveals the Molecular Characteristics of Colorectal Cancer at Distinct Stages of Progression. https://doi.org/10.1158/0008-5472.26934697.v1
508. Li, L., Modi, R., Wu, X., Forman, S. J., & Bhatia, R. (2005). The MDS-Associated Gene DLK Modulates Gene Expression in Human Myeloid Cells by Altering the Activity of Multiple Transcription Factors.. Blood. https://doi.org/10.1182/blood.v106.11.3428.3428
509. Li, L., Yang, B., & Wu, C. (2024). Effect of miR-184 on Multiple Myeloma by Targeting Notch1.. PubMed.
510. Li, M., Kuetemeyer, J. M., Yallowitz, A. R., & Wellik, D. M. (2022). Characterization of a novel <scp><i>Hoxa5eGFP</i></scp> mouse line. Developmental Dynamics. https://doi.org/10.1002/dvdy.563
511. Li, S., Gestl, S. A., & Gunther, E. J. (2023). Supplementary Data from A Multistage Murine Breast Cancer Model Reveals Long-Lived Premalignant Clones Refractory to Parity-Induced Protection. https://doi.org/10.1158/1940-6207.22534243.v1
512. Li, X., Fuqua, T., Breugel, M. E. V., & Crocker, J. (2023). Supplementary Table 1 from Mutational scans reveal differential evolvability of <i>Drosophila</i> promoters and enhancers. Figshare. https://doi.org/10.6084/m9.figshare.22109008
513. Li, Y., Nakka, M., Kelly, A. J., Lau, C. C., Krailo, M., Barkauskas, D. A., Hicks, J. M., & Man, T. (2023). Supplementary Figure Legends from p27 Is a Candidate Prognostic Biomarker and Metastatic Promoter in Osteosarcoma. https://doi.org/10.1158/0008-5472.22411970
514. Li, Y., Nakka, M., Kelly, A. J., Lau, C. C., Krailo, M., Barkauskas, D. A., Hicks, J. M., & Man, T. (2023). Supplementary Figure Legends from p27 Is a Candidate Prognostic Biomarker and Metastatic Promoter in Osteosarcoma. https://doi.org/10.1158/0008-5472.22411970.v1
515. Li, Y., Wang, G., Tan, X., Ouyang, J., Zhang, M., Song, X., Liu, Q., Leng, Q., Chen, L., & Xie, L. (2020). Additional file 1 of ProGeo-neo: a customized proteogenomic workflow for neoantigen prediction and selection. Figshare. https://doi.org/10.6084/m9.figshare.12072549
516. Li, Y., Yang, Q., Liu, Y., Yi, H., Ju, Y., & Qi, G. (2023). POTEE mutation as a potential predictive biomarker for immune checkpoint inhibitors in lung adenocarcinoma. Investigational New Drugs. https://doi.org/10.1007/s10637-023-01375-2
517. Li, Z., Pogany, J., Panavas, T., Xu, K., Esposito, A. M., Kinzy, T. G., & Nagy, P. D. (2009). Translation elongation factor 1A is a component of the tombusvirus replicase complex and affects the stability of the p33 replication co-factor. Virology. https://doi.org/10.1016/j.virol.2008.11.041
518. Liang, B., Chen, R., Wang, T., Cao, L., Liu, Y., Yin, F., Zhu, M., Fan, X., Liang, Y., Zhang, L., Guo, Y., & Zhao, J. (2023). Supplementary Figure Legends from Myeloid Differentiation Factor 88 Promotes Growth and Metastasis of Human Hepatocellular Carcinoma. https://doi.org/10.1158/1078-0432.22452410
519. Liang, B., Chen, R., Wang, T., Cao, L., Liu, Y., Yin, F., Zhu, M., Fan, X., Liang, Y., Zhang, L., Guo, Y., & Zhao, J. (2023). Supplementary Figure Legends from Myeloid Differentiation Factor 88 Promotes Growth and Metastasis of Human Hepatocellular Carcinoma. https://doi.org/10.1158/1078-0432.22452410.v1
520. Liao, X.-M., Guan, Z., Yang, Z.-J., Ma, L., Dai, Y.-J., Liang, C., & Hu, J.-T. (2023). Additional file 1 of Comprehensive analysis of M2 macrophage-derived exosomes facilitating osteogenic differentiation of human periodontal ligament stem cells. Figshare. https://doi.org/10.6084/m9.figshare.22610384
521. Lin, B., Hong, H., Jiang, X., Li, C.-Z., Zhu, S., Tang, N., Wang, X., She, F., & Chen, Y. (2017). WNT inhibitory factor 1 promoter hypermethylation is an early event during gallbladder cancer tumorigenesis that predicts poor survival. Gene. https://doi.org/10.1016/j.gene.2017.04.034
522. Linke, C., Siemens, N., Oehmcke, S., Radjainia, M., Law, R. H. P., Whisstock, J. C., Baker, E. N., & Kreikemeyer, B. (2012). The Extracellular Protein Factor Epf from Streptococcus pyogenes Is a Cell Surface Adhesin That Binds to Cells through an N-terminal Domain Containing a Carbohydrate-binding Module. Journal of Biological Chemistry. https://doi.org/10.1074/jbc.m112.376434
523. Liu, H., Kim, Y., Sharkis, S. J., Marchionni, L., & Jang, Y.-Y. (2011). In Vivo Liver Regeneration Potential of Human Induced Pluripotent Stem Cells from Diverse Origins. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.3002376
524. Liu, J., Tang, X., Li, M., Lu, C., Shi, J., Zhou, L., Yuan, Q., & Yang, M. (2013). Functional MDM4 rs4245739 genetic variant, alone and in combination with P53 Arg72Pro polymorphism, contributes to breast cancer susceptibility. Breast Cancer Research and Treatment. https://doi.org/10.1007/s10549-013-2615-x
525. Liu, J., Wang, Q., & Chen, J. (2024). Case report: A de novo variant of CRMP1 in an individual with a neurodevelopmental disorder. Frontiers in Neuroscience. https://doi.org/10.3389/fnins.2024.1490731
526. Liu, P., Li, Y., Tsai, W., Tsai, L. M., Chao, T., WU, H., & Chen, J. H. (2005). Stromelysin‐1 promoter 5A/6A polymorphism is an independent genetic prognostic risk factor and interacts with smoking cessation after index premature myocardial infarction. Journal of Thrombosis and Haemostasis. https://doi.org/10.1111/j.1538-7836.2005.01515.x
527. Liu, S., Guo, H., Li, D., & Wang, C. (2024). Immunologically effective biomaterials enhance immunotherapy of prostate cancer. Journal of Materials Chemistry B. https://doi.org/10.1039/d3tb03044j
528. Liu, X., Chen, B., Xie, F., Wong, K. Y., Cheung, A. H., Zhang, J., Wu, Q., Fang, C., Hu, J., Wang, S., Xu, D., Chen, J., Wang, Y., Wong, C. C., Chen, H., Wu, W. K. K., Yu, J., Chan, M. W., Tsang, C. M., ... Kang, W. (2024). Figure S4 from FOXP4 Is a Direct YAP1 Target That Promotes Gastric Cancer Stemness and Drives Metastasis. https://doi.org/10.1158/0008-5472.27603441
529. Liu, X., Chen, B., Xie, F., Wong, K. Y., Cheung, A. H., Zhang, J., Wu, Q., Fang, C., Hu, J., Wang, S., Xu, D., Chen, J., Wang, Y., Wong, C. C., Chen, H., Wu, W. K. K., Yu, J., Chan, M. W., Tsang, C. M., ... Kang, W. (2024). Figure S5 from FOXP4 Is a Direct YAP1 Target That Promotes Gastric Cancer Stemness and Drives Metastasis. https://doi.org/10.1158/0008-5472.27603438
530. Liu, X., Chen, B., Xie, F., Wong, K. Y., Cheung, A. H., Zhang, J., Wu, Q., Fang, C., Hu, J., Wang, S., Xu, D., Chen, J., Wang, Y., Wong, C. C., Chen, H., Wu, W. K. K., Yu, J., Chan, M. W., Tsang, C. M., ... Kang, W. (2024). Figure S8 from FOXP4 Is a Direct YAP1 Target That Promotes Gastric Cancer Stemness and Drives Metastasis. https://doi.org/10.1158/0008-5472.27603423
531. Liu, X., Hu, M., Liu, P., Jiao, M., Zhou, M., Lee, A. K., Li, F., & Li, C. (2023). Figure S3 from ATM Paradoxically Promotes Oncogenic Transformation via Transcriptional Reprogramming. https://doi.org/10.1158/0008-5472.22425447
532. Liu, X., Hu, M., Liu, P., Jiao, M., Zhou, M., Lee, A. K., Li, F., & Li, C. (2023). Figure S3 from ATM Paradoxically Promotes Oncogenic Transformation via Transcriptional Reprogramming. https://doi.org/10.1158/0008-5472.22425447.v1
533. Liu, Y., Lv, R., Yan, W., Xu, J., Fan, H., Li, L., Cui, J., Du, C., Deng, S., Sui, W., Zou, D., Xu, Y., Qiu, L., & An, G. (2024). MAF translocation remains a strong prognostic factor despite concurrent chromosomal abnormalities. Haematologica. https://doi.org/10.3324/haematol.2023.284666
534. Liu, Y., Peng, L., Chen, J., Chen, L., Wu, Y., Cheng, M., Chen, M., Ye, X., & Jin, Y. (2023). Additional file 10 of EIF5A2 specifically regulates the transcription of aging-related genes in human neuroblastoma cells. Figshare. https://doi.org/10.6084/m9.figshare.22606931
535. Lohi, H., Kujala, M., Kerkelä, E., Saarialho‐Kere, U., Kestilä, M., & Kere, J. (2000). Identification of six putative anion transporter genes in human and characterization of PAT1 a candidate gene for pancreatic anion exchanger..
536. Loper, R. G., Kammeier, M. L., & Hoffmann, H. (1973). MMPI characteristics of college freshman males who later became alcoholics.. Journal of Abnormal Psychology. https://doi.org/10.1037/h0034959
537. Lorenzo, P., & González, L. (2010). Allelopathy: an ecophysiological trait that favors the invasive ability of plant species.. Ecosistemas.
538. Lougaris, V., Patrizi, O., Baronio, M., Tabellini, G., Tampella, G., Lanzi, G., Salvini, F., Trizzino, A., Parolini, S., & Plebani, A. (2016). p85α is an intrinsic regulator of human natural killer cell effector functions. Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/j.jaci.2016.01.026
539. Lu, C.-S., Shiau, A., Su, B., Hsu, T.-S., Wang, C., Su, Y., Tsai, M., Feng, Y., Tseng, Y., Yen, Y.-T., Wu, C., & Shieh, G. (2020). Additional file 1 of Oct4 promotes M2 macrophage polarization through upregulation of macrophage colony-stimulating factor in lung cancer. https://doi.org/10.6084/m9.figshare.12414284.v1
540. Lu, F., Wang, E., & Liu, H. (2024). Factors correlating the expression of PD-L1. BMC Cancer. https://doi.org/10.1186/s12885-024-12400-9
541. Lu, S., Cai, C., Yan, G., Zhou, Z., Wan, Y., Chen, V., Chen, L., Cooper, G. F., Obeid, L. M., Hannun, Y. A., Lee, A. V., & Lu, X. (2023). Table S1 from Signal-Oriented Pathway Analyses Reveal a Signaling Complex as a Synthetic Lethal Target for p53 Mutations. https://doi.org/10.1158/0008-5472.22412469.v1
542. Lu, S., Catalano, C., Huhn, S., Pardini, B., Bartu, L., Vymetálková, V., Vodičková, L., Levý, M., Büchler, T., Hemminki, K., Vodic̆ka, P., & Försti, A. (2019). Correction: Single nucleotide polymorphisms within MUC4 are associated with colorectal cancer survival. PLoS ONE. https://doi.org/10.1371/journal.pone.0218064
543. Lu, X., Peled, N., Greer, J. P., Wu, W., Choi, P., Berger, A. H., Wong, S., Jen, K., Seo, Y., Hann, B., Brooks, A. N., Meyerson, M., & Collisson, E. A. (2023). Supplementary Figure Legends from &lt;i&gt;MET&lt;/i&gt; Exon 14 Mutation Encodes an Actionable Therapeutic Target in Lung Adenocarcinoma. https://doi.org/10.1158/0008-5472.22415412
544. Lu, X., Peled, N., Greer, J. P., Wu, W., Choi, P., Berger, A. H., Wong, S., Jen, K., Seo, Y., Hann, B., Brooks, A. N., Meyerson, M., & Collisson, E. A. (2023). Supplementary Figure Legends from &lt;i&gt;MET&lt;/i&gt; Exon 14 Mutation Encodes an Actionable Therapeutic Target in Lung Adenocarcinoma. https://doi.org/10.1158/0008-5472.22415412.v1
545. Lu, Y.-H., Dallner, O., Birsoy, K., Fayzikhodjaeva, G., & Friedman, J. M. (2015). Corrigendum to “Nuclear Factor-Y is an adipogenic factor that regulates leptin gene expression”[Mol Metab 4 (2015) 392–405]. Molecular Metabolism. https://doi.org/10.1016/j.molmet.2015.05.004
546. Lubrano-Berthelier, C., Durand, E., Dubern, B., Shapiro, A., Dazin, P., Weill, J., Ferron, C., Froguel, P., & Vaisse, C. (2003). Intracellular retention is a common characteristic of childhood obesity-associated MC4R mutations.. HAL (Le Centre pour la Communication Scientifique Directe).
547. Lucon‐Xiccato, T., Montalbano, G., & Bertolucci, C. (2023). Data from Adaptive phenotypic plasticity induces individual variability along a cognitive trade-off. Figshare. https://doi.org/10.6084/m9.figshare.23522433
548. Lulu, A. M., Cummings, K. L., Jeffery, E. D., Myers, P. T., Underwood, D., Lacy, R. M., Chianese‐Bullock, K. A., Slingluff, C. L., Modesitt, S. C., & Engelhard, V. H. (2023). Supplementary Figures from Characteristics of Immune Memory and Effector Activity to Cancer-Expressed MHC Class I Phosphopeptides Differ in Healthy Donors and Ovarian Cancer Patients. https://doi.org/10.1158/2326-6066.22544321
549. Lulu, A. M., Cummings, K. L., Jeffery, E. D., Myers, P. T., Underwood, D., Lacy, R. M., Chianese‐Bullock, K. A., Slingluff, C. L., Modesitt, S. C., & Engelhard, V. H. (2023). Supplementary Tables from Characteristics of Immune Memory and Effector Activity to Cancer-Expressed MHC Class I Phosphopeptides Differ in Healthy Donors and Ovarian Cancer Patients. https://doi.org/10.1158/2326-6066.22544318
550. Luna, R., Rondón, A. G., & Aguilera, A. (2011). New clues to understand the role of THO and other functionally related factors in mRNP biogenesis. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. https://doi.org/10.1016/j.bbagrm.2011.11.012
551. Luo, J., Liu, H., Li, D. K. J., Song, B., & Zhang, Y. (2021). Additional file 10 of Repression of the expression of proinflammatory genes by mitochondrial transcription factor A is linked to its alternative splicing regulation in human lung epithelial cells. Figshare. https://doi.org/10.6084/m9.figshare.17140918
552. Luo, J., Liu, H., Li, D. K. J., Song, B., & Zhang, Y. (2021). Additional file 4 of Repression of the expression of proinflammatory genes by mitochondrial transcription factor A is linked to its alternative splicing regulation in human lung epithelial cells. Figshare. https://doi.org/10.6084/m9.figshare.17140933
553. Luo, R. (2023). Supplementary data. Figshare. https://doi.org/10.6084/m9.figshare.21334059
554. Luther, J., Yorgan, T., Rolvien, T., Ulsamer, L. P. L., Koehne, T., Liao, N., Keller, D., Vollersen, N., Teufel, S., Neven, M., Peters, S., Schweizer, M., Trumpp, A., Rosigkeit, S., Bockamp, E., Mundlos, S., Kornak, U., Oheim, R., Amling, M., ... David, J. (2018). Wnt1 is an Lrp5-independent bone-anabolic Wnt ligand. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.aau7137
555. Lyaruu, D. M., Schoonderwoerd, M. J., Tio, D., Tse, C., Bervoets, T., DenBesten, P., & Bronckers, A. (2013). Parenteral monofluorophosphate (MFP) is a more potent inducer of enamel fluorotic defects in neonatal hamster molars than sodium fluoride. Odontology. https://doi.org/10.1007/s10266-013-0119-0
556. Lyngstadaas, S. P., Risnes, S., Sproat, B. S., Thrane, P. S., & Prydz, H. (1995). A synthetic, chemically modified ribozyme eliminates amelogenin, the major translation product in developing mouse enamel in vivo.. The EMBO Journal. https://doi.org/10.1002/j.1460-2075.1995.tb00207.x
557. López‐Herradón, A., Rosa, L. R.-D. L., Murillo‐Cuesta, S., Portal‐Núñez, S., Lozano, D., Esbrit, P., & Varela‐Nieto, I. (2012). P03-3 Insulin-like growth factor I-deficiency causes skeletal defects that can be partially compensated by parathyroid hormone-related protein in mice. Growth Hormone & IGF Research. https://doi.org/10.1016/s1096-6374(12)60188-9
558. Löffelhardt, W., Haeseler, A. V., Schleiff, E., Margulis, L., Hall, J. A., & McFall‐Ngai, M. (2007). The β-barrel shaped polypeptide transporter, an old concept for precursor protein transfer across membranes.. Symbiosis.
559. Ma, C., Niu, R., Huang, T., Shao, L.-W., Peng, Y., Ding, W., Wang, Y., Jia, G., He, C., Li, C., He, A., & Liu, Y. (2018). N6-methyldeoxyadenine is a transgenerational epigenetic signal for mitochondrial stress adaptation. Nature Cell Biology. https://doi.org/10.1038/s41556-018-0238-5
560. Ma, L., Shaheen, O., Abboud, I., & el-Rifai, M. (1970). Some ophthalmological factors affecting the personality patterns in primary glaucoma patients as determined by the Minnesota Multiphasic Personality Inventory.. PubMed.
561. Ma, S., Cao, C., Che, S., Wang, Y., Su, D., Liu, S., Gong, W., Liu, L., Sun, J., Zhao, J., Wang, Q., Song, N., Ge, T., Guo, Q., Tian, S., Chen, C. D., Zhang, T., Wang, J., Ding, X., ... Shi, L. (2021). PHF8-promoted TOPBP1 demethylation drives ATR activation and preserves genome stability. Science Advances. https://doi.org/10.1126/sciadv.abf7684
562. Macías‐Hernández, N., Domènech, M., Cardoso, P., Lozano-Fernández, J., Borges, P. A. V., Paulo, O. S., Vieira, A., Enguídanos, A., Amorim, I. R., Rigal, F., Emerson, B. C., & Arnedo, M. A. (2020). Matrices. Zenodo (CERN European Organization for Nuclear Research). https://doi.org/10.5281/zenodo.3941690
563. Macías‐Hernández, N., Domènech, M., Cardoso, P., Lozano-Fernández, J., Borges, P. A. V., Paulo, O. S., Vieira, A., Enguídanos, A., Amorim, I. R., Rigal, F., Emerson, B. C., & Arnedo, M. A. (2020). Matrices. Zenodo (CERN European Organization for Nuclear Research). https://doi.org/10.5281/zenodo.3941691
564. Maddox, D. M., Hicks, W. L., Vollrath, D., LaVail, M. M., Naggert, J. Κ., & Nishina, P. M. (2011). An ENU-Induced Mutation in the<i>Mertk</i>Gene (<i>Mertk<sup>nmf12</sup></i>) Leads to a Slow Form of Retinal Degeneration. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.10-7077
565. Madhavan, D., Zucknick, M., Wallwiener, M., Ćuk, K., Modugno, C., Scharpff, M., Schott, S., Heil, J., Turchinovich, A., Yang, R., Benner, A., Riethdorf, S., Trumpp, A., Sohn, C., Pantel, K., Schneeweiß, A., & Burwinkel, B. (2023). Supplementary Figure 1 from Circulating miRNAs as Surrogate Markers for Circulating Tumor Cells and Prognostic Markers in Metastatic Breast Cancer. https://doi.org/10.1158/1078-0432.22445984
566. Madhavan, D., Zucknick, M., Wallwiener, M., Ćuk, K., Modugno, C., Scharpff, M., Schott, S., Heil, J., Turchinovich, A., Yang, R., Benner, A., Riethdorf, S., Trumpp, A., Sohn, C., Pantel, K., Schneeweiß, A., & Burwinkel, B. (2023). Supplementary Figure 1 from Circulating miRNAs as Surrogate Markers for Circulating Tumor Cells and Prognostic Markers in Metastatic Breast Cancer. https://doi.org/10.1158/1078-0432.22445984.v1
567. Maeda, Y., Echizen, K., Oshima, H., Yu, L., Sakulsak, N., Hirose, O., Yamada, Y., Taniguchi, T., Jenkins, B. J., Saya, H., & Oshima, M. (2023). Supplementary Figure Legends from Myeloid Differentiation Factor 88 Signaling in Bone Marrow–Derived Cells Promotes Gastric Tumorigenesis by Generation of Inflammatory Microenvironment. https://doi.org/10.1158/1940-6207.22533965
568. Maeda, Y., Echizen, K., Oshima, H., Yu, L., Sakulsak, N., Hirose, O., Yamada, Y., Taniguchi, T., Jenkins, B. J., Saya, H., & Oshima, M. (2023). Supplementary Figure Legends from Myeloid Differentiation Factor 88 Signaling in Bone Marrow–Derived Cells Promotes Gastric Tumorigenesis by Generation of Inflammatory Microenvironment. https://doi.org/10.1158/1940-6207.22533965.v1
569. Mahadevan, M. S. (2010). Exposing a DUX Tale. Science. https://doi.org/10.1126/science.1195984
570. Mahlum, L. M. (2001). Mitochondrial function is a primary variable affecting sperm mobility phenotype in the domestic fowl.
571. Mahmud, F. J., Du, Y., Greif, E., Boucher, T., Dannals, R. F., Mathews, W. B., Pomper, M. G., Sysa-Shah, P., Pate, K. A. M., Lyons, C. E., Carlson, B., Chacona, M., & Brown, A. (2020). Correction to: Osteopontin/secreted phosphoprotein-1 behaves as a molecular brake regulating the neuroinflammatory response to chronic viral infection. Journal of Neuroinflammation. https://doi.org/10.1186/s12974-020-02002-0
572. Malek, S. N., Ouillette, P., Kujawski, L., Shangary, S., Talpaz, M., Kaminski, M., Erba, H. P., Shedden, K., Wang, S., & Saddler, C. (2007). Comprehensive Biomarker and Genomic Analysis Identifies p53 Status as the Major Determinant of Response to MDM2 Inhibitors in Chronic Lymphocytic Leukemia.. Blood. https://doi.org/10.1182/blood.v110.11.224.224
573. Malone, C. F., Dharia, N. V., Kugener, G., Forman, A. B., Rothberg, M., Abdusamad, M., González, A. B., Kuljanin, M., Robichaud, A. L., Conway, A. S., Dempster, J. M., Paolella, B. R., Dumont, N., Hovestadt, V., Mancias, J. D., Younger, S. T., Root, D. E., Golub, T. R., Vázquez, F., & Stegmaier, K. (2023). Supplementary Figure S2 from Selective Modulation of a Pan-Essential Protein as a Therapeutic Strategy in Cancer. https://doi.org/10.1158/2159-8290.22539461
574. Malone, C. F., Dharia, N. V., Kugener, G., Forman, A. B., Rothberg, M., Abdusamad, M., González, A. B., Kuljanin, M., Robichaud, A. L., Conway, A. S., Dempster, J. M., Paolella, B. R., Dumont, N., Hovestadt, V., Mancias, J. D., Younger, S. T., Root, D. E., Golub, T. R., Vázquez, F., & Stegmaier, K. (2023). Supplementary Figure S2 from Selective Modulation of a Pan-Essential Protein as a Therapeutic Strategy in Cancer. https://doi.org/10.1158/2159-8290.22539461.v1
575. Manenica, M. (2020). Biofizička svojstva proteina regulatora citokineze 1, PRC1, u fazama mitoze ljudskih stanica.
576. Manning, B. D. (2017). Game of TOR — The Target of Rapamycin Rules Four Kingdoms. New England Journal of Medicine. https://doi.org/10.1056/nejmcibr1709384
577. Marango, J., Shimoyama, M., Nishio, H., Meyer, J. A., Min, D. J., Sirulnik, A., Martinez-Martinez, Y., Chesi, M., Bergsagel, P. L., Zhou, M., Waxman, S., Leibovitch, B. A., Walsh, M. J., & Licht, J. D. (2007). The MMSET protein is a histone methyltransferase with characteristics of a transcriptional corepressor. Blood. https://doi.org/10.1182/blood-2007-06-092122
578. Marciano, D., Aharonson, Z., Varsano, T., Haklai, R., & Kloog, Y. (1997). Novel inhibitors of the prenylated protein methyltransferase reveal distinctive structural requirements. Bioorganic & Medicinal Chemistry Letters. https://doi.org/10.1016/s0960-894x(97)00294-1
579. Marino, D. D., Oteri, F., Rocca, B. M. D., Chillemi, G., & Falconi, M. (2010). ADP/ATP mitochondrial carrier MD simulations to shed light on the structural–dynamical events that, after an additional mutation, restore the function in a pathological single mutant. Journal of Structural Biology. https://doi.org/10.1016/j.jsb.2010.07.015
580. Marino, S. D., Ummarino, R., D’Auria, M. V., Chini, M. G., Bifulco, G., D’Amore, C., Renga, B., Mencarelli, A., Petek, S., Fiorucci, S., & Zampella, A. (2012). 4-Methylenesterols from Theonella swinhoei sponge are natural pregnane-X-receptor agonists and farnesoid-X-receptor antagonists that modulate innate immunity. Steroids. https://doi.org/10.1016/j.steroids.2012.01.006
581. Marjitha, I. S. (2009). Polymorphism of Bone Morphogenetic Protein 15 (BMP15) Gene and its Potential as a Candidate Gene for the Prolificacy of Nilagiri Sheep.
582. Marks, D. F. (2024). Phenotype. Definitions. https://doi.org/10.32388/7xa295
583. Maroney, S. A., Ferrel, J. P., Collins, M. L., & Mast, A. E. (2008). Tissue factor pathway inhibitor‐γ is an active alternatively spliced form of tissue factor pathway inhibitor present in mice but not in humans. Journal of Thrombosis and Haemostasis. https://doi.org/10.1111/j.1538-7836.2008.03033.x
584. Marques, E., Pfohl, M., Wei, W., Tarantola, G., Ford, L. C., Amaeze, O., Alesio, J., Ryu, S., Jia, X., Zhu, H., Bothun, G. D., & Slitt, A. L. (2022). Replacement per- and polyfluoroalkyl substances (PFAS) are potent modulators of lipogenic and drug metabolizing gene expression signatures in primary human hepatocytes. Toxicology and Applied Pharmacology. https://doi.org/10.1016/j.taap.2022.115991
585. Marques, F. Z., Markus, M. A., & Morris, B. J. (2009). Resveratrol: Cellular actions of a potent natural chemical that confers a diversity of health benefits. The International Journal of Biochemistry & Cell Biology. https://doi.org/10.1016/j.biocel.2009.06.003
586. Martino, M. T. D., Leone, E., Amodio, N., Foresta, U., Lionetti, M., Pitari, M. R., Cantafio, M. E. G., Gullà, A., Conforti, F., Morelli, E., Tomaino, V., Rossi, M., Negrini, M., Ferrarini, M., Caraglia, M., Shammas, M. A., Munshi, N. C., Anderson, K. C., Neri, A., ... Tassone, P. (2023). Supplementary Figure 4 from Synthetic miR-34a Mimics as a Novel Therapeutic Agent for Multiple Myeloma: &lt;i&gt;In Vitro&lt;/i&gt; and &lt;i&gt;In Vivo&lt;/i&gt; Evidence. https://doi.org/10.1158/1078-0432.22446636
587. Martino, M. T. D., Leone, E., Amodio, N., Foresta, U., Lionetti, M., Pitari, M. R., Cantafio, M. E. G., Gullà, A., Conforti, F., Morelli, E., Tomaino, V., Rossi, M., Negrini, M., Ferrarini, M., Caraglia, M., Shammas, M. A., Munshi, N. C., Anderson, K. C., Neri, A., ... Tassone, P. (2023). Supplementary Figure 4 from Synthetic miR-34a Mimics as a Novel Therapeutic Agent for Multiple Myeloma: &lt;i&gt;In Vitro&lt;/i&gt; and &lt;i&gt;In Vivo&lt;/i&gt; Evidence. https://doi.org/10.1158/1078-0432.22446636.v1
588. Mathieu, J., Zhou, W., Xing, Y., Sperber, H., Ferreccio, A., Agoston, Z., Kuppusamy, K. T., Moon, R. T., & Ruohola‐Baker, H. (2014). Hypoxia-Inducible Factors Have Distinct and Stage-Specific Roles during Reprogramming of Human Cells to Pluripotency. Cell stem cell. https://doi.org/10.1016/j.stem.2014.02.012
589. Mathur, D., Liao, C., Lin, W., Ferlita, A. L., Alaimo, S., Taylor, S., Zhong, Y., Iacobuzio–Donahue, C. A., Ferro, A., & Xavier, J. B. (2024). Supplementary Data from The ratio of key metabolic transcripts is a predictive biomarker of breast cancer metastasis to the lung. https://doi.org/10.1158/0008-5472.27028795
590. Mathur, D., Liao, C., Lin, W., Ferlita, A. L., Alaimo, S., Taylor, S., Zhong, Y., Iacobuzio–Donahue, C. A., Ferro, A., & Xavier, J. B. (2024). Supplementary Data from The ratio of key metabolic transcripts is a predictive biomarker of breast cancer metastasis to the lung. https://doi.org/10.1158/0008-5472.27028795.v1
591. Matika, O., Robledo, D., Pong‐Wong, R., Woolliams, J. A., Bishop, S., Riggio, V., Hoste, A. E., Walling, G., Archibald, A., & Houston, R. D. (2018). A premature stop mutation in the porcine myostatin gene is a candidate causative mutation for a recessive leg weakness syndrome and a major QTL for muscle depth. Proceedings of the World Congress on Genetics Applied to Livestock Production.
592. Matika, O., Sanchez, D. R., Pong‐Wong, R., Woolliams, J., Bishop, S., Riggio, V., Hoste, A. E., Walling, G., Archibald, A., & Houston, R. D. (2018). A premature stop mutation in the porcine myostatin gene is a candidate causative variant for a recessive leg weakness syndrome and affects muscle depth.
593. Matsuo, A. L., Juliano, M. A., Figueiredo, C. R., Batista, W. L., Tanaka, A. S., & Travassos, L. R. (2023). Supplementary Table 1 from A New Phage-Display Tumor-Homing Peptide Fused to Antiangiogenic Peptide Generates a Novel Bioactive Molecule with Antimelanoma Activity. https://doi.org/10.1158/1541-7786.22518442
594. Matsuo, A. L., Juliano, M. A., Figueiredo, C. R., Batista, W. L., Tanaka, A. S., & Travassos, L. R. (2023). Supplementary Table 1 from A New Phage-Display Tumor-Homing Peptide Fused to Antiangiogenic Peptide Generates a Novel Bioactive Molecule with Antimelanoma Activity. https://doi.org/10.1158/1541-7786.22518442.v1
595. Mayr, C. H., Sengupta, A., Asgharpour, S., Ansari, M., Pestoni, J. C., Ogar, P., Angelidis, I., Liontos, A., Rodríguez‐Castillo, J. A., Lang, N. J., Strunz, M., Porras-Gonzalez, D., Gerckens, M., Sadeleer, L. D., Oehrle, B., Viteri-Alvarez, V., Fernandez, I. E., Tallquist, M. D., Irmler, M., ... Schiller, H. B. (2024). Sfrp1 inhibits lung fibroblast invasion during transition to injury-induced myofibroblasts. European Respiratory Journal. https://doi.org/10.1183/13993003.01326-2023
596. Mazsaroff, I., Holers, V. M., Akana, H., Smith, C. G., Emlen, J. W., Marians, R., & Horvath, C. (2009). TT30, a Novel Human Protein Therapeutic, Selectively Modulates the Complement Alternative Pathway by Targeted Supplementation of Local Factor H Activity.. Blood. https://doi.org/10.1182/blood.v114.22.3021.3021
597. McCoy, A. M., Kemper, A. M., Boyce, M. K., Brown, M. P., & Trumble, T. N. (2020). Additional file 5 of Differential gene expression analysis reveals pathways important in early post-traumatic osteoarthritis in an equine model. Figshare. https://doi.org/10.6084/m9.figshare.13311315
598. McDermott, B., Chinaemerem, O., & Tew, S. R. (2019). Evidence for alternative polyadenylation of the ADAMTS5 mRNA creating a heterogenous pool of transcripts that differ in their response to post-transcriptional cues. Osteoarthritis and Cartilage. https://doi.org/10.1016/j.joca.2019.02.263
599. McDonnell, T. J., & O’Connor, S. (2003). Is the polymorphic arginine form of p53 a risk factor for renal transplant patients?. Advances in Anatomic Pathology. https://doi.org/10.1097/00125480-200301000-00010
600. McIntyre, M. (2020). Top 5 Male Enhancement Pills For MONSTER Performance.
601. Medicine, C. A. M. M. I. (2023). Retracted: Peritumor Edema Serves as an Independent Predictive Factor of Recurrence Patterns and Recurrence‐Free Survival for High‐Grade Glioma. Computational and Mathematical Methods in Medicine. https://doi.org/10.1155/2023/9761763
602. Mefford, H. C. (2014). SNFing for Clues to the Genetics of Autism. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.3009253
603. Mehner, C., Miller, E., Khauv, D., Nassar, A., Oberg, A. L., Bamlet, W. R., Zhang, L., Waldmann, J., Radisky, E. S., Crawford, H. C., & Radisky, D. C. (2023). Supplementary Figure Legends from Tumor Cell–Derived MMP3 Orchestrates Rac1b and Tissue Alterations That Promote Pancreatic Adenocarcinoma. https://doi.org/10.1158/1541-7786.22514128
604. Mehrabian, M., Dylan, B., Wang, H., Zhengrui, X., Ekaterina, R., & Schmitt‐Ulms, G. (2015). PrP-deficiency affects expression of a subset of proteins undergoing pronounced expression levels changes during EMT.. https://doi.org/10.1371/journal.pone.0133741.g003
605. Mehta, S., Watts, G. D., Adamson, J., Hutton, M., Umberger, G., Xiong, S., Ramdeen, S., Lovell, M. A., Kimonis, V., & Smith, C. D. (2007). APOE is a potential modifier gene in an autosomal dominant form of frontotemporal dementia (IBMPFD). Genetics in Medicine. https://doi.org/10.1097/gim.0b013e31802d830d
606. Melsen, B. (1988). Adult orthodontics: factors differentiating the selection of biomechanics in growing and adult individuals.. PubMed.
607. Menegollo, M., Bentham, R. B., Henriques, T., Ng, S. Q., Ren, Z., Esculier, C., Agarwal, S., Tong, E. T., Lo, C., Ilangovan, S., Szabadkai, Z., Suman, M., Patani, N., Ghanate, A., Bryson, K., Stein, R. C., Yuneva, M., & Szabadkai, G. (2024). Supplementary Table S1 from Multistate Gene Cluster Switches Determine the Adaptive Mitochondrial and Metabolic Landscape of Breast Cancer. https://doi.org/10.1158/0008-5472.26934521
608. Menegollo, M., Bentham, R. B., Henriques, T., Ng, S. Q., Ren, Z., Esculier, C., Agarwal, S., Tong, E. T., Lo, C., Ilangovan, S., Szabadkai, Z., Suman, M., Patani, N., Ghanate, A., Bryson, K., Stein, R. C., Yuneva, M., & Szabadkai, G. (2024). Supplementary Table S1 from Multistate Gene Cluster Switches Determine the Adaptive Mitochondrial and Metabolic Landscape of Breast Cancer. https://doi.org/10.1158/0008-5472.26934521.v1
609. Merchiers, P., Bulens, F., Vriese, A. D., Carmeliet, G., Bouillon, R., Belayew, A., & Collen, D. (1997). 5 The multi-hormone responsive enhancer located far upstream from the human tissue-type plasminogen activator gene confers induction by vitamin D. Fibrinolysis & proteolysis/Fibrinolysis and proteolysis. https://doi.org/10.1016/s0268-9499(97)80120-8
610. Mertens, K., Gestel, D., Stempvoort, G. V., Limburg, V., Moret, E. E., & Meijer, A. B. (2007). Somatic Mutations in Factor VIII Inhibitors Determine Their Factor VIII Binding and Inhibitory Properties.. Blood. https://doi.org/10.1182/blood.v110.11.1762.1762
611. Meyer‐Siegler, K. L., Vera, P. L., Iczkowski, K. A., Bifulco, C., Lee, A., Gregersen, P. K., Leng, L., & Bucala, R. (2007). Macrophage migration inhibitory factor (MIF) gene polymorphisms are associated with increased prostate cancer incidence. Genes and Immunity. https://doi.org/10.1038/sj.gene.6364427
612. Mihalache, A., Delplanque, J.-F., Ringot-Destrez, B., Wavelet, C., Gosset, P., Nunes, B., Groux‐Degroote, S., Léonard, R., & Robbe‐Masselot, C. (2014). Structural Characterization of Mucin O-Glycosylation May Provide Important Information to Help Prevent Colorectal Tumor Recurrence.. HAL (Le Centre pour la Communication Scientifique Directe).
613. Miller, B. F. (2009). Energy Balance as an Independent Factor in Protein Metabolism with Special Considerations to Protein Recommendations. Medicine & Science in Sports & Exercise. https://doi.org/10.1249/01.mss.0000352807.45866.cf
614. Miller, J., Drew, L., Green, O., Dukovski, D., McEwan, B., Villella, A., Patel, N., Bastos, C., Cullen, M. D., Danh, H., Wachi, S., Giuliano, K. A., Longo, K., Bhalla, A., Qiu, D., Zou, C., Ivarsson, M., Muñoz, B., & Haberal, M. (2016). WS13.5 CFTR amplifiers are mutation-agnostic modulators that increase CFTR protein levels and complement other CF therapeutic modalities. Journal of Cystic Fibrosis. https://doi.org/10.1016/s1569-1993(16)30137-0
615. Miller, R. M., Kiser, G., Kaysser-Kranich, T., Casaceli, C., Colla, E., Lee, M. K., Palaniappan, C., & Federoff, H. J. (2007). Wild-type and mutant α-synuclein induce a multi-component gene expression profile consistent with shared pathophysiology in different transgenic mouse models of PD. Experimental Neurology. https://doi.org/10.1016/j.expneurol.2006.12.005
616. Misfeldt, A., Boyle, S. C., Tompkins, K. L., Bautch, V. L., Labosky, P. A., & Baldwin, H. S. (2009). Endocardial cells are a distinct endothelial lineage derived from Flk1+ multipotent cardiovascular progenitors. Developmental Biology. https://doi.org/10.1016/j.ydbio.2009.06.033
617. Misfeldt, A., Boyle, S., Tompkins, K. A., Bautch, V. L., Labosky, P. A., & Baldwin, H. S. (2009). Endocardial cells are a distinct endothelial lineage derived from Flk1+ multipotent cardiovascular progenitors. Carolina Digital Repository (University of North Carolina at Chapel Hill). https://doi.org/10.17615/5q7h-a355
618. Mohanty, J. N., Nayak, S., Jha, S., & Joshi, R. K. (2016). A sequence tagged site (STS) marker encoding Copia-like retrotransposable element is associated with male specific sex expression in Momordica dioica Roxb.. Scientia Horticulturae. https://doi.org/10.1016/j.scienta.2016.02.008
619. Mok, S., Evin, G., Li, Q., Beyreuther, K., Masters, C., & Small, D. (1997). A metalloprotease isolated from rat brain cleaves the amyloid precursor protein of Alzheimer's disease generating amyloidogenic fragments.. Journal of Neurochemistry.
620. Montanucci, L., Brünger, T., Bhattarai, N., Boßelmann, C. M., Kim, S., Allen, J. P., Zhang, J., Klöckner, C., Fariselli, P., May, P., Lemke, J. R., Myers, S. J., Yuan, H., Traynelis, S. F., & Lal, D. (2024). Distances from ligands as main predictive features for pathogenicity and functional effect of variants in NMDA receptors. medRxiv (Cold Spring Harbor Laboratory). https://doi.org/10.1101/2024.05.06.24306939
621. Montfort, J. ́., Cam, A. L., Gabillard, J., & Rescan, P. (2016). Additional file 1: of Gene expression profiling of trout regenerating muscle reveals common transcriptional signatures with hyperplastic growth zones of the post-embryonic myotome. Figshare. https://doi.org/10.6084/m9.figshare.c.3621167_d8
622. Monti, P. M., & Smith, N. (1976). Residual fear of the conditioned stimulus as a function of response prevention after avoidance or classical defensive conditioning in the rat.. Journal of Experimental Psychology General. https://doi.org/10.1037/0096-3445.105.2.148
623. Monti, P., Campomenosi, P., Ciribilli, Y., Iannone, R., Inga, A., Abbondandolo, A., Resnick, M. A., & Fronza, G. (2002). Tumour p53 mutations exhibit promoter selective dominance over wild type p53. Oncogene. https://doi.org/10.1038/sj.onc.1205250
624. Mordhorst, A. P., Hartog, M., Meijer, E., Koornneef, M., Laux, T., & Vries, S. C. D. (1997). The primordia timing (pt) mutant facilitates the initiation of embryogenic cell cultures while the pt gene is involved in regulating meristem activity..
625. Moreno-Vázquez, S., Ning, J., & Meyers, B. C. (2005). hATpin, a Family of MITE-like hAT Mobile Elements Conserved in Diverse Plant Species that Forms Highly Stable Secondary Structures. Plant Molecular Biology. https://doi.org/10.1007/s11103-005-8271-8
626. Morganelli, P. M. (1988). Glucocorticoids and interferons regulate the expression of a novel human mononuclear phagoctye-specific antigen.. https://doi.org/10.1349/ddlp.1775
627. Morgenthaler, A. B., Kinney, W. R., Ebmeier, C. C., Walsh, C., Snyder, D. J., Cooper, V. S., Old, W. M., & Copley, S. D. (2019). Author response: Mutations that improve efficiency of a weak-link enzyme are rare compared to adaptive mutations elsewhere in the genome. https://doi.org/10.7554/elife.53535.sa2
628. Morinobu, S. (2011). Are the DNA methylation profiles within the CpG island at the promoter of exon I of the brain-derived neurotrophic factor (BDNF) gene a potent diagnostic biomarker in psychiatric disorders?. Neuroscience Research. https://doi.org/10.1016/j.neures.2011.07.158
629. Moser, M., Binder, O., Wu, Y., Aitsebaomo, J., Ren, R., Bode, C., Bautch, V. L., Conlon, F. L., & Patterson, C. (2003). BMPER, a Novel Endothelial Cell Precursor-Derived Protein, Antagonizes Bone Morphogenetic Protein Signaling and Endothelial Cell Differentiation. Carolina Digital Repository (University of North Carolina at Chapel Hill). https://doi.org/10.17615/1dnm-nj59
630. Mouallem, A., Blanco-Garavito, R., Richard, F., Jung, C., & Souied, E. H. (2017). Genetics of large pigment epithelial detachment in neovascular age related macular degeneration highlights the role of Complement alternative pathway in this particular phenotype.. Investigative Ophthalmology & Visual Science.
631. Mubarak, G., & Zahir, F. (2022). Methionine Is a Major Methyl Donor Whose Dietary Intake Likely Plays a Causative Role for Neurodevelopmental Disorders via Epigenomic Profile Alterations. Springer eBooks. https://doi.org/10.1007/978-981-15-9781-7_4
632. Mukhopadhyay, N. K., Kim, J., Cinar, B., Ramachandran, A., Hager, M. H., Vizio, D. D., Adam, R. M., Rubin, M. A., Raychaudhuri, P., Benedetti, A. D., & Freeman, M. (2023). Supplementary Figure 1 from Heterogeneous Nuclear Ribonucleoprotein K Is a Novel Regulator of Androgen Receptor Translation. https://doi.org/10.1158/0008-5472.22380716.v1
633. Munoz, A. R., Hayward, M. R., Bloom, S. M., Rocafort, M., Ngcapu, S., Mafunda, N. A., Xu, J., Xulu, N., Dong, M., Dong, K. L., Ismail, N., Ndung’u, T., Ghebermichael, M. S., & Kwon, D. S. (2021). Additional file 6 of Modeling the temporal dynamics of cervicovaginal microbiota identifies targets that may promote reproductive health. Figshare. https://doi.org/10.6084/m9.figshare.15058288
634. Murdoch, B., Gallacher, L., Chadwick, K., Fellows, F., & Bhatia, M. (2002). Human embryonic–derived hematopoietic repopulating cells require distinct factors to sustain in vivo repopulating function. Experimental Hematology. https://doi.org/10.1016/s0301-472x(02)00793-2
635. Musselman, D. L., & Nemeroff, C. B. (1993). The Role of Corticotropin-Releasing Factor in the Pathophysiology of Psychiatric Disorders. Psychiatric Annals. https://doi.org/10.3928/0048-5713-19931201-07
636. Müller, G., Hecht, B., Helbl, V., Hinrichs, W., Saenger, W., & Hillen, W. (1995). Characterization of non-inducible Tet repressor mutants suggests conformational changes necessary for induction. Nature Structural & Molecular Biology. https://doi.org/10.1038/nsb0895-693
637. Mıkhael, J., Goodwin, J. W., Qi, X., Xu, W., Stewart, K., Reece, D., Chen, C., Trudel, S., Kukreti, V., & Chang, H. (2007). p53 Deletion Yields High Response Rates but Rapid Progression and Poor Overall Survival in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation.. Blood. https://doi.org/10.1182/blood.v110.11.953.953
638. Na, T., Vetrilé, L. A., Basharova, L. A., & Mikovskaya, O. I. (2002). Antibodies to glutamate as neuromodulators of behavioral reactions in mice with various genotypes.. Bulletin of Experimental Biology and Medicine. https://doi.org/10.1023/a:1015822314452
639. Nahler, G. (2009). adaptation. Dictionary of Pharmaceutical Medicine. https://doi.org/10.1007/978-3-211-89836-9_25
640. Nakamura, T., Takeshita, I., Inamura, T., & Fukui, M. (1992). The 56 kd platelet-derived growth factor (PDGF)-related protein is phosphorylated and the most stable form in human glioma cells. Journal of Neuro-Oncology. https://doi.org/10.1007/bf00172759
641. Nalepa, G. (2015). Guardian gone wild. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.aad3629
642. Nandan, M. O., Ghaleb, A. M., Liu, Y., Bialkowska, A. B., McConnell, B. B., Shroyer, K. R., Robine, S., & Yang, V. W. (2014). Inducible intestine-specific deletion of Krüppel-like factor 5 is characterized by a regenerative response in adult mouse colon. Developmental Biology. https://doi.org/10.1016/j.ydbio.2014.01.002
643. Nd, S., Shcherbatykh, T. V., Kir'yanov, S. A., Voskresenskaya, N. I., Farrer, L. A., & Si, G. (2001). The angiotensin-converting enzyme gene as a possible risk or protective factor in Alzheimer's disease.. Neuroscience and Behavioral Physiology. https://doi.org/10.1023/a:1005264324466
644. Nemajerová, A., Erster, S., & Moll, U. M. (2004). The post-translational phosphorylation and acetylation modification profile is not the determining factor in targeting endogenous stress-induced p53 to mitochondria. Cell Death and Differentiation. https://doi.org/10.1038/sj.cdd.4401526
645. Nesic, K., Hurley, R. M., McGehee, C. D., Kondrashova, O., Harrell, M. I., Zapparoli, G. V., Musafer, A., Wong, M. E., Weroha, S. J., Hou, X., Li, H., Negron, V., Peterson, K., Schneider, P. A., Swisher, E. M., Southey, M. C., Dobrovic, A., Wakefield, M. J., Kaufmann, S. H., & Scott, C. L. (2020). DNA repair gene promoter methylation patterns adapt and influence PARP inhibitor response.. Clinical Cancer Research.
646. Nguyen, H. P., Le, A. Q., Liu, E., Cesarano, A., DiMeo, F., Perna, F., Kapur, R., Walker, B. A., & Tran, N. T. (2023). Corrigendum: Protein arginine methyltransferase 1 is a therapeutic vulnerability in multiple myeloma. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2023.1334733
647. Ni, D., Gozzo, S., IuS, D., Ng, L., & Vg, K. (1983). [Neuroanatomical characteristics of rat strains differing in the ability to form active avoidance conditioned reflexes].. PubMed.
648. Nichols, W. C., Dwulet, F. E., Liepnieks, J. J., & Benson, M. D. (1988). Variant apolipoprotein AI as a major constituent of a human hereditary amyloid. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/s0006-291x(88)80909-4
649. Nickols, N. G., Szablowski, J. O., Hargrove, A. E., Li, B., Raskatov, J. A., & Dervan, P. B. (2023). Supplementary Figure 1 from Activity of a Py–Im Polyamide Targeted to the Estrogen Response Element. https://doi.org/10.1158/1535-7163.22497396
650. Nickols, N. G., Szablowski, J. O., Hargrove, A. E., Li, B., Raskatov, J. A., & Dervan, P. B. (2023). Supplementary Figure 1 from Activity of a Py–Im Polyamide Targeted to the Estrogen Response Element. https://doi.org/10.1158/1535-7163.22497396.v1
651. Nido, G. S., Dick, F., Toker, L., Petersen, K., Alves, G., Tysnes, O., Jonassen, I., Haugarvoll, K., & Tzoulis, C. (2020). Additional file 1 of Common gene expression signatures in Parkinson’s disease are driven by changes in cell composition. Figshare. https://doi.org/10.6084/m9.figshare.12171927
652. Nieto‐Sotelo, J., Wiederrecht, G., Okuda, A., & Parker, C. S. (1990). The yeast heat shock transcription factor contains a transcriptional activation domain whose activity is repressed under nonshock conditions. Cell. https://doi.org/10.1016/0092-8674(90)90124-w
653. Nishimura, D., Searby, C., Alward, W. L., Walton, D. S., Craig, J. E., Mackey, D. A., Kawase, K., Kanis, A. B., Patil, S. R., Stone, E. M., & Sheffield, V. C. (2001). A Spectrum of FOXC1 Mutations Suggests Gene Dosage as a Mechanism for Developmental Defects of the Anterior Chamber of the Eye. The American Journal of Human Genetics. https://doi.org/10.1086/318183
654. Niu, X. H., Chen, Y. C., Zhang, X. W., Xin, D., Zhao, W., Na, Y., & Mao, Z. B. (2010). Macrophage migration inhibitory factor is a direct target of HBP1-mediated transcriptional repression that is overexpressed in prostate cancer. Oncogene. https://doi.org/10.1038/onc.2010.97
655. Niu, Y., Yang, J., Guangtian, Y., Li, R., & Zou, W. (2020). Additional file 1 of Genome-wide characterization of the SPL gene family involved in the age development of Jatropha curcas. Figshare. https://doi.org/10.6084/m9.figshare.12344693
656. Niu, Y., Yang, J., Guangtian, Y., Li, R., & Zou, W. (2020). Additional file 8 of Genome-wide characterization of the SPL gene family involved in the age development of Jatropha curcas. Figshare. https://doi.org/10.6084/m9.figshare.12344726
657. Nocedal, I., Mancera, E., & Johnson, A. D. (2017). Author response: Gene regulatory network plasticity predates a switch in function of a conserved transcription regulator. https://doi.org/10.7554/elife.23250.025
658. Norton, M., Ng, A. C., Baird, S., Dumoulin, A., Shutt, T. E., Mah, N., Andrade‐Navarro, M. A., McBride, H. M., & Screaton, R. A. (2014). ROMO1 Is an Essential Redox-Dependent Regulator of Mitochondrial Dynamics. Science Signaling. https://doi.org/10.1126/scisignal.2004374
659. Norvell, A., & McMahon, S. B. (2010). Rise of the Rival. Science. https://doi.org/10.1126/science.1187159
660. Nourooz‐Zadeh, J., & Pandalai, S. G. (2003). Isoprostanes: selective markers of peroxidation of different fatty acids in the human body..
661. O.L., L., & S.V., S. (2011). Factors of the morphological functional state of organism of women of the first mature age, meaningful for the construction of the standard training.. DOAJ (DOAJ: Directory of Open Access Journals).
662. Ochmann, M., Lemonnier, F., Damotte, D., Delarue, R., Ben‐Neriah, S., Milpied, N., Lamy, T., Tilly, H., Gascoyne, R. D., Steidl, C., Gaulard, P., & Leroy, K. (2012). Mutations of STAT6 DNA Binding Domain Are Characteristic of PMBL and Belong to the Genetic Signature of This Entity.. Blood. https://doi.org/10.1182/blood.v120.21.2645.2645
663. Od, R., Slover, C., & Poon, M. (1976). Immunologic evidence that the properties of human antihemophilic factor (factor VIII) are attributes of a single molecular species. Blood. https://doi.org/10.1182/blood.v47.4.657.657
664. Ohlmeier, S., Vuolanto, M., Toljamo, T., Vuopala, K., Salmenkivi, K., Myllärniemi, M., & Kinnula, V. (2009). Proteomics of Human Lung Tissue Identifies Surfactant Protein A (SP-A) as a Marker of Chronic Obstructive Pulmonary Disease (COPD).. https://doi.org/10.1164/ajrccm-conference.2009.179.1_meetingabstracts.a3775
665. Ohta, S. (2011). Molecular hydrogen is a novel antioxidant to efficiently reduce oxidative stress with potential for the improvement of mitochondrial diseases. Biochimica et Biophysica Acta (BBA) - General Subjects. https://doi.org/10.1016/j.bbagen.2011.05.006
666. Olajide, J. S., Xiong, L., Yang, S., Qu, Z., Xu, X., Yang, B., Wang, J., Liu, B., Ma, X., & Cai, J. (2022). Additional file 6 of Eimeria falciformis secretes extracellular vesicles to modulate proinflammatory response during interaction with mouse intestinal epithelial cells. Figshare. https://doi.org/10.6084/m9.figshare.20278988
667. Oliveira, É. A., Milite, S., Fernández-Mateos, J., Cresswell, G. D., Yara-Romero, E., Vlachogiannis, G., Chen, B., James, C., Patruno, L., Ascolani, G., Acar, A., Heide, T., Spiteri, I., Graudenzi, A., Caravagna, G., Bertotti, A., Graham, T. A., Magnani, L., Valeri, N., & Sottoriva, A. (2025). Supplementary Figure 14 from Epigenetic Heritability of Cell Plasticity Drives Cancer Drug Resistance through a One-to-Many Genotype-to-Phenotype Paradigm. https://doi.org/10.1158/0008-5472.29759785
668. Ono, K., Ide, K., Nakano, R., Sakai, H., Shimizu, S., Tahara, H., Ohira, M., Tanaka, Y., & Ohdan, H. (2024). Polymorphisms in genes involved in regulating follicular helper T cell differentiation predict de novo donor-specific antibody formation after liver transplantation. Human Immunology. https://doi.org/10.1016/j.humimm.2024.111103
669. Ono, K., Ide, K., Nakano, R., Sakai, H., Tahara, H., Ohira, M., Tanaka, Y., & Ohdan, H. (2024). 225.8: Polymorphisms in molecules regulating follicular helper T cell differentiation predict de novo donor specific antibody formation after liver transplantation.. Transplantation. https://doi.org/10.1097/01.tp.0001064432.02077.6e
670. Ori, N., Sessa, G., Lotan, T., Himmelhoch, S., & Fluhr, R. (1990). A major stylar matrix polypeptide (sp41) is a member of the pathogenesis-related proteins superclass.. The EMBO Journal. https://doi.org/10.1002/j.1460-2075.1990.tb07550.x
671. Oswald, A. J., Hollis, R. L., Carragher, N. O., Albertella, M. R., Forment, J. V., Illuzzi, G., Leo, E., Elliott, R., & Gourley, C. (2024). 350 (PB338): Structural variants of BRCA1/2 represent a novel biomarker of homologous recombination deficiency in multiple tumour types. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2024.114863
672. Osório, J., Stiller, K. T., Reiten, B.-K., Kolarevic, J., Johansen, L., Afonso, F., & Lazado, C. C. (2022). Additional file 1 of Intermittent administration of peracetic acid is a mild environmental stressor that elicits mucosal and systemic adaptive responses from Atlantic salmon post-smolts. Figshare. https://doi.org/10.6084/m9.figshare.17870119
673. Owczarek, C. M., Layton, M. J., Metcalf, D., Lock, P., Willson, T. A., Gough, N. M., & Nicola, N. A. (1993). Inter-species chimeras of leukaemia inhibitory factor define a major human receptor-binding determinant.. The EMBO Journal. https://doi.org/10.1002/j.1460-2075.1993.tb06023.x
674. Padmanabhan, A., & Haldar, S. M. (2018). Unusual transcription factor protects against heart failure. Science. https://doi.org/10.1126/science.aav8956
675. Padula, M. C., Leccese, P., Padula, A., D’Angelo, S., & Martelli, G. (2018). ERAP1 molecular characterization: Identification of a de novo allelic variant. HLA. https://doi.org/10.1111/tan.13262
676. Palumbo, J. S., Barney, K. A., Williams, E. A., Shaw, M. A., Mishra, A., Flick, M. J., Talmage, K. E., & Degen, J. L. (2007). Factor XIII Supports Metastatic Potential through a Mechanism Coupled to Natural Killer Cell Function.. Blood. https://doi.org/10.1182/blood.v110.11.1753.1753
677. Palumbo, J. S., Talmage, K. E., Massari, J. V., Jeunesse, C. M. L., Flick, M. J., Jiroušková, M., & Degen, J. L. (2004). Hemostatic Factors Contribute to Tumor Cell Metastatic Potential by a Mechanism Linked to Natural Killer Cell Function.. Blood. https://doi.org/10.1182/blood.v104.11.690.690
678. Pan, Z., Zhou, X., Cao, Z., & Pan, J. (2024). [Latest Findings on the Role of RUNX1 in Bone Development and Disorders].. PubMed. https://doi.org/10.12182/20240360103
679. Panchal, S., Murali, T. S., Suryanarayanan, T. S., & Sanyal, K. (2022). Hypersaline fungi as a source of potentially active metabolites against pathogenic <i>Candida</i> species.. Czech Mycology. https://doi.org/10.33585/cmy.74107
680. Panciera, T., Citron, A., Biagio, D. D., Battilana, G., Gandin, A., Giulitti, S., Forcato, M., Bicciato, S., Panzetta, V., Fusco, S., Azzolin, L., Totaro, A., Tos, A. P. D., Fassan, M., Vindigni, V., Bassetto, F., Rosato, A., Brusatin, G., Cordenonsi, M., & Piccolo, S. (2020). Publisher Correction: Reprogramming normal cells into tumour precursors requires ECM stiffness and oncogene-mediated changes of cell mechanical properties. Nature Materials. https://doi.org/10.1038/s41563-020-0644-5
681. Panda, A., Acharya, D., & Ghosh, T. C. (2017). Insights into human intrinsically disordered proteins from their gene expression profile. Molecular BioSystems. https://doi.org/10.1039/c7mb00311k
682. Panerai, A. E., Arvidsson, L., Conget, I., Bartorelli, A., Sandler, S., Nicoletti, F., Gomis, R., & Sacedote, P. (2001). MFP14, a multifunctional emerging protein with immunomodulatory properties, prevents spontaneous and recurrent autoimmune diabetes in NOD mice. Diabetologia. https://doi.org/10.1007/s001250100519
683. Panzetta, M. E., & Valdivia, R. H. (2024). <i>Akkermansia</i> in the gastrointestinal tract as a modifier of human health. Gut Microbes. https://doi.org/10.1080/19490976.2024.2406379
684. Papp, A. E. D., & Stewart, A. F. (1993). Parathyroid hormone-related protein a peptide of diverse physiologic functions. Trends in Endocrinology and Metabolism. https://doi.org/10.1016/1043-2760(93)90114-t
685. Park, J., Lee, C., Oh, J.-I., Kim, B., Kwon, J. H., Kim, B. K., Ahn, K., & Yoon, S. (2009). Bortezomib Resistant Multiple Myeloma Cells Are Tumor Initiating Cells That Have a Stem Cell-Like Genetic Signature.. Blood. https://doi.org/10.1182/blood.v114.22.2805.2805
686. Patterson, A. M., Kaabinejadian, S., McMurtrey, C., Bardet, W., Jackson, K. W., Zuna, R. E., Husain, S., Adams, G. P., MacDonald, G., Dillon, R. L., Ames, H., Buchli, R., Hawkins, O. E., Weidanz, J. A., & Hildebrand, W. H. (2023). Supplementary Figure Legends from Human Leukocyte Antigen–Presented Macrophage Migration Inhibitory Factor Is a Surface Biomarker and Potential Therapeutic Target for Ovarian Cancer. https://doi.org/10.1158/1535-7163.22503151
687. Patterson, A. M., Kaabinejadian, S., McMurtrey, C., Bardet, W., Jackson, K. W., Zuna, R. E., Husain, S., Adams, G. P., MacDonald, G., Dillon, R. L., Ames, H., Buchli, R., Hawkins, O. E., Weidanz, J. A., & Hildebrand, W. H. (2023). Supplementary Figure Legends from Human Leukocyte Antigen–Presented Macrophage Migration Inhibitory Factor Is a Surface Biomarker and Potential Therapeutic Target for Ovarian Cancer. https://doi.org/10.1158/1535-7163.22503151.v1
688. Percy, M. J., Furlow, P. W., Lucas, G., Li, X., Lappin, T. R., McMullin, M. F., & Lee, F. S. (2007). A Novel HIFalpha Mutation Associated with Familial Erythrocytosis Supports This Isoform Being the Major Regulator of Erythropoietin in Humans.. Blood. https://doi.org/10.1182/blood.v110.11.lb5.lb5
689. Pereira, J. F., Araújo, E. F. D., Brommonschenkel, S. H., Queiroz, C. B. D., Costa, G. G., Carazzolle, M. F., Pereira, G. A. G., & Queiroz, M. V. D. (2015). MpSaci is a widespread gypsy-Ty3 retrotransposon highly represented by non-autonomous copies in the Moniliophthora perniciosa genome. Current Genetics. https://doi.org/10.1007/s00294-014-0469-3
690. Pereira‐Castro, I., García, B., Curinha, A., Neves‐Costa, A., Conde‐Sousa, E., Moita, L. F., & Moreira, A. (2022). MCL1 alternative polyadenylation is essential for cell survival and mitochondria morphology. Cellular and Molecular Life Sciences. https://doi.org/10.1007/s00018-022-04172-x
691. Peyton, L., McCarroll, A., & Zhang, H. (2024). Loss of Function Mutagenesis Protocol v1. https://doi.org/10.17504/protocols.io.ewov19ymklr2/v1
692. Pham, T.-H., Benner, C., Lichtinger, M., Schwarzfischer, L., Hu, Y., Andreesen, R., Chen, W., & Rehli, M. (2012). Dynamic epigenetic enhancer signatures reveal key transcription factors associated with monocytic differentiation states. Blood. https://doi.org/10.1182/blood-2012-01-402453
693. Pickersgill, H. (2010). Modifying Protein Modification. Science Signaling. https://doi.org/10.1126/scisignal.3103ec6
694. Piehowski, P., Petyuk, V., Sontag, R., Gritsenko, M., Weitz, K., Fillmore, T., Moon, J., Makhlouf, H. R., Chuaqui, R., Boja, E. S., Rodriguez, H., Lee, J., Smith, R., Carrick, D. M., Liu, T., & Rodland, K. (2018). MOESM1 of Residual tissue repositories as a resource for population-based cancer proteomic studies. Figshare. https://doi.org/10.6084/m9.figshare.6916502
695. Pincus, D. W., Ryan, C., Smith, R. D., Brent, R., & Resnekov, O. (2013). Correction: Assigning Quantitative Function to Post-Translational Modifications Reveals Multiple Sites of Phosphorylation That Tune Yeast Pheromone Signaling Output. PLoS ONE. https://doi.org/10.1371/annotation/06dfa4e4-30f5-4d37-8559-0f2a9d11f0de
696. Piquet, R., Faugère, A., & Parkes, S. L. (2023). A hippocampo-cortical pathway detects changes in the validity of an action as a predictor of reward. Zenodo (CERN European Organization for Nuclear Research). https://doi.org/10.5281/zenodo.8220639
697. Piquet, R., Faugère, A., & Parkes, S. L. (2023). A hippocampo-cortical pathway detects changes in the validity of an action as a predictor of reward. Zenodo (CERN European Organization for Nuclear Research). https://doi.org/10.5281/zenodo.8220640
698. Pirker, C., Bilecz, Á., Grusch, M., Mohr, T., Heidenreich, B., László, V., Stockhammer, P., Lötsch-Gojo, D., Gojo, J., Gabler, L., Spiegl‐Kreinecker, S., Döme, B., Steindl, A., Klikovits, T., Hoda, M. A., Jakopović, M., Samaržija, M., Mohorčič, K., Kern, I., ... Berger, W. (2023). Supplementary Figure S4 from Telomerase Reverse Transcriptase Promoter Mutations Identify a Genomically Defined and Highly Aggressive Human Pleural Mesothelioma Subgroup. https://doi.org/10.1158/1078-0432.22475780
699. Pirker, C., Bilecz, Á., Grusch, M., Mohr, T., Heidenreich, B., László, V., Stockhammer, P., Lötsch-Gojo, D., Gojo, J., Gabler, L., Spiegl‐Kreinecker, S., Döme, B., Steindl, A., Klikovits, T., Hoda, M. A., Jakopović, M., Samaržija, M., Mohorčič, K., Kern, I., ... Berger, W. (2023). Supplementary Table S6 from Telomerase Reverse Transcriptase Promoter Mutations Identify a Genomically Defined and Highly Aggressive Human Pleural Mesothelioma Subgroup. https://doi.org/10.1158/1078-0432.22475759
700. Placke, T., Örgel, M., Schaller, M., Jung, G., Rammensee, H., Kopp, H., & Salih, H. R. (2023). Supplementary Figure 1 from Platelet-Derived MHC Class I Confers a Pseudonormal Phenotype to Cancer Cells That Subverts the Antitumor Reactivity of Natural Killer Immune Cells. https://doi.org/10.1158/0008-5472.22392338
701. Placke, T., Örgel, M., Schaller, M., Jung, G., Rammensee, H., Kopp, H., & Salih, H. R. (2023). Supplementary Figure 1 from Platelet-Derived MHC Class I Confers a Pseudonormal Phenotype to Cancer Cells That Subverts the Antitumor Reactivity of Natural Killer Immune Cells. https://doi.org/10.1158/0008-5472.22392338.v1
702. Placke, T., Örgel, M., Schaller, M., Jung, G., Rammensee, H., Kopp, H., & Salih, H. R. (2023). Supplementary Movie from Platelet-Derived MHC Class I Confers a Pseudonormal Phenotype to Cancer Cells That Subverts the Antitumor Reactivity of Natural Killer Immune Cells. https://doi.org/10.1158/0008-5472.22392335
703. Placke, T., Örgel, M., Schaller, M., Jung, G., Rammensee, H., Kopp, H., & Salih, H. R. (2023). Supplementary Movie from Platelet-Derived MHC Class I Confers a Pseudonormal Phenotype to Cancer Cells That Subverts the Antitumor Reactivity of Natural Killer Immune Cells. https://doi.org/10.1158/0008-5472.22392335.v1
704. Ploch, S., Kruse, J., Choi, Y., Thiel, H., & Thines, M. (2021). Ancestral state reconstruction in Peronospora provides further evidence for host jumping as a key element in the diversification of obligate parasites. Molecular Phylogenetics and Evolution. https://doi.org/10.1016/j.ympev.2021.107321
705. Poage, G. M., Butler, R. A., Houseman, E. A., McClean, M. D., Nelson, H. H., Christensen, B. C., Marsit, C. J., & Kelsey, K. T. (2023). Supplementary Figure 1 from Identification of an Epigenetic Profile Classifier That Is Associated with Survival in Head and Neck Cancer. https://doi.org/10.1158/0008-5472.22393571
706. Podder, S., Mukhopadhyay, P., & Ghosh, T. C. (2009). Multifunctionality dominantly determines the rate of human housekeeping and tissue specific interacting protein evolution. Gene. https://doi.org/10.1016/j.gene.2009.03.005
707. Pokrývková, B., Grega, M., Klozar, J., Vencálek, O., Nunvář, J., & Tachezy, R. (2022). PD1+CD8+ cells are an independent prognostic marker in patients with head and neck cancer. Zenodo (CERN European Organization for Nuclear Research). https://doi.org/10.5281/zenodo.6651586
708. Pokrývková, B., Grega, M., Klozar, J., Vencálek, O., Nunvář, J., & Tachezy, R. (2022). PD1+CD8+ cells are an independent prognostic marker in patients with head and neck cancer. Zenodo (CERN European Organization for Nuclear Research). https://doi.org/10.5281/zenodo.6874821
709. Polat, A. N., & Özlü, N. (2014). Towards single-cell LC-MS phosphoproteomics. The Analyst. https://doi.org/10.1039/c4an00463a
710. Polk, A., Ye, L., Wang, T., Seymour, E., Bailey, N. G., Singer, J. W., Boonstra, P. S., Lim, M. S., Malek, S. N., & Wilcox, R. A. (2023). Supplementary Figure 5 from Colony-Stimulating Factor-1 Receptor Is Required for Nurse-like Cell Survival in Chronic Lymphocytic Leukemia. https://doi.org/10.1158/1078-0432.22468311
711. Polk, A., Ye, L., Wang, T., Seymour, E., Bailey, N. G., Singer, J. W., Boonstra, P. S., Lim, M. S., Malek, S. N., & Wilcox, R. A. (2023). Supplementary Figure 5 from Colony-Stimulating Factor-1 Receptor Is Required for Nurse-like Cell Survival in Chronic Lymphocytic Leukemia. https://doi.org/10.1158/1078-0432.22468311.v1
712. Posp̂íšilová, Š., Tichý, B., Borská, R., Štruncová, S., Borský, M., Kotašková, J., Kusenda, B., Kovar, H., & Mayer, J. (2005). siRNA silencing of Ewings sarcoma-derived p53 mutants resultsin significant expression changes of neuronal transcriptionfactors..
713. Poul, Y. L., Xin, Y., Ling, L., Mühling, B., Jaenichen, R., Hörl, D., Bunk, D. M., Harz, H., Leonhardt, H., Wang, Y., Osipova, E. V., Museridze, M., Dharmadhikari, D., Murphy, E., Rohs, R., Preibisch, S., Prud’homme, B., & Gompel, N. (2020). Regulatory encoding of quantitative variation in spatial activity of a <i>Drosophila</i> enhancer. Science Advances. https://doi.org/10.1126/sciadv.abe2955
714. Powell, J. A., Thomas, D., Barry, E. F., Kok, C. H., McClure, B. J., Tsykin, A., To, L. B., Brown, A., Lewis, I. D., Herbert, K., Goodall, G. J., Speed, T. P., Asou, N., Jacob, B., Osato, M., Haylock, D. N., Nilsson, S. K., D’Andrea, R. J., López, A. F., & Guthridge, M. A. (2009). Expression profiling of a hemopoietic cell survival transcriptome implicates osteopontin as a functional prognostic factor in AML. Blood. https://doi.org/10.1182/blood-2009-02-204818
715. Prüller, J., Hofer, I., Ganassi, M., Heher, P., Ma, M., & Zammit, P. S. (2020). Correction: A human Myogenin promoter modified to be highly active in alveolar rhabdomyosarcoma drives an effective suicide gene therapy. Cancer Gene Therapy. https://doi.org/10.1038/s41417-020-00251-y
716. Puhr, M., Hoefer, J., Eigentler, A., Ploner, C., Handle, F., Schaefer, G., Kroon, J., Leo, A., Heidegger, I., Eder, I. E., Čulig, Z., Pluijm, G. V. D., & Klocker, H. (2023). Table S1 from The Glucocorticoid Receptor Is a Key Player for Prostate Cancer Cell Survival and a Target for Improved Antiandrogen Therapy. https://doi.org/10.1158/1078-0432.22465317
717. Puhr, M., Hoefer, J., Eigentler, A., Ploner, C., Handle, F., Schaefer, G., Kroon, J., Leo, A., Heidegger, I., Eder, I. E., Čulig, Z., Pluijm, G. V. D., & Klocker, H. (2023). Table S1 from The Glucocorticoid Receptor Is a Key Player for Prostate Cancer Cell Survival and a Target for Improved Antiandrogen Therapy. https://doi.org/10.1158/1078-0432.22465317.v1
718. Purnell, B. A. (2015). Mouse work may lead to male contraceptive. Science Signaling. https://doi.org/10.1126/scisignal.aad7045
719. Pykäläinen, A., Boczkowska, M., Zhao, H., Saarikangas, J., Rębowski, G., Jansen, M., Hakanen, J., Koskela, E. V., Peränen, J., Vihinen, H., Jokitalo, E., Salminen, M., Ikonen, E., Domínguez, R., & Lappalainen, P. (2011). Pinkbar is an epithelial-specific BAR domain protein that generates planar membrane structures. Nature Structural & Molecular Biology. https://doi.org/10.1038/nsmb.2079
720. Pérot, G., Derré, J., Coindre, J., Tirode, F., Lucchesi, C., Mariani, O., Gibault, L., Guillou, L., Terrier, P., & Aurias, A. (2023). Supplementary Figure 1 from Strong Smooth Muscle Differentiation Is Dependent on Myocardin Gene Amplification in Most Human Retroperitoneal Leiomyosarcomas. https://doi.org/10.1158/0008-5472.22380345
721. Pérot, G., Derré, J., Coindre, J., Tirode, F., Lucchesi, C., Mariani, O., Gibault, L., Guillou, L., Terrier, P., & Aurias, A. (2023). Supplementary Figure 1 from Strong Smooth Muscle Differentiation Is Dependent on Myocardin Gene Amplification in Most Human Retroperitoneal Leiomyosarcomas. https://doi.org/10.1158/0008-5472.22380345.v1
722. Qu, G., Fetterer, R. H., Leng, L., Du, X., Zarlenga, D. S., Shen, Z., Han, W., Bucala, R., & Tuo, W. (2014). Ostertagia ostertagi macrophage migration inhibitory factor is present in all developmental stages and may cross-regulate host functions through interaction with the host receptor. International Journal for Parasitology. https://doi.org/10.1016/j.ijpara.2014.01.009
723. Quinn, J. P., Warburton, A., Myers, P., Savage, A. L., & Bubb, V. J. (2013). Polymorphic variation as a driver of differential neuropeptide gene expression. Neuropeptides. https://doi.org/10.1016/j.npep.2013.10.003
724. Quintans‐Júnior, L. J., Oliveira, M. G. B. D., Santana, M. F. D., Santana, M. T. D., Guimarães, A. G., Siqueira, J. S., Sousa, D. P. D., & Almeida, R. N. D. (2011). α-Terpineol reduces nociceptive behavior in mice. Pharmaceutical Biology. https://doi.org/10.3109/13880209.2010.529616
725. Quintás‐Cardama, A., Qiu, Y. H., Post, S. M., & Kornblau, S. M. (2011). High P53 Protein Expression Level Independent of Mutational Status Is An Adverse Prognostic Factor for Survival in Acute Myeloid Leukemia. Blood. https://doi.org/10.1182/blood.v118.21.1490.1490
726. Rad, E. B., Hammerlindl, H., Wels, C., Popper, U., Menon, D. R., Breiteneder, H., Kitzwoegerer, M., Häfner, C., Herlyn, M., Bergler, H., & Schaider, H. (2023). Supplemental Figure Legends from Notch4 Signaling Induces a Mesenchymal–Epithelial–like Transition in Melanoma Cells to Suppress Malignant Behaviors. https://doi.org/10.1158/0008-5472.22410959
727. Radovanović, N., Pešović, J., Perić, S., Radenković, L., Brkušanin, M., Brajušković, G., Stojanović, V. R., & Savić‐Pavićević, D. (2024). 469P Modal allele change as a predictor of skeletal muscle symptoms progression in myotonic dystrophy type 1. Neuromuscular Disorders. https://doi.org/10.1016/j.nmd.2024.07.553
728. Raife, T. J., Mill, J., Hess, A. S., & Haj, A. K. (2022). The Longevity Factor Spermidine Is Highly Heritable in Human Erythrocytes and Is Part of a Complex Phenotype Associated with Human Longevity. Blood. https://doi.org/10.1182/blood-2022-158274
729. Rambold, A. S., & Lippincott‐Schwartz, J. (2011). SevERing Mitochondria. Science. https://doi.org/10.1126/science.1214059
730. Ravuri, S., Zhang, P., Wang, J., Marra, K. G., Kling, R., & Chai, J. (2014). Exogenous connective tissue growth factor preserves the hair‐inductive ability of human dermal papilla cells. International Journal of Cosmetic Science. https://doi.org/10.1111/ics.12146
731. Ray, L. B. (2010). Dephosphorylation to Die For. Science Signaling. https://doi.org/10.1126/scisignal.3150ec364
732. Ray, L. B. (2010). Fueling the Cancer Cell. Science Signaling. https://doi.org/10.1126/scisignal.3122ec153
733. Ray, L. B. (2010). Localized Readiness. Science Signaling. https://doi.org/10.1126/scisignal.3116ec107
734. Ray, L. B. (2010). Rewiring for Longer Life. Science Signaling. https://doi.org/10.1126/scisignal.3125ec177
735. Ray, L. B. (2011). Variable Entrainment. Science Signaling. https://doi.org/10.1126/scisignal.4189ec248
736. Ray, L. B. (2015). Tumor suppressor p53 linked to immune function. Science Signaling. https://doi.org/10.1126/scisignal.aad1352
737. Raynal, N. J., Si, J., Taby, R. F., Gharibyan, V., Ahmed, S., Jelı́nek, J., Estecio, M. R., & Issa, J. J. (2023). Supplementary Figure 5 from DNA Methylation Does Not Stably Lock Gene Expression but Instead Serves as a Molecular Mark for Gene Silencing Memory. https://doi.org/10.1158/0008-5472.22394444
738. Raynal, N. J., Si, J., Taby, R. F., Gharibyan, V., Ahmed, S., Jelı́nek, J., Estecio, M. R., & Issa, J. J. (2023). Supplementary Figure 5 from DNA Methylation Does Not Stably Lock Gene Expression but Instead Serves as a Molecular Mark for Gene Silencing Memory. https://doi.org/10.1158/0008-5472.22394444.v1
739. Rayner, K. J. (2016). The splice of life: Understanding human macrophage polarization. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.aag2111
740. Real, M. V. F., Colvin, M. S., Sheehan, M. J., & Moeller, A. H. (2023). Major urinary protein (<i>Mup</i>) gene family deletion drives sex-specific alterations on the house mouse gut microbiota. bioRxiv (Cold Spring Harbor Laboratory). https://doi.org/10.1101/2023.08.01.551491
741. Real, M. V. F., Colvin, M. S., Sheehan, M. J., & Moeller, A. H. (2024). Major urinary protein ( <i>Mup</i> ) gene family deletion drives sex-specific alterations in the house-mouse gut microbiota. Microbiology Spectrum. https://doi.org/10.1128/spectrum.03566-23
742. Reddi, R., Ganji, R. J., Marapaka, A. K., Bala, S., Yerra, N. V., Haque, N., & Addlagatta, A. (2020). Puromycin, a selective inhibitor of PSA acts as a substrate for other M1 family aminopeptidases: Biochemical and structural basis. International Journal of Biological Macromolecules. https://doi.org/10.1016/j.ijbiomac.2020.10.035
743. Rege‐Cambrin, G., Speleman, F., Kerim, S., Scaravaglio, P., Carozzi, F., Cin, P. D., Michaux, J., Offner, F., Saglio, G., & Berghe, H. V. D. (1991). Extra translocation +der(1q9p) is a prognostic indicator in myeloproliferative disorders.. PubMed.
744. Reyes‐Díaz, A., González-Córdova, A. F., Hernández‐Mendoza, A., & Vallejo‐Córdoba, B. (2016). Péptidos inmunomoduladores derivados de las proteínas de la leche. Interciencia.
745. Richardson, R. S., & Wray, D. W. (2005). The muscle pump is/is not an important determinant of muscle blood flow during exercise.. Journal of Applied Physiology. https://doi.org/10.1152/japplphysiol.00499.2005
746. Richendollar, B. G., Pohlman, B., Elson, P., & Hsi, E. D. (2009). Follicular PD-1+ Lymphocytes in the Tumor Microenvironment Are An Independent Prognostic Factor in Follicular Lymphoma.. Blood. https://doi.org/10.1182/blood.v114.22.134.134
747. Rickelt, S., Condon, C., Mana, M., Whittaker, C. A., Pfirschke, C., Roper, J., Patil, D. T., Brown, I., Mattia, A. R., Zukerberg, L., Zhao, Q., Chetty, R., Lauwers, G. Y., Neyaz, A., Leijssen, L. G., Boylan, K., Yılmaz, Ö., Deshpande, V., & Hynes, R. O. (2023). Supplementary Table S1 from Agrin in the Muscularis Mucosa Serves as a Biomarker Distinguishing Hyperplastic Polyps from Sessile Serrated Lesions. https://doi.org/10.1158/1078-0432.22479827
748. Rickelt, S., Condon, C., Mana, M., Whittaker, C. A., Pfirschke, C., Roper, J., Patil, D. T., Brown, I., Mattia, A. R., Zukerberg, L., Zhao, Q., Chetty, R., Lauwers, G. Y., Neyaz, A., Leijssen, L. G., Boylan, K., Yılmaz, Ö., Deshpande, V., & Hynes, R. O. (2023). Supplementary Table S1 from Agrin in the Muscularis Mucosa Serves as a Biomarker Distinguishing Hyperplastic Polyps from Sessile Serrated Lesions. https://doi.org/10.1158/1078-0432.22479827.v1
749. Ricklefs, F., Mineo, M., Rooj, A. K., Nakano, I., Charest, A., Weissleder, R., Breakefield, X. O., Chiocca, E. A., Godlewski, J., & Bronisz, A. (2023). Supplementary Figure Legend from Extracellular Vesicles from High-Grade Glioma Exchange Diverse Pro-oncogenic Signals That Maintain Intratumoral Heterogeneity. https://doi.org/10.1158/0008-5472.22411338
750. Ricklefs, F., Mineo, M., Rooj, A. K., Nakano, I., Charest, A., Weissleder, R., Breakefield, X. O., Chiocca, E. A., Godlewski, J., & Bronisz, A. (2023). Supplementary Figure Legend from Extracellular Vesicles from High-Grade Glioma Exchange Diverse Pro-oncogenic Signals That Maintain Intratumoral Heterogeneity. https://doi.org/10.1158/0008-5472.22411338.v1
751. Riddle, S., Kasmi, K. C. E., Li, M., Anderson, A. L., Frid, M. G., Flockton, A., McKeon, B., Sokol, R. J., & Stenmark, K. R. (2012). Activated Adventitial Pulmonary Artery Fibroblasts Drive Macrophages Toward A Distinct M2-Like Phenotype Consistent With Promoting Remodeling And Fibrosis In Pulmonary Hypertension. https://doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a5758
752. Rieger, M., Seifert, U., Textoris‐Taube, K., Drung, I., Kloetzel, P., & Kuckelkorn, U. (2007). Intermediate Type Proteasomes show Different Proteolytic Properties and contribute to a High Diversity of Antigenic Peptides in the Early Phase of Infection. GBM Fall meeting Hamburg 2007. https://doi.org/10.1240/sav_gbm_2007_h_001972
753. Rizzo, M. B. D. S. (2020). O papel do fator inibitório da migração de macrófagos (MIF) na modulação de macrófagos associados ao tumor em carcinoma epidermoide da cavidade bucal. https://doi.org/10.11606/t.5.2020.tde-13012020-125811
754. Robson, N. C., Hidalgo, L., McAlpine, T., Wei, H., Martínez, V. G., Entrena, A., Melen, G. J., MacDonald, A. S., Phythian‐Adams, A., Sacedón, R., Maraskovsky, E., Cebon, J., Ramírez, M., Vicente, Á., & Varas, A. (2023). Data Supplement from Optimal Effector Functions in Human Natural Killer Cells Rely upon Autocrine Bone Morphogenetic Protein Signaling. https://doi.org/10.1158/0008-5472.22400555
755. Robson, N. C., Hidalgo, L., McAlpine, T., Wei, H., Martínez, V. G., Entrena, A., Melen, G. J., MacDonald, A. S., Phythian‐Adams, A., Sacedón, R., Maraskovsky, E., Cebon, J., Ramírez, M., Vicente, Á., & Varas, A. (2023). Data Supplement from Optimal Effector Functions in Human Natural Killer Cells Rely upon Autocrine Bone Morphogenetic Protein Signaling. https://doi.org/10.1158/0008-5472.22400555.v1
756. Roca-Pinilla, R., López-Cano, A., Saubi, C., García‐Fruitós, E., & Arı́s, A. (2020). Additional file 4 of A new generation of recombinant polypeptides combines multiple protein domains for effective antimicrobial activity. Figshare. https://doi.org/10.6084/m9.figshare.12441686
757. Rohde, M., Warthoe, P., Gjetting, T., Lukáš, J., Bártek, J., & Strauss, M. (1996). The retinoblastoma protein modulates expression of genes coding for diverse classes of proteins including components of the extracellular matrix.. PubMed.
758. Rossi, D., Spina, V., Deambrogi, C., Lucioni, M., Arcaini, L., Rocque, G. B., Malik, J., Chang, J., Chigrinova, E., Nomdedéu, J., Forconi, F., Marasca, R., Besson, C., Canzonieri, V., Paulli, M., Gattei, V., Bertoni, F., Young, K. H., & Gaïdano, G. (2009). TP53 Mutations, the Most Frequent Genetic Lesion in Richter Syndrome, Represent An Independent Predictor of Survival Post Transformation.. Blood. https://doi.org/10.1182/blood.v114.22.670.670
759. Rota, I. A., Handel, A. E., Maio, S., Klein, F., Dhalla, F., Deadman, M. E., Cheuk, S., Newman, J., Michaels, Y. S., Žuklys, S., Prevot, N., Hublitz, P., Charles, P. D., Gkazi, S. A., Adamopoulou, E., Qasim, W., Davies, E. G., Hanson, I. C., Pagnamenta, A. T., ... Holländer, G. A. (2021). FOXN1 forms higher-order nuclear condensates displaced by mutations causing immunodeficiency. Science Advances. https://doi.org/10.1126/sciadv.abj9247
760. Ruan, H., Liao, Y., Ren, Z., Mao, L., Yao, F., Peng, Y., Ye, Y., Zhang, Z., Li, S., Xu, H., Liu, J., Diao, L., Zhou, B., Han, L., & Wang, L. (2019). MOESM3 of Single-cell reconstruction of differentiation trajectory reveals a critical role of ETS1 in human cardiac lineage commitment. Figshare. https://doi.org/10.6084/m9.figshare.10302758
761. Ruan, H., Liao, Y., Ren, Z., Mao, L., Yao, F., Peng, Y., Ye, Y., Zhang, Z., Li, S., Xu, H., Liu, J., Diao, L., Zhou, B., Han, L., & Wang, L. (2019). MOESM4 of Single-cell reconstruction of differentiation trajectory reveals a critical role of ETS1 in human cardiac lineage commitment. Figshare. https://doi.org/10.6084/m9.figshare.10302764
762. Ryan, R. J., & Bernstein, B. (2012). Genetic Events That Shape the Cancer Epigenome. Science. https://doi.org/10.1126/science.1223730
763. Saadatmand, A. R., Tadjerpisheh, S., Brockmöller, J., & Tzvetkov, M. V. (2012). The prototypic pharmacogenetic drug debrisoquine is a substrate of the genetically polymorphic organic cation transporter OCT1. Biochemical Pharmacology. https://doi.org/10.1016/j.bcp.2012.01.032
764. Sakharov, P. А., Sogorin, E., Agalarov, S. C., & Kolb, V. A. (2020). Modification of the 5' End of mRNA Leader Sequence Alters the Set of Initiation Factors Essential for Initiation of Translation. Molecular Biology. https://doi.org/10.1134/s0026893320030140
765. Sampath, J., Long, P. R., Shepard, R. L., Xia, X., Devanarayan, V., Sandusky, G. E., Perry, W. L., Dantzig, A. H., Williamson, M. J., Rolfe, M., & Moore, R. E. (2003). Human SPF45, a Splicing Factor, Has Limited Expression in Normal Tissues, Is Overexpressed in Many Tumors, and Can Confer a Multidrug-Resistant Phenotype to Cells. American Journal Of Pathology. https://doi.org/10.1016/s0002-9440(10)63538-9
766. Sanchez, B., Zhou, X., Gardiner, A. S., Herbert, G., Lucas, S., Morishita, M., Wagner, J. G., Lewandowski, R. P., Harkema, J. R., Shuey, C., Campen, M. J., & Zychowski, K. E. (2020). Additional file 1 of Serum-borne factors alter cerebrovascular endothelial microRNA expression following particulate matter exposure near an abandoned uranium mine on the Navajo Nation. Figshare. https://doi.org/10.6084/m9.figshare.12599509
767. Sangai, T., Akçakanat, A., Chen, H., Tarco, E., Wu, Y., Do, K., Miller, T. W., Arteaga, C. L., Mills, G. B., González-Angulo, A. M., & Meric‐Bernstam, F. (2023). Supplementary Figure 1 from Biomarkers of Response to Akt Inhibitor MK-2206 in Breast Cancer. https://doi.org/10.1158/1078-0432.22446330
768. Sangai, T., Akçakanat, A., Chen, H., Tarco, E., Wu, Y., Do, K., Miller, T. W., Arteaga, C. L., Mills, G. B., González-Angulo, A. M., & Meric‐Bernstam, F. (2023). Supplementary Figure 1 from Biomarkers of Response to Akt Inhibitor MK-2206 in Breast Cancer. https://doi.org/10.1158/1078-0432.22446330.v1
769. Sangaletti, S., Tripodo, C., Sandri, S., Torselli, I., Vitali, C., Ratti, C., Botti, L., Burocchi, A., Porcasi, R., Tomirotti, A., Colombo, M. P., & Chiodoni, C. (2023). Data Supplement from Osteopontin Shapes Immunosuppression in the Metastatic Niche. https://doi.org/10.1158/0008-5472.22401723
770. Sangaletti, S., Tripodo, C., Sandri, S., Torselli, I., Vitali, C., Ratti, C., Botti, L., Burocchi, A., Porcasi, R., Tomirotti, A., Colombo, M. P., & Chiodoni, C. (2023). Data Supplement from Osteopontin Shapes Immunosuppression in the Metastatic Niche. https://doi.org/10.1158/0008-5472.22401723.v1
771. Santos, E., Pirovani, C. P., Correa, S., Micheli, F., & Gramacho, K. P. (2020). MOESM5 of The pathogen Moniliophthora perniciosa promotes differential proteomic modulation of cacao genotypes with contrasting resistance to witches´ broom disease. Figshare. https://doi.org/10.6084/m9.figshare.11497296
772. Santos, E., Pirovani, C. P., Correa, S., Micheli, F., & Gramacho, K. P. (2020). MOESM8 of The pathogen Moniliophthora perniciosa promotes differential proteomic modulation of cacao genotypes with contrasting resistance to witches´ broom disease. Figshare. https://doi.org/10.6084/m9.figshare.11497320
773. Sanz‐Pamplona, R., López‐Doriga, A., Paré, L., Lázaro, K., Bellido, F., Alonso, M. H., Aussó, S., Guinó, E., Beltrán, S., Castro-Giner, F., Gut, M., Sanjuán, X., Closa, A., Cordero, D., Morón-Duran, F. D., Soriano, A., Salazar, R., Valle, L., & Moreno, V. (2023). Supplementary Table 6 from Exome Sequencing Reveals &lt;i&gt;AMER1&lt;/i&gt; as a Frequently Mutated Gene in Colorectal Cancer. https://doi.org/10.1158/1078-0432.22460753
774. Sanz‐Pamplona, R., López‐Doriga, A., Paré, L., Lázaro, K., Bellido, F., Alonso, M. H., Aussó, S., Guinó, E., Beltrán, S., Castro-Giner, F., Gut, M., Sanjuán, X., Closa, A., Cordero, D., Morón-Duran, F. D., Soriano, A., Salazar, R., Valle, L., & Moreno, V. (2023). Supplementary Table 6 from Exome Sequencing Reveals &lt;i&gt;AMER1&lt;/i&gt; as a Frequently Mutated Gene in Colorectal Cancer. https://doi.org/10.1158/1078-0432.22460753.v1
775. Sarig, R., Rivlin, N., Brosh, R., Bornstein, C., Kamer, I., Ezra, O., Molchadsky, A., Goldfinger, N., Brenner, O., & Rotter, V. (2010). Mutant p53 facilitates somatic cell reprogramming and augments the malignant potential of reprogrammed cells. The Journal of Cell Biology. https://doi.org/10.1083/jcb1904oia10
776. Sarkar, S., Hallström, T., Hammerschmidt, S., Skerka, C., & Zipfel, P. F. (2013). Elongation Factor Tu (Tuf) is a new virulence factor of Streptococcus pneumoniae that binds human complement factors, aids in immune evasion and host tissue invasion. Molecular Immunology. https://doi.org/10.1016/j.molimm.2013.05.202
777. Saul, R. A., & Tarleton, J. (2012). Table 4. [Types of FMR1 Repeat Expansion Pathogenic Variants]..
778. Sawant, A., Deshane, J. S., Jules, J., Lee, C. M., Harris, B. A., Xu, F., & Ponnazhagan, S. (2023). Supplementary Figure 1 from Myeloid-Derived Suppressor Cells Function as Novel Osteoclast Progenitors Enhancing Bone Loss in Breast Cancer. https://doi.org/10.1158/0008-5472.22398200
779. Sawant, A., Deshane, J. S., Jules, J., Lee, C. M., Harris, B. A., Xu, F., & Ponnazhagan, S. (2023). Supplementary Figure 1 from Myeloid-Derived Suppressor Cells Function as Novel Osteoclast Progenitors Enhancing Bone Loss in Breast Cancer. https://doi.org/10.1158/0008-5472.22398200.v1
780. Sb, B., Mitchell, R., Tischer, E., Js, R., SILVA, M. A. T. D., Silver, S. J., Jc, F., Ja, A., & Aaronson, S. A. (1988). Addition of growth hormone secretion signal to basic fibroblast growth factor results in cell transformation and secretion of aberrant forms of the protein.. PubMed.
781. Schellekens, G. A., Jong, B. D., Hoogen, F. V. D., Putte, L. B. A. V. D., & Venrooij, W. J. V. (2015). Citrulline is an Essential Constituent of Antigenic Determinants Recognized by Rheumatoid Arthritis-specific Autoantibodies. 1998.. PubMed.
782. Schmack, A. E., SWARBRICK, P. A., & Crawford, A. M. (1992). MAF45, a highly polymorphic marker for the pseudoautosomal region of the sheep genome, is not linked to the fecXI (Inverdale) gene. Genomics. https://doi.org/10.1016/0888-7543(92)90167-q
783. Schmoeckel, M., Nollert, G., Shah, P., Müller-Höcker, J., Young, V., Kasper-König, W., White, D. J., Hammer, C., & Reichart, B. (1997). Transgenic human decay accelerating factor makes normal pigs function as a concordant species.. PubMed.
784. Schärfe, C., Tremmel, R., Schwab, M., Kohlbacher, O., & Marks, D. S. (2017). Variants_drug_related_genes_AddFile.xlsx. Figshare. https://doi.org/10.6084/m9.figshare.5631751.v1
785. Schürch, W., Sappino, A. P., & Gabbiani, G. (1990). Differentiation repertoire of fibroblastic cells: expression of cytoskeletal proteins as marker of phenotypic modulations.. PubMed.
786. Sciacovelli, M., Gonçalves, E., Johnson, T. I., Zecchini, V., Costa, A. S., Gaude, E., Drubbel, A. V., Theobald, S. J., Abbo, S. R., Tran, M., Rajeeve, V., Cardaci, S., Foster, S., Yun, H., Cutillas, P. R., Warren, A. Y., Gnanapragasam, V. J., Gottlieb, E., Franze, K., ... Frezza, C. (2016). Correction: Corrigendum: Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition. Nature. https://doi.org/10.1038/nature20144
787. Sedzro, J.-C., Smith, S. A., Scott, A. J., Wang, Y., Travers, R. J., Hemp, R., Morse, C. N., & Morrissey, J. H. (2024). Anti-polyphosphate monoclonal antibodies derived from autoimmune mice. Research and Practice in Thrombosis and Haemostasis. https://doi.org/10.1016/j.rpth.2024.102550
788. Seo, H., & Cho, S. (2011). Specific Inhibition of DUSP14 by NSC-95397 in vitro. Bulletin of the Korean Chemical Society. https://doi.org/10.5012/bkcs.2011.32.12.4435
789. Seo, J. H., Cha, J., Park, J., Jeong, C., Park, Z., Lee, H.-S., Oh, S. H., Kang, J., Suh, S. W., Kim, K. H., Ha, J. Y., Han, S. H., Kim, S., Lee, J., Park, J. A., Jeong, J., Lee, K., Oh, G. T., Lee, M.-N., ... Kim, K. (2023). Supplementary Figure 1 from Arrest Defective 1 Autoacetylation Is a Critical Step in Its Ability to Stimulate Cancer Cell Proliferation. https://doi.org/10.1158/0008-5472.22382271
790. Seo, J. H., Cha, J., Park, J., Jeong, C., Park, Z., Lee, H.-S., Oh, S. H., Kang, J., Suh, S. W., Kim, K. H., Ha, J. Y., Han, S. H., Kim, S., Lee, J., Park, J. A., Jeong, J., Lee, K., Oh, G. T., Lee, M.-N., ... Kim, K. (2023). Supplementary Figure 1 from Arrest Defective 1 Autoacetylation Is a Critical Step in Its Ability to Stimulate Cancer Cell Proliferation. https://doi.org/10.1158/0008-5472.22382271.v1
791. Seo, J. H., Cha, J., Park, J., Jeong, C., Park, Z., Lee, H.-S., Oh, S. H., Kang, J., Suh, S. W., Kim, K. H., Ha, J. Y., Han, S. H., Kim, S., Lee, J., Park, J. A., Jeong, J., Lee, K., Oh, G. T., Lee, M.-N., ... Kim, K. (2023). Supplementary Figure 3 from Arrest Defective 1 Autoacetylation Is a Critical Step in Its Ability to Stimulate Cancer Cell Proliferation. https://doi.org/10.1158/0008-5472.22382265.v1
792. Seo, J. H., Cha, J., Park, J., Jeong, C., Park, Z., Lee, H.-S., Oh, S. H., Kang, J., Suh, S. W., Kim, K. H., Ha, J. Y., Han, S. H., Kim, S., Lee, J., Park, J. A., Jeong, J., Lee, K., Oh, G. T., Lee, M.-N., ... Kim, K. (2023). Supplementary Figure 4 from Arrest Defective 1 Autoacetylation Is a Critical Step in Its Ability to Stimulate Cancer Cell Proliferation. https://doi.org/10.1158/0008-5472.22382262.v1
793. Seo, J. H., Cha, J., Park, J., Jeong, C., Park, Z., Lee, H.-S., Oh, S. H., Kang, J., Suh, S. W., Kim, K. H., Ha, J. Y., Han, S. H., Kim, S., Lee, J., Park, J. A., Jeong, J., Lee, K., Oh, G. T., Lee, M.-N., ... Kim, K. (2023). Supplementary Figure 5 from Arrest Defective 1 Autoacetylation Is a Critical Step in Its Ability to Stimulate Cancer Cell Proliferation. https://doi.org/10.1158/0008-5472.22382259
794. Seo, J. H., Cha, J., Park, J., Jeong, C., Park, Z., Lee, H.-S., Oh, S. H., Kang, J., Suh, S. W., Kim, K. H., Ha, J. Y., Han, S. H., Kim, S., Lee, J., Park, J. A., Jeong, J., Lee, K., Oh, G. T., Lee, M.-N., ... Kim, K. (2023). Supplementary Table 1 from Arrest Defective 1 Autoacetylation Is a Critical Step in Its Ability to Stimulate Cancer Cell Proliferation. https://doi.org/10.1158/0008-5472.22382247
795. Seo, J. H., Cha, J., Park, J., Jeong, C., Park, Z., Lee, H.-S., Oh, S. H., Kang, J., Suh, S. W., Kim, K. H., Ha, J. Y., Han, S. H., Kim, S.-H., Lee, J., Park, J. A., Jeong, J., Lee, K., Oh, G. T., Lee, M.-N., ... Kim, K. (2023). Supplementary Figure 3 from Arrest Defective 1 Autoacetylation Is a Critical Step in Its Ability to Stimulate Cancer Cell Proliferation. https://doi.org/10.1158/0008-5472.22382265
796. Seo, J. H., Cha, J., Park, J., Jeong, C., Park, Z., Lee, H.-S., Oh, S. H., Kang, J., Suh, S. W., Kim, K. H., Ha, J. Y., Han, S. H., Kim, S.-H., Lee, J., Park, J. A., Jeong, J., Lee, K., Oh, G. T., Lee, M.-N., ... Kim, K. (2023). Supplementary Figure 4 from Arrest Defective 1 Autoacetylation Is a Critical Step in Its Ability to Stimulate Cancer Cell Proliferation. https://doi.org/10.1158/0008-5472.22382262
797. Seo, J. H., Cha, J., Park, J., Jeong, C., Park, Z., Lee, H.-S., Oh, S. H., Kang, J., Suh, S. W., Kim, K. H., Ha, J. Y., Han, S. H., Kim, S.-H., Lee, J., Park, J. A., Jeong, J., Lee, K., Oh, G. T., Lee, M.-N., ... Kim, K. (2023). Supplementary Figure 5 from Arrest Defective 1 Autoacetylation Is a Critical Step in Its Ability to Stimulate Cancer Cell Proliferation. https://doi.org/10.1158/0008-5472.22382259.v1
798. Sequeira‐Lopez, M. L. S., & Gómez, R. A. (2005). The Renin Cell is a Progenitor for Multiple Cell Types Originating from the Three Main Layers within the Early Embryo. Journal of Investigative Medicine. https://doi.org/10.1177/1081558905053001834
799. Shad, M. A., Wu, S., Rao, M. J., Luo, X., Huang, X., Wu, Y., Zhou, Y., Wang, L., Ma, C., & Hu, L. (2024). Evolution and Functional Dynamics of TCP Transcription Factor Gene Family in Passion Fruit (Passiflora edulis). Plants. https://doi.org/10.3390/plants13182568
800. Sharma, A., Kumar, V., Singh, V. K., Patbandha, T. K., & Vyas, Y. L. (2024). Effect of season on histoarchitecture of pineal gland in buffalo (. PubMed. https://doi.org/10.22099/ijvr.2024.48516.7084
801. Shaw, R. J., & Cantley, L. C. (2012). Ancient Sensor for Ancient Drug. Science. https://doi.org/10.1126/science.1223140
802. Shen, Y., Huang, J., Wang, K., Zheng, J., Cai, L., Gao, H., Li, X., & Li, J. (2020). Correction to: PTH Derivative promotes wound healing via synergistic multicellular stimulating and exosomal activities. Cell Communication and Signaling. https://doi.org/10.1186/s12964-020-00593-y
803. Shi, Y., Daniels‐Wells, T. R., Frost, P., Lee, J., Finn, R. S., Bardeleben, C., Penichet, M. L., Jung, M. E., Gera, J., & Lichtenstein, A. (2023). supplemental figure legends from Cytotoxic Properties of a DEPTOR-mTOR Inhibitor in Multiple Myeloma Cells. https://doi.org/10.1158/0008-5472.22410354
804. Shin, S. Y., Kim, J. H., Baker, A., Lim, Y., & Lee, Y. H. (2023). Supplementary Data from Transcription Factor Egr-1 Is Essential for Maximal Matrix Metalloproteinase-9 Transcription by Tumor Necrosis Factor α. https://doi.org/10.1158/1541-7786.22519323
805. Shin, S. Y., Kim, J. H., Baker, A., Lim, Y., & Lee, Y. H. (2023). Supplementary Data from Transcription Factor Egr-1 Is Essential for Maximal Matrix Metalloproteinase-9 Transcription by Tumor Necrosis Factor α. https://doi.org/10.1158/1541-7786.22519323.v1
806. Shire, J. G. M., & Beamer, W. G. (1990). Acd a pleiotropic mutant with effects on the ploidy of differentiated tissues. Genetics Research.
807. Shiwarski, D. J., Shao, C., Bill, A., Kim, J., Xiao, D., Bertrand, C. A., Seethala, R. S., Sano, D., Myers, J. N., Ha, P. K., Grandis, J. R., Gaither, L. A., Puthenveedu, M. A., & Duvvuri, U. (2023). Supplementary Table 1 from To “Grow” or “Go”: TMEM16A Expression as a Switch between Tumor Growth and Metastasis in SCCHN. https://doi.org/10.1158/1078-0432.22455702
808. Shiwarski, D. J., Shao, C., Bill, A., Kim, J., Xiao, D., Bertrand, C. A., Seethala, R. S., Sano, D., Myers, J. N., Ha, P. K., Grandis, J. R., Gaither, L. A., Puthenveedu, M. A., & Duvvuri, U. (2023). Supplementary Table 1 from To “Grow” or “Go”: TMEM16A Expression as a Switch between Tumor Growth and Metastasis in SCCHN. https://doi.org/10.1158/1078-0432.22455702.v1
809. Sieroń, A. L., Li, S., Khan, M. T. M., Arnold, W. V., Sahrm, K., Fertala, A., Hojima, Y., & Prockop, D. J. (1996). The C-proteinase that processes procollagens to fibrillar collagens is identical to the protein previously identified as bone morphogenic protein-1. Matrix Biology. https://doi.org/10.1016/s0945-053x(96)90001-3
810. Silva‐García, R., Morales-Martínez, M. E., Blanco-Favéla, F., Torres, A., Ríos-Olvera, J., Garrido-Ortega, M. R., Tesoro-Cruz, E., & Rico-Rosillo, G. (2012). The Monocyte Locomotion Inhibitory Factor (MLIF) Produced by Entamoeba histolytica Alters the Expression of Genes Related to the Wound-Healing Process. International Journal of Peptide Research and Therapeutics. https://doi.org/10.1007/s10989-012-9315-y
811. Silvestrini, V. C., Lanfredi, G. P., Masson, A. P., Poersch, A., Ferreira, G. A., Thomé, C. H., & Faça, V. M. (2019). A proteomics outlook towards the elucidation of epithelial–mesenchymal transition molecular events. Molecular Omics. https://doi.org/10.1039/c9mo00095j
812. Simmons, D. M., Mathis, J. M., He, X., Swanson, L. W., & Rosenfeld, M. G. (1992). Brain 4: a novel mammalian POU domain transcription factor exhibiting restricted brain-specific expression.. The EMBO Journal. https://doi.org/10.1002/j.1460-2075.1992.tb05320.x
813. Simon, H., Friis, R. R., Tait, S. W. G., & Ryan, K. M. (2017). Retrograde signaling from autophagy modulates stress responses. Science Signaling. https://doi.org/10.1126/scisignal.aag2791
814. Singh, N., & Warsi, M. A. (2017). 392. Fractal Dimension (FD) of Resting EEG is a Prospective Biomarker for Treatment Response to Electroconvulsive Therapy (ECT). Biological Psychiatry. https://doi.org/10.1016/j.biopsych.2017.02.409
815. Sinzel, M., Tan, T., Wendling, P., Kalbacher, H., Özbalci, C., Chelius, X., Westermann, B., Brügger, B., Rapaport, D., & Dimmer, K. S. (2016). Mcp3 is a novel mitochondrial outer membrane protein that follows a unique IMP‐dependent biogenesis pathway. EMBO Reports. https://doi.org/10.15252/embr.201541273
816. Skelton, R. W., Miller, J. J., & Phillips, A. G. (1985). Long-term potentiation facilitates behavioral responding to single-pulse stimulation of the perforant path.. Behavioral Neuroscience. https://doi.org/10.1037/0735-7044.99.4.603
817. Slamti, L., Perchat, S., Gominet, M., Vilas-Bôas, G. T., Fouet, A., Mock, M., Sanchis, V., Chaufaux, J., Gohar, M. M., & Lereclus, D. (2004). Distinct mutations in PlcR explain why some strains of the Bacillus cereus group are nonhemolytic.. HAL (Le Centre pour la Communication Scientifique Directe). https://doi.org/10.1128/jb.186.11.3531-3538
818. Sm, P., Dw, M., & Lane, D. P. (1992). The conformational change of a murine temperature-sensitive p53 protein is independent of a change in phosphorylation status.. PubMed.
819. Small, G. W., Shi, Y., Higgins, L. S., & Orlowski, R. Z. (2023). Supplementary Figure 4 from Mitogen-Activated Protein Kinase Phosphatase-1 Is a Mediator of Breast Cancer Chemoresistance. https://doi.org/10.1158/0008-5472.22368291
820. Small, G. W., Shi, Y., Higgins, L. S., & Orlowski, R. Z. (2023). Supplementary Figure 4 from Mitogen-Activated Protein Kinase Phosphatase-1 Is a Mediator of Breast Cancer Chemoresistance. https://doi.org/10.1158/0008-5472.22368291.v1
821. Smolander, O.-P., Valter, A., Luhari, L., Pisarev, H., Truumees, B., Planken, A., & Oselin, K. (2022). 1684P Genetic alterations as independent prognostic factors to predict the type of recurrence of lung cancer. Annals of Oncology. https://doi.org/10.1016/j.annonc.2022.07.1763
822. Smoller, B. R., Krueger, J. G., McNutt, N. S., & Hsu, A. K. (1990). "Activated" keratinocyte phenotype is unifying feature in conditions which predispose to squamous cell carcinoma of the skin.. PubMed.
823. Sohal, V. S. (2014). Releasing the Brake Drives Fear Behavior. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.3008282
824. Solana, J., Lasko, P., & Romero, R. (2009). Spoltud-1 is a chromatoid body component required for planarian long-term stem cell self-renewal. Developmental Biology. https://doi.org/10.1016/j.ydbio.2009.01.043
825. Soldano, S., Pizzorni, C., Paolino, S., Trombetta, A. C., Montagna, P., Brizzolara, R., Ruaro, B., Sulli, A., & Cutolo, M. (2017). Correction: Alternatively Activated (M2) Macrophage Phenotype Is Inducible by Endothelin-1 in Cultured Human Macrophages. PLoS ONE. https://doi.org/10.1371/journal.pone.0175238
826. Soldà, T., Galli, C., Guerra, C., Hoefner, C., & Molinari, M. (2024). Author Reply to Peer Reviews of TMX5/TXNDC15, a natural trapping mutant of the PDI family is a client of the proteostatic factor ERp44. https://doi.org/10.15252/rc.2024202641
827. Song, Z., & Liu, Q. (2020). Tolerance factor, phase stability and order–disorder of the pyrochlore structure. Inorganic Chemistry Frontiers. https://doi.org/10.1039/d0qi00016g
828. Spear, T. T., Wang, Y., Foley, K. C., Murray, D. C., Scurti, G., Simms, P., Garrett‐Mayer, E., Hellman, L. M., Baker, B. M., & Nishimura, M. I. (2017). Critical biological parameters modulate affinity as a determinant of function in T-cell receptor gene-modified T-cells. Cancer Immunology Immunotherapy. https://doi.org/10.1007/s00262-017-2032-9
829. Spritz, R. A., Holmes, S. A., Ramesar, R., Greenberg, J. M., Curtis, D., & Beighton, P. (1992). Mutations of the KIT (mast/stem cell growth factor receptor) proto-oncogene account for a continuous range of phenotypes in human piebaldism.. PubMed.
830. Staber, P. B., Zhang, P., Ye, M., Huang, G., Bartholdy, B., Ruscio, A. D., Ebralidze, A. K., & Tenen, D. G. (2009). Autoregulation of the Transcription Factor PU.1 Via Its Evolutionarily Conserved Upstream Regulatory Element Is Critical in Adult Mouse Hematopoiesis.. Blood. https://doi.org/10.1182/blood.v114.22.1468.1468
831. Staib, F., Robles, A. I., Varticovski, L., Wang, X. W., Zeebèrg, B. R., Sirotin, M., Zhurkin, V. B., Hofseth, L. J., Hussain, S. P., Weinstein, J. N., Galle, P. R., & Harris, C. C. (2023). Supplementary Figure 1 from The p53 Tumor Suppressor Network Is a Key Responder to Microenvironmental Components of Chronic Inflammatory Stress. https://doi.org/10.1158/0008-5472.22364687
832. Staib, F., Robles, A. I., Varticovski, L., Wang, X. W., Zeebèrg, B. R., Sirotin, M., Zhurkin, V. B., Hofseth, L. J., Hussain, S. P., Weinstein, J. N., Galle, P. R., & Harris, C. C. (2023). Supplementary Figure 1 from The p53 Tumor Suppressor Network Is a Key Responder to Microenvironmental Components of Chronic Inflammatory Stress. https://doi.org/10.1158/0008-5472.22364687.v1
833. Staib, F., Robles, A. I., Varticovski, L., Wang, X. W., Zeebèrg, B. R., Sirotin, M., Zhurkin, V. B., Hofseth, L. J., Hussain, S. P., Weinstein, J. N., Galle, P. R., & Harris, C. C. (2023). Supplementary Figure 4 from The p53 Tumor Suppressor Network Is a Key Responder to Microenvironmental Components of Chronic Inflammatory Stress. https://doi.org/10.1158/0008-5472.22364675
834. Staib, F., Robles, A. I., Varticovski, L., Wang, X. W., Zeebèrg, B. R., Sirotin, M., Zhurkin, V. B., Hofseth, L. J., Hussain, S. P., Weinstein, J. N., Galle, P. R., & Harris, C. C. (2023). Supplementary Figure 5 from The p53 Tumor Suppressor Network Is a Key Responder to Microenvironmental Components of Chronic Inflammatory Stress. https://doi.org/10.1158/0008-5472.22364672
835. Staib, F., Robles, A. I., Varticovski, L., Wang, X. W., Zeebèrg, B. R., Sirotin, M., Zhurkin, V. B., Hofseth, L. J., Hussain, S. P., Weinstein, J. N., Galle, P. R., & Harris, C. C. (2023). Supplementary Figure 5 from The p53 Tumor Suppressor Network Is a Key Responder to Microenvironmental Components of Chronic Inflammatory Stress. https://doi.org/10.1158/0008-5472.22364672.v1
836. Staib, F., Robles, A. I., Varticovski, L., Wang, X. W., Zeebèrg, B. R., Sirotin, M., Zhurkin, V. B., Hofseth, L. J., Hussain, S. P., Weinstein, J. N., Galle, P. R., & Harris, C. C. (2023). Supplementary Figure 6 from The p53 Tumor Suppressor Network Is a Key Responder to Microenvironmental Components of Chronic Inflammatory Stress. https://doi.org/10.1158/0008-5472.22364669
837. Staib, F., Robles, A. I., Varticovski, L., Wang, X. W., Zeebèrg, B. R., Sirotin, M., Zhurkin, V. B., Hofseth, L. J., Hussain, S. P., Weinstein, J. N., Galle, P. R., & Harris, C. C. (2023). Supplementary Tables S1-S5 from The p53 Tumor Suppressor Network Is a Key Responder to Microenvironmental Components of Chronic Inflammatory Stress. https://doi.org/10.1158/0008-5472.22364663
838. Staib, F., Robles, A. I., Varticovski, L., Wang, X. W., Zeebèrg, B. R., Sirotin, M., Zhurkin, V. B., Hofseth, L. J., Hussain, S. P., Weinstein, J. N., Galle, P. R., & Harris, C. C. (2023). Supplementary Tables S1-S5 from The p53 Tumor Suppressor Network Is a Key Responder to Microenvironmental Components of Chronic Inflammatory Stress. https://doi.org/10.1158/0008-5472.22364663.v1
839. Stamboulian, M., Li, S., & Ye, Y. (2021). Additional file 1 of Using high-abundance proteins as guides for fast and effective peptide/protein identification from human gut metaproteomic data. Figshare. https://doi.org/10.6084/m9.figshare.14361911
840. Stanley, M. S., Michael, P. T., Deborah, M. B. P., Sherri, D. R., Lorri, M. R., Kate, R. F., Beth, W. Z., Diane, M. J., Fitsum, M. B., Barry, P. K., & Margaret, E. B. (2015). H. ducreyi putative PEA transferases contribute to modification of lipid A with PEA.. https://doi.org/10.1371/journal.pone.0124373.g004
841. Stauss, H. J., Fink, M. A., Starr, B., & Schreiber, H. (1987). Altered MHC Class I Genes Can Encode Immunogenic Antigens that Cause Tumor Rejection. Springer eBooks. https://doi.org/10.1007/978-1-4757-0764-9_61
842. Steegenga, W. T., Riteco, N., Laar, T. V., Dekker, P., Bazuine, M., Ham, R. C. V., Oordt, W. V. D. H. V., Hateboer, G., Eb, A. V. D., & Jochemsen, A. G. (1996). MDMX: a novel p53-binding protein with some functional properties of MDM2.. The EMBO Journal. https://doi.org/10.1002/j.1460-2075.1996.tb00919.x
843. Steidl, U., Rosenbauer, F., Gu, X., Owens, B. M., Klippel, S., Wagner, K., Aivado, M., Libermann, T. A., & Tenen, D. G. (2004). Knockdown of the Transcription Factor PU.1 Causes Characteristic Transcriptional Changes in Hematopoietic Stem Cells Prior to Leukemic Transformation.. Blood. https://doi.org/10.1182/blood.v104.11.1112.1112
844. Stein, U., Walther, W., & Wunderlich, V. (1994). Point mutations in the mdr1 promoter of human osteosarcomas are associated with In vitro responsiveness to multidrug resistance relevant drugs. European Journal of Cancer. https://doi.org/10.1016/0959-8049(94)00287-f
845. Steinfeld, T., Pulido-Rios, M., Chin, K. H., King, K., Jx, H., Tw, L., Jasper, J., Ji, Y., Hegde, S. S., & Mammen, M. (2009). <i>In Vitro</i>Characterization of TD-4208, a Lung-Selective and Long-Acting Muscarinic Antagonist Bronchodilator.. https://doi.org/10.1164/ajrccm-conference.2009.179.1_meetingabstracts.a4553
846. Stern, P. (2009). BDNF and Drug Dependence. Science Signaling. https://doi.org/10.1126/scisignal.277ec221
847. Stern, P. R. (2011). Fight, Flee, or Freeze. Science Signaling. https://doi.org/10.1126/scisignal.4180ec188
848. Stern, P. R. (2012). Master Memory Modulator. Science Signaling. https://doi.org/10.1126/scisignal.2002809
849. Stevens, M., & Harris, N. (2001). A cavovarus foot is a predisposing factor for rather than a result of peroneus longus tendinopathy.. PubMed.
850. Stewart, D. A., Yang, Y., Makowski, L., & Troester, M. A. (2023). Supplementary Figure 1 from Basal-like Breast Cancer Cells Induce Phenotypic and Genomic Changes in Macrophages. https://doi.org/10.1158/1541-7786.22517361
851. Stewart, D. A., Yang, Y., Makowski, L., & Troester, M. A. (2023). Supplementary Figure 1 from Basal-like Breast Cancer Cells Induce Phenotypic and Genomic Changes in Macrophages. https://doi.org/10.1158/1541-7786.22517361.v1
852. Stockklausner, C., Duffert, C. M., Dickemann, N., Klotter, A. C., Kuhlee, I. N., Kerber, C., & Kulozik, A. E. (2014). The Predominant Activation of Alternative Signaling Pathways Explains the Differential Propensity of Different c-Mpl Gain-of-Function Mutations to Promote Myeloproliferative Malignancies. Blood. https://doi.org/10.1182/blood.v124.21.1578.1578
853. Stucki, D., Brenneisen, P., Reichert, A. S., & Stahl, W. (2018). The BH3 mimetic compound BH3I-1 impairs mitochondrial dynamics and promotes stress response in addition to its pro-apoptotic key function. Toxicology Letters. https://doi.org/10.1016/j.toxlet.2018.07.017
854. Su, W., Yang, K., Jiang, H., Song, H., Feng, K., & Li, Q. (2022). Human epididymis protein 4 (HE4) is a novel immunohistochemical marker of neuroendocrine differentiation. Virchows Archiv. https://doi.org/10.1007/s00428-022-03387-4
855. Subramanian, K. K., Jia, Y., Zhu, D., Simms, B. T., Jo, H., Hattori, H., You, J., Mizgerd, J. P., & Luo, H. R. (2007). Tumor suppressor PTEN is a physiologic suppressor of chemoattractant-mediated neutrophil functions. Blood. https://doi.org/10.1182/blood-2006-10-055319
856. Subramanian, M., Shodeinde, A., Schwarzwalder, G. M., Menéndez, A. G., Yu, J., Zhao, G., Hao, J., Liang, X., Lai, Y., & Subramanian, R. (2024). Encequidar is a gut-restricted P-GP specific inhibitor that boosts oral bioavailability and inhibits intestinal secretion in rats and dogs.. Drug Metabolism and Pharmacokinetics. https://doi.org/10.1016/j.dmpk.2023.100989
857. Sueblinvong, V., Torres-González, E., Neujahr, D. C., Roser-Page, S., Ritzenthaler, J. D., Rojas, M., & Roman, J. (2010). Aging Lungs Manifest A Pro-fibrotic Phenotype - Potential Mechanisms For Increased Susceptibility To Abnormal Repair In The Elderly. https://doi.org/10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a1968
858. Suresh, S., Rabbie, R., Garg, M., Lumaquin, D., Huang, T., Montal, E., Ma, Y., Cruz, N. M., Tang, X., Nsengimana, J., Newton‐Bishop, J., Hunter, M. V., Zhu, Y., Chen, K., Stanchina, E. D., Adams, D. J., & White, R. M. (2023). Supplementary Figure S1 from Identifying the Transcriptional Drivers of Metastasis Embedded within Localized Melanoma. https://doi.org/10.1158/2159-8290.22541848
859. Suresh, S., Rabbie, R., Garg, M., Lumaquin, D., Huang, T., Montal, E., Ma, Y., Cruz, N. M., Tang, X., Nsengimana, J., Newton‐Bishop, J., Hunter, M. V., Zhu, Y., Chen, K., Stanchina, E. D., Adams, D. J., & White, R. M. (2023). Supplementary Figure S1 from Identifying the Transcriptional Drivers of Metastasis Embedded within Localized Melanoma. https://doi.org/10.1158/2159-8290.22541848.v1
860. Suzuki, M., Yokobori, T., Gombodorj, N., Yashiro, M., Turtoï, A., Handa, T., Ogata, K., Oyama, T., Shirabe, K., & Kuwano, H. (2018). Cover Image, Volume 118, Number 6, November 1, 2018. Journal of Surgical Oncology. https://doi.org/10.1002/jso.25287
861. Svobodová, E., Mrázová, L., Lukšan, O., Elstein, D., Zimran, A., Stolnaya, L., Minks, J., Eberová, J., Dvořáková, L., Jirsa, M., & Hřebı́ček, M. (2011). Glucocerebrosidase gene has an alternative upstream promoter, which has features and expression characteristic of housekeeping genes. Blood Cells Molecules and Diseases. https://doi.org/10.1016/j.bcmd.2010.12.011
862. Szczepaniak, I., & Górka-Kostrubiec, B. (2015). The anthropogenic magnetic particles contain in indoor dust as markers of pollution emitted by different outside sources.. EGUGA.
863. Szumera‐Ciećkiewicz, A., Poleszczuk, J., Kuczkiewicz‐Siemion, O., Paszkiewicz‐Kozik, E., Rymkiewicz, G., Sokół, K., Borysiuk, A., Kotarska, M., Kawecka, M., Owczarek, D., Pytlak, B., Walewski, J., & Prochorec‐Sobieszek, M. (2020). PD1 distribution pattern, regardless of the cell origin, is an independent microenvironmental prognostic factor for progression-free survival in follicular lymphoma. Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2020.153096
864. T.O, M., M.E, G., Kousi, M., R.M, R., Moon, S., Bai, Y., S.C, B., K.L, S., Savage, J., T.F, H., D.M, M., R.A, G., Barak, L. S., P.F, S., A.E, A.-K., Sawa, A., W.C, W., Werge, T., & Katsanis, N. (2020). PCM1 is necessary for focal ciliary integrity and is a candidate for severe schizophrenia. Carolina Digital Repository (University of North Carolina at Chapel Hill). https://doi.org/10.17615/cwjg-e873
865. Tai, S.-B., Huang, C.-M., Chung, C., Sung, P., Wen, Z., & Chen, C. (2024). Prodigiosin Inhibits Transforming Growth Factor<i>β</i>Signaling by Interfering Receptor Recycling and Subcellular Translocation in Epithelial Cells. Molecular Pharmacology. https://doi.org/10.1124/molpharm.123.000776
866. Takasaki, R., Uchida, F., Takaoka, S., Ishii, R., Fukuzawa, S., Ishibashi‐Kanno, N., Warabi, E., Yamagata, K., Tabuchi, K., Bukawa, H., & Yanagawa, T. (2025). Yap1 and P53 May Be Biomarkers to Predict Malignant Transformation in Oral Potentially Malignant Disorders (Opmds). https://doi.org/10.2139/ssrn.5340199
867. Talavera, A., Hendrix, J., Versées, W., Jurėnas, D., Nerom, K. V., Vandenberk, N., Singh, R. K., Konijnenberg, A., Gieter, S. D., Castro-Roa, D., Barth, A., Greve, H. D., Sobott, F., Hofkens, J., Zenkin, N., Loris, R., & García-Pino, A. (2018). Phosphorylation decelerates conformational dynamics in bacterial translation elongation factors. Science Advances. https://doi.org/10.1126/sciadv.aap9714
868. Tamaru, J., Hummel, M., Marafioti, T., Kalvelage, B., Leoncini, L., Minacci, C., Tosi, P., Wright, D. H., & Stein, H. (1995). Burkitt's lymphomas express VH genes with a moderate number of antigen-selected somatic mutations.. PubMed.
869. Tamura, K., Furihata, M., Tsunoda, T., Ashida, S., Takata, R., Obara, W., Yoshioka, H., Daigo, Y., Nasu, Y., Kumon, H., Konaka, H., Namiki, M., Tozawa, K., Kohri, K., Tanji, N., Yokoyama, M., Shimazui, T., Akaza, H., Mizutani, Y., ... Nakagawa, H. (2023). Supplementary Figure 1 from Molecular Features of Hormone-Refractory Prostate Cancer Cells by Genome-Wide Gene Expression Profiles. https://doi.org/10.1158/0008-5472.22368558
870. Tamura, K., Furihata, M., Tsunoda, T., Ashida, S., Takata, R., Obara, W., Yoshioka, H., Daigo, Y., Nasu, Y., Kumon, H., Konaka, H., Namiki, M., Tozawa, K., Kohri, K., Tanji, N., Yokoyama, M., Shimazui, T., Akaza, H., Mizutani, Y., ... Nakagawa, H. (2023). Supplementary Figure 1 from Molecular Features of Hormone-Refractory Prostate Cancer Cells by Genome-Wide Gene Expression Profiles. https://doi.org/10.1158/0008-5472.22368558.v1
871. Tamura, K., Furihata, M., Tsunoda, T., Ashida, S., Takata, R., Obara, W., Yoshioka, H., Daigo, Y., Nasu, Y., Kumon, H., Konaka, H., Namiki, M., Tozawa, K., Kohri, K., Tanji, N., Yokoyama, M., Shimazui, T., Akaza, H., Mizutani, Y., ... Nakagawa, H. (2023). Supplementary Figure 1 Legend from Molecular Features of Hormone-Refractory Prostate Cancer Cells by Genome-Wide Gene Expression Profiles. https://doi.org/10.1158/0008-5472.22368561
872. Tamura, K., Furihata, M., Tsunoda, T., Ashida, S., Takata, R., Obara, W., Yoshioka, H., Daigo, Y., Nasu, Y., Kumon, H., Konaka, H., Namiki, M., Tozawa, K., Kohri, K., Tanji, N., Yokoyama, M., Shimazui, T., Akaza, H., Mizutani, Y., ... Nakagawa, H. (2023). Supplementary Figure 1 Legend from Molecular Features of Hormone-Refractory Prostate Cancer Cells by Genome-Wide Gene Expression Profiles. https://doi.org/10.1158/0008-5472.22368561.v1
873. Tamura, K., Furihata, M., Tsunoda, T., Ashida, S., Takata, R., Obara, W., Yoshioka, H., Daigo, Y., Nasu, Y., Kumon, H., Konaka, H., Namiki, M., Tozawa, K., Kohri, K., Tanji, N., Yokoyama, M., Shimazui, T., Akaza, H., Mizutani, Y., ... Nakagawa, H. (2023). Supplementary Table 1 from Molecular Features of Hormone-Refractory Prostate Cancer Cells by Genome-Wide Gene Expression Profiles. https://doi.org/10.1158/0008-5472.22368555
874. Tamura, K., Furihata, M., Tsunoda, T., Ashida, S., Takata, R., Obara, W., Yoshioka, H., Daigo, Y., Nasu, Y., Kumon, H., Konaka, H., Namiki, M., Tozawa, K., Kohri, K., Tanji, N., Yokoyama, M., Shimazui, T., Akaza, H., Mizutani, Y., ... Nakagawa, H. (2023). Supplementary Table 1 from Molecular Features of Hormone-Refractory Prostate Cancer Cells by Genome-Wide Gene Expression Profiles. https://doi.org/10.1158/0008-5472.22368555.v1
875. Tan, J., Li, Z., Lee, P. L., Guan, P., Aau, M. Y., Lee, S. T., Feng, M., Lim, C. Z., Lee, E. Y. J., Wee, Z. N., Lim, Y. C., Karuturi, R. K. M., & Yu, Q. (2023). Table S4 from PDK1 Signaling Toward PLK1–MYC Activation Confers Oncogenic Transformation, Tumor-Initiating Cell Activation, and Resistance to mTOR-Targeted Therapy. https://doi.org/10.1158/2159-8290.22530350
876. Tan, J., Li, Z., Lee, P. L., Guan, P., Aau, M. Y., Lee, S. T., Feng, M., Lim, C. Z., Lee, E. Y. J., Wee, Z. N., Lim, Y. C., Karuturi, R. K. M., & Yu, Q. (2023). Table S4 from PDK1 Signaling Toward PLK1–MYC Activation Confers Oncogenic Transformation, Tumor-Initiating Cell Activation, and Resistance to mTOR-Targeted Therapy. https://doi.org/10.1158/2159-8290.22530350.v1
877. Tan, K., Mo, J., Li, M., Dong, Y., Han, Y., Sun, X., Ma, Y., Zhu, K., Wu, W., Lü, L., Liu, J., Zhao, K., Zhang, L., Tang, Y., & Lv, Z. (2023). Additional file 4 of SMAD9-MYCN positive feedback loop represents a unique dependency for MYCN-amplified neuroblastoma. Figshare. https://doi.org/10.6084/m9.figshare.22615114
878. Tan, K., Mo, J., Li, M., Dong, Y., Han, Y., Sun, X., Ma, Y., Zhu, K., Wu, W., Lü, L., Liu, J., Zhao, K., Zhang, L., Tang, Y., & Lv, Z. (2023). Additional file 5 of SMAD9-MYCN positive feedback loop represents a unique dependency for MYCN-amplified neuroblastoma. Figshare. https://doi.org/10.6084/m9.figshare.22615117
879. Tan, K., Mo, J., Li, M., Dong, Y., Han, Y., Sun, X., Ma, Y., Zhu, K., Wu, W., Lü, L., Liu, J., Zhao, K., Zhang, L., Tang, Y., & Lv, Z. (2023). Additional file 6 of SMAD9-MYCN positive feedback loop represents a unique dependency for MYCN-amplified neuroblastoma. Figshare. https://doi.org/10.6084/m9.figshare.22615120
880. Tan, S., Zeng, Y., Kuang, S., & Li, J. (2021). Serum Human Epididymis Protein 4 is a Potential Biomarker for Early Chronic Kidney Disease in an Obese Population [Retraction]. Diabetes Metabolic Syndrome and Obesity. https://doi.org/10.2147/dmso.s342648
881. Taniguchi, S., Kimura, J., Yanagisawa, T., Okada, F., & Yamada, T. (2007). F wave as a measure of selective suppression of the anterior horn cells involving only the volitionally inactivated muscle. Clinical Neurophysiology. https://doi.org/10.1016/j.clinph.2007.05.020
882. Tanimura, H., Kohno, K., Sato, S., Uchiumi, T., Miyazaki, M., Kobayashi, M., & Kuwano, M. (1992). The human multidrug resistance 1 promoter has an element that responds to serum starvation. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/0006-291x(92)90571-2
883. Tanner, J., Wright, M. S., & Miller, A. (2002). Diadenosine polyphosphate cellomics: Characterising proteins in prokaryotic stress that evolve and involve diadenosine polyphosphates..
884. Tao, Y., Li, G., Yuping, H., Mekki, M. D., Chen, K., & Wang, J. (2008). MC4RとPOU1F1遺伝子は,北京の成長特性に及ぼす遺伝的影響を示した。【JST・京大機械翻訳】. Hereditas (Beijing).
885. Tao, Y., Tao, Y., Yang, M., Chen, P., Gao, X., Zhang, Y., Zhang, T., Chen, Z., Hou, J., Zhang, Y., Ruan, K., Wang, H., & Hu, R. (2014). Profiling human protein degradome delineates cellular responses to proteasomal inhibition and reveals a feedback mechanism in regulating proteasome homeostasis. Cell Research. https://doi.org/10.1038/cr.2014.122
886. Targett‐Adams, P., McElwee, M., Ehrenborg, E., Gustafsson, M. C. U., Palmer, N. D., & McLauchlan, J. (2005). A PPAR response element regulates transcription of the gene for human adipose differentiation-related protein. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. https://doi.org/10.1016/j.bbaexp.2005.01.017
887. Tatetsu, H., Ueno, S., Hata, H., Yamada, Y., Takeya, M., Mitsuya, H., Tenen, D. G., & Okuno, Y. (2023). Supplementary Figure 1 from Down-regulation of PU.1 by Methylation of Distal Regulatory Elements and the Promoter Is Required for Myeloma Cell Growth. https://doi.org/10.1158/0008-5472.22367873
888. Tatetsu, H., Ueno, S., Hata, H., Yamada, Y., Takeya, M., Mitsuya, H., Tenen, D. G., & Okuno, Y. (2023). Supplementary Figure 1 from Down-regulation of PU.1 by Methylation of Distal Regulatory Elements and the Promoter Is Required for Myeloma Cell Growth. https://doi.org/10.1158/0008-5472.22367873.v1
889. Tatetsu, H., Ueno, S., Hata, H., Yamada, Y., Takeya, M., Mitsuya, H., Tenen, D. G., & Okuno, Y. (2023). Supplementary Figure 1 Legend from Down-regulation of PU.1 by Methylation of Distal Regulatory Elements and the Promoter Is Required for Myeloma Cell Growth. https://doi.org/10.1158/0008-5472.22367876.v1
890. Taylor, D. J., Chhetri, S. B., Tassia, M. G., Biddanda, A., Yan, S. M., Wojcik, G. L., Battle, A., & McCoy, R. C. (2024). Sources of gene expression variation in a globally diverse human cohort. Nature. https://doi.org/10.1038/s41586-024-07708-2
891. Telenti, A. (2011). Faculty Opinions recommendation of A diverse range of gene products are effectors of the type I interferon antiviral response.. Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature. https://doi.org/10.3410/f.9925956.13407055
892. Thase, M. E. (2007). Molecules That Mediate Mood. New England Journal of Medicine. https://doi.org/10.1056/nejmcibr0706377
893. Thomas, S., & Reisman, D. (2005). Localization of a mutant p53 response element on the Tissue Inhibitor of Metalloproteinase-3 promoter: Mutant p53 activities are distinct from wild-type. Cancer Letters. https://doi.org/10.1016/j.canlet.2005.08.027
894. Thomas‐Tikhonenko, A., Black, D. J., & Linial, M. (1995). v-Myc is invariably required to sustain rapid proliferation of infected cells but in stable cell lines becomes dispensable for other traits of the transformed phenotype.. PubMed.
895. Thompson, A. (2024). Metamaterials offer promising new functionalities for orthopedic implants. Scilight. https://doi.org/10.1063/10.0024873
896. Thorrez, L., Laudadio, I., Deun, K. V., Quintens, R., Hendrickx, N., Granvik, M., Lemaire, K., Schraenen, A., Lommel, L. V., Lehnert, S. A., Aguayo‐Mazzucato, C., Cheng, R., Gilon, P., Mechelen, I. V., Bonner‐Weir, S., Lemaigre, F., & Schuit, F. (2009). Tissue-specific repression of certain housekeeping genes is essential to allow specialized tissue function.
897. Thulien, K. J., Reiman, T., Lai, J., Belch, A. R., & Pilarski, L. M. (2007). Molecular Quantification of Pre-Treatment Bone Marrow Clonal Cells in Multiple Myeloma Is a Novel Predictive Indicator of Remission Length.. Blood. https://doi.org/10.1182/blood.v110.11.4757.4757
898. TONDRAVI, M. (1996). Novel osteopetrosis mutation caused by the knock out of the hematopoietic transcription factor PU.1 in transgenic mice.. Bone. https://doi.org/10.1016/8756-3282(96)89392-6
899. Torday, J. S. (2003). Parathyroid hormone-related protein is a gravisensor in lung and bone cell biology. Advances in Space Research. https://doi.org/10.1016/s0273-1177(03)90397-8
900. Toyoda, S., Kawaguchi, M., Kobayashi, T., Tarusawa, E., Toyama, T., Okano, M., Oda, M., Nakauchi, H., Yoshimura, Y., Sanbo, M., Hirabayashi, M., Hirayama, T., Hirabayashi, T., & Yagi, T. (2014). Developmental Epigenetic Modification Regulates Stochastic Expression of Clustered Protocadherin Genes, Generating Single Neuron Diversity. Neuron. https://doi.org/10.1016/j.neuron.2014.02.005
901. Tran, H., Steger, D. J., Iyer, V. R., & Johnson, A. D. (2000). The chromo domain protein Chd1p from budding yeast is an ATP-dependent chromatin-modifying factor. The EMBO Journal. https://doi.org/10.1093/emboj/19.10.2323
902. Trapp, M., Miggitsch, E. M., Schwaberger, G., Egger, J., Wieser, O., Lackner, H., Rohrer, P. M., & Richtig, E. (2008). Skin conductande variability - an important parameter in the fields of psycho-physiology and psycho-dermatology..
903. Treskes, P., Kumar, S., Neef, K., Liakopoulos, O. J., Ac, S., Stamm, C., Wittwer, T., Hescheler, J., Yh, C., & Wahlers, T. (2010). Lineage of conversion of skeletal muscle derived precursor cells into cardiomyocytes - a promising autologous cell source for cardiac cell therapy.. PubMed.
904. Trieu-Duc, V., Oshima, K., Matsumura, K., Iwasaki, Y., Chiu, M.-T., Nikaido, M., & Okada, N. (2022). Additional file 7 of Alternative splicing plays key roles in response to stress across different stages of fighting in the fish Betta splendens. Figshare. https://doi.org/10.6084/m9.figshare.19930317
905. Tu, M. M., Lee, F. Y. F., Jones, R. T., Kimball, A. K., Saravia, E., Graziano, R. F., Coleman, B. M., Menard, K., Yan, J., Michaud, E., Chang, H., Abdel-Hafiz, H., Rozhok, A. I., Duex, J. E., Agarwal, N., Chauca-Diaz, A., Johnson, L. K., Ng, T. L., Cambier, J. C., ... Theodorescu, D. (2019). Targeting DDR2 enhances tumor response to anti–PD-1 immunotherapy. Science Advances. https://doi.org/10.1126/sciadv.aav2437
906. Turan, M. P., Riedo, R., Medo, M., Pozzato, C., Friese‐Hamim, M., Koch, J. P., Coggins, S. A., Li, Q., Kim, B., Albers, J., Aebersold, D. M., Zamboni, N., Zimmer, Y., & Medová, M. (2024). Table S4 from E2F1-Associated Purine Synthesis Pathway Is a Major Component of the MET-DNA Damage Response Network. https://doi.org/10.1158/2767-9764.26404759
907. Turan, M. P., Riedo, R., Medo, M., Pozzato, C., Friese‐Hamim, M., Koch, J. P., Coggins, S. A., Li, Q., Kim, B., Albers, J., Aebersold, D. M., Zamboni, N., Zimmer, Y., & Medová, M. (2024). Table S4 from E2F1-Associated Purine Synthesis Pathway Is a Major Component of the MET-DNA Damage Response Network. https://doi.org/10.1158/2767-9764.26404759.v1
908. Turan, M. P., Riedo, R., Medo, M., Pozzato, C., Friese‐Hamim, M., Koch, J. P., Coggins, S. A., Li, Q., Kim, B., Albers, J., Aebersold, D. M., Zamboni, N., Zimmer, Y., & Medová, M. (2024). Table S4 from E2F1-Associated Purine Synthesis Pathway Is a Major Component of the MET-DNA Damage Response Network. https://doi.org/10.1158/2767-9764.27045875
909. Turan, M. P., Riedo, R., Medo, M., Pozzato, C., Friese‐Hamim, M., Koch, J. P., Coggins, S. A., Li, Q., Kim, B., Albers, J., Aebersold, D. M., Zamboni, N., Zimmer, Y., & Medová, M. (2024). Table S4 from E2F1-Associated Purine Synthesis Pathway Is a Major Component of the MET-DNA Damage Response Network. https://doi.org/10.1158/2767-9764.27045875.v1
910. Ujimatsu, R., Takino, J., Aoki, S., Nakamura, M., Haba, H., Minami, A., & Hiruma, K. (2025). A fungal transcription factor converts a beneficial root endophyte into an anthracnose leaf pathogen. Current Biology. https://doi.org/10.1016/j.cub.2025.03.026
911. Ulgheri, C., Paganini, B., & Rossi, F. (2010). Antisecretory factor as a potential health - promoting molecule in humans and animals..
912. Unknown (1994). Correction: Corrigendum: The Wilson disease gene is a putative copper transporting P–type ATPase similar to the Menkes gene. Nature Genetics. https://doi.org/10.1038/ng0294-214a
913. Unknown (2012). change in the connectivity pattern, shapes the behavioral repertoire of is to be selective: (1) it must entities capable of responding to first. Routledge eBooks. https://doi.org/10.4324/9780203055045-24
914. Unknown (2012). Functional Variability Drives Colorectal Cancer Heterogeneity. Cancer Discovery. https://doi.org/10.1158/2159-8290.cd-rw2012-237
915. Unknown (2012). None. FEMS Microbiology Reviews. https://doi.org/10.1111/fmr.2012.36.issue-3
916. Unknown (2012). p53 Protein Dynamics Regulate Signaling Specificity. Cancer Discovery. https://doi.org/10.1158/2159-8290.cd-rw2012-091
917. Unknown (2012). P58 Proportionality. Certain contexts require a body’s response to be appropriate and necessary to achieve a legitimate aim.. Bloomsbury Publishing Plc eBooks. https://doi.org/10.5040/9781509943517.ch-058
918. Unknown (2012). Variant Enhancer Loci Predict Gene Dysregulation in Colon Cancer. Cancer Discovery. https://doi.org/10.1158/2159-8290.cd-rw2012-053
919. Unknown (2014). A PLK4 Inhibitor Has Single-Agent Activity in Preclinical Tumor Models. Cancer Discovery. https://doi.org/10.1158/2159-8290.cd-rw2014-160
920. Unknown (2014). An Acquired <i>MTOR</i> Mutation Confers Resistance to Allosteric mTOR Inhibition. Cancer Discovery. https://doi.org/10.1158/2159-8290.cd-rw2014-213
921. Unknown (2014). Editorial Information. FEBS Journal. https://doi.org/10.1111/febs.12676_1
922. Unknown (2014). FGFR Inhibitor Works in Multiple Cancers. Cancer Discovery. https://doi.org/10.1158/2159-8290.cd-nb2014-057
923. Unknown (2014). None. Regeneration. https://doi.org/10.1002/reg2.2014.1.issue-3
924. Unknown (2014). PTEN Mutants Act as Dominant Negatives to Disrupt PTEN Activity. Cancer Discovery. https://doi.org/10.1158/2159-8290.cd-rw2014-099
925. Unknown (2014). Reprogramming Factor Expression Leads to Tumor Development. Cancer Discovery. https://doi.org/10.1158/2159-8290.cd-rw2014-045
926. Unknown (2016). <i>PPP2R3B</i> Is a Sex-Linked Melanoma Tumor Suppressor Gene. Cancer Discovery. https://doi.org/10.1158/2159-8290.cd-rw2016-239
927. Unknown (2016). A Polymorphism in the <i>LMO1</i> Super-Enhancer Mediates Neuroblastoma Risk. Cancer Discovery. https://doi.org/10.1158/2159-8290.cd-rw2015-221
928. Unknown (2016). Super-Enhancers Distinguish Medulloblastoma Subtypes. Cancer Discovery. https://doi.org/10.1158/2159-8290.cd-rw2016-020
929. Unknown (2016). The FGFR Inhibitor BGJ398 Has Activity in Tumors with <i>FGFR</i> Alterations. Cancer Discovery. https://doi.org/10.1158/2159-8290.cd-rw2016-229
930. Unknown (2017). <i>CHD1</i> Is a Synthetic-Essential Gene in <i>PTEN</i>-Deficient Prostate Cancer. Cancer Discovery. https://doi.org/10.1158/2159-8290.cd-rw2017-033
931. Unknown (2017). Correction: Ongoing neurogenesis in the adult dentate gyrus mediates behavioral responses to ambiguous threat cues. PLoS Biology. https://doi.org/10.1371/journal.pbio.1002604
932. Unknown (2017). Editorial Expression of Concern: <i>Parkin</i> , a gene implicated in autosomal recessive juvenile parkinsonism, is a candidate tumor suppressor gene on chromosome 6q25–q27. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1704295114
933. Unknown (2017). FOXA1-Dependent Enhancer Reprogramming Promotes Metastasis. Cancer Discovery. https://doi.org/10.1158/2159-8290.cd-rw2017-146
934. Unknown (2017). None. Genes Brain & Behavior. https://doi.org/10.1111/gbb.2017.16.issue-3
935. Unknown (2017). None. WIREs Systems Biology and Medicine. https://doi.org/10.1002/wsbm.2017.9.issue-5
936. Unknown (2017). The MHC I Genotype Influences Early Driver Events in Cancer. Cancer Discovery. https://doi.org/10.1158/2159-8290.cd-rw2017-206
937. Unknown (2018). Enhancer-Driven Gene Expression Changes Facilitate Metastasis. Cancer Discovery. https://doi.org/10.1158/2159-8290.cd-rw2018-015
938. Unknown (2018). None. Clinical & Experimental Immunology. https://doi.org/10.1111/cei.2018.192.issue-1
939. Unknown (2020). Activating MET Mutation. Definitions. https://doi.org/10.32388/bslbhs
940. Unknown (2020). Antimicrobial Peptide. Definitions. https://doi.org/10.32388/xe5b6x
941. Unknown (2020). Cross-Reactive Gut Bacteriophage Protein Enhances Anticancer Therapy. Cancer Discovery. https://doi.org/10.1158/2159-8290.cd-rw2020-131
942. Unknown (2020). Deleterious MRE11 Gene Mutation. Definitions. https://doi.org/10.32388/q12uuc
943. Unknown (2020). Designed Proteins Lead Therapeutics to Cancer Cells, Spare Other Cells. Cancer Discovery. https://doi.org/10.1158/2159-8290.cd-rw2020-127
944. Unknown (2020). Gene. Definitions. https://doi.org/10.32388/fbu9iq
945. Unknown (2020). Genetic factors play such a strong role in human development that genes alone can determine certain human behavioral characteristics.. SAGE Publications, Inc. eBooks. https://doi.org/10.4135/9781544341958.n5
946. Unknown (2020). Glandular Metaplasia. Definitions. https://doi.org/10.32388/f5sl1c
947. Unknown (2020). Matrix Metalloproteinase Inhibitor. Definitions. https://doi.org/10.32388/t2x3e0
948. Unknown (2020). MGMT Gene Promoter Methylation. Definitions. https://doi.org/10.32388/v1vo5f
949. Unknown (2020). None. Wiley Interdisciplinary Reviews Developmental Biology. https://doi.org/10.1002/wdev.v9.5
950. Unknown (2020). Orthodontic Headgear. Definitions. https://doi.org/10.32388/oeqpqc
951. Unknown (2020). Peer Review #1 of Heh2/Man1 may be an evolutionarily conserved sensor of NPC assembly state. https://doi.org/10.15252/rc.2022188078
952. Unknown (2020). Peer Review #2 of Heh2/Man1 may be an evolutionarily conserved sensor of NPC assembly state. https://doi.org/10.15252/rc.2022313929
953. Unknown (2020). Peer Review #3 of Heh2/Man1 may be an evolutionarily conserved sensor of NPC assembly state. https://doi.org/10.15252/rc.2022787471
954. Unknown (2020). Pericyte. Definitions. https://doi.org/10.32388/9lrdtj
955. Unknown (2020). Proteomic Profile. Definitions. https://doi.org/10.32388/0n9dw4
956. Unknown (2020). PTEN Gene Alteration Positive. Definitions. https://doi.org/10.32388/rusu5p
957. Unknown (2020). Quantitative Trait Locus. Definitions. https://doi.org/10.32388/k4asn1
958. Unknown (2020). Recombinant Methionyl Human Brain-Derived Factor. Definitions. https://doi.org/10.32388/q91fra
959. Unknown (2020). Resistance-Linked Stress-Induced Mutagenesis Is MTOR-Mediated in Cancer. Cancer Discovery. https://doi.org/10.1158/2159-8290.cd-rw2020-090
960. Unknown (2020). Retinoic Acid Mediates Monocyte Differentiation and Immune Response. Cancer Discovery. https://doi.org/10.1158/2159-8290.cd-rw2020-044
961. Unknown (2020). TERT Promoter Mutation Negative. Definitions. https://doi.org/10.32388/kxywdu
962. Unknown (2020). Tumor Identification Link Group Identifier. Definitions. https://doi.org/10.32388/583muq
963. Unknown (2021). A Histone Modifier's Phase Separation Is Needed for Antitumor Function. Cancer Discovery. https://doi.org/10.1158/2159-8290.cd-rw2021-136
964. Unknown (2021). Bone Microenvironment Promotes Further Spread from Primary Metastases. Cancer Discovery. https://doi.org/10.1158/2159-8290.cd-rw2021-063
965. Unknown (2021). Corrigendum: M1-type microglia can induce astrocytes to deposit chondroitin sulfate proteoglycan after spinal cord injury. Neural Regeneration Research. https://doi.org/10.4103/1673-5374.330626
966. Unknown (2021). Nongenetic Cell-Intrinsic Properties Govern Malignant Clonal Fitness. Cancer Discovery. https://doi.org/10.1158/2159-8290.cd-rw2021-179
967. Unknown (2021). Review 1: A negative charge at position D<sup>+5</sup> of Motif A is critical for function of the major facilitator superfamily multidrug/H<sup>+</sup> antiporter MdtM. https://doi.org/10.1017/exp.2022.1.pr1
968. Unknown (2022). A Germline Variant Deregulates <i>MYC</i> Expression in <i>IDH1</i>-Mutant Glioma. Cancer Discovery. https://doi.org/10.1158/2159-8290.cd-rw2022-181
969. Unknown (2022). None. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.v56.9
970. Unknown (2022). None. The Plant Journal. https://doi.org/10.1111/tpj.v111.6
971. Unknown (2022). Oncogenic Signaling in Kidney Cancer Requires Renal Lineage Factor PAX8. Cancer Discovery. https://doi.org/10.1158/2159-8290.cd-rw2022-113
972. Unknown (2022). p53 Inactivation Leads to a Predictable Pattern of Genome Evolution. Cancer Discovery. https://doi.org/10.1158/2159-8290.cd-rw2022-153
973. Unknown (2022). Peer Review #1 of Differential modification of protein paralogs reveals conserved sequence determinants of post-translational modification. https://doi.org/10.15252/rc.2022278663
974. Unknown (2022). Peer Review #1 of Multinucleation resets human macrophages for specialized functions at the expense of mononuclear phagocyte identity. https://doi.org/10.15252/rc.2022107403
975. Unknown (2022). Peer Review #3 of Differential modification of protein paralogs reveals conserved sequence determinants of post-translational modification. https://doi.org/10.15252/rc.2022215994
976. Unknown (2022). Specific Anatomic Transcriptomes Drive Oncogenesis in Melanoma. Cancer Discovery. https://doi.org/10.1158/2159-8290.cd-rw2022-061
977. Unknown (2022). Structural Variants Rewire Oncogenic Enhancer–Promoter Interactions. Cancer Discovery. https://doi.org/10.1158/2159-8290.cd-rw2022-223
978. Unknown (2023). <i>CXCL9:SPP1</i> Macrophage Polarity Is Linked to Clinical Outcome in Cancer. Cancer Discovery. https://doi.org/10.1158/2159-8290.cd-rw2023-128
979. Unknown (2023). <i>NOTCH1</i> Mutations Inhibit Tumor Growth in the Esophageal Epithelium. Cancer Discovery. https://doi.org/10.1158/2159-8290.cd-rw2023-014
980. Unknown (2023). A Pan-KRAS Inhibitor Impedes Common KRAS Oncoproteins and Tumor Growth. Cancer Discovery. https://doi.org/10.1158/2159-8290.cd-rw2023-090
981. Unknown (2023). Chronic Inflammation Drives <i>TP53</i>-Mutant Leukemic Evolution. Cancer Discovery. https://doi.org/10.1158/2159-8290.cd-rw2023-151
982. Unknown (2023). Correction to: High <scp>MHC</scp> diversity confers no advantage for phenotypic quality and reproductive performance in a wild bird. Journal of Animal Ecology. https://doi.org/10.1111/1365-2656.13931
983. Unknown (2023). IL4 Signaling in the Bone Marrow Promotes Protumorigenic Myelopoiesis. Cancer Discovery. https://doi.org/10.1158/2159-8290.cd-rw2023-196
984. Unknown (2023). Misoprostol use in obstetrics. Revista Brasileira Ginecologia e Obstetrícia. https://doi.org/10.1055/s-0043-1770931
985. Unknown (2023). Reviewer #1 (Public Review): Transposons are important contributors to gene expression variability under selection in rice populations. https://doi.org/10.7554/elife.86324.3.sa1
986. Unknown (2023). The Proteasome Regulator PSME4 Modulates Antitumor Immunity. Cancer Discovery. https://doi.org/10.1158/2159-8290.cd-rw2023-088
987. Unknown (2023). ZBP1 Mediates Replicative Crisis through Telomere-to-Mitochondria Signaling. Cancer Discovery. https://doi.org/10.1158/2159-8290.cd-rw2023-026
988. Upton, E. M., Schlievert, P. M., Zhang, Y., Rauckhorst, A. J., Taylor, E. B., & Radoshevich, L. (2023). Glycerol monolaurate inhibits . PubMed. https://doi.org/10.17912/micropub.biology.000905
989. Urbischek, M., Rannikmäe, H., Foets, T., Ravn, K., Hyvönen, M., & Roche, M. D. L. (2020). Author Correction: Organoid culture media formulated with growth factors of defined cellular activity. Scientific Reports. https://doi.org/10.1038/s41598-020-68552-8
990. Urizar-Compains, E., Gárate, L., Miranda, E., Valcárcel, L. V., Barrena, N., Martín‐Úriz, P. S., Fernández‐Irigoyen, J., Planes, F. J., José‐Eneriz, E. S., Prósper, F., & Agirre, X. (2024). P-250 Alteration of the m6A Regulatory Genes, With the Special Implication of Virma, Is Crucial for Multiple Myeloma Development. Clinical Lymphoma Myeloma & Leukemia. https://doi.org/10.1016/s2152-2650(24)02153-0
991. Usategui‐Martín, R., & Pérez‐Castrillón, J. L. (2023). Animal Experimental Models in Bone Metabolic Disease. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24119534
992. Usenko, A. B., Emel'yanova, T. G., & Myasoedov, N. F. (2002). [Dermorphins--a natural opioids with unique primary structure that determines their biological specificity].. Biology Bulletin. https://doi.org/10.1023/a:1014359000606
993. Valdés-Hernández, G. V., Cruz-Viera, L., & Comet-Rodríguez, R. (2015). Influencia de las condiciones de operación en la extracción de polifenoles a partir de hojas de Moringa oleifera Lam. Revista CENIC. Ciencias Químicas.
994. Vanasco, V., Ropolo, A., Grasso, D., Álvarez, S., & Vaccaro, M. I. (2018). VMP1 dependent selective mitophagy and mitochondrial fragmentation are protective cellular mechanisms in pancreatitis. Pancreatology. https://doi.org/10.1016/j.pan.2018.05.234
995. VanHook, A. M. (2008). Creating Force from Destruction. Science Signaling. https://doi.org/10.1126/scisignal.138ec334
996. VanHook, A. M. (2016). One way fumarate can promote metastasis. Science Signaling. https://doi.org/10.1126/scisignal.aak9768
997. Vaquero, S. T., Aramburu, J., Ortells, M. C., Buxadé, M., & López-Rodrı́guez, C. (2014). Transcriptional regulation of the stress response by mTOR. Science Signaling. https://doi.org/10.1126/scisignal.2005326
998. Veldkamp, J., Orozco‐Segovia, A., Batis, A. I., Rojas‐Aréchiga, M., & Mendoza, A. (2003). Seed Biology of Palms: A Review.
999. Verma, N., Chouhan, D., Meghana, A., & Tiwari, V. (2024). Molecular Chaperones to Pain Modulators: Heat Shock Proteins the Emerging Players in Chronic Pain Management. Neuropharmacology. https://doi.org/10.1016/j.neuropharm.2024.110263
1000. Veskoukis, A. S., Kerasioti, E., Skaperda, Z., Papapostolou, P. A., Nepka, C., Spandidos, D., Asprodini, E., Taitzoglou, I., & Kouretas, D. (2020). Whey protein boosts the antioxidant profile of rats by enhancing the activities of crucial antioxidant enzymes in a tissue-specific manner. Food and Chemical Toxicology. https://doi.org/10.1016/j.fct.2020.111508
1001. Vida, Y., Collado, D., Nájera, F., Claros, S., Becerra, J., Andrades, J. A., & Pérez‐Inestrosa, E. (2016). Dendrimer surface orientation of the RGD peptide affects mesenchymal stem cell adhesion. RSC Advances. https://doi.org/10.1039/c6ra06177j
1002. Viebig, N. K., Gamain, B., Scheidig, C., Lépolard, C., Przyborski, J. M., Lanzer, M., Gysin, J., & Scherf, A. (2005). A single member of the <i>Plasmodium falciparum var</i> multigene family determines cytoadhesion to the placental receptor chondroitin sulphate A. EMBO Reports. https://doi.org/10.1038/sj.embor.7400466
1003. Vinante, F., Pizzolo, G., Rigo, A., Vincenzi, C., Sorio, C., Cassatella, M. A., & Berton, G. (1992). The CD4 molecule belongs to the phenotypic repertoire of most cases of acute myeloid leukemia.. PubMed.
1004. vitro及In, I., vivo中HetR為homodimer, hetRC, H., HetR二聚體化會影響Heterocyst, & 是否與DNA, H. (2005). HetR homodimer is a DNA-binding protein required for heterocyst differentiation, and the DNA-binding activity is inhibited by PatS.
1005. Voerman, S. E., Marsh, B. C., Bahia, R. G., Pereira‐Filho, G. H., Yee, T. W., Becker, A. C. F., Amado‐Filho, G. M., Ruseckas, A., Turnbull, G. A., Samuel, I. D. W., & Burdett, H. L. (2022). Voerman et al_data from Ecosystem engineer morphological traits and taxon identity shape biodiversity across the euphotic–mesophotic transition. Figshare. https://doi.org/10.6084/m9.figshare.19195344
1006. Waldschmidt, J. M., Kloeber, J. A., Anand, P., Frede, J., Kokkalis, A., Dimitrova, V., Potdar, S., Nair, M. S., Vijaykumar, T., Im, N. G., Guillaumet-Adkins, A., Chopra, N., Stuart, H. S., Budano, L., Sotudeh, N., Guo, G., Grassberger, C., Yee, A. J., Laubach, J. P., ... Lohr, J. G. (2023). Supplementary Figure Legends from Single-Cell Profiling Reveals Metabolic Reprogramming as a Resistance Mechanism in &lt;i&gt;BRAF&lt;/i&gt;-Mutated Multiple Myeloma. https://doi.org/10.1158/1078-0432.22482668
1007. Waldschmidt, J. M., Kloeber, J. A., Anand, P., Frede, J., Kokkalis, A., Dimitrova, V., Potdar, S., Nair, M. S., Vijaykumar, T., Im, N. G., Guillaumet-Adkins, A., Chopra, N., Stuart, H. S., Budano, L., Sotudeh, N., Guo, G., Grassberger, C., Yee, A. J., Laubach, J. P., ... Lohr, J. G. (2023). Supplementary Figure Legends from Single-Cell Profiling Reveals Metabolic Reprogramming as a Resistance Mechanism in &lt;i&gt;BRAF&lt;/i&gt;-Mutated Multiple Myeloma. https://doi.org/10.1158/1078-0432.22482668.v1
1008. Wallin, J. J., Edgar, K. A., Guan, J., Berry, M., Prior, W. W., Lee, L., Lesnick, J., Lewis, C., Nonomiya, J., Pang, J., Salphati, L., Olivero, A. G., Sutherlin, D. P., O'Brien, C., Spoerke, J. M., Patel, S., Lensun, L., Kassees, R., Ross, L., ... Friedman, L. S. (2023). Supplementary Figures 1-4, Tables 1-8 from GDC-0980 Is a Novel Class I PI3K/mTOR Kinase Inhibitor with Robust Activity in Cancer Models Driven by the PI3K Pathway. https://doi.org/10.1158/1535-7163.22496520
1009. Wallin, J. J., Edgar, K. A., Guan, J., Berry, M., Prior, W. W., Lee, L., Lesnick, J., Lewis, C., Nonomiya, J., Pang, J., Salphati, L., Olivero, A. G., Sutherlin, D. P., O’Brien, C., Spoerke, J. M., Patel, S., Lensun, L., Kassees, R., Ross, L., ... Friedman, L. S. (2023). Supplementary Figures 1-4, Tables 1-8 from GDC-0980 Is a Novel Class I PI3K/mTOR Kinase Inhibitor with Robust Activity in Cancer Models Driven by the PI3K Pathway. https://doi.org/10.1158/1535-7163.22496520.v1
1010. Walsby, E., Hewamana, S., Burnett, A. K., Knapper, S., Fegan, C., & Pepper, C. (2008). The Parthenolide Derivative LC-1 Is An Effective Single Agent and Is Highly Synergistic with Existing Therapies in Multiple Myeloma.. Blood. https://doi.org/10.1182/blood.v112.11.1708.1708
1011. Wang, G., Haile, S., Comuzzi, B., Tien, A. H., Wang, J., Yong, T. M., Jelescu-Bodos, A. E., Blaszczyk, N., Vessella, R. L., Masri, B. A., & Sadar, M. D. (2023). Supplementary Figure 1 from Osteoblast-Derived Factors Induce an Expression Signature that Identifies Prostate Cancer Metastasis and Hormonal Progression. https://doi.org/10.1158/0008-5472.22379877
1012. Wang, G., Haile, S., Comuzzi, B., Tien, A. H., Wang, J., Yong, T. M., Jelescu-Bodos, A. E., Blaszczyk, N., Vessella, R. L., Masri, B. A., & Sadar, M. D. (2023). Supplementary Figure 1 from Osteoblast-Derived Factors Induce an Expression Signature that Identifies Prostate Cancer Metastasis and Hormonal Progression. https://doi.org/10.1158/0008-5472.22379877.v1
1013. Wang, G., Haile, S., Comuzzi, B., Tien, A. H., Wang, J., Yong, T. M., Jelescu-Bodos, A. E., Blaszczyk, N., Vessella, R. L., Masri, B. A., & Sadar, M. D. (2023). Supplementary Figure 4 from Osteoblast-Derived Factors Induce an Expression Signature that Identifies Prostate Cancer Metastasis and Hormonal Progression. https://doi.org/10.1158/0008-5472.22379868
1014. Wang, G., Haile, S., Comuzzi, B., Tien, A. H., Wang, J., Yong, T. M., Jelescu-Bodos, A. E., Blaszczyk, N., Vessella, R. L., Masri, B. A., & Sadar, M. D. (2023). Supplementary Figure 4 from Osteoblast-Derived Factors Induce an Expression Signature that Identifies Prostate Cancer Metastasis and Hormonal Progression. https://doi.org/10.1158/0008-5472.22379868.v1
1015. Wang, G., Haile, S., Comuzzi, B., Tien, A. H., Wang, J., Yong, T. M., Jelescu-Bodos, A. E., Blaszczyk, N., Vessella, R. L., Masri, B. A., & Sadar, M. D. (2023). Supplementary Figure Legends 1-9 from Osteoblast-Derived Factors Induce an Expression Signature that Identifies Prostate Cancer Metastasis and Hormonal Progression. https://doi.org/10.1158/0008-5472.22379847
1016. Wang, G., Haile, S., Comuzzi, B., Tien, A. H., Wang, J., Yong, T. M., Jelescu-Bodos, A. E., Blaszczyk, N., Vessella, R. L., Masri, B. A., & Sadar, M. D. (2023). Supplementary Figure Legends 1-9 from Osteoblast-Derived Factors Induce an Expression Signature that Identifies Prostate Cancer Metastasis and Hormonal Progression. https://doi.org/10.1158/0008-5472.22379847.v1
1017. Wang, G., Haile, S., Comuzzi, B., Tien, A. H., Wang, J., Yong, T. M., Jelescu-Bodos, A. E., Blaszczyk, N., Vessella, R. L., Masri, B. A., & Sadar, M. D. (2023). Supplementary Table 1 from Osteoblast-Derived Factors Induce an Expression Signature that Identifies Prostate Cancer Metastasis and Hormonal Progression. https://doi.org/10.1158/0008-5472.22379844
1018. Wang, G., Haile, S., Comuzzi, B., Tien, A. H., Wang, J., Yong, T. M., Jelescu-Bodos, A. E., Blaszczyk, N., Vessella, R. L., Masri, B. A., & Sadar, M. D. (2023). Supplementary Table 1 from Osteoblast-Derived Factors Induce an Expression Signature that Identifies Prostate Cancer Metastasis and Hormonal Progression. https://doi.org/10.1158/0008-5472.22379844.v1
1019. Wang, G., Haile, S., Comuzzi, B., Tien, A. H., Wang, J., Yong, T. M., Jelescu-Bodos, A. E., Blaszczyk, N., Vessella, R. L., Masri, B. A., & Sadar, M. D. (2023). Supplementary Table 3 from Osteoblast-Derived Factors Induce an Expression Signature that Identifies Prostate Cancer Metastasis and Hormonal Progression. https://doi.org/10.1158/0008-5472.22379838
1020. Wang, G., Haile, S., Comuzzi, B., Tien, A. H., Wang, J., Yong, T. M., Jelescu-Bodos, A. E., Blaszczyk, N., Vessella, R. L., Masri, B. A., & Sadar, M. D. (2023). Supplementary Table 3 from Osteoblast-Derived Factors Induce an Expression Signature that Identifies Prostate Cancer Metastasis and Hormonal Progression. https://doi.org/10.1158/0008-5472.22379838.v1
1021. Wang, G., Haile, S., Comuzzi, B., Tien, A. H., Wang, J., Yong, T. M., Jelescu-Bodos, A. E., Blaszczyk, N., Vessella, R. L., Masri, B. A., & Sadar, M. D. (2023). Supplementary Table 4 from Osteoblast-Derived Factors Induce an Expression Signature that Identifies Prostate Cancer Metastasis and Hormonal Progression. https://doi.org/10.1158/0008-5472.22379835
1022. Wang, G., Haile, S., Comuzzi, B., Tien, A. H., Wang, J., Yong, T. M., Jelescu-Bodos, A. E., Blaszczyk, N., Vessella, R. L., Masri, B. A., & Sadar, M. D. (2023). Supplementary Table 4 from Osteoblast-Derived Factors Induce an Expression Signature that Identifies Prostate Cancer Metastasis and Hormonal Progression. https://doi.org/10.1158/0008-5472.22379835.v1
1023. Wang, G., Haile, S., Comuzzi, B., Tien, A. H., Wang, J., Yong, T. M., Jelescu-Bodos, A. E., Blaszczyk, N., Vessella, R. L., Masri, B. A., & Sadar, M. D. (2023). Supplementary Table 5 from Osteoblast-Derived Factors Induce an Expression Signature that Identifies Prostate Cancer Metastasis and Hormonal Progression. https://doi.org/10.1158/0008-5472.22379832
1024. Wang, G., Haile, S., Comuzzi, B., Tien, A. H., Wang, J., Yong, T. M., Jelescu-Bodos, A. E., Blaszczyk, N., Vessella, R. L., Masri, B. A., & Sadar, M. D. (2023). Supplementary Table 5 from Osteoblast-Derived Factors Induce an Expression Signature that Identifies Prostate Cancer Metastasis and Hormonal Progression. https://doi.org/10.1158/0008-5472.22379832.v1
1025. Wang, L., Tang, T., Zuo, K., Liu, N., Wei, Y., & Zhu, X. (2024). A Novel Manganese Ion Delivery Carrier Promotes Immune Cell Proliferation and Enhances Innate Immune Responses. ACS Omega. https://doi.org/10.1021/acsomega.4c06497
1026. Wang, M., Hancock, T., MacLeod, I. M., Pryce, J., Cocks, B. G., & Hayes, B. J. (2017). MOESM6 of Putative enhancer sites in the bovine genome are enriched with variants affecting complex traits. Figshare. https://doi.org/10.6084/m9.figshare.c.3820429_d6
1027. Wang, N., Xu, Y., Qin, T., Wang, F.-P., Ma, L., Luo, X., & Zhang, T. (2013). Myocardin-related transcription factor-A is a key regulator in retinoic acid-induced neural-like differentiation of adult bone marrow-derived mesenchymal stem cells. Gene. https://doi.org/10.1016/j.gene.2013.03.043
1028. Wang, N.-F., Zhao, C.-S., You, Y.-M., Liu, F., Cai, F., & Zhang, D. (2024). [Immuno Phenotypic Characteristics of Bone Marrow Monocytes and Its Clinical Significance in Patients with Multiple Myeloma].. PubMed. https://doi.org/10.19746/j.cnki.issn.1009-2137.2024.06.023
1029. Wang, R., Kumar, B., Doud, E. H., Mosley, A. L., Alexander, M. S., Kunkel, L. M., & Nakshatri, H. (2022). Skeletal muscle-specific overexpression of miR-486 limits mammary tumor-induced skeletal muscle functional limitations. Molecular Therapy — Nucleic Acids. https://doi.org/10.1016/j.omtn.2022.08.022
1030. Wang, S., Wang, M., Yin, S., Fu, G., Li, C., Chen, R., Li, A., Zhou, J., Zhang, Z., & Liu, Q. (2007). A novel variable number of tandem repeats (VNTR) polymorphism containing Sp1 binding elements in the promoter of XRCC5 is a risk factor for human bladder cancer. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. https://doi.org/10.1016/j.mrfmmm.2007.08.011
1031. Wang, Z., Deng, Q., Gu, Y., Li, M., Zhang, Y., Hu, Q., Shenping, Z., Wang, X., & Liang, H. (2023). Additional file 1 of Proteomics and transcriptomics profiling reveals distinct aspects of kidney stone related genes in calculi rats. Figshare. https://doi.org/10.6084/m9.figshare.22625701
1032. Warren, C., Shao, X., Morin, A., Valérie, S., Kwan, T., Ge, B., Dylan, A., Chen, L., Louella, V., Allum, F., Guénard, F., Bouzigon, E., Simon, M.-M., Boulier, E., Redensek, A., Stephen, W., Datta, A., Laura, C., Paul, F., ... Grundberg, E. (2017). Additional file 5: Figure S1. of Functional variation in allelic methylomes underscores a strong genetic contribution and reveals novel epigenetic alterations in the human epigenome. https://doi.org/10.6084/m9.figshare.c.3714919_d6
1033. Wasylishen, A. R., Chan‐Seng‐Yue, M., Bros, C., Dingar, D., Tu, W. B., Kalkat, M., Chan, P.-K., Mullen, P., Huang, L., Meyer, N., Raught, B., Boutros, P. C., & Penn, L. Z. (2023). Supplementary Table 7 from MYC Phosphorylation at Novel Regulatory Regions Suppresses Transforming Activity. https://doi.org/10.1158/0008-5472.22396269
1034. Wasylishen, A. R., Chan‐Seng‐Yue, M., Bros, C., Dingar, D., Tu, W. B., Kalkat, M., Chan, P.-K., Mullen, P., Huang, L., Meyer, N., Raught, B., Boutros, P. C., & Penn, L. Z. (2023). Supplementary Table 7 from MYC Phosphorylation at Novel Regulatory Regions Suppresses Transforming Activity. https://doi.org/10.1158/0008-5472.22396269.v1
1035. Webb, S. (2008). Molecular directors in the timing of neural development. Nature reports. Stem cells. https://doi.org/10.1038/stemcells.2008.125
1036. Webster, K. A., Taylor, A. H., Gustafson, T. A., & Kedes, L. (1997). The anti-cancer agent distamycin A displaces essential transcription factors and selectively inhibits myogenic differentiation.. Molecular and Cellular Biochemistry. https://doi.org/10.1023/a:1006898812618
1037. Wei, Y., Tang, C., Sant, V., Li, S., Poloyac, S. M., & Xie, W. (2016). A Molecular Aspect in the Regulation of Drug Metabolism: Does PXR-Induced Enzyme Expression Always Lead to Functional Changes in Drug Metabolism?. Current Pharmacology Reports. https://doi.org/10.1007/s40495-016-0062-1
1038. Weibel, C., Wheeler, A. L., James, J., Willis, S. M., McShea, H., & Masel, J. (2024). Author response: The protein domains of vertebrate species in which selection is more effective have greater intrinsic structural disorder. https://doi.org/10.7554/elife.87335.3.sa2
1039. Weigand, S., Bischoff, H., Dittrich‐Wengenroth, E., Heckroth, H., Lang, D., Vaupel, A., & Woltering, M. J. (2005). Minor structural modifications convert a selective PPARα agonist into a potent, highly selective PPARδ agonist. Bioorganic & Medicinal Chemistry Letters. https://doi.org/10.1016/j.bmcl.2005.06.023
1040. Weljie, A. M., Neri, P., Sayani, F., & Bahlis, N. J. (2009). Extracellular Metabolite Biomarkers of Bortezomib Resistance in Multiple Myeloma Indicate Involvement of Unexpected Metabolic Pathways.. Blood. https://doi.org/10.1182/blood.v114.22.1839.1839
1041. Welz-Voegele, C., Stone, J. E., Kearney, H. M., Liskay, R. M., Petes, T. D., & Jinks-Robertson, S. (2002). Alleles of the yeast Pms1 mismatch-repair gene that differentially affect recombination- and replication-related processes.. Carolina Digital Repository (University of North Carolina at Chapel Hill). https://doi.org/10.17615/eecr-y406
1042. WenFang, Z., YiFeng, D., Pan, L., Wang, X., Niu, L., ZhenHua, L., Cui, G., & Wang, Z. (2017). A CACTA transposable element in a PpYUC11 gene promoter is associated with the stony hard phenotype in peach.. Guoshu xuebao.
1043. Wernert, N., Raes, M., Lassalle, P., Dehouck, M. P., Gosselin, B., Vandenbunder, B., & Stéhelin, D. (1992). c-ets1 proto-oncogene is a transcription factor expressed in endothelial cells during tumor vascularization and other forms of angiogenesis in humans.. PubMed.
1044. Weston, M., Kaserer, T., Wu, A., Mouravlev, A., Carpenter, J. C., Snowball, A., Knauß, S., Schimmelmann, M. V., During, M. J., Lignani, G., Schorge, S., Young, D., Kullmann, D. M., & Lieb, A. (2019). Olanzapine: A potent agonist at the hM4D(Gi) DREADD amenable to clinical translation of chemogenetics. Science Advances. https://doi.org/10.1126/sciadv.aaw1567
1045. White, D. A., Chan, W., Lü, F., Liu, Y., Taylor, A. J., Morand, E. F., Duffy, S. J., Dart, A. M., Du, X., & Gao, X. (2011). Macrophage Migration Inhibitory Factor (MIF) is a Novel Biomarker and Promotes Cardiac Inflammation Following Acute Myocardial Infarction (AMI). Heart Lung and Circulation. https://doi.org/10.1016/j.hlc.2011.05.094
1046. Wighard, S., Witte, H., & Sommer, R. J. (2024). Conserved switch genes that arose via whole-genome duplication regulate a cannibalistic nematode morph. Science Advances. https://doi.org/10.1126/sciadv.adk6062
1047. Williams, A. D., Korolkova, O. Y., Sakwe, A. M., Geiger, T. M., James, S., Muldoon, R. L., Herline, A. J., Goodwin, J. S., Izban, M. G., Washington, M. K., Smoot, D. T., Ballard, B. R., Gazouli, M., & M’Koma, A. E. (2017). Correction: Human alpha defensin 5 is a candidate biomarker to delineate inflammatory bowel disease. PLoS ONE. https://doi.org/10.1371/journal.pone.0189551
1048. Williams, A. L., Wang, L., Lee, K., Avelar, A., Xie, G., Jia, W., & Shohet, R. V. (2019). Abstract 13620: Loss of Pkm2 Alters Myocardial Glucose Levels Before and After Infarction. Circulation.
1049. Willis, A. C., Jung, E. J., Wakefield, T., & Chen, X. (2004). Mutant p53 exerts a dominant negative effect by preventing wild-type p53 from binding to the promoter of its target genes. Oncogene. https://doi.org/10.1038/sj.onc.1207396
1050. Woski, S. A. (2014). Faculty Opinions recommendation of The dynamic character of the BCL2 promoter i-motif provides a mechanism for modulation of gene expression by compounds that bind selectively to the alternative DNA hairpin structure.. Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature. https://doi.org/10.3410/f.718285554.793491850
1051. Wu, J., Bassinger, S., Tsewang, T. D., Krencicki, M. A., Woods, J. B., & Williams, T. M. (2010). 105-P: The Macaque MHC-DQB1 Locus Is a Polymorphic Single Copy Gene With Allele Groups That Are Closely Related to Their HLA-DQB1 Allele Group Counterparts. Human Immunology. https://doi.org/10.1016/j.humimm.2010.06.156
1052. Wu, T., Chen, W., Zhong, Y., Hou, X., Fang, S., Liu, C., Wang, G., Yu, T., Huang, Y., Ouyang, X., Li, H. Q., Cui, L., & Yang, Y. (2023). Supplementary Fig.1 from Nuclear Export of Ubiquitinated Proteins Determines the Sensitivity of Colorectal Cancer to Proteasome Inhibitor. https://doi.org/10.1158/1535-7163.22507986
1053. Wu, T., Chen, W., Zhong, Y., Hou, X., Fang, S., Liu, C., Wang, G., Yu, T., Huang, Y., Ouyang, X., Li, H. Q., Cui, L., & Yang, Y. (2023). Supplementary Fig.1 from Nuclear Export of Ubiquitinated Proteins Determines the Sensitivity of Colorectal Cancer to Proteasome Inhibitor. https://doi.org/10.1158/1535-7163.22507986.v1
1054. Wu, X., Niu, N., Brismar, K., Zhu, X., Wang, X., Efendić, S., Du, T., Liu, Y., Gu, H. F., & Liu, Y. (2008). Apolipoprotein M promoter polymorphisms alter promoter activity and confer the susceptibility to the development of type 1 diabetes. Clinical Biochemistry. https://doi.org/10.1016/j.clinbiochem.2008.10.008
1055. Wu, Z., Cai, X., Zhang, X., Liu, Y., Tian, G., Yang, J., & Chen, X. (2021). Expression level is a major modifier of the fitness landscape of a protein coding gene. Nature Ecology & Evolution. https://doi.org/10.1038/s41559-021-01578-x
1056. Wulf, G. M. (2022). Mass Spec Data for Fig. 5A olaparib. Figshare. https://doi.org/10.6084/m9.figshare.20640090
1057. Wuyts, W., Schmale, G. A., Chansky, H. A., & Raskind, W. H. (2020). Table 1. [Molecular Genetic Testing Used in Hereditary Multiple Osteochondromas]..
1058. Xie, B., Dashevsky, D., Rokyta, D. R., Ghezellou, P., Fathinia, B., Shi, Q., Richardson, M. K., & Fry, B. G. (2022). Additional file 1 of Dynamic genetic differentiation drives the widespread structural and functional convergent evolution of snake venom proteinaceous toxins. Figshare. https://doi.org/10.6084/m9.figshare.18070661
1059. Xie, B., Dashevsky, D., Rokyta, D. R., Ghezellou, P., Fathinia, B., Shi, Q., Richardson, M. K., & Fry, B. G. (2022). Additional file 28 of Dynamic genetic differentiation drives the widespread structural and functional convergent evolution of snake venom proteinaceous toxins. Figshare. https://doi.org/10.6084/m9.figshare.18070688
1060. Xie, C., Wang, F., Sang, Y., Chen, B., Huang, J.-H., He, F.-J., Li, H., Zhu, Y., Liu, X., Zhuang, S., & Fang, J. (2023). Supplementary Data from Mitochondrial Micropeptide STMP1 Enhances Mitochondrial Fission to Promote Tumor Metastasis. https://doi.org/10.1158/0008-5472.22431981
1061. Xie, C., Wang, F., Sang, Y., Chen, B., Huang, J.-H., He, F.-J., Li, H., Zhu, Y., Liu, X., Zhuang, S., & Fang, J. (2023). Supplementary Data from Mitochondrial Micropeptide STMP1 Enhances Mitochondrial Fission to Promote Tumor Metastasis. https://doi.org/10.1158/0008-5472.22431981.v1
1062. Xu, C., Zhu, H., & Qiu, P. (2019). MOESM1 of Aging progression of human gut microbiota. Figshare. https://doi.org/10.6084/m9.figshare.10071116
1063. Xu, C., Zhu, H., & Qiu, P. (2019). MOESM3 of Aging progression of human gut microbiota. Figshare. https://doi.org/10.6084/m9.figshare.10071131
1064. Xu, J., Zhang, B., Cai, J., Peng, Q., Hu, J., Askar, P., Shangguan, J., Su, W., Zhu, C., Sun, H., Zhou, S., Chen, G., Yang, X., & Gu, Y. (2023). Additional file 4 of The transcription factor Stat-1 is essential for Schwann cell differentiation, myelination and myelin sheath regeneration. Figshare. https://doi.org/10.6084/m9.figshare.23583634
1065. Xu, X. M., Wang, J., Xuan, Z., Goldshmidt, A., Borrill, P., Hariharan, N., Kim, J. Y., & Jackson, D. (2011). Chaperonins Facilitate KNOTTED1 Cell-to-Cell Trafficking and Stem Cell Function. Science. https://doi.org/10.1126/science.1205727
1066. Yadav, S. K., ARCHANA, A., Singh, R., Singh, P. K., & Vasudev, P. G. (2019). Insecticidal fern protein Tma12 is possibly a lytic polysaccharide monooxygenase.. Planta. https://doi.org/10.2210/pdb6if7/pdb
1067. Yadav, S. K., Karthik, K., Mahadevappa, M., & Das, S. (2024). Atorvastatin-based nanoparticle-decorated glyceryl monostearate as a targeted drug carrier for inhibition of atherosclerosis lesions. New Journal of Chemistry. https://doi.org/10.1039/d4nj01322k
1068. Yahata, N., & Inoue, H. (2020). Induced Pluripotent Stem Cell. Definitions. https://doi.org/10.32388/s3h77c
1069. Yamamoto, T., Kano, K., Masuoka, S., Emiko, S., Soichi, Y., Kawazoe, M., Satō, H., Makoto, K., Shigeru, M., Tanaka, N., Kaichi, K., Kawai, S., & Nanki, T. (2017). Folylpolyglutamate synthase遺伝子多型は細胞内メトトレキサートのポリグルタメート化に影響し,また民族差を有する. 日本リウマチ学会総会・学術集会プログラム・抄録集.
1070. Yamamura, Y., Kawamura, Y., Oiwa, Y., Oka, K., Onishi, N., Saya, H., & Miura, K. (2021). Additional file 1 of Isolation and characterization of neural stem/progenitor cells in the subventricular zone of the naked mole-rat brain. Figshare. https://doi.org/10.6084/m9.figshare.16911243
1071. Yan, T., Ren, L., Shen, C., Wang, Z., Yu, Y.-N., Liang, Q., Tang, J., Chen, Y., Sun, D., Zgodziński, W., Majewski, M., Radwan, P., Kryczek, I., Zhong, M., Chen, J., Liu, Q., Zou, W., Chen, H., Hong, J., & Fang, J. (2023). Supplementary Figure Legends from miR-508 Defines the Stem-like/Mesenchymal Subtype in Colorectal Cancer. https://doi.org/10.1158/0008-5472.22417241
1072. Yan, T., Ren, L., Shen, C., Wang, Z., Yu, Y.-N., Liang, Q., Tang, J., Chen, Y., Sun, D., Zgodziński, W., Majewski, M., Radwan, P., Kryczek, I., Zhong, M., Chen, J., Liu, Q., Zou, W., Chen, H., Hong, J., & Fang, J. (2023). Supplementary Figure Legends from miR-508 Defines the Stem-like/Mesenchymal Subtype in Colorectal Cancer. https://doi.org/10.1158/0008-5472.22417241.v1
1073. Yancey, K. B., Lazarova, Z., Anhalt, G. J., Gammon, W. R., Briggaman, R. A., Welch, M., Huff, C., & Domloge‐Hultsch, N. (1993). Autoantibodies to epiligrin are a specific marker for a unique form of cicatricial pemphigoid (CP). Journal of Dermatological Science. https://doi.org/10.1016/0923-1811(93)90946-m
1074. Yang, A., Rajeshkumar, N., Wang, X., Yabuuchi, S., Alexander, B. M., Chu, G. C., Hoff, D. D. V., Maitra, A., & Kimmelman, A. C. (2023). Supplementary Table 1 from Autophagy Is Critical for Pancreatic Tumor Growth and Progression in Tumors with p53 Alterations. https://doi.org/10.1158/2159-8290.22529540.v1
1075. Yang, B., Jiang, Y., Yang, J., Zhou, W., Yang, T., Zhang, R., Xu, J., & Guo, H. (2023). Additional file 1 of Characterization of metabolism-associated molecular patterns in prostate cancer. Figshare. https://doi.org/10.6084/m9.figshare.23304952
1076. Yang, I., Oh, S. Y., Jang, S., Kim, I. Y., Sung, Y. M., & Seong, J. K. (2022). <i>Mettl14</i> mutation restrains liver regeneration by attenuating mitogens derived from non-parenchymal liver cells. BMB Reports. https://doi.org/10.5483/bmbrep.2022.55.12.140
1077. Yang, J., Price, M. A., Li, G. Y., Bar‐Eli, M., Salgia, R., Jagedeeswaran, R., Carlson, J., Ferrone, S., Turley, E. A., & McCarthy, J. B. (2023). Supplementary Figure 1 from Melanoma Proteoglycan Modifies Gene Expression to Stimulate Tumor Cell Motility, Growth, and Epithelial-to-Mesenchymal Transition. https://doi.org/10.1158/0008-5472.22378815
1078. Yang, J., Price, M. A., Li, G. Y., Bar‐Eli, M., Salgia, R., Jagedeeswaran, R., Carlson, J., Ferrone, S., Turley, E. A., & McCarthy, J. B. (2023). Supplementary Figure 1 from Melanoma Proteoglycan Modifies Gene Expression to Stimulate Tumor Cell Motility, Growth, and Epithelial-to-Mesenchymal Transition. https://doi.org/10.1158/0008-5472.22378815.v1
1079. Yang, Y., & Li, G. (2020). Additional file 1 of Post-translational modifications of PRC2: signals directing its activity. Figshare. https://doi.org/10.6084/m9.figshare.13173719
1080. Yang, Z., Zhang, J., Jiang, D., Khatri, P., Solow-Cordero, D. E., Toesca, D. A., Koumenis, C., Denko, N., Giaccia, A. J., Le, Q., & Koong, A. C. (2023). Supplementary Table S4 from A Human Genome-Wide RNAi Screen Reveals Diverse Modulators that Mediate IRE1α–XBP1 Activation. https://doi.org/10.1158/1541-7786.22512718
1081. Yang, Z., Zhang, J., Jiang, D., Khatri, P., Solow-Cordero, D. E., Toesca, D. A., Koumenis, C., Denko, N., Giaccia, A. J., Le, Q., & Koong, A. C. (2023). Supplementary Table S4 from A Human Genome-Wide RNAi Screen Reveals Diverse Modulators that Mediate IRE1α–XBP1 Activation. https://doi.org/10.1158/1541-7786.22512718.v1
1082. Yao, L., Qin, Y., King, E., Buddavarapu, K., Chocrón, E. S., Lechleiter, J. D., Aronin, N., Sass, M., Schiavi, F., Opocher, G., Toledo, R. A., Toledo, S. P. A., Stiles, C. D., Aguiar, R. C., & Dahia, P. L. M. (2010). <i>FP/TMEM127</i>is a Novel Pheochromocytoma Susceptibility Gene.. https://doi.org/10.1210/endo-meetings.2010.part3.or1.or20-6
1083. Ye, X., Huang, X., Fu, X., Zhang, X., Lin, R., Zhang, W., Zhang, J., & Lü, Y. (2023). Additional file 1 of Myeloid-like tumor hybrid cells in bone marrow promote progression of prostate cancer bone metastasis. Figshare. https://doi.org/10.6084/m9.figshare.22757268
1084. Yeremenko, N., Polzer, K., Noordenbos, T., Zwerina, J., Tak, P. P., Schett, G., & Baeten, D. (2009). F.131. DKK-1, a Master Regulator of Bone Remodelling, is Abundantly Expressed in Peripheral Inflammatory Arthritis. Clinical Immunology. https://doi.org/10.1016/j.clim.2009.03.381
1085. Yi, C., & VanHook, A. M. (2014). <i>Science Signaling</i> Podcast: 6 May 2014. Science Signaling. https://doi.org/10.1126/scisignal.2005400
1086. Yi, L., Lu, C.-W., Hu, W., Sun, Y., & Levine, A. J. (2023). Supplementary Figure Legends 1-3 from Multiple Roles of p53-Related Pathways in Somatic Cell Reprogramming and Stem Cell Differentiation. https://doi.org/10.1158/0008-5472.22395260
1087. Yi, L., Lu, C.-W., Hu, W., Sun, Y., & Levine, A. J. (2023). Supplementary Figure Legends 1-3 from Multiple Roles of p53-Related Pathways in Somatic Cell Reprogramming and Stem Cell Differentiation. https://doi.org/10.1158/0008-5472.22395260.v1
1088. Yi, Y., Huang, X., Lynn, K. D., & Thorpe, P. E. (2023). Supplementary Figure Legend from Phosphatidylserine-Targeting Antibody Induces M1 Macrophage Polarization and Promotes Myeloid-Derived Suppressor Cell Differentiation. https://doi.org/10.1158/2326-6066.22535974
1089. Yi, Y., Huang, X., Lynn, K. D., & Thorpe, P. E. (2023). Supplementary Figure Legend from Phosphatidylserine-Targeting Antibody Induces M1 Macrophage Polarization and Promotes Myeloid-Derived Suppressor Cell Differentiation. https://doi.org/10.1158/2326-6066.22535974.v1
1090. Yoshida, T., Sakamoto, H., Miyagawa, K., Odagiri, H., & Terada, M. (1988). [Studies on hst, a transforming gene which belongs to a new superfamily of growth factors].. PubMed.
1091. You, H., & Lu, B. (2023). Diverse Functions of Multiple Bdnf Transcripts Driven by Distinct Bdnf Promoters. Biomolecules. https://doi.org/10.3390/biom13040655
1092. Yousefi, S., Deng, R., Lanko, K., Salsench, E. M., Nikoncuk, A., Linde, H. C. V. D., Perenthaler, E., Ham, T. J. V., Mulugeta, E., & Barakat, T. S. (2021). Additional file 12 of Comprehensive multi-omics integration identifies differentially active enhancers during human brain development with clinical relevance. Figshare. https://doi.org/10.6084/m9.figshare.16829110
1093. Yousefi, S., Deng, R., Lanko, K., Salsench, E. M., Nikoncuk, A., Linde, H. C. V. D., Perenthaler, E., Ham, T. J. V., Mulugeta, E., & Barakat, T. S. (2021). Additional file 13 of Comprehensive multi-omics integration identifies differentially active enhancers during human brain development with clinical relevance. Figshare. https://doi.org/10.6084/m9.figshare.16829116
1094. Yousefi, S., Deng, R., Lanko, K., Salsench, E. M., Nikoncuk, A., Linde, H. C. V. D., Perenthaler, E., Ham, T. J. V., Mulugeta, E., & Barakat, T. S. (2021). Additional file 6 of Comprehensive multi-omics integration identifies differentially active enhancers during human brain development with clinical relevance. Figshare. https://doi.org/10.6084/m9.figshare.16829164
1095. Yu, Y., Scheel, T. K. H., Luna, J. M., Chung, H., Nishiuchi, E., Scull, M. A., Echeverría, N., Ricardo-Lax, I., Kapoor, A., Lipkin, W. I., Divers, T. J., Antczak, D. F., Tennant, B. C., & Rice, C. M. (2018). Correction: miRNA independent hepacivirus variants suggest a strong evolutionary pressure to maintain miR-122 dependence. PLoS Pathogens. https://doi.org/10.1371/journal.ppat.1007303
1096. Zan, E. D., Stiphout, R. V., Gapp, B. V., Blomen, V. A., Brummelkamp, T. R., & Nijman, S. M. (2020). Quantitative genetic screening reveals a Ragulator-FLCN feedback loop that regulates the mTORC1 pathway. Science Signaling. https://doi.org/10.1126/scisignal.aba5665
1097. Zarbl, H., Latreille, J., & Jolicoeur, P. (1987). Revertants of v-fos-transformed fibroblasts have mutations in cellular genes essential for transformation by other oncogenes. Cell. https://doi.org/10.1016/0092-8674(87)90632-5
1098. Zeibig, J., Karlic, H., Lohninger, A., Damsgaard, R., & Smekal, G. (2005). Do blood cells mimic gene expression profile alterations known to occur in muscular adaptation to endurance training ?. European Journal of Applied Physiology. https://doi.org/10.1007/s00421-005-1405-5
1099. Zhan, H., Tang, W., Liang, Z., Chen, Q., Li, M., Li, Y., Lao, S., Pan, H., Huang, L.-Y., Huang, M., Hu, X., & Zhao, J. (2017). Plasminogen Activator Inhibitor-1 Polymorphism Confers a Genetic Contribution to the Risk of Recurrent Spontaneous Abortion: An Updated Meta-Analysis. Reproductive Sciences. https://doi.org/10.1177/1933719117702013
1100. Zhang, B., Gojo, I., & Fenton, R. G. (2002). Myeloid cell factor–1 is a critical survival factor for multiple myeloma. Blood. https://doi.org/10.1182/blood.v99.6.1885
1101. Zhang, J., Chen, S., Zhang, W., Zhang, J., Liu, X., Shi, H. Y., Che, H., Wang, W., Li, F., & Yao, L. (2008). Human differentiation-related gene NDRG1 is a Myc downstream-regulated gene that is repressed by Myc on the core promoter region. Gene. https://doi.org/10.1016/j.gene.2008.03.002
1102. Zhang, J., Tian, Q., Sakagami, H., Kondo, H., Endo, S., & Suzuki, T. (2005). p55 protein is a member of PSD scaffold proteins in the rat brain and interacts with various PSD proteins. Molecular Brain Research. https://doi.org/10.1016/j.molbrainres.2004.12.023
1103. Zhang, L., Maalouf, A., Makri, S. C., Banerjee, J., Suru, A., Tam, A., Calizo, A., Pollard, K., Wang, J., Danilova, L., Ioannou, M., Levin, A. S., Morris, C. D., Rhee, D. S., Belzberg, A. J., Blakeley, J. O., Ladle, B. H., Pardoll, D. M., Lucas, C. G., ... Llosa, N. J. (2024). Supplementary Figure 4 from Multidimensional Immunotyping of Human NF1-Associated Peripheral Nerve Sheath Tumors Uncovers Tumor-Associated Macrophages as Key Drivers of Immune Evasion in the Tumor Microenvironment. https://doi.org/10.1158/1078-0432.27938397
1104. Zhang, M., Jang, H., & Nussinov, R. (2020). PI3K inhibitors: review and new strategies. Chemical Science. https://doi.org/10.1039/d0sc01676d
1105. Zhang, R., Liu, T., Senju, S., Haruta, M., Hirosawa, N., Suzuki, M., Tatsumi, M., Ueda, N., Maki, H., Nakatsuka, R., Matsuoka, Y., Sasaki, Y., Tsuzuki, S., Nakanishi, H., Araki, R., Abe, M., Akatsuka, Y., Sakamoto, Y., Sonoda, Y., ... Uemura, Y. (2023). Supplementary Figure Legends from Generation of Mouse Pluripotent Stem Cell–Derived Proliferating Myeloid Cells as an Unlimited Source of Functional Antigen-Presenting Cells. https://doi.org/10.1158/2326-6066.22538455.v1
1106. Zhang, R., Yan, K., Wu, Y., Yao, X., Li, G., Ge, L., & Chen, Z. (2021). Additional file 1 of Quantitative proteomics reveals the effect of Yigu decoction (YGD) on protein expression in bone tissue. Figshare. https://doi.org/10.6084/m9.figshare.16800593
1107. Zhang, S., Liu, X., Liu, Z., Wang, Y., Hu, Q., Ma, T.-Z., & Sun, S.-Z. (2009). Stem cells modified by brain-derived neurotrophic factor to promote stem cells differentiation into neurons and enhance neuromotor function after brain injury.. PubMed.
1108. Zhang, S., Wang, M., Feng, J.-R., Chang, Y., Ji, S., & Wu, Y. (2020). Author response: Reversible promoter methylation determines fluctuating expression of acute phase proteins. https://doi.org/10.7554/elife.51317.sa2
1109. Zhang, X., Ma, S., Naz, S. I., Soderblom, E. J., Aliferis, C., & Kraus, V. B. (2024). Plasma extracellular vesicles carry immune system-related peptides that predict human longevity. GeroScience. https://doi.org/10.1007/s11357-024-01454-z
1110. Zhang, Y., Lu, Y., Yuan, B.-Z., Castranova, V., Shi, X., Stauffer, J. L., Demers, L. M., & Chen, F. (2005). The Human mineral dust-induced gene, mdig, is a cell growth regulating gene associated with lung cancer. Oncogene. https://doi.org/10.1038/sj.onc.1208668
1111. Zhang, Y., Martens, J. W., Yu, J. X., Jiang, J. N., Sieuwerts, A. M., Smid, M., Klijn, J. G., Wang, Y., & Foekens, J. A. (2023). Supplementary Figure 1 from Copy Number Alterations that Predict Metastatic Capability of Human Breast Cancer. https://doi.org/10.1158/0008-5472.22379823
1112. Zhang, Y., Martens, J. W., Yu, J. X., Jiang, J. N., Sieuwerts, A. M., Smid, M., Klijn, J. G., Wang, Y., & Foekens, J. A. (2023). Supplementary Figure 1 from Copy Number Alterations that Predict Metastatic Capability of Human Breast Cancer. https://doi.org/10.1158/0008-5472.22379823.v1
1113. Zhang, Y., Martens, J. W., Yu, J. X., Jiang, J. N., Sieuwerts, A. M., Smid, M., Klijn, J. G., Wang, Y., & Foekens, J. A. (2023). Supplementary Table 1 from Copy Number Alterations that Predict Metastatic Capability of Human Breast Cancer. https://doi.org/10.1158/0008-5472.22379811
1114. Zhang, Y., Martens, J. W., Yu, J. X., Jiang, J. N., Sieuwerts, A. M., Smid, M., Klijn, J. G., Wang, Y., & Foekens, J. A. (2023). Supplementary Table 1 from Copy Number Alterations that Predict Metastatic Capability of Human Breast Cancer. https://doi.org/10.1158/0008-5472.22379811.v1
1115. Zhao, X., Lü, L., Pokhriyal, N., Ma, H., Duan, L., Lin, S., Jafari, N., Band, H., & Band, V. (2023). Supplementary Figure Legends 1-4 from Overexpression of RhoA Induces Preneoplastic Transformation of Primary Mammary Epithelial Cells. https://doi.org/10.1158/0008-5472.22377840.v1
1116. Zhao, X., Wang, C., Wang, Y., Lin, H., Wang, H., Hu, H., & Wang, J. (2019). MOESM1 of Comparative gene expression profiling of muscle reveals potential candidate genes affecting drip loss in pork. Figshare. https://doi.org/10.6084/m9.figshare.11308478
1117. Zhen-huan, Z. (2014). PA1(PTIP associated protein1)は,乳癌において独立した予後因子である。. 日本乳癌学会学術総会プログラム・抄録集.
1118. Zheng, B., Liao, Z., Locascio, J. J., Lesniak, K. A., Roderick, S. S., Watt, M. L., Eklund, A. C., Zhang‐James, Y., Kim, P. D., Hauser, M. A., Grünblatt, E., Moran, L., Mandel, S., Riederer, P., Miller, R. M., Federoff, H. J., Wüllner, U., Papapetropoulos, S., Youdim, M. B. H., ... Scherzer, C. R. (2010). <i>PGC-1</i> α, A Potential Therapeutic Target for Early Intervention in Parkinson’s Disease. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.3001059
1119. Zhou, C., Wei, Z., Zhang, Z., Zhang, B., Zhu, C., Chen, K., Chuai, G., Qü, S., Xie, L., Gao, Y., & Liu, Q. (2019). MOESM5 of pTuneos: prioritizing tumor neoantigens from next-generation sequencing data. Figshare. https://doi.org/10.6084/m9.figshare.10094366
1120. Zhou, J., Zhang, W., Wei, C., Zhang, Z., Yi, D., Peng, X., Peng, J., Yin, R., Zheng, Z., Qi, H., Wei, Y., & Wen, T. (2020). Additional file 1 of Weighted correlation network bioinformatics uncovers a key molecular biosignature driving the left-sided heart failure. Figshare. https://doi.org/10.6084/m9.figshare.12610430
1121. Zhu, W., Lönnblom, E., Förster, M., Johannesson, M., Tao, P., Meng, L., Lu, S., & Holmdahl, R. (2020). Natural polymorphism of Ym1 regulates pneumonitis through alternative activation of macrophages. Science Advances. https://doi.org/10.1126/sciadv.aba9337
1122. Zou, D., Dong, L., Li, C., Yin, Z., Rao, S., & Zhou, Q. (2020). Correction to: The m6A eraser FTO facilitates proliferation and migration of human cervical cancer cells. Cancer Cell International. https://doi.org/10.1186/s12935-020-01473-8
1123. Zu, H.-Y., Qu, Z., Ren, J., Chen, X., & Du, J.-Z. (2014). [Hypoxia change the gene expression of insulin-like growth factors family in rat prefrontal cortex].. PubMed.
1124. Аleksandr, A., Anna, N., & Dmytro, N. (2023). Single Nucleotide Variants of the PNPLA3 Gene are Important Genetic Modifiers for the Progression of Metabolically Unhealthy Obesity in Children. Metabolism. https://doi.org/10.1016/j.metabol.2023.155450